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PREFACE 
Many real and potential hazards will face astronauts’ during operations 
in space. Some of these hazards might be of little medical significance; 
others might produce serious medical problems. 
In this report, an attempt is made to describe the characteristics 
and suggest the management in space of possible medical problems which 
might arise from hazards of space operations; attention will therefore 
not be given to possible naturally-occurring diseases. Writing is oriented 
to missions during which, due to the time required to return to Earth, 
the diagnosis and interim treatment of medical problems will have to be 
carried out in space. Therefore it is assumed in this report that diagnostic 
and treatment facilities will be available, and that advanced spacecraft 
concerned will provide a “shirtsleeve” environment in. which multidisciplined 
crews, including medically-trained personnel, will be able to live in 
reasonable comfort. 
To lay the groundwork of Clinical Space Medicine, a field in which 
very little has been written and no experience gained to date, this report 
covers more than just the clinical manifestations, diagnosis, and treat- 
ment of possible medical problems in space. Wherever necessary, 
various hazards of space operations are defined and analysed in order to 
determine their possible medical effects. The pathophysiologic 
characteristics of medical problems are discussed, frequently in detail, 
to provide the rationale for the prevention and treatment of the problems 
in space. Many pertinent basic medical facts are stated not only to 
refresh memories of physicians not actively engaged in the practice of 
medicine, but also to familiarize non-medical readers, such as design 
engineers and operations analysts with the cause, natural history and 
performance impairment to be expected of each medical problem. An 
effort is also made to provide a substantial bibliography for workers in 
Clinical Space Medicine and to identify areas of research which will contribute 
to this field. 
::: 
“a traveller in interplanetary space” (Webster’s New International 
Dictionary, Second Edition, 1934) 
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This report focuses on the primary goals of Clinical Space Medicine - 
namely to prevent the occurrence of medical problems in space and to 
restore an astronaut who is suffering from a medical problem to an 
optimum functional capability as quickly as possible. It is conceivable, 
however, that an astronaut might have to forego definitive treatment 
temporarily while he performs a task vital to mission safety or success. 
During this period of time, his symptoms might be alleviated with 
supportive measures. 
The first five chapters of this report are concerned with the various 
effects of decompression an astronaut could suffer. Medical problems 
which could result from thermal stresses are discussed in Chapters 6 
and 7. Possible medical consequences of weightlessness are considered 
in Chapters 8, 9 and 10, and those of “particles” travelling in space in 
Chapters 11 and 12. Various traumatic injuries receive attention in 
Chapters 13 and 14. Medical problems produced by carbon dioxide, 
which will always be the major gaseous contaminant of space atmospheres, 
are reviewed in Chapter 15. Since the risks of oxygen toxicity and chronic 
exposure to trace atmospheric contaminants should be virtually eliminated 
in advanced space systems, these medical problem areas will not be 
discussed in this report. Finally, Chapter 16 gives consideration to the 
general aspects of the diagnosis and treatment of medical problems in space. 
I am most grateful to Drs. A. H. Schwichtenberg, E. M. Roth and 
T. M. Fraser of the Department of.Aerospace Medicine, The Lovelace 
Foundation for Medical Education and Research, for their many constructive 
comments which greatly assisted me in the preparation of this report. The 
many contributions of Dr. U. C. Luft of the Department of Physiology are 
also acknowledged. Gratitude is also expressed to my secretaries, 
Mrs. J. H. Rigler and Mrs. J. J. Whalon, and to our Chief Document 
Librarian, Mrs. J. Wilson, and her staff for their immense help. 
D. E. B. 
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CHAPTER 1 
ACUTE HYPOXIA 
A rapid unforeseen loss of the atmospheric pressure in a space- 
craft cabin or space suit, leading to manifestations of acute hypoxia, 
possibly ebullism (Chapter 2) and explosive decompression injuries 
(Chapter 3), will undoubtedly always be a major hazard facing astronauts 
during operations in space. Any number of causes of such a critical event 
are conceivable. Considered foremost is penetrating damage to a space 
suit, possibly from contact with rugged terrain on a lunar or planetary 
surface, a pointed tool, a sharp projection from the spacecraft exterior, 
or a meteoroid. Decompression of the spacecraft cabin might result from 
a structural failure due to an excessive spacecraft docking or landing im- 
pact, or from penetration of a cabin wall by a meteoroid. Other po s sible 
causes of acute hypoxia include an accidental disconnect or failure of a 
pressure valve in a life support system, and an emergency decompression 
for fire extinguishment or for removal of a toxic atmospheric contaminant. 
Finally, acute hypoxia could result from depletion of oxygen supplied by 
a portable life support system, or from the purging of a spacecraft 
cabin atmosphere with carbon dioxide or inert gas to extinguish a fire. 
In this chapter, an attempt is made to present aspects of acute 
hypoxia considered pertinent to the space situation. Under separate 
headings are discussed the sequence of clinical events which would occur 
during a severe acute hypoxic exposure in space, various measures 
which might be used in resuscitating a hypoxic astronaut, the so-called 
“oxygen par adox”, and the characteristics and management in space of 
the sequelae of hypoxia - posthypoxic cerebral edema and delayed post- 
hypoxic encephalopathy. 
Clinical Events in Acute Hypoxia 
In their excellent review of the literature on hypoxia, Van Liere and 
Stickney (96) made note of the fact that all tissues of the body are im- 
mediately affected to some degree when a rapid significant reduction of 
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the partial pressure of inspired oxygen occurs. However the remarkable 
intolerance of the central nervous system, especially the brain to 
oxygen deprivation, accounts for the earliest and most striking manifesta- 
tions of acute hypoxia (8) . 
If an astronaut should suffer acute hypoxia, he could lose “useful 
consciousness” after a latent period of several seconds to many minutes. 
The term “useful consciousness” has been used to define that period 
during which purposeful acts can still be performed (98) . It is noted 
that the slower the onset of hypoxia, the more specific must be the 
definition of the performance degradation which reflects loss of “useful 
(78) consciousness” . 
A hypoxic astronaut’s “time of useful consciousness” will depend 
upon the rate of reduction and the final level of the partial pressure of 
oxygen in his ambient atmosphere. During this period, the astronaut 
should be able to function normally, so that if he recognizes the cause 
of a hypoxic event, he should be capable of initiating a life- saving emer- 
gency measure or declaring his situation to other members of the crew. 
Once beyond the “time of useful consciousness”, however, he could 
either enter a brief “prodromal period”, which is usually characterized 
by a high degree of helplessness, or suddenly lapse into unconsciousness. 
The results of numerous decompression studies indic’ate that the 
“time of useful consciousness” of an astronaut who is rapidly decompressed 
to a relatively low partial pressure of oxygen should be reasonably pre- 
dictable (4, 5, 7, 10, 22, 41, 66, ‘7, 76, 78, 101) It is noted that 
there is a marked variation in individual susceptibility to acute hypoxia, 
except at relatively high altitudes (7) . Data on the mean “times of useful 
consciousness ” following rapid decompressions of humans who are 
breathing either air or oxygen throughout decompression are shown in 
Figure 1. 1. The curves in this figure demonstrate that: 
-the “time of useful consciousness” becomes 
shorter with increasing altitude until a minimum 
time is reached. From data cited by Luft (64, 66)) 
this time appears to vary from about 10 to 15 seconds. 
It is reached at about 46,,000 feet (106 mm Hg or 2. 04 
psia) when air is breathed throughout decompression, 
2 
or about 52,000 feet (79 mm Hg or 1.53 psia) 
when oxygen is breathed throughout decompression (93) . 
Notably, the “time of useful consciousness” remains 
unchanged for decompressions above 52,000 feet 
whatever the concentration of oxygen in the inspired 
gas might be. 
-below 50,000 feet, the use of pure oxygen delays 
the onset of unconsciousness considerably, so that 
in decompressions to 45,000 feet breathing oxygen, 
“useful consciousness” may be fully maintained for 
many minutes while breathing air under the same 
circumstances leaves little more than 10 seconds 
for emergency action. The difference in shape be- 
tween the two curves can be attributed to the presence 
of nitrogen in the air-breathing decompr es sions. 
30,000 - BREATHING AIR - 4.36 225.6 
20,000 ’ ’ ’ I-- l I I 
0 2 3 
6.75 
4 
349.1 
5 6 
Minutes 
Figure 1. 1 “Times of useful consciousness” on 
exposure to various high altitudes after 
rapid decompression, accomplished in 
less than one second. from sea level 
breathing 100 per cent oxygen. 
(After Luft (65)) . 
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Decompression studies have also demonstrated that there is a 
“critical time of exposure ” within which an individual must recommence 
breathing an adequate partial pressure of oxygen if “useful conscious- 
ness” is to be continuously preserved (3, 4, 66, 7’) This time . 
apparently also reaches a minimum with increasing altitude. Bryan 
and Leach (lo) found that oxygen had to be given within 7 set to subjects 
decompressed from 8,000 feet (564 mm Hg or 10.91 psia) to 40,000 feet 
(141 mm Hg or 2.72 psia) in 2. 5 set in order to preserve continuous 
consciousness. The average “time of useful consciousness” in their 
studies was 15 sec. Luft and co-workers (66) , noted that the “critical 
time of exposure” should not exceed 5 to 6 set in rapid decompressions 
(2 set) to altitudes above 52, 000 feet (79 mm Hg or 1. 53 psia). Their 
subjects lost “useful consciousness ” 15 to 17 set after decompression. 
Since the “time of useful consciousness” and the “critical time of 
exposure ” for maintenance of consciousness of an astronaut who is 
rapidly decompressed to a low partial pressure of oxygen appear to 
be reasonably predictable, such information could be of great value if 
applied to the handling of unanticipated and controlled decompressions 
in space. If an unanticipated decompression of a space suit or space- 
craft cabin should occur, an automatic emergency oxygen supply system 
might keep the suit or cabin pressure at a level which will not only be 
associated with a minimum loss of oxygen, but will also maintain “useful 
consciousness” for a reasonable period of time while an astronaut carries 
out emergency measures such as sealing a leak, returning to the space- 
craft, or donning a space suit. A controlled decompression with an 
astronaut remaining “usefully conscious ” throughout the decompression 
might be a practical emergency procedure under certain circumstances. 
For example, an astronaut might reduce his space suit pressure to 
give himself enough mobility to negotiate an obstacle or to release him- 
self from a trapped situation. A controlled reduction of the cabin 
pressure might be used to dump into space most of an atmosphere 
accidentally contaminated with chemically-active particles and droplets. 
This measure might also be used for extinguishing a fire and, secondarily, 
for its cooling effect and removal of noxious fumes from the cabin 
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atmosphere. It must be noted, however, that rapid permanent extinguish- 
ment of a fire can be attained only by decompressing to a vacuum until 
the temperature of a burning system is below ignition temperature. 
Thus an astronaut, who will undoubtedly not have time to don a space 
suit prior to decompression for fire extinguishment, may experience 
the consequences of both hypoxia and ebullism (Chapter 2). If the 
spacecraft cabin atmosphere contains an inert gas, he will be subjected 
to a risk of decompression sickness (Chapter 4). It is assumed that if 
any controlled decompression produces a loss of consciousness, recom- 
pression will be programmed to occur within a time period sufficient 
to prevent sequelae of hypoxia and possibly ebullism. 
Additional data, particularly on “time of useful consciousness”, 
should be obtained in decompression experiments which closely simulate 
situations in which acute hypoxia might occur in space. Decompressions 
at various rates and to various partial pressures of oxygen should be 
carried out from anticipated space suit and spacecraft cabin atmospheres. 
Finally it is pointed out that “time of useful consciousnessl’ data should 
be obtained on individuals performing under various work loads which 
could be associated with space suit operations. 
Depending on the rate of the decompression and the final partial 
pressure of oxygen reached, loss of consciousness from hypoxia may 
or may not be preceded by a “prodromal period”, the characteristics 
of which are presented below. From the decompression studies cited 
above, it can be concluded that unconsciousness will usually occur 
with startling suddenness, preceded by virtually no subjective or 
obj ective symptoms, following decompression on air to 46,000 feet 
(106 mm Hg or 2.04 psia) and above, or following decompressions on 
oxygen to 52,000 feet (79 mm Hg or 1. 53 psia) and above. Occasionally, 
a “prodromal period”, which can last about 3 set, immediately precedes 
loss of consciousness following such decompressions. This relatively 
short period is characterized by amnesia and uncoordinated or clonic 
movements. 
As the rate of decompression decreases or the final partial pressure 
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of oxygen increases, the “prodromal period” will increase in duration. 
The common, well documented manifestations of hypoxia at this point 
are predominantly due to central nervous system malfunction, character- 
ized by aberrations of mental function, such as errors in and loss of 
interpretation and judgment, overconfidence, confusion, euphoria, 
drowsiness, paranoia and amnesia, and of neuromuscular activity, 
such as incoordination and clonic movements 
(41, 64, 67, 72) 
. 
The question arises as to whether manifestations of acute hypoxia, 
especially during a relatively prolonged prodromal period, could be 
recognized by an astronaut exposed to hypoxic conditions. If so, he 
might possibly be able to initiate appropriate emergency measures or 
signal the incident to other members of the crew. Classically, most 
individuals are unable to recognize subjectively any manifestations of 
acute hypoxia. On repeated hypoxic exposures and with adequate train- 
ing , some do learn to recognize hypoxia if it comes on slowly. However, 
it is apparent that such a capability cannot be relied upon during 
operations in space, especially if hypoxia is of rapid onset or the attention 
of an astronaut is focused on a seemingly more important matter at 
the time of a hypoxic event. Therefore, even though astronauts should 
be well trained in this area, primary reliance will have to be placed on 
devices which sense and adequately warn of changes of the partial pressures 
of oxygin in spacecraft cabin and space suit atmospheres and, wherever 
possible, command the restoration of an adequate oxygen tension. 
As part of a hypoxia indoctrination program, it is advisable for an 
astronaut to observe carefully the response of each fellow astronaut 
to hypoxia. Since many individuals exhibit a stereotyped response, 
such as euphoria, paranoia and drowsiness, to a lowered partial pres- 
sure of inspired oxygen, the knowledge of any manifestations which 
characterize an astronaut’s response to hypoxia might be of some value 
in recognizing and possibly in distinguishing it from other causes of 
central nervous system malfunction, such as acute carbon dioxide toxicity, 
hypothermia and hyperthermia. Even though cyanosis is a reasonably 
good sign of hypoxia, this sign will be difficult to monitor visually during 
space suit operations. Devices which sense and warn of the occurrence 
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of cyanosis might be considered, but these should be ancillary to those 
which monitor partial pressure of atmospheric oxygen. 
If exposure of an unconscious astronaut to a low partial pressure 
of oxygen continues , vital systems of his body will quite rapidly cease 
to function normally. Respiration usually fails early. Although 
peripheral circulatory collapse usually coincides with or soon follows 
cessation of respiration, some degree of cardiac activity may continue 
for a prolonged period of time. It is readily apparent that the times 
at which these events occur are related to the partial pressure of oxygen 
to which an individual is exposed. Data on humans from which these times 
might be predicted are spar se, for in human decompression experi- 
ments, exposures to low partial pressures of oxygen are stopped when 
consciousness is lost. Studies of prolonged accidental hypoxic events 
have yielded only very rough estimations of the durations of such events. 
If deprived of oxygen, man has no mechanism which will enable 
him to survive more than a very few minutes. It is a well established 
fact that serious permanent damage of brain tissues begins to occur 
about 4 minutes after arrested cerebral circulation (84, 88). This 
time might be somewhat increased in cases where the cardiovascular 
system continues to function, and so continues to supply glucose 
and other nutrients to and remove toxic metabolites from the brain (19). 
Cessation of respiration frequently occurred at the same time as 
loss of consciousness during a decompression study in which human 
subjects were decompressed in less than one second from 33,000 feet 
(196 mm Hg or 3. 80 psia) to about 55, 000 feet (69 mm Hg or 1. 33 psia) 
while breathing oxygen (11) . On the other hand, this event did not 
occur in similar studies in which individuals were exposed to altitude 
until consciousness was lost (3,43, 101) . If one assumes that 
exposure to a very low partial pressure of oxygen is essentially 
equivalent to a sudden circulatory arrest, respiration will cease within 
one minute after the exposure, cessation being preceded by stertorous 
periodic breathing (16, 43, 84) . 
It is extremely difficult to establish exact times to death for various 
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acute hypoxic exposures (6%. One study of hypoxic fatalities, in bomber 
air cr ews , estimated that after onset of exposure 22 deaths apparently 
occurred between 5 and 15 minutes, and 4 deaths in less than 5 
(11) minutes . It is noted that all these fatalities occurred at altitudes 
of less than 32, 000 feet (206 mm Hg or 3. 98 psia). Another study 
of 75 hypoxic fatalities at similar altitudes reported that the exact 
duration of exposure was known in only 6 cases, being less than 3 minutes 
in 4 cases and from 5 to 6 minutes in the other two (57) . Lewis and 
Haymaker (57) have noted that times to death appear to be much the 
same above certain altitudes. This may be. due in part to the fact 
that once breathing stops, death occurs within a few minutes irres- 
pective of the low partial pressure of oxygen to which an individual 
is exposed. Hence support of an astronaut’s respiration would be 
indicated if it does not return to normal immediately after he is exposed 
to an adequate partial pressure of oxygen. 
Events which will occur as a hypoxic individual progresses slowly 
through the unconscious period to death are similar to those occurring 
dur ing deepening ane s the s ia 
(16, 43, 54, 84) 
. One who is lightly un- 
conscious might be very difficult to manage. Restlessness, hyper- 
irritability and rigidity are characteristic. Convulsions and vomiting 
commonly occur. As unconsciousness deepens, generalized flaccidity 
gradually appears. Respiration becomes irregular, stertorous and 
finally c ea s e s . The pupils dilate. The pulse usually responds to severe 
hypoxia by becoming slower. Blood pressure increases initially, then 
decreases as both peripheral and central circulatory mechanisms fail. 
Resuscitation 
As quickly as possible, an astronaut unconscious from hypoxia must 
be exposed to as high a partial pressure of oxygen as can be attained. 
The importance of recompression as a resuscitative measure should be 
emphasized, particularly if a hypoxic astronaut is in a state of apnea. 
Recompression per se is equivalent to a deep inspiration (65). An -- 
adequate airway must be assured by measures appropriate to the situation, 
such as positioning the head with the neck in extension or inserting an oral or 
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endotracheal airway, if these specialized techniques can be carried out 
in space. If breathing does not start within or remains highly irregular 
a few seconds after oxygen is restored, artificial respiration should 
be commenced, using techniques such as exhaled air ventilation or 
intermittent positive pressure oxygen administration by mask (75) . 
Most individuals breathe unassisted, if they are to survive hypoxia, 
within the first minute after the restoration of oxygen. Continued irr e- 
gular breathing will be associated with a high probability of severe brain 
damage, and hence a poor prognosis for survival. 
Other than the restoration of oxygen, initial resuscitative measures 
which might be applied to any hypoxic individual will be determined by 
the conditions under which the hypoxic exposure occurred and by sound 
clinical judgment. A vasopressor drug, such as metaraminol, might 
be administered parenterally if hypotension continues beyond the 
immediate resuscitative period. The frequent administration of 
sodium bicarbonate and calcium gluconate solution intravenously are 
also considered primary drugs for use in this situation (34) . Unless 
“shock” might be due in part to hypovolemia, the administration of 
a blood volume expander should not be required following a purely 
hypoxic exposure. (34) Gordon believes that the early use of an intra- 
venous rapid-acting cardiac glycoside, such as digoxin, to improve 
cardiac function is contraindicated except in situations where there is 
definite evidence of cardiac decompensation. Of interest in this respect 
is the report by Webb and Haymaker (57) pointing out that pulmonary 
edema was one of the most common post mortem findings in fatalities 
from acute hypoxia at altitude (69 of 74 cases examined). Moreover, 
Holmstrom (42) points out that survivors of an acute hypoxic exposure 
at altitude not infrequently develop pulmonary edema as a serious clinical 
complication which requires special medical attention, particularly in 
cases with delayed recovery. One wonders, therefore, whether the 
routine prophylactic administration of an intravenous cardiac glycoside 
might be indicated for individuals who suffer a moderate to severe 
hypoxic exposure. By improving cardiac function, such a measure would 
combat pulmonary edema and assist in providing required rapid tissue 
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r eoxygenation. This- area does appear to require study. 
Situations where resuscitative measures will be delayed, hampered 
and even impossible to carry out in space are easily envisaged. Other 
than possibly restoring an adequate partial pressure of oxygen in the 
space suit, artificial respiration, if required, will probably not be 
accomplished until the suit helmet is removed after a hypoxic astronaut 
is brought back into a pressurized spacecraft or airlock. 
Resuscitation should be attempted on any hypoxic individual in 
whom there is any chance of cardiac activity or if dilated pupils respond 
to light, for even if his respiration has ceased, there will be no immediate 
,indication as to how much initial irreversible brain damage has occurred (34) . 
The level of cardiac activity can be monitored initially by palpation 
especially of the carotid pulse, since it is more accessible merely by 
removing the space suit helmet and since other pulses, such as the radial, 
brachial and femoral pulses, might be inaccessible because of space 
suit and clothing. As well, the carotid pulse persists when the peripheral 
pulses are no longer palpable (34) . When possible, cardiac activity 
might also be monitored by cardiac auscultation, blood pressure 
recording and, if possible on board the spacecraft, by electrocardio- 
graphy. Gordon (34) has suggested that external cardiac compression, 
or cardiopulmonary resuscitation be instituted if the heart is functioning 
but the systemic arterial pressure is under 50 mm Hg. 
The duration that resuscitative measures should be carried out will 
also be determined by sound clinical judgment. If vital signs such as 
respiration, pupillary reaction to light, and response to painful stimuli 
do not appear and continue to improve, prognosis for survival is poor. 
Depending mainly on the duration and severity of his hypoxia, an 
unconscious individual being resuscitated might regain full consciousness 
rapidly, or remain in a state characterized by impaired mental and 
motor function, or some level of unconsciousness, for a period of minutes 
to many days, or permanently. A secondary, often fatal deterioration 
of consciousness can occur either within hours of a hypoxic exposure 
without full consciousness having been regained, or within several days 
after a seemingly complete but prolonged recovery from a severe exposure. 
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These neurologic sequelae are attributed to reversible and irreversible 
hypoxic brain damage which results not only from the low partial 
pressure of oxygen at the time of exposure, but apparently also from 
the cerebral edema which follows severe hypoxia. Therefore, if full 
consciousness is not restored immediately by initial resuscitative 
measures discussed above, attention must be given to minimizing per- 
manent brain damage by measures directed at cerebral edema. This 
is an area to be discussed below in detail. 
Finally, it should be pointed out that Balke and co-workers (3) have 
reported that a measurable reduction in work capacity, associated with 
subjective symptoms of fatigue, occurred in subjects who returned to 
near sea level conditions after they were exposed to air at an altitude 
of 16,000 feet (412 mm Hg or 7.96 psia) for over 3 hours. This raises 
the question as to when an astronaut, who has apparently recovered 
completely from a hypoxic exposure, should be started back on activity 
associated with high work loads, unless absolutely necessary. 
The “Oxygen Paradox” 
Most individuals (about 85 percent in one series) who are still 
in a mildly hypoxic state can apparently experience a continued, often 
accelerated deterioration of consciousness for usually 15 to 30 seconds 
after they start breathing an adequate partial pressure of oxygen (26, 35, 
55, 77) . This event is most likely to occur if pure oxygen is restored 
rapidly just before the onset of severe hypoxic manifestations; it is 
not in evidence after loss of consciousness (26, 77) . The question 
as to whether or not exertion or fatigue might be aggravating remains 
(35) unanswered . 
The cause of this apparently normal reaction to reoxygenation is 
unknown. The temporary decrease and even cessation of breathing fre- 
quently observed on reoxygenation may promote continuance of existing 
cerebral hypoxia until adequately oxygenated blood reaches brain tissues (6, 
35) . Constriction of cerebral vessels possibly from the hypocapnia 
associated with hypoxia or from elevation of the arterial oxygen tension 
on reoxygenation does not appear to be a mechanism involved in producing 
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this response to reoxygenation (77) . A frequently observed, temporary 
vasodepressor response to reoxygenation, thought from animal studies 
as possibly being due to the release of a transiently-acting vasodilator 
substance, may contribute causally (12, 35) . 
A few individuals studied (2 of 180 in one series) are predisposed 
to suffer a severe disturbance of consciousness under the same reoxy- 
genation circumstances as described above (77) . The clinical picture 
presented by this truly paradoxical action of oxygen, or so-called 
“oxygen paradox”, varies considerably between individuals, but is con- 
stant from episode to episode in the same individual (27, 77) This . 
reaction, which usually lasts from 15 to 30 seconds in duration, is 
most likely to occur after exercise or a prolonged hypoxic exposure (74, 
77) . Typical examples of this phenomenon are a narcoleptic episode 
with a marked decrease of muscle tonus, an abrupt short-lasting 
hypertonia of skeletal muscles, an episode of peculiar hyperkineses 
and a sudden loss of consciousness as in an epileptic attack (77) . 
The cause of the “oxygen paradox” is unknown. There appears 
to be no characteristic physiologic or pathologic features, including 
narcoleptic or epileptic tendencies, which distinguish individuals 
prone to this reaction from those not prone (35, 77) . The degree of 
reaction is reportedly enhanced by hyperventilation, but not significantly 
altered by the addition of carbon dioxide to the inspired air (77) . 
Mechanisms mentioned for the reaction to reoxygenation discussed above 
may play a causative role. 
Possible serious implications of the “oxygen paradox” occurring 
in an operational space situation are readily apparent. Accordingly, 
the elimination of astronaut candidates in whom this reaction can be 
demonstrated is considered mandatory. 
Posthypoxic Cerebral Edema 
Although there has been a great deal of writing in the area of acute 
hypoxia in the past, only in recent years has attention been focused on 
the posthypoxic state and, in particular, on posthypoxic cerebral edema as 
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the major sequela of acute hypoxia. It has become a generally accepted 
fact that even though irreversible damage of brain tissues can occur 
at the time of an acute hypoxic event, such damage can, on occasion, 
be minor as compared to that caused by posthypoxic swelling, or 
edema of these tissues. The following discussion deals briefly with 
the pathophysiology, clinical manifestations, diagnosis and treatment 
of posthypoxic cerebral edema. Greater detail on various aspects 
of this syndrome is provided in reviews by Allison (1) Cope (16), 
Harley (36), Sadove and co- worker s (88)) Wyant (’ 04): and others (21 ’ 
61, 62, 84) . 
Pathophysiology 
Edema can occur in any body tissue which is subjected to an abnor- 
mally low partial pressure of oxygen for a sufficient period of time (104) . 
Because of their remarkable sensitivity to a reduced oxygen supply, the 
brain tissues appear to be the most prone to become edematous following 
such an exposure (84) . 
Cerebral edema has been demonstrated in experiments in which 
animals were subjected either to low partial pressures of oxygen or 
circulatory arrest (13, 23, 24, 48, 63, 99) . It was observed in about 
one- third of the high altitude human hypoxic fatalities reported by Lewis 
(57) and Haymaker . Perhaps the best indication of edema being by far 
the major factor in causing the posthypoxic clinical manifestations 
to be described below has been the clinical improvement in both animals 
and man resulting from the use of tissue dehydrating agents directed 
at reducing this edema (2, 16, 20, 32, 37, 47, 49, 73, 82, 85, 88, 89) 
. 
Until recently, the pathophysiologic mechanisms involved in producing 
posthypoxic cerebral edema have been similarly stated by many investi- 
gator s (16, 48, 61, 62, 84) . Hypoxia was thought to cause primarily 
an increase in the permeability of brain capillaries, which then allowed 
leakage of plasma protein from them. The consequent rise in inter- 
cellular osmotic pressure could then draw fluid out of blood vessels, 
leading to the formation of intercellular edema. The edema fluid would 
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act as a physical barrier, interfering with the passage of oxygen across 
the intercellular space to reversibly damaged brain cells. Intracellular 
edema was also thought to occur from an excessive passage of sodium 
and chloride ions, and hence water into cells which are functionally 
altered from hypoxia 
(16, 62, 71, 84) . It was also postulated that 
once the cerebrospinal fluid allows for maximum expansion of the 
brain in its rigid bony casing, brain tissues would not only be 
mechanically compressed, but also have their perfusion, and hence 
oxygen supply diminished. Since these various effects of edema result 
in further hypoxic damage, the vicious circle of “hypoxia-edema-more 
hypoxia” would become established. The recurrence of a decreased 
oxygen supply could then be sufficient to inflict a final insult upon 
brain cells, converting reversible into irreversible damage. Thus 
it is understandable how brain damage, which is initially limited in 
degree, can assume fatal proportions or progress on to some degree 
of temporary or permanent decerebration of an individual when it 
would appear that the crisis at the time of an acute hypoxic exposure 
has passed. 
Another mechanism might also be involved to some degree in the 
formation of posthypoxic cerebral .edema. Studies utilizing the electron 
microscope have shown that glial cells in the brain swell markedly 
when the brain is subjected to such edema causing factors as hypoxia, 
hypotonic perfusion, toxic chemical agents and cold (36, 38, 44, 56, 59, 
60, 79, 83) . As discussed in a number of recent reviews, glial cells 
appear to give nutritive support to neurons and participate in the blood- 
brain barrier 
(36, 52, 68, 79, 83) 
. The high metabolic activity asso- 
ciated with these and possibly other functions of glia would make these 
cells also highly susceptible to hypoxia, and hence would give reason 
for the glial edema observed after a hypoxic exposure. 
It is readily apparent from the vast literature in this area that much 
research on hypoxia remains to be done to elucidate clearly the mechanisms 
involved in pr educing po sthypoxic cerebral edema. Hopefully, such 
continuing research will yield optimum methods of combating this edema 
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therapeutically in space. 
Permanent histopathologic changes in brain tissue following a 
hypoxic exposure have been compr’ehensively reviewed by Courville (18) , 
Yant and co-workers (105) , and others (40, 45) . Since most of these 
changes are irreversible, they are not pertinent to the treatment of 
posthypoxic cerebral edema. It is pointed out that the majority of the 
clinical residues of hypoxia correlate with damage seen in the cerebral 
cortex, cerebellar cortex and pyramidal nuclei. 
Clinical Manifestations 
Posthypoxic clinical manifestations, which have in most circum- 
stances been attributed to cerebral edema, can vary considerably. 
They may appear up to several hours after either an apparently normal 
or a partial recovery from an acute hypoxic exposure (2, 16, 84). On 
the one extreme, symptoms apparently from only mild edema are 
experienced for a few hours (20, 97) . They include headache, nausea 
with or without vomiting, drowsiness, emotional instability, and 
impairment of judgment, insight and logic. It is important to note 
that an astronaut in this state might be unable to perform required 
operational tasks. 
On the other extreme is the clinical picture associated with more 
severe cerebral edema. It is characterized by coma, with signs 
depending on the depth of the coma (2, 16, 17, 49, 84, 89) Respiration . 
may be stertorous or gasping. Pronounced sweating of the face and 
neck is common, and marked hyperthermia may occur early. The 
pupils are usually equal in size and dilated. The eyes may be open 
and staring, and a coarse nystagmus may be present. Restlessness, 
twitching movements of the limbs and actual convulsions are signs which 
often appear as coma deepens. Decerebrate rigidity is characteristic 
of deep coma. The pre-terminal events of posthypoxic cerebral edema 
include an increase in pulse rate, flaccidity, loss of deep tendon reflexes, 
hyperthermia and Cheyne-Stokes respiration. 
Maximum recovery from posthypoxic cerebral edema, if left untreated, 
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may take hours to many days (50, 97) . For some time, then, an astro- 
naut could be a serious management problem, being unable to fulfill 
his own needs while in the comatose state. Even after return of 
consciousness, there could be a prolonged period of altered mental 
functioning, which could make him a potential danger to the mission 
or a useless member of the crew. It must also be remembered that 
some degree of incomplete recovery might occur. Cases of 
permanent hypoxic brain damage are well documented in the literature (19 
17, 18, 50, 57, 84) . Coma can be permanent, with the affected 
individual usually dying soon from intercurrent infection or aspiration, 
unless rigorous supportive care is given. Residual motor involvement 
usually takes the form of impairment of fine coordination, spasticity 
or athetosis. Common mental sequelae are impairment of judgment, 
insight and logic, and emotional instability. It is considered reasonable 
to assume that any degree of permanent brain damage will affect the 
astronaut’s highly developed skills. 
It must be remembered that some degree of irreversible brain 
damage can occur in the pre-edematous stage of an acute hypoxic ex- 
posure. To this damage could be added that caused by cerebral edema, 
resulting in serious mental and motor impairment of an astronaut. 
It is also possible for the initial irreversible brain damage to be 
sufficient to produce impairment in spite of measures which might 
adequately control posthypoxic cerebral edema. The literatllre seems 
to support the view that if an astronaut has a severe hypoxic exposure 
and remains deeply comatose from the time oxygen is restored, no 
early decision can be given as to what his prognosis for recovery might 
be. A failure to respond adequately to therapy in the immediate period 
after a hypoxic exposure would be a strong indication of permanent 
brain damage. 
Diagnosis 
For the most part, the diagnosis of posthypoxic cerebral edema 
should be obvious, especially if a deterioration of consciousness follows 
within a few hours what appears to be progressive recovery from an acute 
16 
hypoxic exposure. The major identifying feature of cerebral edema, 
if the astronaut remains in a semi-conscious or unconscious state 
after restoration of oxygen, will be a deterioration in his condition. 
It is possible that posthypoxic cerebral edema might have to be 
distinguished from air embolic phenomena associated with decompression 
sickness (Chapter 4) or resulting from lung disruption due to explosive 
decompression (Chapter 3), meteoroid blast (Chapter 12), or trauma 
(Chapter 14). Cerebral concussion, acute subdural hematoma, and 
internal hemorrhage (Chapter 14), might also conceivably enter into 
the differential diagnosis. It is apparent that the history and physical 
examination, finding in particular localizing signs characteristic of 
the above conditions, should distinguish these conditions from posthypoxic 
cerebral edema. The thought should still be kept in mind, however, 
that as the result of a decompression event, air embolism and post- 
hypoxic cerebral edema could occur together. 
Treatment 
In the light of the foregoing discussion of the pathophysiology of 
posthypoxic cerebral edema, it would appear that any measure directed 
at breaking the vicious circle of “hypoxic- edema-more hypoxia” 
would be an effective form of treatment of posthypoxic cerebral edema. 
With this principl- e in mind, Sadove and co-workers 638) in 1953 reported 
success with dehydration therapy in humans suffering from posthypoxic 
cerebral edema. Their treatment entailed either repeated intravenous 
injections of a 50 percent glucose solution or the continuous intravenous 
administration of a 25 percent glucose solution. These investigators 
found that posthypoxic coma markedly lightened soon after each admin- 
istration of hypertonic glucose. However, after a time coma returned 
although to a lesser depth than pre-treatment. The improvement phase 
was attributed to an initial net loss of water from brain tissues into the 
hyperosmotic intravascular compartment. The rebound phase was 
thought due to a rapid return of water along with glucose, which passed 
in excess from the intravascular compartment, so to swell the intercellular 
and intracellular compartments. It was thought, therefore, that agents 
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which are of larger molecular size and hence have a greater tendency 
to remain in the intravascular compartment would be more effective 
than hypertonic glucose in producing cerebral dehydration. Several 
more effective agents suggested were concentrated human serum 
albumin, plasma expander s such as dextr an and polyvinylpyr r olidone 
and quadruple-concentrated plasma. 
In the past 14 years, a number of dehydrating agents, or so-called 
osmotic diuretics, have been used successfully in the treatment of 
posthypoxic cerebral edema. Experiments on animals have shown 
that urea and mannitol are effective in decreasing brain volume, in- 
creasing cerebral blood flow, decreasing cerebrospinal fluid pressure, 
and producing clinical improvement of this syndrome (9, 13, 32, 33, 
37, 47, 73, 82, 102) - . Success in treating humans has been reported 
for sucrose, albumin, urea and mannitol (2, 16, 51, 81, 84, 85, 89, 90) . 
Of all the dehydrating agents used in the past, mannitol would appear to 
be the most appropriate for the treatment of posthypoxic cerebral 
edema in space. In animal and human experiments, which studied the 
cerebrospinal fluid pressure responses to intravenous equimolar doses 
of hypertonic urea and mannitol, it has been shown that urea produces 
a greater decline of this pressure, but the mannitol effect lasts longer (73, 
82, 91, 102) . Furthermore, it was noted that although a secondary 
rise of cerebrospinal fluid pressure occurred after the administration 
of both of these agents, this rebound effect was much greater with 
urea. These findings correlate well with human clinical results, for 
mannitol appears to be not only more effective than urea and other 
dehydrating agents mentioned above in reducing the cerebral edema, 
but is also much less likely to produce rebound (48, 51, 84, 85) . 
The clinical usefulness of mannitol has been attributed to the fact that 
it possesses the many properties desirable for a dehydrating agent, 
for it is non- toxic, is not significantly metabolized or stored in the body, 
remains almost entirely outside of the intracellular compartment, and 
is excreted rapidly by the kidneys (21, 25, 85, 91, 102) Since mannitol . 
is not reabsorbed in significant amounts from the renal tubules, it 
acts as an osmotic diuretic. This characteristic accounts for the well 
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known usefulness of this drug in preventing acute renal tubular necrosis 
from a variety of causes. A practical advantage of mannitol is the fact 
that it is easily dissolved in the concentration recommended for 
injection. Therefore,it is apparent that a strong case can be made 
for using mannitol in the treatment of posthypoxic cerebral edema 
in space. However, this view must be substantiated as this drug 
receives greater clinical usage with time. 
Mannitol is administered in various concentrations (e. g. , 20 
percent solution) only by the intravenous route. Doses of up to 200 gm 
spread over a 24 hour period have been used safely (39, 51) . Because 
of the high urinary output which will accompany the administration of 
this agent to a comatose astronaut, his urinary bladder should be 
catheterized. 
What should be the indication for and the time of ‘administration of 
a cerebral dehydrating agent to an astronaut who has suffered an acute 
hypoxic exposure? From past experience, it appears that cerebral 
edema should be assumed responsible for some of the neurologic 
manifestations which occur up to several hours after exposure. 
Theoretically and clinically, a dehydrating agent should be administered 
for both preventive and therapeutic purposes. Such an agent should 
be given to an astronaut, who shows an inadequate neurologic response 
to oxygen, as soon as there is clinical evidence of adequate cardiovascular 
function. 
Hypothermia has been markedly effective when used experimentally 
for the treatment of posthypoxic cerebral edema in animals (9, 85, 103, 
106) . This measure, usually combined with dehydration therapy, has 
reportedly been highly beneficial in treating this syndrome in humans (36, 
61, 84, 88, 89, 95, 100, 103) 
. 
Reasons for its efficacy, as given by 
Harley (36) and Wolfe (’ 04), center on the improved balance between 
oxygen availability and demand in cooled, edematous brain tissues. 
Hyperpyr exia, which in itself can produce permanent brain damage, is 
prevented. Even in normal individuals, hypothermia reduces brain 
volume and intracranial pressure (27) . Thus, according to the more 
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recent concept of the cause of posthypoxic cerebral edema, hypothermia 
minimizes damage of brain elements, including the glial cells, and 
any associated edema. 
The level of hypothermia recommended for the treatment of post- 
hypoxic cerebral edema has been between 30” C (86” F) and 32” C (89.6” F) 
(36, 104) 
. The importance of controlling shivering, which can detrimen- 
(36) tally increase cerebral oxygen consumption, has been emphasized . 
As is used even today, suppression of shivering would be possible 
with chlorpromazine. 
Although hypothermia would apparently be of great value in the 
treatment of posthypoxic cerebral edema in space, therapeutic hypo- 
thermia might be operationally impossible in the foreseeable future. 
It is conceivable, however, that adequate total body cooling might be 
attained with a water-cooled space suit. 
Finally, it should be mentioned that corticosteroids and cortico- 
steroid-antihistamine combinations have been employed with great 
success in the relief of the edema and signs and symptoms associated 
with brain tumors (‘4, 28, 30, 31, 44, 53, 58, 70) In animal . 
studies, these agents have also reduced edema of cerebral tissues 
induced by toxic agents and cold 
(60, 87, 94) 
. Such drugs appear to 
combat edema formation primarily by reducing capillary leakage. How- 
ever, their value in the treatment of posthypoxic cerebral edema remains 
to be determined. 
Various supportive measures are required in treating an astronaut 
who is suffering from posthypoxic cerebral edema. Measures to 
assure adequate oxygenation may include continuing his exposure to 
100 percent oxygen, assisting his ventilation, maintaining a clear airway 
by measures mentioned above, and removing secretions from his 
respiratory tract. Provided there is no chance of serious respiratory 
depression, a sedative such as sodium phenobarbital might be required 
for controlling mental and motor manifestations, including convulsions, 
associated with posthypoxic cerebral edema. An oral or systemic tran- 
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quiliz ing drug , such as chlorpromazine, might also be of benefit 
in this situation. Intravenous fluids and electrolytes might be needed 
not only for feeding a comatose astronaut, but also for restoring his 
blood volume and electrolyte losses if dehydration therapy is carried 
out. Since gastric dilatation often accompanies the onset of cerebral 
edema, oral feeding should be withheld for the immediate posthypoxic 
period. Nasogastric intubation might be required for relieving this 
condition; it can also be used for feeding a comatose astronaut. 
Catheterization of the urinary bladder might be required, especially 
if a cerebral dehydrating agent is administered. A broad spectrum 
antibiotic might be given prophylactically for secondary respiratory 
and urinary tract infection if the period of coma is prolonged. 
Delayed Posthypoxic Encephalopathy 
Delayed posthypoxic encephalopathy is a serious neurologic deter- 
ioration which occurs several days following a seemingly normal clinical 
recovery from an acute hypoxic exposure. This problem is fortunately 
a very rare consequence of acute hypoxia, for Shillito and co-workers (92) 
discovered that only 13 cases of delayed posthypoxic encephalopathy 
occurred in 21, 000 cases of carbon monoxide poisoning. Hence it will 
only be briefly discussed here. 
A clear clinical picture of delayed posthypoxic encephalopathy 
has been presented in reviews by Plum (80) and Shillito (92) and their 
respective co-workers. The hypoxic exposure is usually severe, with 
most individuals awakening from posthypoxic coma within 24 hours 
and resuming full activity in 4 or 5 days. A clinically normal period 
of 2 to 10 days, and occasionally longer, follows. Then, abruptly, 
these individuals become irritable, apathetic, and confused. Some are 
agitated or manic. Motor control is usually clumsy, and diffuse skeletal 
muscle spasticity may develop. This neurologic deterioration may 
progress to coma and death, or be arrested at any level. Some individuals 
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recover to full health over a period of many months. 
Extensive cerebral hemispheric demyelination, with no predilection 
for perivascular regions, appears to be the major pathologic abnor- 
mality common to all cases of delayed posthypoxic encephalopathy. 
Cerebral edema or swelling is absent as is damage to nerve cell bodies 
and axons. 
The cause of this condition is not known. Although cerebral de- 
myelination has followed hypoxia in several experimental studies, this 
paradox of extensive demyelination coupled with neuronal preservation 
has rarely been seen in such studies (80) . Recent findings would 
support the hypothesis that injury to the glia, which appear to be not 
only involved in the production and maintenance of myelin but also highly 
sensitive to oxygen lack, are responsible for this delayed consequence 
of hypoxia (36y 68). 
Unfortunately there are no clinical signs which predict delayed 
posthypoxic encephalopathy before it occurs. The history of a hypoxic 
exposure and the diffuse findings with long latency described above 
should distinguish this syndrome from other conditions, such as psy- 
chiatric disease and chronic subdural hematoma. 
Since the etiology of posthypoxic cerebral encephalopathy is unknown, 
it is possible to make no more than empirical suggestions for its treat- 
ment. This syndrome appears to occur for no defined reason after 
an individual recovers and resumes full activity after a severe hypoxic 
exposure, so that it might be wise to restrict the physical activity of 
an astronaut in such a situation as much as possible for many days. 
Once neurologic deterioration occurs, only the supportive forms of 
therapy discussed previously for posthypoxic cerebral edema can be 
suggested at this time. 
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CHAPTER 2 
EBULLISM SYNDROME 
Especially during extravehicular operations in space, astronauts 
will risk accidental exposure to an ambient pressure which is equal to 
or less than the effective vapor pressure of body fluids at body tempera- 
ture. Such an exposure will lead to profuse evaporation and outgassing 
of these fluids, with the formation of vapor bubbles in tissues, blood 
vessels and body cavities. This phenomenon has been termed ltebullism” 
and its resulting clinical manifestations, the “ebullism syndrome” (2% 
(26). For all practical purposes, ebullism can be expected to occur at 
ambient pressures of 47 mm Hg (63,000 ft) or less. 
It must be kept in mind that an astronaut subjected to ebullism will 
also suffer from primary acute anoxia (Chapter 1). Moreover, injuries 
sustained during an “explosive ‘I decompression (Chapter 3) could further 
complicate the clinical picture of an astronaut who has experienced 
a decompression event. 
A discussion of the pathophysiology, clinical manifestations, diag- 
nosis and treatment of the ebullism syndrome follows. For more detail- 
ed information on the general aspects of this syndrome, including the 
results of animal experimentation in this area, reference is made to 
a recent monograph by Roth (22) Also pertinent are reviews by Luft 
(20) , Ward (26), and others (2’ i6’ 28). 
Pathophysiology 
The ebullism syndrome as it could occur in an astronaut has not 
been described for man. Moreover, only in the past few years have 
manned orbital flights and the increasing use of man-rated space simu- 
lators necessitated experiments exposing animals to “space” in order 
to predict with a reasonable degree of confidence what effects such an 
exposure could have on astronauts (3, 4, 5, 7, 8, 9, 10, 11, 12, 18, 24) . 
There appears to be no reason to suggest why the results of such experi- 
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merits, particularly those with large primates, should not be reasonably 
but cautiously extrapolated to man. 
Animal experiments have shown that ebullism does not occur uni- 
formly throughout the body (7, 20, 23) . Vaporization and outgassing 
tend to occur at various places in the body, depending on such local 
factors as temperature, hydrostatic pressure, tissue elasticity, solute 
concentration, and the presence of gas nuclei (17) . These factors account 
for the early appearance of vapor bubbles at or even slightly above a 
-total ambient atmospheric pressure of 47 mm Hg in sites such as the 
pleural cavity and in the large central venous channels. In the former 
site, the pressure is usually less than that of the ambient atmosphere 
and in the latter site, the hydrostatic pressure is minimum and tempera- 
ture of the blood is maximum 
(11, 13, 17) 
. As would be expected, pro- 
fuse vaporization from the warm moist membranes of the respiratory 
passages and ocular conjunctivae occurs at a total ambient pressure 
close to 47 mm Hg W)* 
The most significant pathophysiologic events observed during 
ebullism appear to result from bubble formation within the cardiovascu- 
lar system. Almost immediately after decompression to an ambient 
atmospheric pressure at which ebullism can occur, vapor bubbles form 
at the entrance of the great veins into the heart (7, 13) . Vaporization 
then rapidly progresses in a retrograde fashion through the venous sys- 
tem to the capillary level. Venous return is blocked by this “vascular 
vapor lock”. This leads to a precipitous fall in cardiac output, a 
simultaneous reduction of the systemic arterial pressure, and the develop- 
ment of vapor bubbles in the arterial system and in the heart itself, 
including the coronary arteries (7, 15, 20) . Systemic arterial and 
venous pressures then approach equilibrium with that of water vapor (9) . 
Animal studies have demonstrated that the circulation virtually ceases 
completely within 10 to 15 seconds after explosive decompression to 
an ambient atmospheric pressure of 30 to 40 mm Hg and within 10 seconds 
after rapid decompression to near-vacuum (9, 10, 15) . Interestingly, 
these cardiovascular effects of ebullism contrast with the cardiovascular 
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effects of profound acute hypoxia per se, in that the cardiovascular pres- 
sure response to hypoxia is manifested by a transient fall in systemic 
arterial blood pressure followed by a’ rebound, then a gradual decline 
(14) over several minutes due to hypoxic circulatory failure . Hence 
the pathologic effect of ebullism, particularly on brain tissues, might 
be even more severe than the effect of profound acute hypoxia per se, 
for if cardiovascular ebullism occurs, the tissues will be deprived not 
only of oxygen but also of the supply of other circulating nutrients such 
as glucose and the removal of toxic metabolites such as carbon dioxide 
and lactic acid (27). 
During an ebullism exposure, cardiac damage might result from 
stretching of the myocardium by expanding gas inside the heart, com- 
bined with the effects of fulminating anoxia (7). These factors were cited 
to explain the markedly abnormal cardiac electrical activity frequently 
observed in dogs explosively decompressed to an ambient atmospheric 
pressure of 30 mm Hg, and the failure to resuscitate the dogs so exposed 
for over 3 minutes in duration . (7) They might also have been involved 
in producing the fatal cardiac arrhythmias observed in other animal ex- 
(3, 4, 5, 9, 19, 24) posures to near-vacuum . 
Profuse fluid vaporization from the moist membranes in the respira- 
tory tract apparently can traumatize delicate lung tissues (3) . Water 
vapor, oxygen, carbon dioxide and nitrogen or other inert gases,if pre- 
sent in the atmosphere prior to decompression, pour out of the pulmo- 
nary blood and tissues and rapidly escape through the airways into the 
surrounding environment. Whether the widespread pulmonary edema, 
atelectasis, congestion and hemorrhage observed in animals following 
ebullism are due to a disruptive effect of escaping gases, to tissue cold 
injury from fluid vaporization or to some combination of these factors 
has not been determined. The severity of lung damage does increase 
with the rate of decompression and the duration of the ebullism exposure . (3) 
Interestingly, serious lung damage was not observed in dogs subjected 
to near-vacuum unless their exposure time exceeded 90 seconds (11, 12) . 
Denitrogenation, or the breathing of oxygen for a period of time prior 
to exposure also exercised a significant protective effect on the degree 
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(4, 5, 11, 12) 
of lung involvement . Finally, it is noted that the atelectasis 
observed in animals exposed to total ambient atmospheric pressures at 
which ebdlism occurred might in part be attributed to a displacement 
of intra-alveolar gasses by fluid vapor, followed by collapse of vapor- 
filled spaces on recompression (20) . The vapor which forms in the 
pleural “space”, and so partially collapses the lung, might also be an 
important factor in producing atelectasis (14). 
Heat losses mainly from fluid vaporization in the respiratory tract 
and on the skin surface has diminished the lower esophageal temperature 
of animals decompressed to near-vacuum for survivable lengths of time 
by several degrees centigrade (9) . Lowered body temperature reduces 
the vapor pressure of body fluids as well as tissue metabolism. However 
it is not known whether this phenomenon would affect survival. No doubt 
the body cooling takes place mostly within the chest and at the skin surface. 
Because of cardiovascular vapor lock, cooled blood cannot circulate to 
highly oxygen-sensitive brain tissues until brain perfusion is restored 
after recompression. Since this blood would be an admixture of blood 
from cooled and uncooled parts of the body, it would probably not be cool 
enough to confer significant protection from hypoxia on brain tissues 
between the moment of recompression and the restoration of adequate 
brain tis sue oxygenation. Finally, whether blood cooling .from ebullism 
could ever be great enough in a human to produce fatal ventricular 
fibrillation (Chapter 7) remains to be determined. 
Vaporization and outgassing at sites in the body other than those 
mentioned above appear to be of minor pathophysiologic significance. 
Projectile vomiting, defecation, lacrimation, salivation, and urination 
have been observed in animals at the time of exposure to ambient atmospheric 
pressures at which ebullism occurred (3, 4, 5, 7, 8, 13, 14, 15, 17, 18, 24) . 
Most important from a clinical standpoint in the ebullism syndrome 
appears to be the consequences of the profound anoxic exposure combined 
with the damaging effects of intravascular, and possibly extr avascular 
bubbles which might fail to reabsorb completely coincident with 
recompression. Roth (23’ summarized his discussion of the dynamics of 
subcutaneous vapor pockets forming in ebullism by stating that there is first 
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a rapid conversion of liquid water to the vapor phase. This phenomenon 
reaches a peak rate at about one minute and then probably continues on at 
a slower rate for several minutes. He noted that there is an original rush 
of carbon dioxide, nitrogen, and oxygen into the pocket, but that carbon 
dioxide gradually becomes the most abundant gas. Reference was made 
to the pressure data of Kemph and co-workers (17) , who showed that by 60 
seconds after decompression to an ambient atmospheric pressure at which 
ebullism occurs, these gases may make up to about 10 percent of the 
total pressure within subcutaneous vapor bubbles. If it is assumed that 
the diffusion of gases into and out of vapor bubbles within the cardiovascular 
system approximates the diffusion of gases into and out of subcutaneous 
vapor bubbles , then there is a likelihood that some intravascular bubbles 
might fail to reabsorb completely on recompression, especially if the pre- 
decompression ambient atmosphere contains an inert gas. The probability 
of this occurring will increase with the length of time that ebullism is ex- 
per ienced. These post-ebullism bubbles could then continue to act as 
emboli, and so inflict temporary and possibly permanent tissue damage. 
By blocking blood flow through such critical tissues as the heart, brain, 
and lungs, they could conceivably be the major contributor to post-recom- 
pression death. 
The rate of decay of a post-ebullism bubble is determined by the 
same factors which control the rate of reabsorption of a bubble of decom- 
pression sickness (Chapter 4). Complicated theoretical considerations 
beyond the scope of this discussion indicate that post-ebullism bubbles will 
always contain higher levels of carbon dioxide and oxygen than inert gas, 
and hence should reabsorb much more rapidly than bubbles of decompression 
(22) sickness . It is noted that the rate of reabsorption of a post-ebullism 
bubble will vary inversely with the amount of inert gas in the bubble, and 
hence on the duration of the decompression exposure. Roth (22) has dis- 
cussed the significance of various inert gases in the reabsorption of post- 
ebullism bubbles . He concluded that because of its low permeation co- 
efficient in blood, neon in a bubble would be reabsorbed more rapidly and 
therefore would be a “safer” inert gas for an astronaut to have in his 
ambient atmosphere than nitrogen. It was also postulated that nitrogen 
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would be a “safer” gas than helium. He predicted, however, that the over- 
all dependence of the ebullism syndrome on the type of inert gas used 
would be much less for this syndrome than for decompression sickness. 
The observation that animals recover less rapidly after a brief exposure 
to a total ambient pressure at which ebullism occurs than after a decom- 
pression episode at a partial pressure just below this level has been attri- 
buted primarily to the existence of post-ebullism bubbles (20) . 
The recovery of dogs, squirrel monkeys, and chimpanzees has been 
studied after their exposure to near-vacuum for varying periods of time (3, 
4,. -5, 7, 8, 9, 10, 18, 19, 24) . Perhaps the experimental observa- 
tions which might best be extrapolated to man are those on chimpanzees 
(18, 19). However, when extrapolating the following experimental obser- 
vations to man it must be kept in mind that the functional capabilities of 
man are much higher than the chimpanzee. Thus man might suffer a 
severe loss of higher psychomotor functions with a degree of brain damage 
which would still allow a chimpanzee to function adequately. Several 
c himpanz e e s , denitrogenated by breathing pure oxygen for four hours prior 
to decompression, have tolerated exposures to ambient atmospheric pres- 
sures of less than 2 mm Hg for up to 210 seconds with a return of apparently 
normal psychophysiologic function after recompression. Manifestations 
during the period of recovery are not unlike those during a recovery from 
a severe acute hypoxic episode. The time for first purposeful movement 
to occur after recompression increases with the duration of exposure, 
being about five minutes for a 60 second exposure, 20 minutes for a 120 
second exposure, and 40 minutes for a 150, 180 and 210 second exposures. 
Likewise, the time for apparently complete recovery of normal psychomotor 
functioning after recompression increases with the time of exposure, being 
about 90 minutes for a 60 second exposure and less than four hours for 120, 
150, 180 and 210 second exposures. From the time of first purposeful 
movement until recovery, these chimpanzees demonstrated varying degrees 
of confusion, lag time in task performance, diminished perception of audi- 
tory and visual stimuli, and motor incoordination and rigidity. Whether 
or not personality changes could occur and persist for varying periods of 
time, or even permanently, after recovery from the more prolonged exposures 
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remains to be determined. It is apparent that such experiments must be 
carried out on a larger population, extending the duration of exposure 
beyond 210 seconds before a more complete picture of all the possible 
manifestations, -both temporary and permanent, of the ebullism syndrome 
can be presented for the chimpanzee. If spacecraft cabin atmospheres 
are to contain inert gas, then these primates should also be decompressed 
while breathing such atmospheres in order to determine inert gas contri- 
bution to clinical effects which, as noted above, could be markedly aug- 
mented in such a situation by post-ebullism bubbles. 
Experiments with animal species other than the chimpanzee would 
suggest that when as astronaut experiences ebullism beyond 150 seconds 
in duration, the period of temporary functional impairment will be in- 
creasingly prolonged and manifestations of permanent brain damage will 
appear and rapidly increase in severity, especially if the astronaut is 
decompressed from an atmosphere containing inert gas t3, 4, 5)a From 
autopsies on animals which did not survive ebullism and observation of 
animals which recovered, it appears that brain damage in the ebullism 
syndrome is more diffuse than focal in nature. Cerebral edema (Chapter 
1) resulting from the combined effects of the acute anoxic exposure and 
under certain circumstances brain tissue hypoxia secondary to blockage 
of cerebral vessels by post-ebullism bubbles will no doubt play the major 
role in the production of temporary and permanent cerebral manifestations 
of the ebullism syndrome. Finally there is experimental evidence that 
one or more post-ebullism bubbles can produce nervous tissue damage 
of a more focal nature. One dog subjected to ebullism exhibited severe 
post-decompression paralysis which gradually recovered over a period 
of weeks (3, 4, 5) . Its spinal cord had numerous demyelinated lesions ‘o 
which seemed to be the result of gas bubble emboli (11, 12) . Another dog 
manifested severe post-decompression paralysis which slowly improved 
over a two month observation period. This time focal lesions were found 
in both the brain and spinal cord, especially in their white matter (8). The 
predilection of white matter for such damage may be due to the fact that as 
compared to gray matter, it is not only less vascular but also has a greater 
(8) solubility for nitrogen . Intra- and possibly extravascular, or autochthonous 
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bubble formation have both been implicated in the production of this pathology. 
Blockage of coronary arterial blood flow in an astronaut is con- 
sidered a serious possible consequence of post-ebullism bubbles. Due to 
the cumulative effects of an inadequate myocardial blood supply, impaired 
cardiac function could manifest itself immediately after recompression, 
or from minutes to many hours thereafter. Permanent myocardial damage 
leading to some degree of chronic myocardial insufficiency might even 
be possible. 
It is conceivable that by depriving vascular beds of an adequate 
blood supply, ebullism bubbles could produce such wide-spread vascular 
injury, leading to impaired vasomotor control and loss of plasma through 
damaged capillary walls, that circulatory collapse might occur. As in 
decompression sickness (Chapter 4), this might occur up to several hours 
after recompression. Myocardial insufficiency secondary to bubble emboli 
might or might not assist in producing “shock”. As in decompression 
sickness, the lungs could well be the main site of this plasma loss, es- 
pecially since vapor bubbles tend to form in the right side of the heart. 
Animals autopsied after ebullism have demonstrated marked pulmonary 
edema. The observations that the pulmonary edema is much less severe, 
and is associated with a lower mortality rate in those animals which denitrogenate 
as compared to those that breathe air prior to decompression lend support 
for the prediction on the theory that inert gas can play a detrimental role 
in the ebullism syndrome 
(11, 12, 22) 
. 
Clinical Manifestations 
The fact that the ebullism syndrome has not been described to date 
foreman bears re- emphasis. Moreover, animal experimentation has 
yielded data for near-vacuum exposures lasting up to only 210 seconds. 
Therefore the predicted clinical manifestations of the ebullism syndrome 
in man must be based not only on such data but also, for exposures longer 
than 210 seconds, on theoretical considerations. 
From the discussion of man’s clinical response to acute hypoxia in 
Chapter 1, it is apparent that if an astronaut is suddenly exposed to an 
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ambient atmospheric pressure at which ebullism will occur, time of 
useful consciousness will be about 10 to 15 seconds. As shown in ebullism ex- 
per iments, and also pointed out in Chapter 1, hypoxic manifestations 
should not appear if, after a one second or less time to altitude, recom- 
pression is accomplished within 4 to 5 seconds’ of exposure (4, 5). 
Loss of consciousness will be abrupt. The ensuing state of flaccid 
paralysis might be preceded by tonic and clonic seizures lasting up to 
several seconds in duration. Systemic arterial pressure will fall preci- 
pitously, probably within 15 seonds after decompression. Breathing will 
be arrested about the time consciousness is lost or within a few seconds 
thereafter . 
Marked abdominal distension will occur immediately after being 
decompressed, and possibly promote vomiting, defecation and urination, 
which could create an extremely serious particle and droplet hazard in 
the weightless environment if the exposure is survived (Chapter 9). A 
striking swelling of the subcutaneous tissues, beginning in loose skin 
areas such as the eyelids, axillae, scrotum, and neck will be noticeable 
within 10 seconds after decompression. As exposure continues beyond 
this time, this swelling will extend rapidly, creeping into some adjacent 
areas and extending rapidly into others. Since man’s skin is “tighter” 
than the skin of animals, it is likely that this swelling will be much less 
in humans than that seen in animal exposures. 
In general, the rate of recovery of an astronaut after suffering the 
effects of ebullism will be determined by such factors as the duration of 
his decompression, the rate of recompression and whether or not air or 
oxygen is breathed during recompression. As might be expected, the 
shorter the exposure and the faster the rate recompression while breath- 
ing oxygen, the greater and less complicated the recovery of animals sub- 
jected to near-vacuum (4, 5) . 
If a recompressed astronaut survives the immediate effects of 
ebullism and resuscitative measures are not employed, it might take up 
to a minute or more for adequate respiration to return, depending on the 
duration of his decompression. Recompression will in essence be a first 
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breath. If an astronaut is recompressed with oxygen there need not be 
an urgent requirement for artificial respiration, for adequate apneic 
oxygenation of pulmonary blood can occur for a period of time without 
interference from carbon dioxide accumulation providing, of course, 
his airways are unobstructed. Respiration might remain irregular for 
several minutes. If longer, the probability of severe temporary and 
possibly permanent brain damage will be great. 
A recompressed astronaut’s cardiovascular function might also 
take up to several minutes to return to an adequate level. Failure to do 
so might be due mainly to myocardial insufficiency caused by bubble 
embolization to the coronary arteries. This clinical state is characterized 
by a persistent tachycardia, arterial hypotension and venous distension. 
As mentioned previously, impaired vasomotor control and plasma loss 
might conceivably contribute significantly to the production of circulatory 
collapse, which might occur up to several hours after recompression and 
possibly have fatal consequences. 
If an astronaut who is suffering from the ebullism syndrome does 
not have the benefit of therapeutic measures other than recompression, 
his time to maximum recovery might take hours to days and even weeks. 
Since it is thought that prolongation of recovery would be due to cerebral 
edema, the psychomotor manifestations which an astronaut will present 
will be much the same as those described for post-hypoxic cerebral edema 
(Chapter 1). Although considered more unlikely following ebullism, focal 
reversible or irreversible damage of brain tissues might occur, the clinical 
picture from this being thought essentially the same as that described for 
decompression sickness (Chapter 4). 
Finally it is considered possible that pulmonary atelectasis secondary 
to ebullism could be severe enough to produce inadequate pulmonary venti- 
lation. This problem would be characterized by rapid shallow breathing 
and persistent cyanosis. Hypoxia and carbon dioxide retention secondary 
to atelectasis might lead to death. Persistent atelectasis favors pulmonary 
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infection, which could seriously complicate an astronaut’s recovery 
from ebullism. 
Diagnosis 
The diagnosis of ebullism itself should be obvious. However cer- 
tain manifestations of the ebullism syndrome which occur after recom- 
pression might only be diagnosed by history, physical examination, and 
the use of special diagnostic procedures. The crepitus of subcutaneous 
bubbles might possibly be felt after recompression in a surviving case of 
prolonged exposure. Deepening unconsciousness, prolonged uncon- 
sciousness or delayed deterioration of consciousness after recompress- 
ing an astronaut might be indicative of either cerebral edema or cardio- 
vascular “shock”. Tachycardia, arterial hypotension and venous dis- 
tension might be diagnostic of cardiac failure. Rapid shallow breathing 
and persistent cyanosis might represent pulmonary atelectasis. If 
possible on-board the spacecraft, a hematocrit determination could be 
used to diagnose pulmonary atelectasis. 
Treatment 
Up to the present time, the treatment of the ebullism syndrome has 
not received attention. Experimentation is certainly warranted in this 
area to justify the use of specific therapeutic measures which are 
indicated by theoretical considerations. In addition, a number of resus- 
citative supportive measures should be available and administered as 
sound clinical judgment dictates. 
The initial resuscitative measures which might be applied to an 
astronaut who has suffered ebullism are similar to those discussed 
in detail under acute hypoxia in Chapter 1. He should be exposed to as 
high a partial pressure of oxygen as possible. However, in order to 
minimize the risk of pulmonary atelectasis which accompanies the use 
of 100 percent oxygen at reduced pressures, it might be wise to switch 
him to an inert gas-oxygen mixture as soon as his cyanosis clears. 
From theoretical considerations, it is conceivable that immediate 
recompression of an astronaut to hyperbaric levels to hasten the reab- 
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sorption of post-ebullism bubbles might be a highly effective measure 
in the treatment of the ebullism syndrome. The rationale of having a 
recompression facility available for the treatment of this syndrome as 
well as decompression sickness and other air embolic phenomena 
which might occur during space operations is discussed under the treat- 
ment of decompression sickness in Chapter 4. If an astronaut can be 
recompressed, it is thought that due to the relatively lower inert gas 
content of post-ebullism bubbles, an adequate clinical result might 
be attained at an even lower ambient pressure in the treatment of 
ebullism than in the treatment of decompression sickness. This will 
particularly be so if ebullism results from decompression of the space 
suit, for an astronaut will be breathing 100 percent oxygen and so 
releasing the inert gas of the spacecraft cabin atmosphere from his 
body tissues for a period of time before his ebullism exposure. Since 
the lower the partial pressure of nitrogen in the inspired gas, the 
greater is the reabsorption rate of bubbles which contain nitrogen, 
it would seem advisable to have an astronaut breathing 100 percent 
oxygen or another inert gas throughout the period of his hyperbaric 
(14) recompression . On the other hand, the tendency of a pure oxygen 
environment to produce pulmonary atelectasis must be kept in mind. 
It is noted that if 100 percent oxygen is breathed, the recompression 
pressure would have to be limited to the lower pressure range (up to 3 
atmospheres absolute) to prevent oxygen toxicity. 
Positioning a recompressed astronaut in the head-down, left lateral 
position to minimize the migration of air emboli into the coronary and 
brain vessels will obviously be of no therapeutic benefit in the weightless 
environment. This measure should be carried out, however, if ebullism 
has occurred under sub-gravity conditions. If manifestations of pulmo- 
nary atelectasis are in evidence, reinflation of his lungs should be 
attempted. Mouth-to-mouth breathing or intermittent positive pressure 
oxygen are suitable means by which this might be accomplished initially. 
If he is conscious and if residual pulmonary atelectasis is found still 
to be present, he might continue periodic pressure breathing or be 
encouraged to cough or breathe deeply at intervals. 
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An astronaut suffering from the ebullism syndrome who does not 
respond adequately to oxygen should be treated for cerebral edema 
according to the indications and measures discussed under post-hypoxic 
cerebral edema in Chapter 1. If undertaken, dehydration therapy should 
begin as soon as possible after his systemic arterial pressure is 
restored to an adequate level. Because of myocardial infarction and 
plasma loss, this factor may be more critical in the therapy of ebullism 
than in post-hypoxia per se. 
Various forms of supportive therapy should be administered as 
indicated. An intravenous vasopressor, such as metaraminol, and a 
rapid-acting intravenous cardiac glycoside, such as digoxin, might 
be given until the systemic arterial pressure stabilizes. The cardiac 
glycoside might be continued indefinitely if it appears that myocardial 
damage has occurred. Other intravenous fluids might be given not 
only for the feeding of an unconscious or semiconscious astronaut, but 
also for restoring excessive fluid and electrolyte losses from dehydra- 
tion therapy. Such fluids must be given with care if myocardial damage 
has occurred. 
The question as to whether a pulmonary vasodilator could provide 
some relief of the clinical manifestations produced by post-ebullism 
bubbles trapped in the pulmonary circulation remains to be answered. 
Such an effect would depend to some degree on the ability of such a drug 
to release the vascular spasm at sites of bubble lodgment. Isoproterenol 
would be the drug of choice, not only for its pulmonary vasodilatory 
activity, but also for its positive inotropic and chronotropic actions (1, 6). 
Since metaraminol is a pulmonary vasoconstrictor, the administration of 
this drug to restore systemic arterial pressure in this situation is 
(1) debatable . On the one hand, it might tend to counteract the effect of a 
pulmonary vasodilator or if a vasodilator is not given, might seriously 
jeapordize pulmonary blood flow already partially blocked by bubbles. 
On the other hand, metaraminol might have no further effect on pulmo- 
nary vessels already maximally vasoconstricted due to bubbles. Experi- 
mentation in this area therefore appears indicated. 
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Sedation with a drug, such as phenobarbital, might be required for 
controlling mental and motor manifestations, including convulsions, 
of the ebullism syndrome. Since gastric dilatation often accompanies 
cerebral edema, oral feeding should not be attempted in the immediate 
post-recompression period. Nasogastric intubation may be needed 
for relieving gastric dilatation and used later if required for feeding. 
Urinary bladder catheterization should be undertaken if an astronaut is 
semicomatose or comatose. Prophylactic antibiotic therapy should be 
rendered if some degree of pulmonary atelectasis persists or if an 
astronaut remains in coma for a prolonged period of time. 
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CHAPTER 3 
“EXPLOSIVE” ” DECOMPRESSION INJURIES 
However remote the possibility might be, astronauts will always 
face the potential hazard of “explosive I1 decompression during space 
missions. Such an extremely rapid reduction of the ambient atmospheric 
pressure of a spacecraft cabin might be caused by penetration of the 
cabin wall by a large meteoroid or structural failure resulting from a 
landing accident on a moon or planet. The. space suit might be 
accidentally perforated by accidental contact with sharp stationary ob- 
jects or with .tools and other movable extravehicular equipment during 
extravehicular operations. 
Theoretical analyses of “explosive” decompression transients 
have been presented by Haber and Clamann (8) and others 
(12, 13, 15) 
. 
These analyses indicate that the possible injuries from an “explosive” 
decompression are determined by the change in absolute pressure, 
the ratio of the initial to the final ambient atmospheric pressure and 
the rate of decompression. It is important to remember that one of 
the main factors which determines the rate of decompression is the 
ratio of the volume (V) of the spacecraft or space suit to the effective 
area (A) of the decompression orifice. This ratio becomes the time 
characteristic (t,) of decompression when the velocity of sound (C) 
is included in the relationship 
tc =y& 
for the particular volume and decompression orifice under consideration. 
It is noted that the time characteristic is independent of pressure. 
It is noted that for thermodynamic reasons, the flow of gases through 
an opening in the spacecraft cabin wall or in the space suit cannot exceed 
the speed of sound. On the other hand, one of the physical characteristics 
of an explosion is that its air blast is supersonic. Therefore the term 
“explosive I’ decompression is actually a misnomer. However, it is com- 
monly used to refer to extremely rapid decompressions occurring in 
less than one second (2). 
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During “explosive I’ decompression, an exposed astronaut might 
sustain injuries inflicted internally by the rapid expansion of gases in 
gas-containing organs such as the lungs. A variety of mechanical 
injuries (Chapter 14) might be inflicted externally not only by being 
displaced or being struck by displaced objects as the cabin air rushes 
toward the decompression orifice, but also by the factor causing the 
decompression. After “explosive I’ decompression, acute hypoxia 
(Chapter 1) and ebullism (Chapter 2) will probably be experienced. 
This chapter is mainly concerned with the pathophysiology, clinical 
manif e stations, diagnosis and treatment in space of possible internally 
inflicted, “explosive I1 decompression injuries. The most likely exter- 
nally inflicted injuries are mentioned, but discussion of their treatment 
is reserved for Chapter 14. 
Internally Inflicted Injuries 
Pathophysiology 
Since the solid and liquid constituents of the body are not deformed 
by changes of ambient atmospheric pressure, only those organs which 
contain appreciable amounts of free gas are immediately affected by 
“explosive ‘I decompression. Whenever expanding intracorporeal 
gases cannot readily escape during an “explosive” decompression, 
they will exert pressure on surrounding tissues. Due to their fragile 
structure and the large amount of gas they contain, the lungs are more 
susceptible to injury by overpressure than the abdominal organs (13) . 
It has been established experimentally that if the intact mammalian 
lung-thorax system is permitted to expand passively, lung structure 
will disrupt at pressure differentials across the lungs and chest wall 
of about 80 mm Hg (1, 17) . This is in contrast to the pressure differen- 
tials of more than 150 mm Hg frequently tolerated in the act of coughing, 
during which active muscular effort actually reduces lung volume by 
compressing its gas content (13) . 
Fortunately the probability that an astronaut’s respiratory passages 
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could be obstructed and hence overdistended by trapped intrapulmonary 
gases at the instant of an “explosive ” decompression is very remote. 
Moreover , it appears that patent airways will allow adequate escape 
(13) of expanding gases under all but the most extreme conditions . 
These conditions can be fulfilled if the difference between the time 
characteristic of the spacecraft cabin or space suit and that of an 
astronaut’s respiratory passages is such that a transient pressure 
differential of a sufficient magnitude builds up between the lung and 
ambient atmospheric pressures. Since the volume of the lungs 
varies with respiration, it is apparent that the time characteristic 
of the lungs also varies with the phase of expiration. The trans- 
thoracic pressure differential for patent airways would therefore be 
greatest when decompression occurs at the time of full inspiration. 
The time characteristic of “explosive” decompression required 
for injury or death is unknown for humans (15). The results of animal 
s tudie s , reviewed by Luft ,413) , indicate that a cabin V/A ratio of 
2 
about 1. 2 (m3/m ), or a time characteristic of about 3 milliseconds, 
is associated with a 50 percent mortality. If such data can be rea- 
sonably extrapolated to man, only the apparently uncomplicated expo- 
sures of Sweeney , (18) who had the cabin V/A ratio about 1 (m3/m2), 
have been within the expected lethal range. It has been noted, however, 
that even if these human decompressions occurred with the respiratory 
passages closed and the lungs at mid-respiratory volume, the change 
in ambient atmospheric pressure would have been insufficient, despite 
the low V/A ratio, for a critical overpressure of about 80 mm Hg to 
be produced in the lung . (13) Finally the point should be brought out 
that even though the rate of gas escape from the spacecraft cabin or 
space suit and from the lungs depends mainly on the molecular weight 
of the gas under consideration. The molecular weights of the various 
gases which are being considered for use as spacecraft cabin atmos- 
pheres are probably not of great significance in influencing the magnitude 
of the “explosive I’ decompression hazard. 
In his discussion of lung injuries caused by “explosive” decompression 
with the respiratory passages patent, Luft (13) described three phases 
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of lung decompression. The first phase is under essentially isometric 
conditions, with no change in volume; it is due to the inertia in the 
system. This phase is probably associated with the highest trans- 
thoracic pressures. In the second phase, the transthoracic pressure 
is attenuated due to the expansion of the chest and the escape of gas 
through the airways. The third phase is again isometric. The chest 
is normally expanded until the overpressure is dissipated by the es- 
cape of gas through the trachea. Disruption of pulmonary tissues 
probably occurs to the greatest degree when these tissues reach 
their limits of tensile strength during the third phase. However, 
structural damage might also occur during the first and second phases. 
In these phases, the differences in acceleration of intrathoracic tissues 
under the impulsive pressure loading could result in disruptive lesions 
similar to those encountered in meteoroid blast (Chapter 12). Luft 
pointed to convincing experimental evidence that overdistension of the 
lungs and not the pressure pulse of the first and second phases per se 
is the mechanism primarily responsible for lung disruption. Animals 
given pneumothoraces have survived “explosive” decompressions 
which would have been absolutely fatal otherwise. This suggests but 
does not prove that distension is the critical factor (11) . The fact 
that surrounding an animal’s trunk with an inelastic fabric or plaster 
cast markedly increases tolerance to “explosive” decompression 
further substantiates this view (4, 5, 14)- . 
Although highly unlikely, it is possible that an “explosive” decom- 
pression might occur when an astronaut’s respiratory passages are 
closed, such as during swallowing and breath holding. Lung injuries 
occurring under these circumstances will be caused by the same 
mechanisms as those above. However, injuries due to over distension 
of the lung will always be more serious than those due to the pressure 
pulse of the first and second phases of lung decompression (13). The 
pressure gradient ( APL) across the lungs and passively distended 
chest wall in this situation can be estimated from the following 
relationship derived by Luft (13) . 
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[ 
V. 
APL= +(P.-47) 
1 1 + 47 - Pf max 
Vi is defined as the lung volume prior to decompression, Vmax as the 
maximum intact volume of the lungs, Pi as the initial ambient atmos- 
pheric pressure, and P f 
as the final ambient atmospheric pressure 
which, in the space situation, would be zero. It is apparent from this 
equation that when the initial and final pressures of decompression are 
given, the volume of gas trapped in the lungs relative to their total 
capacity is the factor which determines the transpulmonic pressure 
gradient which could cause overdistension and disruption of lung tissues. 
From the above equation, the pressure gradient which might exist 
across an astronaut’s lungs and passively distended chest wall if an 
“explosive” decompression to a vacuum occurs while his respiratory 
passages are closed was calculated both for different ambient atmos- 
pheric pressures which are currently used in the spacecraft (7 psia and 
5 psia) and space suit (3.7 psia), and three different lung volumes prior 
to decompression: full inspiration (Vi/Vmax = 1. 0), the normal end ex- 
piratory position (Vi/Vmax = 0. 55), and full expiration (Vi/Vmax = 0. 25). 
This data is presented in Table 3. 1. 
V. 
V1 
max 
1.0 
0. 55 
0. 25 
APL at 
Pi = 7.0 psia 
(362 mm Hg) 
362 mm Hg 
220 mm Hg 
126mmHg 
APL at APL at 
P q i 
5.0 psia P 
i 
= 3.7 psia 
( 259 mm Hg) (191 mm Hg) 
259 mm Hg 191 mm Hg 
164 mm Hg 121 mm Hg 
100 mm Hg 83 mm Hg 
Table 3.1 Pressure gradients (APL) which might exist across an 
astronaut’s lungs and passively distended chest 
wall if an “explosive ” decompression in space occurs 
while his respiratory passages are closed. They are 
calculated for different ambient atmospheric pressures. 
(P.) and lung volumes (Vi) prior to decompression to 
a Gacuum (Pf = 0). 
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It is most interesting to note that all such pressure gradients under 
these conditions are over the previously stated critical level of about 
80 mm Hg. Therefore an “explosive ” decompression in space while 
an astronaut’s respiratory passages are closed is considered a very 
great hazard from the standpoint of serious lung injury from overdisten- 
sion. 
The pathophysiologic effects of the pressure pulse and the lung over- 
distention which occur during an “explosive ” decompression have been 
described by Hitchcock (9), Karstens (lo), and others (2’ 7y ’ 3y ’ 9). 
Since these effects are similar to those produced by blast (3) , discussion 
of this area is reserved for Chapter 12. 
“Explosive ” decompression does not appear to have a serious patho- 
physiologic effect on the gastrointestinal tract. The gastrointestinal 
tract of experimental animals decompressed from 523 mm Hg to 87 mm 
Hg in 15 milliseconds showed no gross pathology (6) . It has been diffi- 
cult to produce actual disruption of the gastrointestinal tract in animal 
experiments, even with the most severe decompressions (4, 16, 19) . 
In humans, abdominal gas pains caused by “explosive” decompression 
has usually been no more severe than that resulting from slower de- 
compressions through the same pressure range (2) . As pointed out 
in Chapter 12, severe gastrointestinal dilatation might itself elicit a 
severe bradycardia. An expanded stomach might displace the dia- 
phragm upwards and so possibly embarrass respiration (2) . A tem- 
porary gastrointestinal ileus might conceivably occur secondary to 
severe dilatation. 
Expanding air in the middle ears should escape without producing 
injury,even during the most severe “explosive” decompressions. This 
is also true for the escape of air from the sinus cavities, provided 
that the sinus passages are unobstructed (2) . 
Clinical Manifestations 
Since the pathophysiologic effects of “explosive” decompression 
on the lung are similar to those produced by blast, it can be assumed that 
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the clinical manifestations associated with lung involvement would 
be the same in both situations. These manifestations are described 
in Chapter 12. 
As mentioned above, injuries from the rapid expansion of gas in 
the gastrointestinal tract and middle ear and sinus cavities are not 
an expected result of “explosive” decompression. Gastrointestinal 
distension might be associated with severe pain. Through a vagal 
reflex elicited by the distension, faintness or syncope might occur. 
Gastric distension might displace the diaphragm upwards, and so 
possibly embarrass respiration during the decompression period. A 
period of gastrointestinal ileus might conceivably follow severe disten- 
sion. Expanding gases in the gastrointestinal tract might cause pro- 
jectile vomiting and defecation. 
Diagnosis 
The diagnosis of internally inflicted injuries of explosive decom- 
pression should in most cases be obvious from an astronaut’s history 
and physical examination. Reference is made to the diagnosis of blast 
injuries to the lung in Chapter 12. 
Treatment 
The treatment of the consequences of lung injury due to “explosive” 
decompression would be the same as those outlined for blast in Chapter 12. 
Although injuries from the expansion of gas in the gastrointestinal 
tract are not anticipated, it should be mentioned that the oral intake of 
foods and fluids should be restricted until there is reasonable assurance 
that gastrointestinal distension has not produced an ileus. If ileus 
occurs, especially if it is accompanied by vomiting, nasogastric suction 
might be required. 
Externally Inflicted Injuries 
From past experience, the most serious consequences resulting 
from the accidental “explosive ‘I decompression of pressurized aircraft 
have been the few unfortunate incidents in which an individual located 
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in the direct vicinity of the opening has been physically blown out of 
the cabin with the blast of escaping air or has been severely injured 
by striking or by being struck by objects in the cabin (2) . The rush of 
air through communicating channels or narrow passageways is often 
sufficient to propel an object or person within these areas with projec- 
tile-like velocities. Thus it appears that injuries might be inflicted 
during an “explosive ” decompression, especially if an astronaut is un- 
restrained and is either close to the decompression orifice or in a 
narrow passageway between parts of the spacecraft cabin, or if items 
of equipment or other materials in the spacecraft cabin become detached 
or fragmented at the moment of decompression. This missile hazard will 
be particularly great if the cause of the “explosive” decompression is 
a meteoroid penetration (Chapter 12). The role of spacecraft cabin 
volume in determining the magnitude of this hazard must be kept in 
mind, for the greater this volume, the greater the potential momentum 
of an astronaut’s body and disrupted structures produced by decompression. 
The principles of treatment of various externally inflicted injuries 
which could result from an I’ explosive” decompression are discussed 
in Chapter 14. 
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CHAPTER 4 
DECOMPRESSION SICKNESS 
Past experience has indicated that astronauts may be exposed to a 
risk of decompression sickness during extravehicular operations which 
require decompression from an atmosphere containing an inert gas. 
Such a risk will also be present following an emergency or accidental 
decompression of an inert gas atmosphere to an ambient pressure at which 
death does not immediately result from acute hypoxia (Chapter 1) or the 
combined effects of acute hypoxia and ebullism (Chapter 2). 
As will be pointed out in this chapter, analysis of the risk of decom- 
pression sickness suggests that the potential incidence of minor manifes- 
tations of decompression sickness is quite low, and of major manifestations 
extremely low. However, until ground simulator and space operational 
experience confirm this optimistic attitude, it remains advisable to 
consider and prepare for the treatment of decompression sickness, 
especially for missions during which there will be much extravehicular 
activity. 
A detailed discussion of decompression sickness here would be 
redundant in the light of many excellent reviews which have covered all 
known aspects of this syndrome, particularly as it occurs following 
ascent to altitude (‘0, 44, ‘4, ‘5, 79, 81, 88, 89) This brief presenta- . 
tion summarizes only those aspects of decompression sickness considered 
pertinent to the occurrence and treatment of it in space. Further detail 
in this area can be sought in the key literature cited. 
Pathophysiology 
The pathophysiology of decompression sickness has received detailed 
consideration by Adler (1, 2) Catchpole and Gersh (18) , , Clamann (‘O), 
Harvey (46), Hay-maker and Johnston (47) , Kern (59), Luft (64), Rait (79),. 
Wittmer W), and many others (3, 7, 14, 19, 22, 23, 44, 77, 80, 81) . 
The following discussion is mainly concerned with the basic mechanisms 
involved in the production of this syndrome and the risk of its occurrence 
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relative to the use of various inert gases which might be considered for 
use in spacecraft cabin atmospheres. More specific pathophysiologic 
mechanisms will be considered in the subsequent discussion of the 
clinical manifestations of decompression sickness. 
Many theories have been advanced to explain the various manifesta- 
tions of decompression sickness. Most investigators believe that this 
syndrome results from the pressure and volume effects of bubbles which 
appear in the blood and tissues of the body when the sum of the partial 
pressures of gases dissolved in the body fluids becomes sufficiently 
greater than that of the ambient atmosphere. 
The literature pertinent to the formation and growth of bubbles 
formed in decompression sickness has been summarized by Roth (81) 
and others (3, 20, 33, 59, 64) . It is thought that bubbles most likely 
originate as water vapor cavities in areas where large local decreases 
in hydrostatic pressure can occur (81) . Such areas include moving 
joints, the insertions of contracting muscles, and vortices of turbu- 
lent zones of blood flow. It has also been suggested that a bubble might 
originate from a stable bubble nucleus formed in tiny hydrophobic niches 
in tissue structures (20, 21) . The occurrence of pressure pulses and 
the propagation of sound waves have even been postulated as mechanisms 
in initiating bubble formation (20) . 
Whatever focal event might be responsible for initiating bubble 
formation, an essential prerequisite must apparently be fulfilled before 
a bubble can persist and grow to a size at which it can exert pathophysio- 
logic effects. The sum of the partial pressures of gases dissolved in 
the fluid surrounding a bubble must be sufficiently greater than the absolute 
pressure (hydrostatic pressure plus ambient atmospheric pressure) being 
exerted on the fluid. This pressure difference then favors bubble growth 
from diffusion of gases into the bubble. In this respect, the nitrogen 
(or other inert gas) in the atmosphere which is breathed prior to decom- 
pression becomes the major contributor to bubble growth, due to its 
high partial pressure as compared to other dissolved gases at the sites 
where bubbles tend to form and grow. In the absence of gaseous super- 
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saturation of the surrounding fluid, a bubble will eventually collapse, the 
dissolution of gases and water’ vapor in it being driven mainly by the sur- 
face tension of its wall. 
The initial rate of growth of a decompression bubble is proportional 
to the total amounts of gases available at the liquid-vapor interface. 
Because carbon dioxide has a higher permeation coefficient than other 
gases, it is the main early constituent of bubbles formed at altitude. 
This appears to account for the greater propensity for decompression 
sickness when exercising at altitude, and possibly for the fact that most 
decompression symptoms which occur at altitude rapidly disappear 
following a relatively slight increase in the ambient atmospheric pres- 
sure (7, 11, 46, 51, 64, 81) . As a bubble continues to grow, both the 
amounts of gases in the fluid surrounding the bubble and the diffusion 
constants of these gases will determine the rate of bubble growth. In 
time, the relative proportions of gases in a bubble will become propor- 
tional to the partial pressures of these gases in the surrounding fluid 
medium I81 ). 
The non- super saturated blood which circulates through a tissue or 
past an intravascuiar site where a bubble is formed affects the growth 
rate as well as the peak size and rate of decay of the bubble. After 
decompression, the systemic venous blood, for all practical purposes, 
loses all of its supersaturated gas in passing through the lungs (15) . 
Accordingly, as soon as a bubble is formed it begins to compete for 
gases with surrounding supersaturated tissues which are in turn being 
perfused, and so desaturated, by non- supersaturated blood. The degree 
of support given to bubble growth by a tissue will therefore be directly 
proportional to the rate of gas desaturation of the tissue. This rate 
which will depend on the relative solubility of nitrogen or other inert 
gas in the tissue as compared to blood, on the rate of blood perfusion 
of the tissue and, apparently to a very minor degree, on the diffusibility 
of the gas through the tissue (56, 81) . Taking solubility and perfusion 
factors into account, it is obvious why poorly perfused adipose or fatty 
tissues, in which nitrogen has a high solubility, support bubble growth 
so well. A favorable situation for bubbles also exists in poorly perfused 
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tissues such as fibrous tissue, cartilage and bone. 
The ultimate size which an expanding bubble can attain is determined 
by the distensibility of the medium surrounding the bubble. Loose tissues 
favor the growth of large bubbles, which are usually asymptomatic due 
to the low deformation pressures associated with their growth. On the 
other hand, tight tissues such as tendons and joint capsules limit growth 
of bubbles. Such bubbles reach maximum sizes rather quickly.and are 
associated with high tissue deformation pressures which, by triggering 
of pain responses and reflex vasospasm, disrupting tissues, and com- 
promising tissue blood flow, are apparently responsible for many of 
the manifestations of decompression sickness. 
Roth (81) has assessed the role which various inert gases might play 
in determining the rate of pressure or volume rise of a bubble and, 
therefore, in determining the risks of decompression sickness. Such 
an evaluation is quite pertinent to the selection of suitable spacecraft 
atmospheres. It also assists in the determination of appropriate mea- 
sures which an astronaut might take in an operational situation, prior 
to and while decompressing from an atmosphere containing an inert 
gas, in order to prevent the occurrence of decompression sickness. 
Helium, neon and nitrogen appear to be the most suitable gases to consider 
for use in spacecraft cabin atmospheres. In the light of both his theoretical 
predictions and available empirical data, Roth concluded in essence that: 
-theory and empirical data indicate that the potential 
incidence of the minor manifestations of decom- 
pression sickness after decompression from an 
atmosphere containing helium probably does not 
differ from that after decompression from an 
atmosphere containing nitrogen, assuming that 
the inert gas and oxygen compositions are similar 
in both atmospheres. Neon might be somewhat 
more favorable than either helium or nitrogen in 
reducing this incidence. 
-theory indicates more striking differences between 
the various inert gases as far as the potential inci- 
dence of the major manifestations of decompression 
sickness is concerned, Although the potential inci- 
dence of “chokes” should be about equal for nitrogen 
and helium, the potential incidence of cardiovascular 
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and neurologic manifestations should be much less 
for helium than for nitrogen. Roth noted, however, 
that evidence from diving experiments indicates a 
less distinct difference between these gases. On 
theoretical grounds , neon should yield the lowest 
incidence of these manifestations of decompression 
sickness. 
-empirical data in this area is greatly needed. 
Clinical Manifestations 
The clinical manifestations of decompression sickness experienced 
by an astronaut would be similar to those of decompression sickness at 
altitude described by Adler (1, 2) , Clamann (20), Ferris and Engel (36) , 
Kern (59), Luft (64), Gribble (44), Roth (81), and Mclver (70). Ref- 
erence is made to many clinical reports of cases of decompression sick- 
ness at altitude (9, 10, 17, 21, 26, 31, 38, 54, 65, 68, 71, 82, 87) The 
pathologic findings in fatal cases have also been well documented 
(2: 10, 
18, 26, 47, 65, 69, 76) . Reference is also made to differences in the 
clinical manifestations of decompression sickness between aviators and 
divers (44, 47, 59) . 
Decompression sickness occurs in aviators after an ascent from 
ground level conditions of about 760 mm Hg (14. 7 psia) to ambient atmos- 
pheric pressures of apparently always less than about 380 mm Hg (7. 3 
psia, 18, 000 ft. ), and usually less than 320 mm Hg (6. 2 psia, 22, 000 
ft ) (39, 59, 81). . It should be noted that the latent period, rate and peak 
frequency of clinical manifestations of decompression sickness appearing 
after ascent are primarily functions of altitude and physical activity. 
Theoretical predictions of Nims (75) were substantiated by Anthony 
and co-workers (4) who observed that even under the most predisposing 
circumstances, signs and symptoms of decompression sickness may 
not appear for at least 5 to 10 minutes after a decompression event. 
Their rate of onset was found to increase to a peak in about 20 to 40 
minutes, and then to decline practically to zero 2 hours after decompres- 
sion. It is interesting to note that the clinical manifestations of decom- 
pression sickness have been found to appear sooner when helium as opposed 
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to nitrogen is the diluent gas in the pre-decompression atmosphere (6) . 
It should be noted, however, that this observation was made in short 
term experiments so that some nitrogen might have remained in 
tissues from the original air exposure to conbribute to the production 
of “helium ‘bends I II. 
The marked influence which physical activity has on the rate of 
appearance of clinical manifestations of decompression sickness 
deserves emphasis here, especially in the light of the fact that 
extravehicular operations in space will be associated with strenuous 
physical activity. This relationship was studied intensively by Henry 
(51) who published data presented graphically in Figure 4. 1. 
CISE 
EXERCISE 
0 30 60 90 120 
DURATION OF EXPOSURE TO ALTITUDE - min 
Figure 4. 1 Effect of physical activity on 
appearance of clinical manifes- 
tations of decompression sick- 
ness at 38, 000 feet. Standard 
exercise was 10 step-ups onto 
a 9 inch stool in 30 seconds, 
repeated every 5 minutes. 
(After Henry (51) , redrawn for Bioastronautics Data Book (74)) 
The clinical manifestations of decompression sickness in aviators 
fall into four categories - “bends”, “chokes”, skin manifestations, and 
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neurocirculatory manifestations. 
“Bends” 
“Bends” is the term used for most common clinical manifestations 
of decompression sickness. It is characterized by musculoskeletal 
discomfort which is usually described as a deep, poorly localized, waxing 
and waning, dull, gnawing pain which ranges in severity from mild dis- 
comfort to excruciating agony. “Bends” pain usually begins in the peri- 
articular tissues, and then radiates distally along the bone shaft. Reflex 
,weakness of the involved limb commonly occurs. “Bends” can be some- 
what relieved by relaxing or applying pressure over the painful area. 
It may even gradually subside in intensity if the afflicted individual is 
able to “sit it out”. However, the increased risk of other more serious 
manifestations of decompression sickness occurring if a decompression 
exposure is prolonged must be kept in mind. 
“Bends” are prone to occur in the joints that are involved in motion, 
especially the knees, ankles, shoulders, wrists, and elbows. Instances 
of “bends” pain in the sternum, ribs, cranium, and vertebrae have also 
(1, 2) been reported . The popular notion that “bends” is prone to occur 
at sites of previous injury has not been substantiated (207 42) Notably, . 
it is rare for this symptom to appear after 90 minutes exposure to altitude. 
Practical inflight experience has demonstrated that exposure to cold 
makes one more likely to develop decompression sickness, especially 
“bends”. 
X-ray findings of bubbles and the clinical pictures presented by 
individuals suffering from “bends” have in general correlated poorly (16, 
36) . Bubbles with and without associated symptoms have been seen on 
x-ray in synovial spaces of joints, in bursae, and in vaginal sheaths of 
tendons 
(12, 36, 84) 
. They have apparently also been seen in fascial 
planes and connective tissue spaces in muscles, and in tissue spaces 
around blood vessels (55, 83) . Crepitation has also been felt along tendon 
sheaths in which gas bubbles were visualized by x-ray (36) . X-ray 
studies in animals have indicated that some of the thin radiolucent lines 
and more diffuse areas which have been attributed to extravascular bubbles 
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may actually be long, cylindrically- shaped intravascular bubbles (18). 
The presence of bubbles in veins leading from exercising muscles also 
suggests that intravascular bubbles at muscular insertions could be a 
cause of “bends” 
(16, 18, 46) 
. 
It is a well known fact that on descent, “bends” almost invariably 
disappears completely. Of interest is the recent observation that 
“nitrogen ‘bends’ ” were relieved at somewhat lower pressures than 
“helium ‘bends’ ‘I (61, Immediate reascent causes crepitus and x-ray 
findings to return, thus indicating that the bubbles are compressed but 
their contained gases are not completely redissolved until some time 
after descent (‘O, 36). As the time period between exposures to decom- 
pression events lengthens, the time of onset and the progression of 
“bends” pain are slowed (83) . Re-exposure after 24 hours “on the ground” 
is apparently not accompanied by an increased “bends” susceptibility 
over that seen regularly (59). Twinges of pain may occasionally be ex- 
perienced in the affected part up to 5 days post-exposure. In very rare 
instances , signs and symptoms of mild inflammation may develop in 
the affected part and reach a peak intensity 12 to 36 hours post-exposure. 
The marked influence which physical activity has on the occurrence 
of “bends” deserves further comment. It is noted that straining exercise 
is not only a factor in the location of “bends”, but also a very important 
factor in influencing the incidence of “bends” and the speed it develops 
once altitude is reached (36, 43) . By the same token, strenuous physical 
activity has been shown to lower the altitude threshold for this manifes- 
tation by several thousand feet 
(20, 25, 37) 
. For example, such activity 
was found to increase the total number of “bends” incidents and shift 
the ratio of light to severe “bends” from 38, 000 feet (155 mm Hg or 
3. 0 psia) to 28, 000 feet (247 mm Hg or 4. 8 psia) (20) . Increasing the 
frequency of exercise may decrease this threshold still further. 
Although the mechanism whereby muscular activity intensified the 
incidence and severity of these manifestations is still controversial, 
as mentioned previously , elevated local partial pressures of carbon 
dioxide and large mechanically induced negative pressures associated with 
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muscular action appear to be the major contributors to this intensification. 
“Chokes” 
“Chokes” is the next most common clinical manifestation of decom- 
pression sickness. It usually occurs after a longer exposure to altitude 
than that required for “bends”. “Chokes” is an alarming peculiar form 
of substernal distress, characterized by chest pain, cough and respira- 
tory distress, all of which are aggravated by deep inspiration or cough- 
ing . The appearance of this symptom complex is usually heralded by 
an inspiratory, substernal burning pain which is relieved by deep 
inspiration. This pain gradually increases in severity and is experienced 
during all phases of respiration. Paroxysms of non-productive coughing 
commence and become more and more frequent. Breathing becomes 
difficult and the affecte.d individual experiences a sense of suffocation 
and apprehension. In late stages, cyanosis, syncope and “shock” can 
occur. The clinical manifestations of “chokes” are ameliorated by 
descent, but can persist for several hours depending on the period 
of time they are suffered at altitude. During this period, deep breath- 
ing can cause a recrudescence of symptoms. 
Strangely, a fiery red mucosal lining in the pharynx and larynx 
if often seen in cases of “chokes”. This sign can persist for many 
hours after descent. Auscultation, x-rays and electrocardiograms 
have never shown any very specific abnormalities in “chokes”. Right 
heart dilatation has been seen in x-rays taken during “chokes” (16) . 
Rales and x-ray findings of pulmonary congestion have been observed 
for a few hours after descent (59). 
“Chokes” is currently thought to be due to a reflex phenomenon 
arising from irritation of the pulmonary tissues by gas emboli which 
obstruct blood flow through pulmonary arterioles and capillaries (81) . 
Animal studies have supported this view (487 63, 70, 72) In such . 
studies , marked bubble formation on the venous side of the circulation 
following a decompression event was found to be associated with a rapid 
shallow respiration and pulmonary hypertension. Although quite variable, 
the clinical syndrome resulting from the intravenous injection of air in 
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humans often resembles “chokes” (81) . As will be discussed below, 
the possibility that fat emboli from disrupted adipose tissue can lodge 
in the pulmonary vessels, and so play a role in producing “chokes”, 
remains controversial. 
Skin Manifestations 
The skin manifestations of decompression sickness are mild, 
usually occurring only after a relatively prolonged exposure to a decom- 
(36) pression event . They may occur in conjunction with or presage 
more serious manifestations of decompression sickness. It is notable 
that about 10 percent of those cases progressing to circulatory collapse 
present previous skin manifestations (81) 
tations have been described. 
. Four types of skin manifes- 
1. A subjective cold sensation can be experienced 
during decompression. This sensation may or 
may not be due to decompression per se. -- 
2. Tiny intracutaneous gas blebs can appear and 
produce an intense itching sensation which is 
usually referred to as “creeps”. Prickling 
and burning sensations are also commonly 
associated with these blebs, which might in 
fact be gases trapped in the glands of the 
skin (81). 
3. Subcutaneous emphysema rarely occurs. It 
is usually found on the forearms and thighs, 
where it can produce moderate pain and 
tenderness. Crepitus can be felt and gas 
can be seen on x-ray. 
4. Actual skin lesions can occur. These lesions 
appear most frequently in individuals who are 
for some reason susceptible to “chokes”. 
They are usually found on the chest, shoulders, 
and abdomen. A lesion first develops in a 
small skin area, then spreads out irregularly 
in all directions. In early stages it has a 
pale, mottled, cyanotic appearance. Later 
its center becomes erythematous and warm. 
Mild to moderate pain may occur at this stage; 
crepitus has not been found (81). During des- 
cent, this skin lesion becomes diffusely red 
and hot, and usually disappears about 3 to 5 
minutes after descent. Four to 6 hours later, 
the lesion area again becomes tender. This 
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delayed response is maximal at 24 to 36 hours 
after descent, and can be associated with sub- 
cutaneous edema which may persist for several 
days. 
It is probable that gas emboli in skin blood 
vessels is the cause of this clinical manifestation 
of decompression sickness. The mottled cyanotic 
appearance of the involved skin area is apparently 
due to the dilatation of superficial venules and 
capillaries adjacent to areas of severe vasocon- 
striction (81). This phenomenon can even result 
in petechial hemorrhages from damaged capillaries. 
Although subcutaneous fat is a source of these emboli, 
it has been suggested that emboli from this and other 
sources reach the cutaneous vessels at altitude by 
passing from the venous to the arterial side of the 
circulation through the large pulmonary arteriovenous 
shunts and in rare instances, through a patent foramen 
ovale (18). However, there is the possibility that gas 
emboli also-form within the arterial system (81). 
Neurocirculatory Manifestations 
The cardiovascular and neurologic manifestations of decompression 
sickness have usually been described under this heading 
(1, 2, 10, 14, 36, 
65, 68, 81) . This is no doubt due to the fact that these manifestations 
often occur together and are the most serious, variable, poorly under- 
stood, rarely occurring manifestations of this syndrome. 
Malette and co-workers (65) separated cases suffering from neuro- 
circulatory manifestations of decompression sickness into two clinical 
categories. In one category, the signs and symptoms of disturbed 
cardiovascular function predominated. In the other, those of disturbed 
neurologic function predominated. At opposite ends of the scale were 
cases with only cardiovascular or with only neurologic manifestations. 
Between these extremes were various mixtures, with the clinical findings 
of the one or other category predominating. It is of interest to note that 
when these cases were arranged in this manner, no fatalities occurred 
in the group whose manifestations were only neurological (26, 65) On . 
the other hand, when cardiovascular disturbances were part of the 
clinical picture , a very significant mortality rate existed. 
A fall in systemic arterial blood pressure, often accompanied by a 
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marked bradycardia can occur at altitude. This reaction can be accom- 
panied by the usual symptoms of arterial hypotension, such as pallor, 
perspiration, faintness and loss of consciousness. Hypotensive 
episodes reportedly occur in about 10 percent of severe “bends” and 
25 percent of “chokes” cases, and can also be associated with decom- 
pression effects which are not usually classified as decompression sick- 
ness, such as gastrointestinal distension, aerosinusitis and aerotitis 
media (1, ‘0) . It should be noted that certain signs and symptoms simi- 
lar to those due to, but not associated with hypotension, can occur at 
altitude (36, 59). Hyperventilation is associated with manifestations 
such as paresthesias, lightheadedness, reduction in consciousness and 
tetany. Manifestations of acute hypoxia have been outlined in Chapter 1. 
Lightheadedness can be associated with the paroxysms .of coughing and 
cyanosis due to “chokes”. In such a case, actual loss of consciousness 
is rare. 
Hypotensive episodes at altitude are usually relieved immediately 
by descent or within 30 minutes thereafter (59, 81) . Quite rarely, 
however, hypotension persists to a varying degree. In this case circu- 
latory collapse, or the so-called delayed “shock” syndrome, frequently 
occurs in less than one hour to several hours after descent. Notably, 
this syndrome is most likely to appear in individuals who have experienced 
major manifestations of decompression sickness at altitude, especially 
severe “chokes”. However it has arisen on rare occasions without 
any premonitory or minimal signs or symptoms of decompression sick- 
ness having occurred at altitude . (81) 
It appears that any one or more of a number of mechanisms might 
be the cause of hypotension at altitude. In all probability, the simple 
syncopal,or vasovagal reaction is the commonest mechanism. An ex- 
planation of the cause of syncope associated with “chokes” must take 
into account various factor s, such as reflex bradycardia induced by the 
chest pain or by gas or other emboli in the pulmonary circulation, 
cardiac insufficiency due to extensive blockage of the pulmonary circula- 
tion by these emboli, and the peripheral vasodilatory effects of hypoxia 
and secondary hypercarbia which can occur with “chokes”. Cases of 
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syncope at altitude have been associated with frank cardiac distur- 
bances such as coronary occlusion, paroxysmal auricular fibrillation 
and bundle branch block (8). A bubble or bubbles entering the coronary 
arterial system might well have been the cause of death in one of the 
cases of decompression sickness reported by Robie and co-workers (80) . 
Finally, it is conceivable that vasodepressor syncope might result 
from an autonomic imbalance caused by embolic damage of the central 
nervous system. 
The delayed “shock” syndrome is characterized by a marked loss 
of plasma into the extravascular compartment, especially in the form 
of pulmonary edema and pleural effusion. It has been shown in recent 
animal experiments and assumed in the numerous human cases of the 
delayed “shock” syndrome cited above that death from hypovolemic 
“shock” can occur unless measures are taken immediately to supplement 
the diminishing blood volume (23, 24) . The basic mechanisms under- 
lying this syndrome are, however, an enigma. The fact that it has been 
effectively treated by hyperbaric recompression supports the view that 
the shock is secondary to a scattering of air emboli throughout the body 
(10, 13, 21, 31, 32, 81) . As mentioned previously, bubbles formed 
in tissues at altitude might conceivably cross over from the venous to 
the arterial side of the circulation while an individual is at altitude. 
However, it is possible that this phenomenon would more likely occur 
during and after descent, when the bubbles have been made smaller. 
The probable routes of bubble passage are considered to be both well 
defined, anatomically normal shunts such as pulmonary arteriovenous 
anastomoses, bronchovenous shunts and large pleural capillaries, and 
pathologic shunts such as a patent foramen ovale (14, 18, 47, 65, 76, 89) 
This cross-over concept becomes even more plausible when one takes 
into consideration the fact that high pulmonary arterial, and hence 
right heart pressures which can result from embolic blockage of the 
pulmonary circulation, would tend to drive bubbles through these shunts, 
It is also thought that bubbles can also be formed on the arterial side 
of the circulation (81). 
The question arises as to why “shock” characteristically appears 
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some time after descent. As mentioned above, decrease in bubble size 
by descent may favor bubble cross-over. It has also been suggested that 
as a bubble gets smaller, it is more apt to migrate distally beyond 
collateral circulation points, and so produce ischemia (81) . As well, 
one must remember that decompression bubbles can persist for many 
hours before they are absorbed completely (33, 46) . These bubbles 
would then exert their damaging effects on blood vessels for some time, 
so that the clinical onset of “shock” from loss of plasma sufficient to 
produce this manifestation would be justifiably delayed. Finally, it 
should be noted that the marked loss of intravascular fluid into the 
lungs and pleural “space” might be due to the fact that the lungs act 
as a filter for emboli, and hence would be more likely to suffer more 
embolic damage than would be expected in other tissues. 
The reason for the increased capillary permeability in the delayed 
“shock” syndrome is as yet to be defined. It is probable that tissue 
hypoxia from vessel blockage and irritative vasopasm induced by 
bubbles renders capillaries hyperpermeable. Since heparin appears 
to confer some protection on animals undergoing decompression, it has 
been suggested that bubbles promote platelet clumping, agglutination 
of erythrocytes and formation of plasma flocculates which lead to vas- 
cular thromboses (5, 41, 61) . Blockage of vessels by thrombi could 
then enhance the damaging effect of bubbles. In contrast to this success 
with heparm, however, a similar series of experiments failed to demon- 
strate any protective action of another anticoagulant, bishydroxy- 
coumarin (41). One explanation for this difference in findings is the 
possibility that heparin exerts its major protective effect though its 
antiproteolytic activity, which would tend to diminish the vasodilatory 
and injurious effects of the breakdown products of hypoxic tissues on 
(5) vessel walls . Another explanation centers on the observation that 
partially depolymerized hyaluronic acid (PDHA) has also had a protec- 
tive action in decompressed animals. Interestingly, both hepar in and 
PDHA have lipemia-clearing activity (41) . The possible implications 
of this are discussed below. Finally, it has been thought possible that 
biologically-active substances such as bradykinin, histamine, and sero- 
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tonin might be triggered in tissues by bubble expansion or blockage of 
blood flow, and so participate to some extent in the production not only 
of the delayed “shock” syndrome but also of other manifestations of 
decompression sickness (27, 60) . 
A not infrequent finding in fatal cases of decompression sickness 
has been the presence of microscopic fat emboli in the small arterial 
vessels and capillaries throughout the body, especially in the lungs (47, 
65, 76, 80) . These emboli have also been. demonstrated in animal 
decompression experiments (19, 22, 23) . The source and role of 
these emboli in the etiology of the delayed “shock” syndrome remains 
(81) unclear . Murray (73) has postulated that the high concentration of 
total circulating lipids associated with “shock”, severe illness and 
trauma is due to the mobilization and subsequent aggregation of fat 
from body fat depots through increased activity of a hypothalamic “fat 
center”. After finding more cholesterol in fat emboli than in depot 
fat in decompressed animals, LeQuire and co-workers (62) suggested 
that fat emboli of decompression sickness form primarily within the 
circulatory system as the result of physiochemical alterations induced 
by products of tissue damage and “shock”, rather than by entering the 
circulatory system from fat depots disrupted by decompression bubbles. 
Further support for an intravascular aggregation of fat in decompression 
sickness has been given by the observations that heparin and PDHA, 
both of which have fat-clearing activity, confer significant protection 
onanimals undergoing decompression (41) . 
In contrast to the views expressed above, Whiteley (86) could find 
no experimental evidence which would lend support for an intravascular 
aggregation of fat in decompression sickness. He postulated that fat 
enters the circulation at the site of tissue injury and that an injury itself 
can somehow modify the vascular bed, making it more sensitive to intra- 
vascular fat. Rait (79) has outlined a specific mechanism for the, release 
of fat emboli from tissues into the circulation in decompression sickness. 
The presence of both fat emboli and a fatty liver in many of the fatal 
cases of decompression sickness studied suggested to him that a causal 
relationship existed between these findings. It appeared that a fatty liver 
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under decompression ideally fulfills the three requirements, stated by 
Harris (45) , for fat embolism to occur. Firstly, a fatty liver contains 
a free, fluid, readily mobilizable fat. Secondly, the liver is essentially 
indistensible, so that intrahepatic tissue pressures higher than the 
hepatic venous pressure can develop as bubbles form in fatty hepatic 
cells. Thirdly, the liver possesses patent veins with open ends which 
do not collapse (sinusoidal system). Rait also noted that the presence 
of bone marrow emboli and, in some cases, fat emboli in fatalities 
from decompression sickness might also be explained by applying this 
mechanism to the bone marrow. Finally, he supported his fatty liver 
concept by pointing out that dietary management directed at reducing 
the prevalence of fatty liver in the Royal Australian Air Force has 
apparently accounted for the low incidence of the delayed “shock” 
syndrome in this group. 
Intravascular fat could produce hypoxic tissue damage by inter- 
fering with blood flow. It could also hydrolyse into free fatty acids 
which would damage capillary endothelium, and so render it hyper- 
per meable. It is thought that the means by which fat emboli cross 
over from the venous to the arterial side of the circulation would be 
the same as that described above for bubbles, and that the lungs would 
again bear the brunt of embolic damage due to their filtering action. 
Also of interest is the fact that the circulatory collapse due to traumatic 
fat embolism is also a delayed phenomenon, if death does not occur 
immediately due to acute right ventricular failure secondary to 
blockage of pulmonary blood flow. This delay has been attributed to 
the time required for sufficient fatty acids to be released and sub- 
sequently exert their damaging effects . (78) 
Finally it should be pointed out that recent animal studies of Henn 
and WEnsche (49) might have shed some light on the roles of bubble 
and fat emboli in producing the delayed “shock” syndrome of decom- 
pression sickness. These investigators suggested that the time of ascent 
to altitude was critical in determining the type of emboli produced. 
Roth (81) has summarized the data from their experiments, which indi- 
cated that there might be both altitude and rate thresholds for the pro- 
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duction of fat emboli. A review of the literature on fatal cases of decom- 
pression sickness and two cases of their own in which fat emboli were 
found suggested that an ascent rate between 8 and 12 Km/min (26,400 
to 37, 000 ft/min) is the threshold for fat emboli in humans. Roth 
pointed out, however, that rates of 1000 to 1500 m/min (3000 to 4800 
ft/min) have also been associated with fat emboli in humans (81) . 
Further investigation of this phenomenon is indicated. 
The neurologic manifestations of decompression sickness are 
usually of a highly diversified but focal nature (59). As pointed out 
above, they are frequently associated with other manifestations of 
decompression sickness. Those that develop at altitude are usually 
transitory, lasting minutes to a few hours after descent (20) . They 
can also appear at any time up to 12 hours after descent from altitude (81) . 
The most common neurologic manifestation is a homonomous, scintillat- 
ing scotoma with sparing of central vision (87) . Other possible signs 
and symptoms include various hemipareses, monopareses, focal or 
generalized convulsions, aphasias, sensory disturbances and sensorial 
clouding (1, 20, 59, 81) . It is noted that such important signs as im- 
pairment of judgment and inability to assess the true nature of the sit- 
uation can be pronounced (71) . Such manifestations can vary considerably 
before a stabilized clinical picture is established. 
The disappearance of neurologic manifestations of decompression 
sickness is frequently followed by an intense throbbing headache on the 
side which is contralateral to the neurologic .lesion. This headache 
has been occasionally experienced, however, without an antecedent 
neurologic event (59). This headache is often associated with nausea, 
vomiting, prostration, photophobia, and increased pain on head move- 
ment. It usually lasts from one to 12 hours in duration. 
Those neurologic manifestations with a delayed onset can take 
up to several weeks to disappear (20) . Reported cases of permanent 
neurologic sequelae of decompression sickness in aviators have been 
exe eptionally rar e , in contrast to such cases in divers (9, 20, 44, 59) . 
The electroencephalogram of individuals suffering from neurologic 
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manifestations of decompression sickness usually shows irregular slow 
waves at foci corresponding to neurologic findings (81) ., It shows no 
abnormalities in those suffering from the headache described above, 
however. 
It should be noted that the neurologic manifestations of decompression 
sickness do have to be distinguished from other neurologic signs and 
symptoms which can also occur at altitude. A convulsion can result 
from cerebral hypoxia accompanying a hypotensive episode or from 
a hypoxic exposure (59). Weakness of an extremity simulating a 
neurologic lesion can be seen with “bends”. As well, neurologic signs 
and symptoms can be caused by hypocapnia associated with hyperventila- 
tion. 
The neurologic manifestations of decompression sickness are generally 
thought to be caused by focal hypoxia of brain tissue, not only from a 
blockage of blood flow, but also from local vasospasm induced by vas- 
cular irritation by bubbles (1, 90) . There is also the possibility that 
such manifestations might be caused by bubbles forming in cerebral 
veins and tissues. Interestingly, the incidence of spontaneous migraine 
is apparently higher in those individuals who develop a scotoma and 
headache associated with decompression sickness at altitude; similar 
electroencephalographic findings have been recorded in both instances 
(38, 59, 68) . This would lead one to speculate that bubbles might be 
preferentially generated at a turbulent site in the cerebral arterial tree, 
and hence tend to lodge in the same area of the occipital cortex after 
each altitude exposure (81) . Otherwise, the various mechanisms 
postulated for delayed “shock” syndrome have also been applied to the 
neurologic manifestations of decompression sickness. It is interesting 
to speculate that fat emboli might be the cause of at least some delayed 
neurologic manifestations, especially those which require a prolonged 
period for recovery or leave permanent sequelae. 
Diagnosis 
For the purpose of diagnosis,the requirement for thorough familiarity 
. with the numerous recorded cases (2, 9, 10, 17, 18, 21, 26, 31, 38, 54, 
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65, 68, 71, 82, 85, 87) as well as the general aspects of decompression 
sickness cannot be overstressed. Any otherwise unexplainable sign 
or symptom which appears while an astronaut is in a decompression 
situation should be presumed to be a manifestation of decompression 
sickness. The strongest evidence supporting the occurrence of this 
syndrome would obviously be the relief or alteration of signs and symp- 
toms by recompression. 
Most important from a diagnostic standpoint are a detailed history, 
thorough physical examination and subsequent close observation of an 
astronaut who has experienced manifestations of decompression sickness 
such as severe “bends”, “chokes”, syncope and neurologic signs and 
symptoms while in a decompression situation, especially if signs and 
symptoms persist for some time after recompression. As noted above, 
the delayed “shock” syndrome is frequently preceded by such manifesta- 
tions. Cardiovascular function should be monitored by repeatedly record- 
ing both pulse rate and systemic arterial blood pressure. Frequent 
recording of the hematocrit, if possible in space, should be undertaken 
to diagnose plasma loss. An electrocardiogram might be indicated if 
embolic myocardial damage is suspected. As mentioned previously, 
focal neurologic involvement in decompression sickness is usually 
associated with typical electroencephalographic abnormalities over 
the involved brain area. 
Prevention 
If an astronaut could be exposed for operational reasons or in an 
emergency to an ambient pressure at which decompression sickness can 
occur, the risk of this condition developing can be lessened by several 
means. Most apropos to the space situation is the selection of a suitable 
pressure and inert gas composition of the atmosphere from which and 
to which an astronaut can have a safe, rapid decompression. Another 
measure which would be feasible to undertake in space is preoxygenation. 
The use of pure oxygen atmospheres in space would be the ideal 
preventive measure for decompression sickness. However, as Roth (81) 
pointed out in his recent assessment of atmospheres which have been 
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suggested for use in space, risks of fire and oxygen toxicity in particular 
mitigate against the use of pure oxygen as a spacecraft cabin atmosphere. 
On theoretical and empirical grounds, he predicted the risks of decom- 
pression sickness which would be present if an astronaut, who had been 
equilibrated with various 50 percent inert gas-oxygen mixtures in a 
spacecraft cabin at 7.0 psia (354 mm Hg) atmospheric pressure, is 
decompressed. He noted that rapid decompression from such an 
atmosphere , containing nitrogen as its inert gas, to a space suit at- 
mosphere containing 100 percent oxygen at 3. 5 psia (179 mm Hg) 
would be associated with a marked reduction in both the frequency and 
severity of “bends”, as compared to a similar decompression from air 
at 14. 7 psia (760 mm Hg). He predicted that the incidence of “bends” 
in a physically fit astronaut in equilibrium with such an atmosphere 
should be less than 7 percent if moderate exercise is performed, as 
was essentially the finding in human experiments (28, 29) , and much 
less than one percent during piloting operations or while an astronaut 
is at rest. These values were about three times those predicted for 
decompression to 100 percent oxygen at 5.0 psia (258 mm Hg). Con- 
sidering the risk of decompression sickness associated with other inert 
gases, Roth predicted that helium might be associated with a greater 
“bends” frequency than nitrogen. This appears to have been substan- 
tiated by recent experiments, which also showed that “helium ‘bends’ ” 
appeared sooner than “nitrogen ‘bends’ ” (6, 58) . Finally, Roth noted 
that there is theoretical evidence supporting neon as producing a much 
lower incidence of neurocirculatory manifestations, “chokes”, and 
even “bends” than either nitrogen or helium. Others have arrived at 
similar conclusions using slightly different physical models (6). 
Pr eoxygenation, or the continuous breathing of 100 percent oxygen 
for a period of time before decompression can be highly effective in 
preventing decompression sickness (6, 20, 28, 29, 58, 66, 67, 81) . 
Since this procedure must allow tissues which desaturate slowly to 
reach a “safe” level of dissolved nitrogen or other inert gas, the duration 
of preoxygenation is the major factor in determining its success. Even 
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if an astronaut has a short period of preoxygenation before decompression, 
the risk of suffering from decompression sickness will diminish. As 
well, the duration of decompression before signs and symptoms of de- 
compression sickness appear will decrease (52, 57, 66, 67) It . 
should be noted that this latent period can be shortened somewhat if 
preoxygenation is accomplished while an individual is being decom- 
pressed, presumably due to the formation of silent bubbles at pre-“bends” 
altitudes 
(50, 58, 81) 
. Increase in age, physical conditioning, and phy- 
sical activity during preoxygenation decrease the time required to accom- 
plish an adequate preoxygenation 
(20, 64, 66, 81) 
. 
Preoxygenation rules for astronauts have also been suggested by 
Roth (81) in his detailed assessment of this area. He recommended a 
minimum of two or possibly three hours preoxygenation time for astro- 
nauts who have been breathing air at 14. 7 psia (760 mm Hg) to equili- 
brate to the level of total body nitrogen in a 50 percent nitrogen-oxygen 
mixture in a spacecraft cabin at 7.0 psia (364 mm Hg) atmospheric 
pressure. He predicted that without preoxygenation, it would take an 
astronaut about 8 hours to equilibrate with this atmosphere. Whether 
preoxygenation should be carried out prior to decompressions from a 
50 percent inert gas-oxygen mixture in a spacecraft cabin at 7.0 
psia (364 mm Hg) atmospheric pressure to 100 percent oxygen at 3. 5 
psia (179 mm Hg) space suit atmosphere remains debatable, however, 
especially in the light of the low risk and mild clinical manifestations 
anticipated from such decompressions. When carried out for one-half 
hour in recent simulations of these space atmosphere exposures, this 
measure was quite effective in preventing “nitrogen ‘bends’ ” but 
apparently was not effective in preventing “helium ‘bends’ ‘I, although 
the symptoms of “helium ‘bends’ ” had more of a tendency to disappear 
spontaneously when decompression exposures were continued (6) . It 
should be pointed out that these were short-term experiments, so that 
some nitrogen might have remained in tissues from the original air 
exposure, to contribute to the production of “helium ‘bends’ ” following 
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decompression from the 50 percent helium-oxygen atmosphere at 7.0 
psia. 
Finally, it should be pointed out that an astronaut who experiences 
any manifestation of decompression sickness should be restricted, if 
possible, from being decompressed for at least 24 hours. 
Treatment 
Once a presumptive diagnosis of decompression sickness has been 
made, an afflicted astronaut should be recompressed as soon as possible 
to at least the atmospheric pressure with which he was equilibrated be- 
fore decompression. “Bends” will in most instances completely dis- 
appear on recompression. If not, local pressure and massage over 
the involved joint areas may bring some relief. “Chokes” symptoms 
should be ameliorated, but might persist or recrudesce on deep breath- 
ing up to several hours after recompression. During this period, a 
suitable analgesic might be required for the relief of such symptoms. 
It does not appear to have been established whether the breathing of 
100 percent oxygen is of greater value than the breathing of other gas 
mixtures in the relief of “chokes” symptoms. 
The major aspects of the treatment of decompression sickness 
center on its cardiovascular and neurologic manifestations. The fact 
that little is known about the specific pathophysiologic mechanisms 
involved in producing these manifestations should be kept in mind. 
Accordingly, therapeutic measures suggested here may be inadequate 
as compared to those which might be used in the future. 
Hyperbaric recompression has been used in aviation and diving 
with remarkable success in the treatment primarily of the delayed 
“shock” syndrome and the neurologic manifestations of decompression 
sickness, but also of “bends” and “chokes” not relieved by descent 
(10, 13, 17, 21, 31, 40) 
. It is apparent that in order to be maximally 
effective, this measure must be commenced as soon as possible after 
its requirement is recognized. In the past, United States Air Force 
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authorities have recommended that aviators requiring recompression 
be taken to a maximum “depth” of 6 atmospheres absolute, and de- 
compression from this pressure be carried out in accordance with 
the standard United States Navy diving tables for the treatment of 
decompression sickness and air embolism. However, there is now 
both rational and empirical justification for the use of a recompression 
profile to a maximum “depth” of 3 atmospheres absolute with oxygen 
being breathed during recompression (40, 71) . The theoretical bases 
for this are summarized in Table 4. 1. It is pointed out that if ex- 
perience justifies the use of such a profile for the treatment not only 
of manifestations of decompression sickness, but also possibly of 
other air embolic phenomena, the weight penalty associated with taking 
a recompression facility into space may be markedly diminished. 
.haracteristics Standard Navy Treatment Tables 3 ATM. ABS. Oxygen Table 
Maximal 
PI-SSSlX.2 
Applied 
Time of Pain unrelieved after 30 min. at depth not 
Exposure likely to be bends pain; symptoms persist- 
.t Maximal ing after 2 hr. probably herald residual 
Pl-SSSllrS tissue damage. 
ldications 
to Begin 
Ascent 
Expiration of 30 min. period or 30 min. 
plus time to relief on Table 4 of Standard 
Navy Table. 
‘ressure-time 
Ascent 
Pattern 
Decompression to 60 ft. rapid, limited 
by decompression sickness risk; stage 
ascent pattern with rapid pressure 
changes: 30 ft/lZ hr. stage prevents 
new bends. 
Respired 
Air 
An amount of compression in excess of that 
needed for relief; limited by: Diminishing 
efficiency of added pressure to reduce 
bubble size; nitrogen narcosis; air density; 
heat of compression; risk of decompression 
sickness. 
Usually compressed air deeper than 60 
ft. ; gradient for N2 elimination post- 
poned until O2 ,stops; 0 needed to 
prevent bends I” Table 2 attendants. 
- 
Limited by pressure-time aspects of O2 
toxicity risk and undefined retinal 
risk; Maximal bubble-ambient gradient 
for inert gas; Maximal efficiency of 
collateral circulation potential to supply 
compromised tissue foci. 
Not established; at least 1. 5-2 hr. ; 
Oxygen toxicity protection from inter- 
spersed air-breathing periods being 
investigated for ma”. 
Establish that remission is complete; 
Remain a” additional arbitrary period 
unless ended by 02 exposure concern. 
No risk of decompression sickness from 
treatment, slow pressure changes of 
continuous ascent maximize inert-gas 
elimination gradient and least disturb 
bubble nuclei, or cavitation-prone 
turbulent streams. 
02 primarily, to supply tissues harmed 
by occlusive bubble emboli, to assist 
inert-gas elimination from bubbles; not’ 
required to avoid bends from the treat- 
ment. 
Table 4.1 Summary of recompression method characteristics and 
their theoretical bases. 
(After Goodman (40)) 
The question is raised as to whether or not to recommend the instal- 
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lation of a recompression facility on board future spacecraft for the treat- 
ment of decompression sickness, air- embolic phenomena associated 
with meteoroid penetration (Chapter 12), explosive decompression 
(Chapter 3), and the ebullism syndrome (Chapter 2). Assuming that 
suitable spacecraft cabin atmospheres will be selected, current pre- 
dictions fortunately indicate that the probability of serious manifestations 
of decompression sickness occurring during space operations will be 
(81) extremely low . It is also thought that other unforeseen events which 
could result in serious manifestations due to bubble emboli are poten- 
tially rare. Therefore, in the light of the predicted rarity of serious 
clinical problems due to bubble embolic phenomena in space, transport- 
ing a recompression chamber into space does not appear justified at 
the present time. However, it is considered possible that in the future, 
recompression facilities such as reinforced, appropriately equipped 
air locks which offer a minimum weight penalty might be placed in 
spacecraft, and space, lunar and planetary stations when large-scale 
extravehicular operations are to be carried out and significant risks 
of such problems occurring are anticipated. 
Any plasma loss associated with decompression sickness must be 
immediately replaced, using either plasma or another suitable plasma- 
expanding agent such as dextran. A vasopressor or intravenous saline 
solution would be inappropriate for treating impending or manifest 
“shock”, but should be used until a plasma-expanding agent is made 
available or if such an agent is not available. The volume of plasma 
requiring replacement might be determined by calculating the static 
plasma deficit. If pulmonary edema is part of the clinical picture, it 
would be wise to administer a plasma-expanding agent slowly to avoid 
aggravation of this condition. Successful therapy of plasma loss is 
indicated by the level and stability of the pulse rate and systemic arterial 
pressure, by repeated determination of the hematocrit and by a steady 
urine output of at least 30 ml per hour. 
The question arises as to whether or not mannitol or another 
suitable osmotic diuretic should be administered in conjunction with a 
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plasma- expanding agent to an astronaut who suffers the delayed If shock” 
syndrome. As pointed out in Chapter 1, mannitol has been used effec- 
tively for the prevention of acute renal failure from a variety of hypoxic 
factors, and for the treatment of post-hypoxic cerebral edema. There- 
fore it should be administered prophylactically for renal failure to an 
astronaut who progresses to the “shock” stage of the delayed “shock” 
syndrome. Also conceivable is the possibility that mannitol might be 
used effectively to reduce and possibly reverse the diffuse extravasation 
of plasma which is characteristic of this syndrome. By the same token, 
mannitol might even be an effective form of treatment for the neurologic 
manifestations of decompression by reducing the focal embolic brain 
edema which presumably accounts for such manifestations. It must be 
pointed out, however, that the possible usefulness of this or any other 
therapeutic agent in the therapy of decompression sickness remains 
to be established. 
Total body hypothermia has apparently been effective in the treat- 
ment of the neurologic manifestations of decompression sickness (35) . 
As was pointed out in Chapter 1, hypothermia reduces tissue oxygen 
demand, assists in the control of cerebral edema, and controls the 
hyperpyrexia so often associated with severe brain damage. Although 
hypothermia might be a valuable therapeutic measure for neurologic 
manifestations and perhaps the delayed “shock” syndrome of decompression 
sickness, rendering an afflicted astronaut hypothermic might be impos- 
sible to accomplish in space in the foreseeable future. It is conceivable, 
however, that adequate total body cooling might be attained with a space 
suit water-cooled garment. Recommended hypothermic levels are given 
in Chapter 1. Suppression of shivering would be possible with chlorpro- 
mazine. 
Most authorities have recommended that 100 percent oxygen at 
ground level ambient atmospheric pressure be administered as indicated 
to cases suffering from the delayed “shock” syndrome of decompression 
sickness (1, 31, 32, 53) . It has been suggested, however, that the cere- 
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bra1 vasoconstrictor effect of a high partial pressure of oxygen might 
in fact seriously compromise blood flow to brain tissue which has al- 
ready been rendered ischemic by a combination of embolic blockage 
of blood flow and reflex irritative vasospasm (10, 90) . Because of its 
potent cerebral vasodilating action, 3. 5 percent carbon dioxide has 
been added to high oxygen atmospheres, but the greater effectiveness 
of such gas mixtures over 100 percent oxygen in the treatment of the 
delayed “shock” syndrome , or even the neurologic manifestations of 
decompression sickness, remains to be proven (90) . Moreover, it 
should be remembered that currently proposed spacecraft cabin atmos- 
pheric pressures will not provide oxygen at a partial pressure which 
can significantly reduce cerebral blood flow. This would even be the 
case if an intravehicular astronaut is pressurized in his space suit. 
Other therapeutic measures should be carried out as dictated by 
the particular case of decompression sickness. The intravenous admin- 
istration of a rapid-acting cardiac glycoside, such as digoxin, might 
be considered if there is evidence of embolic myocardial damage or 
right heart strain secondary to embolic blockage of pulmonary blood 
flow or pulmonary edema. A sedative,such as phenobarbital, might be 
required to control an agitated astronaut. If an osmotic diuretic has 
been used, an electrolyte solution might be given intravenously to 
replace fluid and electrolytes , which are characteristically lost in 
excess as a result of osmotic therapy. Intravenous feeding might 
also be required. A clear airway must be insured by whatever means 
possible. 
Finally, it should be mentioned that the potential usefulness of 
heparin in the treatment of decompression sickness remains to be 
determined. Whether or not this drug provided beneficial effects in 
animal decompression experiments through its anticoagulant, pro- 
teolytic or lipemia-clearing activity remains unanswered. The solution 
of this problem may lead not only to a better understanding of the basic 
mechanisms underlying the serious manifestations of decompression 
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sickness, but also to the possible discovery of agents which might be 
potentially useful in the treatment of decompression sickness in space. 
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CHAPTER 5 
AEROTITIS MEDIA AND AEROSINUSITIS 
Aerotitis media and aerosinusitis are well known, occasionally in- 
capacitating medical problems which result usually from an elevation 
of the ambient atmospheric pressure. Their occurrence during routine 
operations in space is considered unlikely; any cases will probably be 
attributed to certain predisposing factors. Since there has been a vast 
amount of detailed writing in this area, the discussion which follows 
will be brief, citing major works and presenting information which 
is pertinent only to missions in space. 
Aerotitis Media 
The generally accepted definition of aerotitis media was originally 
stated by Armstrong and Heim (2) as: “an acute or chronic traumatic 
inflammation of the middle ear caused by a pressure differential be- 
tween the air in the tympanic cavity and that of the surrounding atmos- 
phere”. The non-infectious character of this condition must be empha- 
sized, for only in very rare instances is infection a secondary compli- 
cation (14, ‘5, 27, 33, 35, 39) . 
Pathophysiology 
An astronaut might fail or be unable to open voluntarily one or both 
Eustachian tubes and so provide adequate middle ear ventilation during a 
recompression in space. Pressure in the middle ear might then become 
sufficiently negative relative to that of the ambient atmosphere to traumatize 
tissues surrounding this “semi-rigid” cavity. For all practical purposes, 
positive pressure differentials, even during “explosive” decompressions 
in space, should not be great enough to produce damage, provided that 
astronauts’ Eustachian tubes have reasonably normal patency (1, 14, 33) . 
The anatomy and physiology of the Eustachian tube has been dis- 
cussed in detail by many authors (1, 14, 24, 26, 32) pertinent to . 
this discussion is the fact that the tube has a flutter valve action which 
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opposes the passage of air from the nasopharynx into the middle ear 
cavity unless the tube is opened by contraction of its dilator muscles. 
This must be accomplished voluntarily by various acts such as swallow- 
ing, yawning, grinding movements of the lower jaw or the Valsalva 
maneuver. It is apparently impossible for these muscles to over- 
come a negative pressure differential of more than 80 to 90 mm Hg. (1, 2 
Either failure or inability of an astronaut to open the Eustachian 
tube during recompressions in space might occur under a variety of 
circumstances. A rapid recompression may not allow sufficient time 
or he might be too preoccupied to perform an adequate equalizing 
maneuver. Notably, maximum negative pressure differentials develop- 
ed in the middle ear on recompressions from the present space suit 
atmospheric pressure of 3. 7 psia (191 mm Hg) to possible spacecraft 
cabin atmospheric pressures of either 5. 0 psia (259 mm Hg) or 7. 0 
psia (362 mm Hg) will be such that the astronaut should.be only able 
to equalize immediately after recompression to 5 psia. Rapid emer - 
gency recompression modes which follow large decompressions of 
either space suit or spacecraft cabin might also lead to excessive 
negative pressure differentials. Inability to perform the highly effective 
Valsalva maneuver while in a “closed” space suit will undoubtedly be 
a factor predisposing to middle ear trauma from rapid suit or suit 
to cabin r ecompre s sions. Finally one should keep in mind that an un- 
conscious astronaut and probably most semi-conscious astronauts will 
be incapable of equalizing. 
The question arises as to whether a common cold or any other non- 
specific acute or chronic upper respiratory infection predisposes to 
aerotitis media. Such a condition might produce inflammatory swell- 
ing , especially in and around an otherwise normal Eustachian tube, 
sufficient to impair tubal function. A positive correlation between the 
incidence of aerotitis media and both the size of the adenoid and the 
presence of lymphoid tissue has been noted, but the magnitude of this 
relationship did not allow accurate prediction in individual cases (31) . 
The role of infection could not be separated from that of lymphoid tissue 
in obstruction of the Eustachian tube (14). Extensive studies on 
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flying and diving personnel have failed to reveal a significant correlation 
between the incidence of aerotitis media and upper respiratory 
infections 
(11, 16, 17, 33) . Another study even added the number of 
individuals excused from altitude chamber operations because of 
severe upper respiratory infection to the number who suffered from 
aerotitis media, but still failed to establish a definite relationship (33) . 
The possibility that an astronaut might experience increased difficulty 
in ventilating his middle ears if his nasopharynx becomes inflamed 
cannot be denied, however. Accordingly, an upper respiratory infec- 
tion might predispose to aerotitis media under certain circumstances 
in space, such as a rapid recompression or inability of an astronaut 
to perform the Valsalva maneuver during recompression. 
So-called “secondary” or “delayed” aerotitis media can be caused 
by the absorption of oxygen from the middle ear; increase of the at- 
mospheric pressure per se does not play a causative role (1, 4, 14, 27, 38) . 
It usually appears in aviators who have breathed oxygen during descent 
and have failed to ventilate their middle ears adequately after descent, 
and is attributed to the effect of a high pressure gradient for oxygen 
being established between the middle ear cavity and the well perfused, 
metabolically active tissues of the middle ear. Clinical manifestations 
due to development of negative pressure in the middle ear usually 
appear some 2 to 6 hours after descent, in most cases while asleep 
during which the frequency of swallowing, and therefore of equalizing 
is reduced (l). Also of note is the fact that the absorption of oxygen 
can aggravate aerotitis media caused by an atmospheric pressure change (14) . 
Astronauts will undoubtedly run a risk of developing “delayed” aero- 
titis media after being recompressed in 100 percent oxygen from a space 
suit atmospheric pressure of 3. 7 psia (191 mm Hg) to a spacecraft cabin 
atmosphere containing 50 percent nitrogen and 50 percent oxygen at 
a total pressure of 7. 0 psia (362 mm Hg). The risk following suit 
recompression to a 100 percent oxygen atmosphere at 5.0 psia (259 mm 
Hg) should be essentially no different than that for continuous exposure 
to such a cabin environment. It has been shown that the continuous* 
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absorption of oxygen from the middle ear (commonly referred to as 
“aural atelectasis” if no signs of aerotitis media are present) while 
living in this atmosphere is sufficiently rapid to cause discomfort 
after a period of several hours of sleep (12, 13) . Equalizing maneuvers 
were successful, so that “delayed” aerotitis media did not develop. 
Prolonged exposures to oxygen atmospheres at other pressures have 
presented a similar picture (19, 20) . Therefore, even though aural 
atelectasis commonly occurs in pure oxygen atmospheres, it appears 
from experience to date that there may be only a remote risk of 
serious “delayed” aerotitis media from exposure to such atmospheres 
during space mis s ions. 
The probable sequence of events responsible for producing the 
clinical picture of aerotitis media has been determined from animal 
experiments (7, 11) . The pathologic changes in the middle ear appear 
to be primarily vascular in nature, for some degree of hyperemia is 
nearly always present both in the tympanic membrane and in the mucosa 
of the middle ear. Mucosal edema and hemorrhage may occur singly 
or together, the hemorrhagic areas varying from tiny petechiae to large, 
(14) confluent areas . These effects are probably caused by a combina- 
tion of factors attributable to negative pressure. These factors include 
vasodilatation sufficient to produce a temporary vascular paralysis, 
a stagnation of tissue blood flow, imbalance of osmotic and hydrostatic 
forces between vessel and tissue fluids, a disruption of overdistended 
small vessels and the tearing apart of mucosal and fibrous tissue 
layer s. As this condition progresses, a non-inflammatory sterile fluid 
transudate appears in the middle ear cavity; there may even be gross 
hemorrhage (30, 36) . Since fluid and blood are space filling, the 
negative pressure differential decreases and consequently the progression 
of pathologic changes is arrested. Although the transudate and blood 
in the middle ear cavity are usually completely reabsorbed, blood in middle 
ear tissues can organize and hence possibly lead to some degree of 
permanent hearing loss. 
It has been reported that at about a 200 mm Hg negative pressure 
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differential, the tympanic membrane may disrupt (1) . However this 
event apparently occurs at this level of pressure only in individuals 
with previous tympanic membrane disease, so that the critical 
pressure of a normal tympanic membrane might be considerably 
higher (1, 28) . Although negative pressure differentials sufficient to 
produce disruption will probably not be attainable during the space 
suit to spacecraft cabin recompressions in space discussed above, 
it is apparent that such pressures might be reached during large 
emergency recompressions of either the space suit or spacecraft 
cabin. 
Clinical Manifestations 
Aerotitis media may be acute or chronic, unilateral or bilateral 
and mild or severe, depending on the degree and frequency of pressure 
differential insults on the ear. The incidence of monaural or binaural 
involvement is often about equal, although in monaural cases, signs 
of trauma from negative pressure are usually noted in the other 
asymptomatic ear (15, 16) . The clinical manifestations of acute 
aerotitis media may begin during or immediately following recom- 
(1) pressions . Symptoms of “delayed” aerotitis media usually appear 
some 2 to 6 hours after recompression while breathing oxygen. 
The negative pressure which develops in the middle ear during 
recompression produces discomfort in the involved ear, then pain 
which may radiate to the temporal region, cheek, and parotid gland 
on the affected side (1) . The pain occurs usually when the pressure 
differential reaches 100 mm Hg and is usually stabbing in character; 
it can begin gradually or suddenly and vary from mild to unbearable (1) . 
Its intensity does not necessarily parallel objective findings, for 
afflicted individuals have complained of severe pain and yet on exami- 
nation were found to have no changes indicating the presence of aerotitis 
media (34). Conversely, slight or even no pain has been reported in 
instances of tympanic membrane disruption (23). Pain is usually 
relieved on early ventilation of a mildly traumatized middle ear. 
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More severe trauma is followed by a sense of soreness in the ear and 
an occasional sharp pain caused by movement of the inflamed tympanic 
(1) membrane . Disruption of the tympanic membrane is accompanied 
by a sharp piercing pain, a loud “explosive report” which is felt and 
heard in the affected ear; associated vertigo and nausea may persist 
for many hours. With disruption, acute pain quickly subsides, but 
a dull ache may remain for up to 2 days. 
Partial deafness is the most frequent complaint of individuals 
suffering from aerotitis media 
(14, 23, 27) 
. A conduction type of 
hearing loss of up to 15 to 30 decibels can persist from a few hours 
to many days in duration, depending mainly on such factors as the 
degree of immobilization of the tympanic membrane by a persisting 
pressure differential and by edema and blood which accumulates in 
the membrane, and whether a fluid transudate or blood accumulates 
in the middle ear cavity 
(1, 10, 15, 31) 
. 
This loss may be fairly uniform for the various frequencies 
or may in certain individuals affect principally the lower or the 
higher frequencies (1, 27) . In general, hearing for the lower frequen- 
cies seems to be depressed first, and as more fluid is drawn into 
the middle ear cavity, the high frequencies become more and more 
effected (27). It is noted that permanent perceptive type- of deafness 
may rarely occur, presumably due to labyrinthine hemorrhage (10) . 
There are always temporary sensations of “fullness” and “stuffi- 
nes s” in an involved ear (27) . These symptoms are often accompanied 
by a feeling of fluid in the ear (14) . Tinnitus .occur s infrequently. 
Vertigo is also uncommon; when present, it is usually unilateral (18) . 
Bubbling sounds may be heard on blowing the nose, swallowing or 
(27) yawning . Another symptom which occasionally appears is autophony, 
in which the individual’s own voice and breathing sounds unusually 
loud to him (1, 27) . 
The appearance of the tympanic membrane in aerotitis media 
often, but not always correlates with symptoms of this condition fairly 
closely (14). 
_ - 
A classification of progressive pathologic changes 
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visualized on otoscopy has been advanced by Teed (34) , and is some- 
what altered here to correspond with the excellent account of otoscopic 
findings presented by Armstrong (1). It is noted that the tympanic 
membrane may or may not be retracted at the time of otoscopic 
examination. 
Grade 1 - injection of the blood vessels running 
over the pars flaccida and along the handle of the 
malleus. At a more advanced stage, there is 
erythema of the upper and posterior portion of 
the tympanic membrane. 
Grade 2 - redness of the entire tympanic membrane 
and adjacent portions of the external auditory canal. 
The tympanic membrane develops a translucent 
appearance, and small droplets of fluid may be 
seen on its medial surface. 
Grade 3 - gross fluid and bubbles in the middle ear; 
this may be temporarily concealed by congestion 
and edema of the tympanic membrane. 
Grade 4 - hemorrhage into the substance of the 
tympanic membrane and/or into the middle ear; 
this may be temporarily concealed by congestion 
of the tympanic membrane. If it occurs, a traumatic 
rupture of the tympanic membrane will usually be 
linear, quite extensive, and may involve any portion 
of this structure; the margins of a fresh rupture are 
red, the whole tympanic membrane is intensely 
inflamed and there is usually a small amount of 
blood in the external auditory canal. 
Acute aerotitis media has generally a good prognosis, provided 
that treatment is adequate and sufficient time is allowed for complete 
recovery (14). The recovery period may vary from a few hours to 3 
or 4 weeks in duration. Both the rapidity with which treatment is 
initiated following exposure and the type of treatment employed may 
affect the prognosis. As mentioned above, middle ear infection is a 
very uncommon complication of acute aerotitis media. 
Finally, it should be pointed out that repeated insults on the 
middle ear can lead to a chronic form of aerotitis media (1, 37) This . 
is probably caused by a partial stenosis of the Eustachian tube prevent- 
ing adequate pressure equalization (1) . Symptoms are aggravated by 
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repeated recompression, and include continuous feelings of “fullness” 
and “stuffiness” , occasionally tinnitus, and rarely pain in the 
affected ear. Whether hearing acuity is diminished in this c,ondition 
is not known, but it has been observed that atmospheric pressure 
changes are capable of producing permanent injury to both the middle 
ear and cochlea portion of the middle ear (1, 37) . Signs of chronic 
aerotitis media include a dull, lusterless and slightly thickened 
tympanic membrane, and a diminished or absent light reflex (1) . 
Diagnosis 
History of recompression exposure and the associated appearance 
of symptoms and otoscopic findings discussed above usually make the 
diagnosis of aerotitis media easy. Asymptomatic injection of vessels 
in the tympanic membrane can appear in association with upper 
respiratory tract disease, after performing the Valsalva maneuver 
and in 50 percent of all individuals exposed to large rapid r ecom- 
pressions (1, 33) . However, the presence of only Grade 1 changes 
and the absence of symptoms in these situations should allow differen- 
tial diagnosis . 
Prevention 
Normal upper respiratory passages, middle ears and Eustachian 
tubes, and a proven capability to equalize during reasonably rapid 
recompressions by the simple maneuvers, such as swallowing, yawn- 
ing, or grinding movements of the lower jaw, are prerequisites for 
astronaut selection. It is important to note again that the astronauts 
are unable to perform the Valsalva maneuver while in a “closed” 
space suit. 
If difficulty with equalization occurs during recompression from 
a space suit to spacecraft cabin atmospheric pressure, adequate volun- 
tary control might be attained by decompressing to a pressure which 
provide s relief, then by recompressing more slowly. However, in 
an emergency recompression, an astronaut who cannot equalize will 
have to suffer the consequences of having a negative pressure develop 
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in one or both of his middle ears. 
An astronaut with an upper respiratory infection should if possible 
avoid decompression-recompression operations. As noted above, 
an inflammatory reaction in and around the Eustachian tube might 
predispose to difficulty in ventilating the middle ear, especially if 
he is unable to perform the Valsalva maneuver. Prophylactic ad- 
ministration of a topical or oral decongestant agent to be mentioned 
below might be considered. Even though this procedure was un- 
successful in two large scale studies, more potent and specific drugs 
are pr e sently available (21, 31) . This area therefore requires further 
study. 
“Delayed” aerotitis media after recompression to an atmosphere 
containing an inert gas can be prevented by ventilating the middle ear, 
especially if a sleep period is soon to follow. Armstrong (1) suggests 
that adequate ventilation can be accomplished by performing about 
six reverse Valsalva maneuvers (taking a mouthful of water, holding 
the nostrils closed and swallowing). If there is a risk of “delayed” 
aerotitis media from living in a 100 percent oxygen environment, 
no preventive measures can be suggested other than short sleep 
periods, periodic equalization (even though no requirement might 
be felt), and optimum hydration to promote adequate salivation and 
thus frequent Eustachian tube opening through swallowing. 
Treatment 
The majority of cases of acute aerotitis media in aviators are 
mild, requiring either no therapy or minimum conservative therapy 
(1, 14, 27) . This should not be taken to mean, however, that a similar 
situation will always exist in space, for failure of highly experienced 
astronauts to equalize will probably in most instances result from the 
predisposing events discussed above, and could lead to serious cases 
of aerotitis media unless negative pressure differentials are im- 
mediately equalized. 
Relief of negative pressure in the middle ear may be attempted 
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first by shrinking the nasal mucous membrane, including that in around 
the Eustachian tube orifice, with a suitable vasoconstrictor or decon- 
gestant spray, such as l/1000 epinephrine, or oral preparatiion, such 
as pseudoephedrine or triprolidine. The Valsalva maneuver should 
then be performed again. If this attempt at equalization fails, inflation 
of the Eustachian tube might be tried with a technique which uses air 
delivered at a controlled positive pressure, if such is available in 
space, according to the same principles as politzerization 
(14, 21, 22, 23) . 
The control valve should be set initially to’deliver a pressure of 20 mm Hg 
and if this is not sufficient to provide relief, this pressure can be raised 
by 5 or 10 mm Hg increments (14). 
Paracentesis or myringotomy should be performed only in cases 
which fail to respond to methods of vasoconstriction and inflation. 
They are highly skilled procedures which demand extreme care to 
avoid implanting infectious organisms into a culture medium which 
would otherwise remain sterile (1) . Cleansing and sterilization of the 
external auditory canal and tyrnpanic membrane might be accomplished 
with an antiseptic agent such as hexachlorophene on a cotton-tipped 
applicator. Local anesthesia is ineffective. Paracentesis is the 
procedure of choice. Aspiration of transudate or blood from the middle 
ear cavity should be carried out when indicated, for it appears to hasten 
recovery and may prevent the formation of adhesions with subsequent 
permanent hearing impairment (1, 14, 27, 36) . If only partcentesis is 
to be performed, a short-bevel 22 gauge needle might suffice. If 
aspiration is indicated, a double-barreled paracentesis needle, which 
allows a compensatory passage of air into the middle ear while fluid is 
being withdrawn, should be used (2%. Myringotomy might be performed 
with a larger needle or a myringotomy knife. The prophylactic administration 
of a systemic antibiotic might be indicated following either of these 
procedures. 
Catheterization of the Eustachian tube is not a recommended pro- 
cedure to be attempted in space. The most important objection to 
it is the great possibility of producing serious permanent damage to 
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the tissues at the Eustachian orifice 
(9, 14, 27) . 
Other possible therapeutic requirements include a suitable analgesic 
or sedative for the control of pain, and an antibiotic for secondary 
infection. 
A ruptured tympanic membrane requires no specific treatment, un- 
less secondary infection occurs (1) . Except in emergency situations, 
decompression-recompression maneuvers should not be carried out 
until healing is complete. 
Aerosinusitis 
As on Earth, the potential incidence of aerosinusitis in space will 
probably be much less than that of aerotitis media (1, 6). Therefore 
this clinical entity will be discussed only briefly here. 
Aerosinusitis is also acute or chronic inflammation caused by 
a pressure differential, usually negative, but in this case existing 
between a semi-rigid nasal cavity, or nasal sinus, and the ambient 
(6) atmosphere . Usually only one sinus is involved - the frontal most 
frequently, then the maxillary sinus and rarely the ethmoid sinus (1, 6, 8) . 
The pathophysiologic mechanisms responsible for producing aero- 
sinusitis have been elucidated by Campbell (5, 6) . Aerosinusitis in 
an otherwise normal nose is most commonly due to inflamed tissue 
blocking a sinus ostium or, in the case of the frontal sinus, the duct 
connecting the nasal cavity with the sinus. This tissue has a ball valve 
effect in that air is allowed good exit into the sinus but poor entry during 
pressure change. This effect is undoubtedly enhanced by viscous sticky 
secretions in the area. The pathologic changes which can be produced by 
a negative pressure differential in a sinus are similar to those described 
previously for aerotitis media. Of note, however, is the fact that infec- 
tion appear.s to be a common complication of aerosinusitis, in most cases 
no doubt due to either an extension of the infection which caused the blockage, 
103 
I - 
or infection already existing in a sinus. 
Readily apparent factors predisposing to aerosinusitis include 
upper respiratory infection involving the nasal mucous membrane 
and rapid recompression if partial stenosis of an ostium or duct exists. 
Aerosinusitis as a consequence of living in a 100 percent oxygen 
environment has not been described, but is considered possible. 
Clinically, aerosinusitis is characterized by persistent pain which 
often begins suddenly and is usually localized over the affected sinus 
(1, 6) . Lacrimation can occur (1) . Infection of a sinus may be 
accompanied by severe throbbing pain, and possibly fever and general 
malais e. Nasal bleeding might follow severe trauma to the sinus 
mucous membrane (5). On examination, local tenderness can often 
be elicited over the affected sinus, and redundant tissue and a purulent 
discharge might be seen about the sinus opening. 
The most important measure preventing the occurrence of aero- 
sinusitis in space is obviously the selection of astronauts with normal 
nasal and sinus cavities and most particularly, adequate sinus open- 
ings. Other preventive measures are those which were discussed 
for “Aerotitis Media”. 
The treatment of aerosinusitis is directed at the relief of the ob- 
struction with an appropriate decongestant, the control of pain and 
the treatment of concurrent or secondary infection (1, 5, 6) . 
104 
REFERENCES 
1. Armstrong, H., Aerotitis Media and Aerosinusitis, in Aerospace 
Medicine, H. Armstrong, (ed..). Baltimore,illiams 
and Wilkins Co. , 1961, pp. 162-174. 
2. Armstrong, H. G., Heim, J. W., Effect of Flight on the Middle 
Ear. J.A.M.A., 109:417-421, 1937. 
3. Aschan, G. K., Aero-otitis Media anu Aerosinusitis; Experi- 
mental Histopathological Changes Due to Oxygen 
Deficiency and Oxygen Poisoning. Acta Otolaryng. , 
Suppl.69:1- 93, 1948. 
4. Bowen, w. J., Delayed Acute Aero-otitis Media and Methods 
of Prevention. U. S. Naval Med. Bull. , 44:247-252, - 
1945. 
5. Campbell, P. A. , Aerosinusitis. Acta Otolaryng., 35:107-114, 
1942. 
- 
6. Campbell, P. A., Aerosinusitis - Its Cause, Course, and 
Treatment. Ann. Otol. , 53:291-302, 1944. -- 
7. Chang, H., Margaria, R., Gelfan, S., Pressure Changes and 
Barotrauma Resulting from Decompression and Recom- 
pression in the Middle Ear of Monkeys. Arch. Otolaryng., 
51:378-399, 1950. - 
8. Dickson, E. D. D., King, P. F., Results of Treatment of Otitic 
and Sinus Bar otrauma. J. Aviat. Med. , 27:92-99, 1956. - 
9. Farrior, J. B. , Histopathologic Considerations in Treatment 
of the Eustachian Tube. Arch. Otolaryng. , 37:609- 621, 
1943. 
- 
10. Fowler, E. P. I Jr., Causes of Deafness in Fliers. Arch. 
Otolaryng. , 42:21-32, 1945. - 
11. Haines, H. L. , Harris, J. D. , Aerotitis Media in Submariners. 
Ann. Otol. , 55:347-371, 1946. - 
12. Helvey, W. M., Albright, G. A., Benjamin, F. B., et al, Effects 
of Prolonged Exposure to Pure Oxygen on Human Perfor- 
mance. RAC 393- 1 (ARD- 807- 701), Republic Aviation 
Corporation, Farmingdale, Long Island, New York, 1962. 
13. Herlocher, J. E. , Quigley, D. G. , Behar, V. S. , et al, Physio- 
logic Response to Increased Oxygen Partial Pressure. 
I. Clinical Observations. Aerospace Med., 35:613-618, 
1964. 
- 
105 
14. Hyde, R. W., Aerotitis Media: A Critical Review. Ann. Otol., 
61:937- 975, 1952. 
15. Kos, C. M., Effect of Barometric Pressure Changes on Hear- 
ing . Trans. Amer. Acad. Ophthal. Otolaryng., 49: - 
75-81, 1944. 
16. Lieberman, A. T., Aero-otitis Media in Pressure Chamber 
“Flights”. Arch. Otolaryng., 43:500-507, 1946. 
17. Melvin, W. , cited by Hyde, R. W., (see ref. 14). 
18. Merica, F. A., Vertigo Due to Obstruction of the Eustachian 
Tubes. J.A.M.A., 118:1282-1284, 1942. 
19. Michel, E. L. , Langevin, R. W. , Gell, C. F. , Effect of 
Continuous Human Exposure to Oxygen Tension of 418 
mm Hg for 168 Hours. Aerospace Med., 31:138-144, 
1960. 
- 
20. Morgan, T. E., Jr., Ulvedal, F., Welch, B. E., Observations 
in the SAM Two-Man Space Cabin Simulator. II. 
Biomedical Aspects. Aerospace Med., 32:591-602, 1961. - 
21. Ogden, F. W., A Study of the Effects of Vasoconstrictor 
Solutions on Altitude Chamber Aero-otitis Media. NAS- 
NRC-CAM-170, National Research Council, Committee on 
Aviation Medicine, Washington, D. C. , 1943. 
22. Ogden, F. W., Modified Politzerization in Treatment of Aero- 
otitis Media. Proj. No. 173, U. S. Air Force Sch. 
Aviation Med. , Randolph Field, Texas, 1943. 
23. Perlman, H. B., Quantitative Tubal Function. Arch. Otolaryng., 
38:453-465, 1943. 
- 
- 
24. Perlman, H. B., Mouth of Eustachian Tube: Action During 
Swallowing and Phonation. Arch. Otolaryng. , 53:353- 
369, 1951. 
- 
25. Requarth, W. H., Aero-otitis Media in Compressed Air Workers: 
Treatment with Helium-Oxygen Mixtures. J. A. M. A. , 
116:1766-1769, 1941. 
- 
26. Rich, A. R., Physiological Study of Eustachian Tube and Its 
Related Muscles. Bull. Hopkins Hosp. , 31:206-214, 1920. -- 
27. Schechter, D. C. , Aerotitis Media. Arch. Otolaryng. , 66:117- 
126, 1957. 
- 
106 
28. Schubert, H. ,,,Uber die Widerstandsfghigkeit des Trommelfells 
gegen Uberdruck der Aussenluft. (The Capacity of the 
Tympanic Membrane to Resist High Atmospheric 
Pressure. ) Exerpta Medica, Section II, (Physiology, 
Biochemistry and Pharmacology), 2: 945, 1950. 
29. Seltzer, A. P. , Newly Designed Paracentesis Needle for Use 
in Aerotitis Media. Arch. Otolaryng. , 53:672-674, 1951. - 
30. Senturia, B. H., Gessert, C. F., Carr, C. D., Baumann, E. S., 
Aerotitis Media. Arch. Otolaryng. , 74: 141- 149, 1961. - 
31. Shilling, C. W. , Haines, H. L. , Harris, J. D. , Kelly, W. J. , 
The Prevention and Treatment of Aerotitis Media. 
U. S. Naval Med. Bull. , 46:1529- 1558, 1946. - 
32. Simkins, C. S., Functional Anatomy of the Eustachian Tube. 
Arch. Otolaryng., 38:476-484, 1943. I 
33. Stewart, C. B. , Warwick, 0. H., Bateman, G. L., Acute 
Otitic Barotrauma Resulting from Low-Pressure 
Chamber Tests. J. Aviat. Med., 16:385-408, 1945. - 
34. Teed, R. W., Factors Producing Obstruction of the Auditory 
Tube in Submarine Personnel. U. S. Naval Med. Bull., 
42:293- 306, 1944. - 
35. Teed, R. W., A Contribution of War Experience to the Etiology 
of Otitis Media. Trans. Amer. Acad. Ophthal. Otolaryng. , 
53:254-260, 1949. - 
36. Trowbridge, B., A New Treatment of Acute Aero-otitis Media. 
Arch. Otolaryng. , 50:255- 263, 1949. - 
37. Vail, H. H. , Traumatic Conditions of the Ear in Workers in 
an Atmosphere of Compressed Air. Arch. Otolaryng. , 
10:113-126, 1929. - 
38. Wiseheart, R. H., A New Method for Treatment of Acute Aero- 
otitis Media. Ann. Otol. , 52:581-588, 1943. - 
39. Wright, R. W., Aero-otitis Media; A Further Report of Purulent 
Otitis Media Complicating Aero- otitis Media. Ann. 
oto1. , 54:499-511, 1945. -- 
CHAPTER 6 
HEAT DISORDERS, INCLUDING DEHYDRATION 
The heat disorders are clinical manifestations of disordered physio- 
logy resulting from the imposition of an excessive heat load on the body. 
The heat load may be either metabolic or environmental heat, or both. 
The most likely cause of any heat disorder suffered in space is 
thought to be an inadequacy or failure of the temperature control system 
of a space suit during an extravehicular operation. However, -even 
with the highly effective temperature control systems currently being 
developed for space suits, it is thought that there will still be a risk 
of a heat disorder occurring during future space missions (30) . 
This chapter very briefly discusses various aspects of the heat 
disorders considered pertinent to the space situation. Greater detail 
on these disorders can be obtained from the excellent reviews of 
Leithead and Lind (24), Minard and Copman (27), Webb (33) and other 
literature to be cited here. 
Classification 
The classification of the heat disorders presented by Leithead and 
Lind (24) . is well oriented from a clinical standpoint. It outlines these 
disorders in terms of cause, and points out that signs and symptoms 
associated with the physiologic compensatory mechanisms are just as 
much heat disorders as are the clinical manifestations caused by the 
actual failure of thermoregulation. This classification follows: 
1. The disorders which result from, and may 
complicate the processes of thermorenulation: 
4 
b) 
c) 
Due to circulatory instability - hueat syncope. 
Due to water and electrolyte imbalance - 
heat edema, water-depletion heat exhaustion, 
salt-depletion heat exhaustion, heat cramps. 
Due to skin changes - prickly heat, anhidrotic 
heat exhaustion. 
2. The disorders which result from failure of ther- 
mor egulation: heatstroke, heat hyperpyrexia. 
3. The disorders which are characterized by apathy 
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or fatigue, or deterioration in the performance 
of skilled tasks without any evidence of the 
entities listed above: acute heat fatigue. 
It should be kept in mind that one or more of the above heat disorders 
can be suffered at the same or different times, during or after exposure 
to a heat load. Since many heat disorders share common clinical 
manifestations, an accurate diagnosis in the absence of certain 
laboratory measures might be difficult. Fortunately, however, most 
of them respond rapidly to the same treatment. 
Clinical Manifestations 
Heat Syncope (Heat Collapse, Heat Prostration, Heat Exhaustion). 
Heat syncope characteristically follows sudden exposure to a severe 
heat load. Although some degree of water depletion may play a role in 
its genesis, this syndrome has been attributed primarily to heat-induced 
peripheral vasodilatation which leads to systemic arterial hypotension (33) . 
The associated deficiency of cerebral blood flow might be indicated 
at first by lightheadedness or dizziness. Acute fatigue, restlessness, 
nausea and blurring of vision might also precede syncope, and may be 
severe enough to render the afflicted individual incapable of undertaking 
a life- saving action. Rectal temperature is usually not significantly 
elevated, unless the individual who suffers heat syncope has been 
exercising. 
Heat syncope is more apt to occur in individuals who are unused to 
heat or the combined stresses of heat and work (33) . It would probably 
not be expected to occur in physically fit astronauts, especially if they are 
repeatedly exposed to the range of thermal conditions expected in emer- 
gency situations in space (33) . 
In the weightless environment, syncope provoked by a sudden postural 
change should not occur. For this reason, syncope in this environment 
will probably be a manifestation of a more serious circulatory impair- 
ment than syncope while sitting or standing in the gravity environment. 
As was pointed out in Chapter 10, both simulation studies to determine how 
the body responds to weightlessness and experience to date in space indicate 
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that prolonged exposure to weightlessness will lead to a temporary, and 
possibly a permanent decrease of blood volume. This and other cardio- 
vascular adaptations to weightlessness appear to enhance the tendency 
to orthostatic tolerance (Chapter 10). Hence one would expect that 
cardiovascular adaptations to weightlessness would increase an astro- 
naut’s susceptibility to the hypotensive effect of heat stress imposed 
either during operations in a gravity environment, such as while 
exploring a lunar or planetary surface, or when accelerative forces 
are applied in the head-to-foot direction during landing and take-off 
operations. The various methods under study for assuring normal 
orthostatic tolerance on return to a gravity environment are discussed 
in Chapter 10. 
Heat Edema 
This condition usually is a trivial consequence of a prolonged expo- 
sure to heat. Mild edema usually occurs in the feet. Since the gravitational 
component of intravascular hydrostatic pressure determines its production 
and distribution on Earth, heat edema may not occur in space. However, 
it is possible that mild venous occlusion produced by garment cuffs around 
extremities could predispose to heat edema, especially if an astronaut 
must endure a heat load for a prolonged period of time. This condition 
conceivably might develop after prolonged extravehicular activities in a 
gravity environment. 
Water-Depletion Heat Exhaustion (Water-Deficiency Heat Exhaustion, 
Dehydration). 
Water-depletion heat exhaustion, more commonly referred to as 
“dehydration”, results from failure to replace body water, lost in this 
case by sweating, through the inability to find or ensure an adequate intake 
of fluids. A “space-oriented” review of pertinent literature in this area has 
recently been completed by Webb (33) . Other information can be obtained 
from the major references cited in this chapter. 
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Signs and symptoms of dehydration have been summarized in chart 
form, as shown in Figure 6. 1. It is important to note that such clinical 
manifestations, especially fatigue, can appear quite suddenly and with 
such severity as to lead to a serious decrement in task performance. 
One must also keep in mind that,as military experience in hot climates 
has shown, small amounts of dehydration can easily become cumulative 
if continued day after day. 
Of interest is the well known fact that men working in heat fail to 
drink back water as fast as it is lost. Attempts to do so often lead 
to feelings of nausea and abdominal distension (33) . This phenomenon, 
referred to by various authors as “mild dehydration”, “voluntary 
dehydration”, “voluntary under-drinking”, and “involuntary hypohydr a- 
tion”, can lead to water depletion which may amount to one to two 
percent of the initial body weight 
(7, 18, 22, 33) 
. Dehydration due 
to voluntary under-drinking does not usually produce clinical manifes- 
tations. However, a clinically overt disorder can result from a 
sudden further demand placed on the body’s water stores. 
A connection between orthostatic intolerance and mild dehydration 
has been established (1, 6) . As would be expected, a markedly 
exaggerated orthostatic response is produced by a combination of 
dehydration, mild elevation in body core temperature, and bed rest, 
the latter supposedly producing the circulatory effects which can occur 
in the weightless environment (Chapter 10). Again the potentially 
disastrous effects of allowing such a combination of stresses to act on 
an astronaut, especially in a gravity environment during a space mission, 
are readily apparent. 
Salt-Depletion Heat Exhaustion 
This condition is due to the inadequate replacement of sodium chloride 
lost usually in prolonged sweating. It may occur even if fluid replacement 
is adequate. 
Salt-depletion heat exhaustion is characterized mainly by fatigue. 
However,other signs and symptoms which can appear are dizziness, 
anorexia, nausea, vomiting, headache, mental confusion, muscle cramps, 
111 
i" r . Thirst 
_ Stronger thirst, vague discomfort and sense of oppression, loss of appetite. 
Increasing hemoconcentration. 
Economy of movement. 
Lagging pace. flushed skin, impatience; in some, weariness and sleepiness, 
nausea, emotional instability. 
men Tingling in arms, hands, and feet; heat oppression, stumbling, headache; fit 
suffer heat exhaustion; increases in body temperature, pulse rate and respiratory rate. 
Labored breathing, dizziness, cyanosis. 
_ Indistinct speech. 
C 
Increasing weakness, mental confusion. 
muscles; positive Romberg sign (inability to balance with eyes closed); 
general incapacity. 
Delirium and wakefulness; swollen tongue. 
Circulatory insufficiency; marked hemoconcentration and decreased blood volume; 
failing renal function. 
apathy; 
skin; inability to swallow. 
Dim vision. 
Sunken eyes; painful urination. 
Deafness; numb skin; shriveled tongue. 
Stiffened eyelids. 
Cracked skin; cessation of urine formation. 
_ Bare survival limit 
t Death 
I 
I 
Figure 6. 1 Dehydration. 
(After Webb (33)) . 
constipation or diarrhea. Severe cases can progress into “shock”, coma 
and death. The urine in all but the late stages of this syndrome is of 
reasonable volume, but contains negligible amounts of sodium chloride. 
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The plasma sodium concentration is decreased. 
In contrast. to water-depletion heat exhaustion, this syndrome 
characteristically tends to begin slowly, producing milder, more 
chronic symptoms (24). Recognition of salt-depletion heat exhaustion 
is usually difficult, and hence its treatment tends to be delayed. 
Water and salt-depletion heat exhaustion usually co-exist, the 
one or other possibly predominating, but both requiring treatment (24) . 
Mor cover, by specifically treating the one disorder, it is possible to 
make the other manifest clinically. From the above considerations, 
an astronaut with a presumably adequate dietary sodium intake will 
more likely experience primarily water-depletion heat exhaustion. 
Heat Cramps 
Heat cramps are painful spasms of voluntary muscles. They are 
usually associated with hard physical work in a hot environment. The 
causative factor appears to be intracellular overhydration (24) . This 
can apparently result from either primary salt depletion or the replace- 
ment of sweat losses with unsalted water. The cramps may occur during 
or after exposure to a heavy work load. There are no prodromal symp- 
toms. A typical cramp lasts about 30 seconds and then relaxes spontaneously. 
It is noted that the pain and muscular spasm of a heat cramp could con- 
ceivably be severe enough to incapacitate an astronaut temporarily. 
Prickly Heat (Heat Rash, Miliaria) 
This well known skin condition appears to result mainly from prolonged 
wetting of skin by sweat, as in a hot humid environment. It is apparently 
due to blockage of sweat gland ducts by keratin debris and edematous 
epithelium (24). Associated symptoms can be annoying or be severe 
enough to disable the afflicted individual. 
Prickly heat characteristically commences as many small discrete 
red papules on a mildly erythematous skin. These papules may develop 
into tiny vesicles which contain a clear or milky fluid, each surrounded 
by an erythematous area. In long-standing cases, the vesicles might 
become secondarily infected, forming pustules (19). Hence, untreated 
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prickly heat can progress into an infected eczematous skin reaction. 
Prickly heat is particularly prone to develop in skin creases where 
sweat collects and is poorly evaporated (e. g., axillae, front of elbows, 
groins, back of knees), or in areas where clothing exerts pressure, 
prevents adequate sweat evaporation, or chafes the skin (3.) waist, 
sternum, back, shoulders, neck). It produces a sensation which is 
usually described as an intense prickling or tingling that comes on 
in waves and is triggered by an increase in sweating, by a sudden 
movement or by contact with clothing (24). Severe itching and burn- 
ing sensations are also common. It is readily apparent that this 
condition could seriously impair an astronaut’s performance by 
producing sleep loss or severe distraction during critical work periods. 
The question as to whether prickly heat could lower the threshold for 
symptoms from radiation to skin in space (Chapter 11) remains to be 
answered. 
The occurrence of prickly heat will be highly unlikely in a com- 
for table “shirt- sleeves” spacecraft cabin environment. On the other 
hand, it might conceivably result from prolonged operations in an 
inadequately ventilated, excessively warm space suit. 
Anhidrotic Heat Exhaustion 
Anhidrotic heat exhaustion affects individuals who are usually exposed 
for several months to a hot climate (24) . Hence this syndrome would 
be most unlikely to occur in space. 
This condition is characterized by the appearance of numerous dis- 
crete vesicles, mainly in the skin of the trunk and proximal parts of the 
limbs, and by diminished or absent sweating (anhidrosis) in the areas 
covered by this rash. In anhidrotic heat exhaustion, there is not only 
a decrease in sweat delivery to the skin surface due to sweat gland 
blockage, but also a depression of sweat production. Vesicles in this 
condition are.more deeply situated than, and may even co-exist with the 
vesicles of prickly heat (24). There are usually no signs of dehydration, 
in spite of the fact that polyuria for an unknown reason occasionally 
(24) occurs . The concentration of sodium chloride in the sweat is usually 
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elevated. 
The major symptom accompanying anhidrotic heat exhaustion is 
(24) marked fatigue . Palpitation and a sensation of oppression on 
exposure to heat are also experienced. Mild to moderate hyperthermia 
(100 to 102” F) has been observed. These symptoms usually subside 
rapidly on ceasing work and on exposure to a cool environment. 
Recovery of sweating is slow and heat tolerance may remain below 
normal for some time. As a rule, heatstroke does not follow, but 
must be distinguished from anhidrotic heat exhaustion. 
Heatstroke (Heat Apoplexy, Hyperthermia, Heat Hyperpyrexia) 
Heatstroke is characterized by a total absence of sweating, a self- 
perpetuating hyperthermia of usually 106” F or higher i and a severe 
disturbance of consciousness and brain function. Without treatment, 
this condition usually progresses on to death. 
Very little is known about heatstroke, for as one of the most urgent 
of all medical emergencies, its immediate treatment has taken priority 
over its clinical investigation. Since it is associated with a high 
mortality, even when adequate cooling of an individual is carried out, 
this serious heat disorder cannot be induced for experimental purposes 
in man. 
Heatstroke is not the usual response of man to extreme heat stress. 
The more common consequences which have been described above are, 
in contrast, characterized by continued sweating at reduced rates and 
a moderate or no elevation of body temperature. In a space flight context, 
there conceivably may be a situation where collapse results from combined 
heat stress and circulatory insufficiency without a remarkable rise in 
body temperature (33). In this situation, the astronaut might be unable 
to take some life-saving action, so that if the heat stress continues, 
serious or fatal heatstroke might develop. 
The pathogenesis of heatstroke is unknown. The question as to how 
much the decline in sweating is peripheral or central in origin remains to 
be answered (27). Of note is the fact that the cessation of sweating and 
hence of the most important mechanism of body heat dissipation is permanent 
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unless heroic measures are undertaken to lower the body temperature. 
A prodromal period of up to 5 days may precede heatstroke. 
Symptoms such as headache, dizziness, weakness, restlessness, 
syncope, nausea, vomiting, tachycardia, a feeling of oppressive heat, 
muscle cramps and dyspnea may occur 
(24, 33) . The prodrome appears 
to belong to a category in which heat exhaustion with moderate hyper- 
thermia is the underlying disorder. If this prodrome is recognized 
and adequately treated, heatstroke is prevented. More often, however, 
an individual has the prodromal period measured in minutes, especially 
if exposed temporarily to a severe heat load. In fact he can be essen- 
tially asymptomatic up to the moment he loses consciousness. 
Cessation of sweating involving the entire body, including the face 
and axillae, may be often noted immediately prior to the onset of 
heatstroke. Other signs and symptoms in this critical period are a 
flushed dry skin, an increase in the rate and depth of breathing, a 
growing restlessness, an inability to fix attention on any task, and 
frequently pallor around the eyes and lips (33) . 
The skin of an individual suffering from heatstroke is character- 
istically hot, dry, and flushed. On occasion it becomes cyanotic. 
The body temperature tends to be highest in those cases with the 
shortest prodromal period, thus indicating the potential seriousness 
of this condition and the need for heroic emergency medical measures. 
If the prodrome is prolonged, the temperature is usually less than 
106” F. Central nervous signs and symptoms vary from mild con- 
fusion to delerium, convulsions, and coma. A direct relationship 
between the nervous manifestations and the degree and duration of 
hyperthermia is apparently always evident. Breathing is rapid and deep. 
Signs of “shock’: such as pallor, cyanosis, hypotension, “thready” 
pulse and oliguria, are not seen until heatstroke is far advanced. 
This type of circulatory failure is considered to be predominantly peripheral 
in origin by Minard and Copman (27) and cardiac in origin (forward 
heart failure) by Gold (16). In spite of opposing views, however, treat- 
ment should probably be intensively directed at both causes of failure 
as “shock” usually heralds a rapid death. Except in those cases which 
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are preceded by severe heat exhaustion, hemoconcentration and changes 
in blood electrolytes are usually not seen in heatstroke. The state 
of acid-base balance during heatstroke remains to be determined. 
For a more detailed discussion of the clinical and pathologic findings 
in heatstroke, reference is made to the studies of Malamud and co- 
workers (26) and the review of Gottschalk and. Thomas (17). Reference 
is also made to the Army experiences with heatstroke in World War II, 
summarized by Schickele (31) . 
An over-all mortality figure in the range of 15 to 25 percent in 
heatstroke would seem to be a reasonable estimate from past data (2, 23) t 
although Leithead and Lind (24) give a figure of 20 to 50 percent 
(average 35 percent). The majority of individuals who survive heat- 
stroke usually recover (27). Their body temperature usually remains 
unstable from 3 to 21 days, so that a strong predisposition for recur - 
rence of heatstroke or other heat disorders exists during this time. 
A small percentage of individuals are chronically disabled to some 
degree by neurological lesions which most commonly involve the cere- 
bellum (e. g., ataxia or motor incoordination, and dysarthria). Mental 
disturbances may range from those detected only by a special examina- 
tion, to a complete change in personality or actual dementia (23) . 
Heat Hyperpyr exia 
Heat hyperpyrexia is a term used in the classification of heat dis- 
orders by Leithead and Lind (24) to refer to a condition which differs 
from heatstroke in that the individual is still conscious and rational, 
and sweating is still present. The rectal temperature is usually above 
105” F, but tends to be lower than in heatstroke. According to this 
definition, heat hyperpyrexia could conceivably represent either a form 
of heat exhaustion with hyperthermia, the prodrome of heatstroke, or 
a condition of hyperthermia following severe exercise. It is, therefore, 
a vague term which if not defined more specifically, might best be discarded. 
Acute Heat Fatigue 
A decrement in the performance of skilled mental and physical tasks 
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tends to occur in unusually hot environments. The reason for this 
has not been given. It is not associated with any of the clinical mani- 
festations listed above. The degree of impairment is influenced by 
such factors as motivation, type of task, degree of acclimatization 
to heat and physical condition. Many different kinds of performance 
can be affected, including those which depend principally on perceptual 
activities , on thought processes of differing complexity, and on sen- 
sorimotor coordinations of response mechanisms (24) . This problem 
is not considered to require treatment other than a reduction of environ- 
mental temperature to a tolerable level. For further detail on this prob- 
lem, reference is made to Leithead and Lind (24) . 
Diagnosis 
For the most part, the diagnosis of most heat disorders in space 
will be obvious from the history and physical examination of an affected 
astronaut. Special laboratory procedures such as determinations of 
serum and urine sodium concentrations, even if possible in space, 
should not be required unless the signs and symptoms force consideration 
of a differential diagnosis. Information concerning past fluid intake 
and urine output might prove valuable, particularly in the diagnosis of 
a disorder which begins slowly. Rectal temperature readings would 
be preferable, but oral readings might suffice. For features diagnostic 
of the various heat disorders, reference is made to the preceding brief 
discussions of those disorders and to the references cited. 
Prevention 
The question arises as to whether or not an astronaut should be 
acclimatized to heat in anticipation of a possible exposure to an excessive 
heat load in space. Of great value in assessing the feasibility of this 
measure are the numerous writings cited in the following brief discussion 
of this area. 
Acclimatization to heat is a qualitative and loosely used term referring 
to a complex physiologic response to an increased heat load. This res- 
ponse improves thermoregulatory processes, so that the potential harmful 
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effects of a heat load on the body are minimized and hence optimum 
body functioning is maintained. In spite of intensive investigation, 
the basic mechanism underlying acclimatization to heat has not been 
defined. Numerous studies have shown that with repeated exposures 
to an increased heat load, the thermal threshold for sweating and the 
concentration of salt in the sweat progressively decrease, and the 
(1, 4, 5, 11, 13, 14, 20, 
maximum sweat rate progressively increases 
25, 29, 34) . Concomitantly, the elevation of skin and rectal tem- 
peratures and the pulse rate during an exposure, and the expenditure 
of energy for a given work load become progressively less. Other 
physiologic parameters measured during the acclimatization process 
have been discussed by Leithead and Lind (24) , Bass (3) , Robinson (28), 
(12, 15) and Fox and co-workers . The end result of acclimatization to 
heat is the loss of the characteristic subjective discomfort, lassitude, 
and impaired ability to work which affect the exposed, unacclimatized 
individual. As well, acclimatization markedly reduces the incidence 
of heat disorders. 
Evidence is conclusive that this acclimatization process with its 
many physiologic variables behaves in many ways like a single physiologic 
response. Robinson and co-workers (2% clearly demonstrated the 
effectiveness of combining hard work with heat exposure to produce 
rapid acclimatization. The following characteristics of heat acclimatiza- 
tion, as presented by Bass (3) have been supported by many investiga- 
tors (4, 5, 11, 25, 28, 29, 34; . 
Heat acclimatization begins with the first 
exposure to heat, progresses rapidly 
and is usually well developed in 5 to 9 days. 
It can be induced by short, intermittent 
work periods in the heat lasting at least 
two hours daily. The general pattern of 
acclimatization is the same for short, 
severe exertion as for moderate work of 
longer duration. Inactivity in the heat 
usually produces only slight acclimatization. 
Subjects in good physical condition usually 
acclimatize more rapidly and are usually 
capable of doing more work in the heat. 
Good physical condition, however, does not 
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in itself confer acclimatization. 
The ability to perform “maximal” work 
in the heat is attained quickly by progress- 
ively increasing the work load within the 
capacity of the individual. 
Acclimatization to severe conditions will 
facilitate performance at lesser conditions 
and provide “partial” acclimatization to 
more severe conditions. 
Inadequate water and salt replacement 
can retard the acclimatization process. 
Acclimatization to heat is well retained 
during periods of no exposure for about 2 
weeks. Thereafter , it is lost at a rate 
which varies among individuals. The major 
portion is lost within 1 to 2 months. Main- 
tenance of optimum physical condition pro- 
motes the best retention of acclimatization. 
Is it practical to attempt prophylactic acclimatization of an astronaut 
to heat in order that he might better handle an unanticipated high heat 
load in space? Since the major portion of this acclimatization appears 
to be lost within 1 to 2 months, it would seem impractical to carry 
out this measure prior to a mission of this duration. On the other hand, 
it is conceivable that acclimatization to heat, and so the optimum use 
of sweating as a thermoregulatory response, could be maintained in 
space by subjecting an astronaut to repeated high work (exercise) loads 
in a warm environment such as an inadequately cooled space suit. This 
view has been supported by the reports of Blockley (7) , Roth (30) and 
Webb (33). If such training were carried out, an astronaut would be 
prepared to take full advantage of a gas ventilating system during an 
extravehicular mission. Other advantages to acclimatization to heat would 
include a lessening of the susceptibility to circulatory insufficiency in 
situations involving some degree of heat load (33) . It is of interest to 
note that Fox and co- workers (14) , have reported success in acclimatizing 
individuals to heat by artificially elevating the body temperature. The 
role of physical condition in determining both the ability of an unacclimatized 
astronaut to handle a high heat load and the duration of retention of 
acclimatization must also be considered. 
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The requirement for acclimatization to heat will be greatly influenced 
by future evaluations of the risks of inadequacy or failure of temperature 
control systems under various conditions which might result in the 
exposure of an astronaut to a high heat load. Therefore, it appears 
that the practicability of acclimatization to heat will depend on a con- 
tinued evaluation of risk. This will in turn depend for the most part 
on the reliability data from the future development and testing of 
temperature control systems, and on the type and duration of the mission. 
Other preventive measures are readily apparent, for all must be 
taken to prevent heat disorders, whether on Earth or in space. The 
main measures include an adequate salt and water intake, and adequately 
functioning spacecraft cabin and space suit temperature control systems. 
Ideally, serious dehydration should be prevented by taking small amounts 
of water during the time the water loss is high. Drinking large amounts 
of water may produce diuresis with a net loss of body water (21) . As 
well, gastric distress and even vomiting - a very serious hazard in 
the weightless environment (Chapter 8) - may be provoked. If heat- 
stroke is suffered by an astronaut, he should not perform activity 
which could result in a heat load being forced upon him for at least 2 
to 3 weeks. 
Finally, it should be remembered that singly or combined, a loss 
of acclimatization, a decrement in physical condition, and a decrease 
in circulating blood volume on return to a gravity environment or due 
to voluntary under-drinking in space are factors which could seriously 
increase the susceptibility of an astronaut to heat stress and should, 
therefore, always be brought into consideration when the setting of 
normal and emergency tolerance limits to heat loads in space. 
Treatment 
The treatment of heat disorders has been discussed in detail by 
Leithead and Lind (24), Minard and Copman (27), and others (8’ 99 329 
33) . With the exception of heatstroke, all heat disorders which could 
occur in space should be cured rapidly and completely if adequately treated. 
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Based on well established principles, treatment will usually include 
a period of rest in a cool environment and the r,eplacement of depleted 
body salt and water. Rarely might it be necessary to use special 
measures to lower the body temperature or to treat “shock”. 
Heat syncope on Earth usually responds rapidly on exposing the 
afflicted individual to a cool environment. However, if heat syncope 
occurs in space it should be assumed that since there is no postural 
hypotensive effect in the weightless environment, the syncope has 
been contributed to by a decrease in blood volume due to one or more 
related or unrelated causes, such as voluntary under-drinking, ex- 
cessive sweating, inactivity or weightlessness per se. This might 
mean that syncope in an astronaut exposed to a heat load should be con- 
sidered a possibly serious “shock” state which should be treated 
intensively with intravenous fluids, a vasopressor and oxygen if the 
astronaut does not respond rapidly to a cool environment. 
Water and salt-depletion heat exhaustion and heat cramps should 
all be treated in the same manner. As previously pointed out, both 
water and salt-depletion will probably co-exist, so that the specific 
treatment of the one disorder could make the other disorder manifest 
clinic ally. Therefore, assuming that the kidneys can selectively handle 
either excess water or sodium chloride, salted water should be admin- 
istered for both water and salt-depletion heat exhaustion. Usually 0.1 to 
0. 2 percent salt in water given orally suffices. However, if an astronaut 
is vomiting or seriously depleted, isotonic saline should be given intra- 
venously. Salt tablets of any form are not indicated, for they dissolve 
too slowly and are very prone to cause gastrointestinal upset. An 
afflicted astronaut should rest in a comfortable cool environment. 
Rarely, special cooling measures discussed below might be required. 
Both prickly heat and anhidrotic heat exhaustion respond well to con- 
tinuous exposure to a dry, cool environment. Dry non-irritant clothing 
must be worn, Washing with an antiseptic soap, such as hexachlorophene, 
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will help to prevent or control secondary skin infection. If well estab- 
lished, a skin infection might require treatment with a suitable local 
or systemic broad spectrum antibiotic. 
Heatstroke is a medical emergency requiring immediate “heroic” 
treatment. The body core temperature of an afflicted astronaut must 
be decreased as quickly as possible to 102” F. An acute lowering of 
body temperature below 102” F can apparently lead to a cardiac 
arrhythmias, and should, therefore, be avoided (32) . The practicability 
of various body temperature-lowering methods for use in space should 
be investigated. Evaporative cooling, accomplished by passing dry 
air over moist clothing might be possible in the space cabin. More 
practical, however, might be the use of a space suit liquid cooling 
garment. In this case, the vasoconstrictive effect of cold, especially 
on skin vessels, will be an important factor in considering an optimum 
coolant temperature. It is also noted that the effect of surface cooling 
is usually markedly enhanced by vigorous skin massage. The admin- 
istration of cold fluids orally should also be considered for cases 
which are able to ingest these fluids. At the present time, chlor- 
promazine is being administered intravenously to patients being 
cooled for heatstroke, apparently for its role in depressing the hypo- 
thalamic center for heat conservation, in promoting peripheral vaso- 
dilatation, in abolishing shivering due to cold, and in preventing convul- 
sions, restlessness and other hyperirritable states (24). 
For reasons already discussed, an astronaut suffering from heat- 
stroke and associated “shock” should receive oxygen and a vasopressor 
drug, such as metaraminol, even though such a drug might reduce heat 
dissipation by producing peripheral vasoconstriction. From the work 
of Gold (16), administration of a rapid-acting cardiac glycoside intra- 
venously may be valuable in hyperpyrexia or early heatstroke, even 
in the absence of frank “shock”. Such a measure must be undertaken a, 
with extreme caution because of the possible presence of marked 
electrolyte abnormalities which are conducive to digitalis intoxication. 
Intravenous fluids should be administered with care to avoid precipitation 
123 
of acute pulmonary edema, but can be given more intensively if serious 
salt or water depletion has been evident prior to onset of the heat- 
stroke. The fluid of choice is normal saline. An osmotic diuretic, 
such as mannitol, might be added to this regimen if the danger of 
renal damage from “shock” exists. Sedatives or narcotics should 
not be given in heatstroke. If the astronaut is comatose, attention 
must be given to maintaining a clear airway, and urethral catherization. 
An astronaut with hyperpyrexia unassociated with other signs or 
symptoms should rest in a cool environment and be watched carefully. 
His fluid intake should be kept at an optimum level. A special cooling 
measure might be indicated if his body core temperature remains ele- 
vated or if signs and symptoms of other heat disorders appear. 
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CHAPTER 7 
COLD INJURY AND HYPOTHERMIA 
d Recent discussions of space suit and spacecraft cabin thermal c ntrol 
have indicated that an astronaut’s risk of exposure to an excessive heat 
loss will be much less than his risk of exposure to an excessive heat load 
(Chapter 6) during space operations 
(30, 44, 77) 
. It is even conceivable that 
potential medical problems from heat loss will be virtually eliminated in 
future space systems. For the present, however, these problems should 
be considered possible, especially if an extravehicular astronaut is ren- 
dered immobile for a period of time in a shaded space environment. In 
this situation, local or total body conductive heat loss might be increased 
by an abnormal amount of moisture in his space suit, by an increased 
thermal conductivity of his suit insulation due to compression against an 
external object and by wide-spread contact between his suit and a cold 
lunar, planetary or spacecraft surface. It is also remotely possible that 
continued operation of an astronaut’s suit thermal control system during 
such an exposure could be a factor contributing to a medical heat loss prob- 
lem. 
It has been speculated that either artificially-induced hypothermia or 
more preferrably an induction into a state resembling hibernation might 
provide a means of protecting astronauts from various hazards during long 
space missions (17, 57) . However, the practicability of such a measure 
remains to be proven. 
In this chapter, the pathophysiology, clinical manifestations, diagnosis, 
prevention, and treatment of cold injury, resulting from excessive local 
body heat loss, and hypothermia, resulting from excessive accidental total 
body heat loss, will be discussed briefly. For greater detail than that to 
be presented here, one can consult the many excellent reviews cited. 
Pathophysiology 
Cold Injury 
Cold injury is tissue damage which can result from either the non-freez- 
ing or freezing of tissues. Since the extent and severity of the damage depends 
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upon a great number of factors, a critical exposure temperature for cold injury 
in humans cannot be clearly defined. The major factors which could con- 
tribute to this injury in the space situation are the exposure temperature, 
the duration of exposure and the amount of conductive heat loss contributed 
by moisture in the space suit or other failures of thermal protection by the 
suit. Other important factors will be discussed below. To give some idea 
as to what exposures could cause cold injury, it is noted that past experience, 
particularly in military operations, has shown that the feet are usually in- 
jured following their exposure in excess of 12 hours in water at temperatures 
below 50°F (immersion foot) or in excess of 24 hours in moisture near 
freezing (trench foot) (6, 26, 62) . Thus cold injury could occur below 10°C 
(50°F) if the duration of the exposure is sufficiently prolonged (61). 
It is important to note that various tissues do not show the same degree 
of susceptibility to cold injury. Blood vessels, nerves and striated muscles 
are highly sensitive to cold (6) . Skin, fascia, connective tissue, bone and 
tendon are quite resistant (6) . Damage to deep structures, such as nerve 
and muscle, can therefore occur without the overlying skin being signifi- 
cantly damaged by cold. 
The pathophysiology of cold injury remains uncertain (48, 65, 67) . 
One reason for this has been the paucity of tissue from humans available for 
study during the acute phases of this injury (66). Most author itie s believe 
that cold injury can be secondary to vascular changes in the tissue during 
cold exposure and rewarming, due to direct injury of the tissue by cold, or 
from some combination of these mechanisms (6, 8, 16, 26, 51, 52, 62, 63, 
67, 89, 92) . Because the management of cold injury is directed at 
these possible mechanisms, they are discussed below in some detail. Al- 
though not definitely stated, these considerations apply in particular to cold 
injury of the limbs. For readily apparent reasons, the damage develops at 
first distally, then progresses proximally in the limb. 
Cold-induced constriction of arterioles and small arteries can conceivably 
produce local hypoxic tissue damage. Further lowering of the local tissue 
temperature secondary to vasoconstriction sets up a vicious cycle which 
leads to further local hypoxia. The vasoconstriction can be not only due to 
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a normal local response to cold, but also to the centrally-induced, generalized 
peripheral vasoconstriction which occurs if the total body heat loss is suffi- 
cient to force the body to preserve its core temperature (42, 46) . Of great 
interest are the observations that vasoconstriction might not occur if the 
bo.dy does not have to conserve heat, and that constricted vessels in cold 
extremities can be reopened if the total body heat is maintained at a level 
bordering on positive heat balance 
(4, 75, 81, 84) 
. These findings point to 
the importance of maintaining adequate total body heat during exposure to 
both local and generalized heat loss. 
Apparently to protect the vasoconstricted extremity from cold injury, 
the so-called hunting or Lewis phenomenon occurs (58) . This rather complex 
response to cold is a periodic vasodilatation which allows periodic surges 
of warm arterial blood to pass through the cooling tissues (‘6, 58) It is . 
usually triggered at tissue temperatures below 10°C (50°F) (4oy 45). ‘The 
hunting phenomenon may do little to provide adequate heat and oxygen re- 
placement to cooled peripheral tissues in man, however, for apparently the 
capillary flow in these tissues increases only slightly while most of the 
blood passes through arteriovenous anastomoses (39, 45) . Moreover , it 
has also been shown that this phenomenon can be prevented or reduced in 
magnitude by an excessive total body heat 10s s (12, 28) , or by emotional 
states such as anxiety (2, 12) . Even in subjects who are generally warm, 
the transient vasoconstriction caused by deep respiration or startle is con- 
siderably prolonged when the hand or finger is exposed to cold (7) . Therefore 
the hunting phenomenon might at best be a poor and unpredictable protective 
mechanism. However, this discussion of the body’s attempt to protect it- 
self from cold injury does suggest that specific measures which increase 
both peripheral blood flow and tissue perfusion might offer some protection 
from cold injury. 
The major vascular mechanism of cold injury appears to be the irrever- 
sible vascular occlusion and subsequent tissue hypoxia which follow the re- 
warming of frozen tissues or tissues exposed to non-freezing cold for long 
periods of time 
(6, 26, 51, 52, 53, 68) 
. From observations made in 
extensive animal experimentation, Kulka (51, 52, 53) described the 
sequence of cold-induced vascular changes as: arterial and arteriolar con- 
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striction, excessive venular- capillary dilatation, increased endothelial 
leakage, erythrostasis, arteriovenous shunting, segmental vascular necrosis 
and massive thrombosis. He noted that neural, humoral or hemic factors 
may all contribute to the production of the three basic functional defects of 
vasoconstriction,venular dilatation and endothelial leakage (51) . Mundth 
(67, 68) has also presented evidence which indicates that the primary 
pathologic process in response to freezing injury appears to be an alteration 
in the intravascular cellular stability with the formation of platelet and 
erythrocyte aggregates. It has also been noted that the tissue damage can 
be enhanced further by vasoconstriction proximal to the injured area, 
mechanical irritation and bacterial infection (26, 52). As will be discussed, 
various measures which are directed at improving local tissue perfusion, 
and inhibiting intravascular cellular aggregation and clotting have had a 
beneficial effect on tissue survival and function following cold injury. 
Although freezing can cause tissue damage by mechanically disrupting 
cellular structure, especially in highly specialized tissues, it is a well 
known fact that certain tissues can survive unquestionable freezing (52, 63) . 
On the other hand, death of other tissues has occurred in spite of there being 
no histological evidence of disruption (62) 
tulated in reviews by Meryman 
(61, 62, 6;) 
The reason for this has been pos- 
. He stated that during freezing, 
intracellular dehydration occurs. This dehydration results from extracellular 
ice crystal formation. The remaining , unfrozen extracellular fluid is ren- 
dered hyperosmotic with respect to the intracellular fluid, so that water is 
drawn osmotically from the cells. The high concentrations of electrolytes 
and other cell constituents then causes cumulative injury to the cell through 
biochemical means, such as denaturation from electrolyte concentration 
and unnatural chemical bonding (63) . Meryman also noted that rapid freezing 
is tolerated better than slow freezing (61, 62) . However, he quoted reports 
indicating that the successful survival of rapidly frozen tissues depends 
primarily on rates of freezing and subsequent rewarming which cannot be 
attained in the clinical situation. 
It is possible that a prolonged exposure of certain tissues to low non- 
freezing temperatures could cause an irreversible imbalance in the function 
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of metabolic enzyme systems (48, 77). . However, this view is not definitely 
stated by other authors (6, 26, 891, 
Outside of the conclusion that cold or frozen tissue should be rewarmed 
as quickly as possible, no specific beneficial measures appear to be indi- 
cated by the above considerations of the mechanisms of direct injury by cold. 
Therefore the prognosis apparently cannot be improved if the damage has 
been caused by the direct effect of cold. Notably, this contrasts to the sig- 
nificant improvement derived from measures which are directed at the 
vascular mechanisms of, cold injury. 
Clinical Manifestations 
Cold injury usually occurs quite insidiously, so that warning symptoms 
are often insufficient to prevent tissue damage. The only warning symptoms 
may be paresthesias followed by anesthesia of the exposed part. In cases 
of hand exposure, manual dexterity will, of course, be impaired. The 
skin is usually erythematous at first, but then becomes pale or waxy-white 
in appearance. Frozen tissue is described as “dead white”. It is hard 
and may even be brittle. It is completely lacking in sensation and move- 
ment. 
In the past, cold injury has been classified clinically under one of four 
categories - chilblains, immersion foot, trench foot, and frostbite. Al- 
though this more operational classification could apply to cold injuries in 
space, it is generally believed that such injuries are best classified simply 
as two types - freezing or non-freezing. Even this classification could be 
considered inappropriate, for a local cold exposure in space would undoubtedly 
produce a graded injury, characterized by a possible freezing injury of the 
most exposed part and lesser degrees of non-freezing injury progressing 
centrally from this part. Fortunately, however, tissue damage and its 
management are very similar for both freezing and non-freezing injury, 
the only variable being severity of the damage. 
Most authors describe cold injuries as falling into one of four degrees 
of severity. Since it takes several days for the degree of freezing and non- 
freezing tissue damage to become fully manifest, this classification is of 
little value from therapeutic and prognostic standpoints in the immediate 
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period after a cold exposur’e 
(6, 26, 48, 65) . Mills has pointed out that a 
cold injury in its early stages may be classified often as no more than 
superficial or deep (64) . However, the broader classification summari 
(6, 11, 20, 26, 48, 70, 74, ‘2), is useful for below from many author S 
.zed 
a 
detailed description of the clinical manifestations and the course of cold 
injury as related to its severity. 
First Degree - hyperemia and edema. During rewarm- 
ing, the skin initially becomes mottled and cyanotic, 
then red, hot, and dry. This hyperemia blanches poorly 
on pressure, with capillary refilling being very slug- 
gish or absent. At first there is frequently an intense 
burning or itching sensation; later there is a deep- 
seated ache. In milder cases, these symptoms may 
cause intense discomfort for several hours, and then 
gradually disappear without serious sequelae. In 
more severe cases, they are not only more severe 
and prolonged, lasting for periods up to several days, 
but deep aching pain, paresthesias, cyanosis, hyper- 
hidrosis and coldness of the injured part may appear 
2 to 3 weeks after injury and persist for many months. 
Edemas usually begins within 3 hours after rewarming 
and usually disappears within 10 days if the patient 
is at rest. Desquamation of the superficial layers of 
the skin begins 5 to 10 days and may continue for 
several weeks. 
Second Degree - vesicle formation. The signs and 
symptoms of first degree cold injury are also present. 
However, the edema is usually not marked and dis- 
appears within 3 to 5 days after rewarming. 
touch and position sense are usually absent. 
Light 
A throb- 
bing or aching pain is usually experienced from 3 to 20 
days after injury. Blisters and, in more severe cases, 
huge blebs may appear within 6 to 12 hours after rewarm- 
ing. These vesicles, which usually form on the dorsum 
of the fingers, hand and great toes, and on the heel, are 
often deep in the epidermis. However, they do remain 
superficial to the germinative layer, so that the epidermis 
is regenerated. The vesicles may contain blood as well 
as fluid transudate. They dry, forming black eschars 
within 10 to 24 days after rewarming. Hyperhidrosis may 
occur as well at this time. The eschar gradually separates 
leaving a thin, soft, poorly keratinized skin which is 
easily traumatized. 
Third Degree - necrosis of the skin and subcutaneous 
tissue. This cold injury involves the full thickness of the 
skin and often extends into the subcutaneous tissue. 
Vesicles may appear at the periphery of the area of third 
degree injury. Edema of the involved part is extensive, 
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usually disappearing with 6 days. This injury is asso- 
ciated with burning, aching, throbbing or shooting pains 
which begin in the second week and persist for about 
5 weeks. The skin over the area of a third degree 
injury usually dries to a black, hard eschar, which 
eventually separates from poorly vascularized under- 
lying granulation tissue. Epithelialization of this 
area is gradual, healing often taking 2 to 3 months. 
Hyperhidrosis and cyanosis of the involved part may 
appear between the fourth and tenth week after injury 
and persist for months, resulting in a prolonged un- 
comfortable convalescence. It should be noted that 
trauma due either to injury other than cold or to 
superimposed infection may complicate this degree of 
cold injury and result in a more extensive tissue loss. 
Fourth Degree - destruction of the entire injured part, 
including bone, with resulting loss of the part. Upon 
r ewarming , the skin becomes mottled and cyanotic. 
Edema begins rapidly, starting within an hour and 
r caching a maximum within 6 to 12 hours. Bleb for- 
mation is common. In most fourth degree cold in- 
juries, the extent of injury becomes apparent only as 
the edema resolves, the eschar formation or gangrene 
frequently not being evident until 2 to 3 weeks after 
injury. In severe injuries, the affected tissue will 
progress rapidly to dry gangrene and mummification. 
Demarkation between living and dead tissue becomes 
fully apparent in about one month, and extends down 
to bone in 2 months or more after injury. 
Finally it should be noted that following any degree of cold injury, an 
astronaut could become sensitized to some degree to a further cold (65, 
66) . With a mild injury, the involved part might be sensitized to 
cold for days or weeks and with a severe injury, this sensitization might be 
permanent (26). For such cases, even a minor exposure to cold may be 
followed by an exaggerated and prolonged reactive vasodilatation with asso- 
ciated redness, edema and tingling pain. Edema of a urticarial type and even 
systemic reactions are also possible (91) . 
Diagnosis 
The diagnosis of cold injury in space should be obvious on clinical obser- 
vation, with no special diagnostic procedures being required. It is again 
pointed out that cold injury often requires several days to become fully 
manifest, so that an early prediction of the extent and severity of a cold 
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injury will be impossible. 
Prevention 
Emphasis is placed on the importance of recognizing and adequately 
correcting for certain physiological and space suit and spacecraft cabin 
design factors which will undoubtedly influence the risk of exposure of 
the astronaut to an excessive heat loss and subsequent cold injury during 
space missions. As mentioned previously, these factors would apply 
particularly to operations in the space suit in a shaded space environment. 
The distal parts of an astronaut’s extremities, especially the fingers, 
will be highly susceptible to cold injury, due not only to their large sur - 
face area per volume of tissue and their usual marked vasoconstrictive 
response to cold, but also the fact that, for mobility, only minimal suit 
insulative material will surround these parts. Moisture in the suit and 
direct contact of the surface of the suit with other materials in a shaded 
space environment could lead to an excessive conductive heat loss, parti- 
cularly from a minimally insulated distal extremity. When designing 
and fitting space suits, consideration must be given to avoiding constric- 
tions and tightness which in any way might jeopardize the blood flow to an 
extremity, and thus increase the susceptibility of the extremity to cold in- 
jury. The “coolant” of suit liquid cooling systems could pass through hand 
and foot areas last, so providing a “fail safe” effect. 
As mentioned previously, the maintenance of adequate total body heat 
during a localized or extensive heat loss from the space suit might serve 
to protect an astronaut from cold injury by preventing the localized vasocon- 
striction or the centrally-induced, generalized peripheral vasoconstriction 
in response to cold. Thus if an astronaut is subjected to an excessive heat 
loss through one or more areas of his suit, he might attain some protec- 
tion from cold injury by having the amount of heat removed from his suit 
by the life support system reduced, even to the point of allowing him to go 
into slightly positive heat balance. Increased body heat production through 
physical activity would play a similar role. However, it must be remem- 
bered that anxiety and other possible factors (e..g. , hypocapnia).might 
tend to prevent this protective effect (75) - . 
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The importance of continuous physical activity for providing suffi- 
cient metabolic heat to maintain thermal balance in the space suit under 
all circumstances is readily apparent. The suggestion that ingestion 
of food of a high specific dynamic action prior to a possible exposure to 
an excessive heat loss might have some protective value, by reason of its 
tendency to increase the basal heat production of the body, has not 
been supported in recent experiments (492 75) . 
It has been suggested that agents which prevent or abolish a cold- 
induced vasoconstriction might be useful in’protecting an exposed part 
.from cold injury (75). However, no topical vasodilators appear to exist 
which can be used to give a graded response, or which will not be absorbed 
and hence result in a whole-body effect. Systemic administration of such 
agents will probably always be contraindicated unless their action is highly 
specific and the cold exposure anticipated will be of a short duration. 
The marked influence of systemic hypoxia on the extent and severity 
(20, 55) of tissue damage by cold is well known . In space, this hypoxia 
would be most likely caused by a reduction of the ambient oxygen tension. 
On the other hand, an elevated partial pressure of oxygen tends to produce 
a peripheral vasoconstriction which can contribute to cold injury (2%. 
It is apparent, therefore, that the vascular effects of oxygen at the partial 
pressures to be used in the space suit should be investigated. 
The view is generally held that prolonged exposure to weightlessness 
will produce both a decrease in the total blood volume and a decrease in 
capacity of the vessels in the lower extremities to maintain their tone when 
an astronaut stands upright in a gravity environment. If these effects are 
not prevented or corrected before an astronaut walks on a lunar or plane- 
tary surface, a potential or manifest state of orthostatic hypotension might 
result, depending on the ability of his body to compensate for his inade- 
quate circulating blood volume. This compensation would occur mainly 
by peripheral vasoconstriction, which could lead to the astronaut being 
more susceptible to cold injury of the feet. It also considered possible 
that this susceptibility might be enhanced by the use of elastic garments to 
prevent orthostasis. 
All environmental conditions being equal, the Negro appears to be about 
six times more vulnerable to cold injury than the Caucasian . (26) It appears 
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that a physiologic basis does exist for this difference (60, 76) . As well, 
the geographic origin of man seems to be a significant factor among Cau- 
casian personnel in the incidence of cold injury, for origin from the warmer 
climates of the United States has been shown to predispose to cold injury 
(16, 66, 70). However , whether these factors would be significant enough 
to influence selection of astronauts is debatable. Finally, it will b.e nec- 
essary to rule out the presence of cold agglutinins in astronaut candidates. 
It is pointed out again that following any degree of cold injury, an 
astronaut could become sensitized to some degree to cold. with milder in- 
juries, the involved part might be sensitized to cold for days or weeks, and 
with more severe injuries, this sensitization might be permanent. 
As will be discussed under “hypothermia”, the possible protective effect 
of cold acclimatization, even if it exists, remains debatable. 
Treatment 
The treatment of cold injury remains controversial, due mainly to the 
lack of knowledge of the mechanisms of cold injury (6, 55, 65, 70). Since 
more definitive forms of therapy will not be accomplished in the space 
environment, the more conservative methods for the treatment of cold in- 
juries in space will have to suffice. It is noted that all cold injuries receive 
basically the same treatment from the beginning, modifications being 
carried out as indicated by the degree of injury. 
Initially, the injured part should be completely uncovered and all items 
of clothing or equipment which might in any way restrict blood flow to the 
part removed. Rewarming of the cold-injured part to body temperature 
should be accomplished as quickly as possible by exposing the part to 
temperatures recommended above 32°C (89.6”F) but not above 42°C (107.6”F) 
by most authors (6, 16, 33, 34, 55, 65, 72) . Methods which maximize heat 
transfer by conduction are preferred. Even though a water bath will not 
be practical in space, surrounding the injured part with flexible plastic 
container s, such as a balloon splint, containing warm fluid might be a useful 
substitute. Moist warm towels might also be used. It is pointed out that 
good conductive heat transfer can be obtained by placing the injury in contact 
with warm areas, such as the axilla, perineal area, and trunk, of either an 
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injured or uninjured astronaut’s body. As will be discussed, rewarming 
of an astronaut suffering from generalized hypothermia should be done 
gradually, so that the above methods of rewarming will apply only to cold 
injured areas. Massage of the rewarming part is contraindicated because 
of the possibility of causing further trauma to the injured tissue (34, 65, 
70, 89). The use of ultrasound to rewarm cold-injured tissues is not 
recommended, as there is evidence of it having deleterious effects in 
deep tissue injuries (65) . 
The major aims of treatment after rewarming should be the prevention 
of further trauma to and possible infection of damaged tissues, and the 
maintenance of an optimum range of movement in the damaged part (19, 55) . 
It is again emphasized that the degree and extent of cold injury may become 
fully evident only after several days. Hence a more serious injury than 
that observed initially should always be anticipated. 
The damaged part should be gently washed with a mild, antiseptic 
soap (e. g. , (65) hexachlorophene soap) . Whereas lesions without vesicles 
are usually left exposed under sterile conditions on Earth, all cold 
injuries in space should be dressed in order to provide optimum protection 
from further trauma and infectious organisms. Dressings should be loose 
and dry, and cotton pledgets should be placed between digits to avoid 
maceration (50, 65) . Debridement of vesicles should not’ be undertaken initially 
unless they are disrupted (6, 26, 33, 54, 89) . Petrolatum dressings as 
indicated in burn therapy should never be applied (6, 65, 92) . 
Antibiotics are usually given to cases of cold injury only if there is 
obvious deep infection (55’ 65y 70). However 8 in the space situation , con- 
sideration might be given to prophylactic antibiotic administration, especially 
to possible third and fourth degree cold injuries, in order to maximize the 
protection of the damaged tissue from invasion by pathogenic organisms. 
Such therapy should be continued until a clean demarkation is evident, 
Dressings should be changed daily. At this time, wet dead tissue 
from ruptured vesicles might be removed, infected vesicles opened and, 
if indicated, constricting eschars bivalved (6, 33) . Optimum cleanliness 
must be maintained. If in any way contaminated, the injured area should 
be gently washed with antiseptic soap and dried. As soon as the acute in- 
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flammation has subsided, active physiotherapy should be commenced (6, 
55, 92) . The performance of digital exercises of each joint of every in- 
volved digit throughout the waking hours and Buerger’s exercises at least 
four times daily have been recommended (65). It should be kept in 
mind that all parts of an injured extremity should be exercised. 
All eschars should be allowed to separate rather than being removed 
surgically (55). In fourth degree injuries, so-called physiological amputa- 
tion will occur, usually in 2 months or more after injury. If adequate care 
is taken to keep the injured part dry and free from infection, the possibility 
of wet gangrene and the requirement for surgical amputation will be remote. 
Circumferential eschars, which tend to constrict and so restrict blood 
supply 9 should be bivalved if possible 
(6, 33, 55) . 
Although pain is usually not a serious problem in cold injury, a , 
non-narcotic analgesic or tranquilizing drug might be indicated’ in the 
period after thawing (6, 48, 65) . A tetanus toxoid booster prior to missions in 
space should eliminate the need for such an injection following cold injury. 
A cold-injured astronaut should receive a vitamin supplemented diet which 
is high in calories and protein content. 
Various measures directed at improving local tissue perfusion and 
inhibiting intravascular cellular aggragation and clotting have been studied 
for their possible beneficial effect on tissue survival and function following 
cold injury. Meryman pointed out that it would not be fair to presume that 
none of these measures have been clinically successful, since the evaluation 
of therapeutic procedures in clinical frostbite is hampered by the lack of 
criteria for determining the severity of injury prior to the initiation of 
therapy. However, the vasodilator drugs have generally not been proven 
effective either experimentally or clinically (6, 26’) . This might in part 
be due either to a negation of the possible increase in blood flow through the 
dilated vessels at the site of injury by the systemic hypotension associated 
with use of these drugs, or to delays in attempting to forestall circulatory 
obstruction immediately after thawing before such obstruction develops. 
Regional sympathectomy has been somewhat successful in animal experi- 
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ments, reducing both edema and the amount of tissue loss (259 37)e As a 
therapeutic measure in human cases, it has been highly effective in reduc- 
ing the number of severity of sequelae, such as coolness, hyperhidrosis, 
pallor, vasospastic complaints, and ulcers, which follow cold injury (78, 79). 
The inherent difficulties in assessing the effectiveness of sympathectomy on 
the extent of tissue loss in human cases are readily apparent. Surgical 
sympathectomy is a highly specialized, major procedure, the performance 
of which would be precluded by the space situation. However, success in 
the treatment of sequelae of cold injury by sympathectomy would suggest 
that the sympatholytic drugs and, in certain cases, regional sympathetic 
nerve block with a local anesthetic might also be effective in the treatment 
of these sequelae. 
Low molecular-weight dextran has been administered to cold injury 
cases because it has been shown to be a specific agent for the inhibition of 
intravascular cellular aggregation and the improvement of small vessel 
blood flow in injured tissue (67) . The beneficial results obtained with this 
agent in animal experiments do not appear to be attributable to the ex- 
pansion of plasma volume and hemodilution which it also produces (5, 67, 68, 69) 
The actual clinical effectiveness of this drug remains to be established, 
however 
(26, 33, 69, 71, 80) 
. 
Heparin, used to prevent microvascular clotting, has had success in 
animal experiments (33, 73) . However, its effectiveness in human cold in- 
jury cases has not been proven (6, 55, 92) . 
If vasodilating, anti- sludging, or anti- coagulant agents are in fact proven 
clinically useful, in the treatment of cold injury, it is readily apparent that 
they must be administered as soon as possible after and perhaps before start- 
ing the rewarming of the injured area, and for many hours to several days 
thereafter . Unfortunately, the early administration of such agents to cold 
injury cases has up to this time been difficult and most often impossible to 
accomplish. Therefore the results of well controlled animal experiments 
may well have to be relied on in anticipating their clinical effectiveness for 
some time to come. 
Steroids, administered in attempts to limit the inflammation associated 
with cold injury, and flavenoids, taken for the reduction of capillary perme- 
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ability and fragility in cold injured tissue have not been beneficial in the treat- 
ment of cold injury (90) . 
Hypothermia 
Pathophysiology and Clinical Manifestations ~_. 
Hypothermia, which has been discussed in several excellent reviews, 
has been defined as a state of body temperature which is below normal in 
a homeothermic organism (9, ‘3, ‘8, 27, 54, 56, 82, 83, 85) Little (59) . 
attempted to make this definition more meaningful by stating terms which 
could be used to characterize the depth and duration of the hypothermia 
under consideration. The depth of hypothermia was categorized in terms 
of body core temperature, as light (37” to 32°C; or 98. 6” to 89. 6”F), inter- 
mediate or moderate (32” to 26°C; or 89. 6” to 78. 8°F); deep (26” to 20°C; 
or 78. 8” to 68”F), and profound (under 20” C, or 68” F); and the duration of 
hypothermia as acute (few hours), and chronic or prolonged (many hour s, 
days, or weeks). This classification has a greater application to considera- 
tions of hypothermia used as a therapeutic tool than to considerations of 
hypothermia acquired accidentally. However, each depth of hypothermia 
categorized above appears to correlate well with the clinical picture an 
astronaut might present if rendered hypothermic to a particular level of 
body core temperature. The clinical features of these various depths of 
hypothermia ar e : 
Initial Response to Cold. The initial response to cold 
mimics intense stimulation of the sympathetic nervous 
system, being characterized by intense shivering, 
marked peripheral vasoconstriction, elevation of sys- 
temic arterial pressure and significant increases in 
oxygen consumption, respiratory rate, and cardiac 
output (59). This stress response may actually pro- 
duce a slight rise in temperature, and so delay the 
onset of hypothermia which will eventually result if 
physiological compensatory mechanisms are inadequate (9). 
Light Hypothermia (37” to 32°C; or 98. 6” to 89. 6°F). 
This depth of hypothermia is characterized by a sensation 
of severe cold and intense shivering which may be painful, 
especially around the neck. The toes and fingers become 
increasingly painful, then numb. Respiration is increased 
in rate and depth from the onset of hypothermia but sub- 
sequently decreases, especially below 34. 5” C (94.1 OF), 
in a manner that can lead to respiratory acidosis 
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in spite of an overall normal arteriovenous oxygen 
difference being maintained (83, 87). It is also pointed 
out that as the body temperature decreases, the 
solubility of carbon dioxide in body fluids increases 
and the oxygen carrying capacity of the blood de- 
creases. An increase in metabolic rate occurs dur- 
ing a normal response to cold, persisting until the 
core temperature has fallen to approximately 35°C 
(95”F), and thereafter declines to reach basal values 
or lower in the intermediate or moderate hypothermia 
range (15, 27). As the temperature falls, the heart 
rate decreases. During this period, the blood pres- 
sure falls, but only gradually (15). 
Intermediate or Moderate Hypothermia (32” to 26” C; 
or 89. 6” to 78.8”F). At this depth of hypothermia, the 
individual becomes increasingly somnolent and resistant 
to pain, and,finally loses consciousness (3, 32). Shiver- 
ing ceases between 33°C (91.4”F) and 30°C (86OF), 
but muscular rigidity may persist to 27” C (80. 6°F) (15). 
Respiration will continue to decrease, becoming irregular 
about 30” C (86°F) and finally cease about 28°C (82.4”F) 
(15). Cardiac arrhythmias (nodal rhythm, auricular 
fibrillation, ventricular extrasystole s, etc. ) appear at 
core temperatures below 30°C (86°F) (15). Ventricular 
fibrillation becomes an increasing hazard at tempera- 
tures below 28°C (82.4”F) (87). Hypothermia in this 
range might occasionally aggravate epilepsy and certain 
other types of seizures (59). 
Deep Hypothermia (26” to 20°C; or 78.8” to 6!“F). 
Death usually occurs about 25” C (77”F), from either 
ventricular fibrillation or cardiac asystole (3, 15). 
However, the lethal temperature might be quite varia- 
ble as demonstrated by a case in which a woman 
survived a fall in core temperature to 18” C (64.4”F) 
or even lower (15, 57). 
Profound Hypothermia (under 20°C; or 68°F). Survival 
of accidental hypothermia to this level is considered 
highly unlikely. 
The general effect of hypothermia is currently thought to be entirely 
depressive, even though there is an increasing tendency of the heart to be- 
come more sensitive to the development of arrhythmias and the central ner- 
vous system to become more excitable as the core temperature of the body 
falls . Accordingly, the slowdown of body functions do not appear to parallel 
each other. Hence a potentially dangerous physiochemical state can result 
(57) . The physiologic changes that occur in response to hypothermia are 
142 
complex and not well understood. Yet they may be tolerated for some period 
of time without harm. For example, Talbott (85, 86) and Dill and Forbes 
(27) treated patients suffering from psychoses by slowly cooling them to 
a rectal temperature of about 26. 5°C (79. 7°F). The patients were main- ’ 
tained at this temperature level for periods of up to 24 hours and then 
slowly rewarmed. There were two deaths from cardiac failure during 
the hypothermic phase in the series of 20 cases, with no after-effects be- 
ing noted in the survivors. 
The most serious complication of hypothermia has been ventricular 
fibrillation, which occurs particularly at temperatures below 28°C (82.4”F). 
Unfortunately, there appears to be no proven method of reversing this 
arrhythmia in an individual who is in the hypothermic state. Moreover , it 
is highly unlikely that the standard methods of defibrill&tion, which are in 
themselves often only momentarily effective, could be undertaken in the 
space situation. 
Lewis (54) has cited work which has shown that an impressive irrever- 
sible cardiac failure can develop in cases of prolonged hypothermia. This 
fatal event appeared particularly during rewarming. Conflicting evidence 
has been presented on the important question of the occurrence of other 
hypothermic organ damage (59). 
The most common complication which might occur on rewarming a hypo- 
thermic astronaut is so-called rewarming shock (31). This syndrome con- 
sists of the development of hypotension and acute circulatory collapse, 
which is characterized by tachycardia, diminished cardiac output and inade- 
quate respiration (’ ‘). It appears to be due to acidosis which is predomi- 
nately metabolic in origin although, as previously mentioned, carbon 
dioxide accumulation due to cold- induced respiratory depression and in- 
creased solubility of this gas in cooled body fluids also occurs and might 
contribute to some degree to the acidosis (59). Shivering and rapid warmth- 
induced increases of blood flow through the vascular beds of cold muscle 
masses during rewarming can result in marked increases of circulating acid 
metabolites, and so produce or aggravate rewarming shock. Undoubtedly 
other factors can also be implicated in the etiology of rewarming shock. A 
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marked warmth-induced peripheral vasodilatation might itself be condu- 
cive to shock or seriously aggravate the tendency to shock produced by 
metabolic acidosis. As well, the loss of circulating plasma volume, which 
occurs during prolonged hypothermia, might be inadequately restored if 
rewarming is accomplished rapidly (15, 85, 86, 88) . There is also the 
po s sibility that car disc inade qilacy, caused by a reduction of muscular 
glycogen or myocardial damage from prolonged hypothermia, might contri- 
bute to rewarming shock (15) . 
Another significant complication of rewarming has been discussed by 
Burton and Edholm (15). It has been noted that rapid increases in blood 
flow through cooled parts of the body can result in a large volume of cooled 
venous blood returning to the heart. For example, Behnke and Yaglou (10) 
recorded sharp falls of gastric, oral and rectal temperatures initially on 
rewarming their subjects. Burton and Edholm (15) thus suggested that 
the resulting drop in cardiac temperature might produce cardiac arrest or 
ventricular fibrillation, par titularly under conditions of rapid r ewarming. 
Diaenosis 
The level of the core temperature of a hypothermic astronaut should 
be determined as soon as possible in order to decide on the potential 
seriousness of the situation and thus the therapeutic approach to be followed. 
For example, shivering can occur over a wide range of temperatures (37” to 
30°C; or 98. 6” to 89. 6*F), so as a clinical finding it alone could indicate 
either a mild response to cold or a serious clinical situation. On the other 
hand, an astronaut could be stuporous or unconscious, not shivering, and 
yet hypothermic (core temperature less than 3O”C, or 89.6”F). The 
level of core temperature might conceivably also be necessary to establish 
the diagnosis of hypothermia as distinct from other causes of stupor or 
unconsciousness. If ever possible in space, determination of blood pH 
could serve as a valuable adjunct in deciding on specific therapy of a hypo- 
thermic astronaut. 
Prevention 
The question arises as to whether or not acclimatization of man to a cold 
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environment is possible and if so, whether or not such a long-lasting ad- 
justment of physiological .functions should be induced in an astronaut if 
unusually high risks of excessive local or total body heat losses are 
anticipated during operations in space. Although it has been well estab- 
lished that true physiologic acclimatization to heat occurs (Chapter 6), 
Davis (21) has pointed out that there is a significant group of investigators 
who have found that there is no defined evidence of cold acclimatization in 
man. On the other hand, various recorded changes in the reaction of the 
peripheral blood circulation to cold and in the cold-induced increase in 
metabolism after repeated or prolonged cold exposure have been interpreted 
as evidence of acclimatization to cold in man. 
In his excellent review and from his studies in this area, Hellstram (46) 
pointed out that much evidence can be accumulated to show that cold-induced 
vasodilatation is more marked and comes on more rapidly in individuals 
who are chronically exposed to cold in their occupations, as compared to 
those who work in a warm environment. These workers also demonstrated 
-> a higher pain threshold and better manual functioning on cold exposure, 
and a lowered response to the cold pressor test as compared to those who 
work in a warm environment. He found no convincing evidence of a seasonal 
variation in these parameters studied in students. Daily exposure of one 
hand to cold water (temperature initially 3”C, rising to 12°C during 30 
minutes) for 11 to 15 consecutive working days in the early summer in a 
thermally “neutral” environment did not appear to alter hand blood circula- 
tion or the deteriorating effect of cold on hand function. Such was also the 
case when the same local cold exposure was applied 6 days a week for 3 
weeks during the winter to individuals who sat naked at 15. 5°C ambient air 
temperature for 70 minutes. However, a reduction of cold-induced pain 
in the exposed hand and a decrease in the cold pressor response took place 
in both experiments. 
Davis (21, 22, 23, 24) has managed to produce a significant elevation 
of the shivering threshold of individuals exposed, nude, 8 hours a day for 31 
days to an-ambient air temperature of 11. 8°C. This was also found to 
result from seasonal or climatic temperature decreases. He concluded that 
the elevation of the shivering threshold appears to define the occurrence 
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of cold acclimatization in man with some precision. Using this criterion, 
Davis demonstrated that the seasonal cold acclimatization in man was not 
retained over the summer whereas the acclimatization following the chronic 
nude cold exposure was retained through at least one summer season. 
Heat acclimatization in these studies did not affect artificially or naturally 
induced cold acclimatization. This finding, in the light of the demonstra- 
tion by others that heat acclimatization is unaffected per se by cold ex- 
4pI;,” ‘TJi 
indicates both acclimatizations can co-exist in an individual (36, 
. Studying other parameters, Davis found that the initial cold- 
induced heat production in unacclimatized subjects was consistently higher 
(value of 64 percent above basal) in those studied in the summer as com- 
pared to those studied in the winter season (value of 30 to 40 percent above 
basal). After the chronic nude cold exposure, this response stabilized 
around 30 to 40 percent in both groups. Lastly, he found that the body 
core temperature of the chronic exposure group decreased significantly on 
cold exposure. 
Numerous other studies described in the literature point as well to 
the fact that most past work on acclimatization to cold in man has been 
concentrated on efforts to establish criteria for it, prove its very exist- 
ence in various groups of cold-exposed subjects and evaluate the degree 
of cold exposure necessary to produce changes of physiological reactions 
which deserve interpretation as evidence of acclimatization to cold. It is 
apparent that the possible degree of cold acclimatization which can take 
place in man has not been startling -- a sharp contrast to the rather over- 
whelming evidence that true physiologic acclimatization to cold exists in 
other non-hibernating homeotherms (43) . Moreover, it does not appear 
to have been proven that cold acclimatization can actually offer man signi- 
ficant protection from cold injury or accidental hypothermia. Thus, at the 
present time the conclusion can be drawn that even if cold acclimatization 
could confer some protection in an astronaut, the practicability of inducing 
it might be outweighed by the exposure temperature and duration which 
would be required for its induction. As well, possible loss of cold acclima- 
tization over early months of a prolonged mission in space would also 
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suggest impracticability. 
Treatment 
In order to minimize the risk of the complications of hypothermia 
discussed previously, an astronaut’s normal body temperature should be 
restored as slowly as possible. By allowing the peripheral tissues to 
rewarm slowly, the acid metabolites and carbon dioxide which have accu- 
mulated in these tissues will be slowly washed out into the systemic circu- 
lation. Thus adequate time will be allowed for the breakdown and buffering 
of these metabolites, so preventing severe metabolic acidosis and possible 
rewarming shock. Moreover, a marked warmth-induced peripheral vaso- 
dilatation might itself be conducive to shock or seriously aggravate the 
tendency to shock produced by metabolic acidosis. It is also possible for 
the volume of plasma lost during a prolonged period of hypothermia to be 
inadequately restored if rewarming is accomplished rapidly (15) . Lastly, 
slow rewarming decreases the risk of a further drop in cardiac temperature, 
and so possible fatal cardiac arrhythmias, by keeping the flow of cold 
venous blood from the cold peripheral tissues to the heart to a minimum. 
To accomplish slow rewarming, the entire body surface of a hypo- 
thermic astronaut should be exposed to normal environmental tempera- 
tures (about 23°C; or 72°F). Accordingly, his body will be allowed to re- 
warm by metabolic activity alone. As noted elsewhere in this chapter, a 
local cold injury should, however, be rewarmed as quickly as possible. 
Under certain circumstances, a hypothermic astronaut might have to be 
rewarmed while in a space suit. Optimum temperature control settings 
which will allow a slow rewarming of his body will have to be determined, 
depending on whether a gas or fluid system is used for temperature control 
in the suit. 
Whether a drug such as chlorpromazine should be administered to 
minimize shivering during the rewarming process remains controversial (69). 
This measure could keep the acid metabolites contributed by muscular activity 
to a minimum, so reducing the tendency to rewarming shock due to meta- 
bolic acidosis. As well, the metabolic heat output by muscular activity 
could be minimized, so allowing a slow rewarming of the body. However, 
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since drugs such as chlorpromazine are also vasodilatory, their use might 
be contraindicated. 
If r ewar ming “shock” occurs , intensive treatment of this serious 
event should be commenced immediately, with appropriate measures being 
selected as sound clinical judgment dictates. A solution of glucose, 
saline, and bicarbonate in water should be administered intravenously. 
Oxygen should be given. An appropriate vasopressor, such as metara- 
minol, might be indicated. If the possibility of cardiac damage from the 
hypothermia exists, a cardiac glycoside, such as digoxin, might be given 
intravenously. Possible external sources producing excessive body heat- 
ing should be removed. 
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CHAPTER 8 
MEDICAL PROBLEMS DUE TO PARTICLE AND DROPLET 
CONTAMINATION OF THE SPACECRAFT 
CABIN ATMOSPHERE 
Introduction 
Particles and droplets of all sizes tend to remain suspended in the 
weightless environment. Various forms of particulate and liquid matter 
can, therefore, present much greater hazards if introduced into a confined 
atmosphere in space than if introduced into a confined atmosphere on Earth. 
These contaminants might not only give rise to certainmedical problems 
in space, but also might produce temporary or permanent malfunctioning 
of spacecraft components which are vital to the safety of the mission. 
By recognizing all possible sources of particles and droplets which 
might contaminate the spacecraft cabin atmosphere, various preventive and 
control measures can be taken to eliminate or minimize both potential and 
real particle and droplet hazards in space. As well, an astronaut might 
take specific measures to protect himself in a “high risk” situation. How- 
ever, even though these measures might seemingly eliminate the likelihood 
of medical problems in space from contaminant-astronaut contact, it still 
must be assumed that such problems might be the result of an unforeseen 
accident or failure of the environmental control system to remove rapidly 
enough larger particles and droplets of debris which will inevitably be intro- 
duced into the spacecraft cabin atmosphere. Therefore the various clinical 
problems which might arise if the astronaut should be exposed to particle 
and droplet contamination of the spacecraft cabin atmosphere should be pre- 
dicted and their management in space considered. 
Sources 
A simple classification of the major possible sources of particle and 
droplet contamination of the spacecraft cabin atmosphere is presented in 
Table 8.1. These sources fall under one of two categories - exogenous 
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sources, or sources existing outside of the spacecraft in space, and endo- 
genous sources, or sources existing within the spacecraft itself. 
EXOGENOUS 
Meteoroid 
Extravehicular 
ENDOGENOUS 
Construction 
Maintenance and Repair 
Preflight 
lnflight 
Operation 
Food -Water- Waste 
Astronaut 
Experiment 
Table 8. 1 Sources of Particle and Droplet Contamination 
The major exogenous sources are meteoroids and other extravehicular 
sources. Meteoroids which completely penetrate the wall of the spacecraft 
will lead to free-floating particles of meteoroid and wall. Further particle 
and even droplet contamination can result if structures within the cabin 
are disrupted by fragments of meteoroid and wall or by the blast wave 
produced by the “explosive oxidation” of vaporized meteoroid and wall 
materials. Fumes and smoke can be produced by the “explosive oxidation” 
and possibly by fires caused by the ignition of combustible materials by 
molten and hot fragments of meteoroid and wall. Fragments may also dis- 
rupt electrical circuits and structures which contain flammable liquids and 
gases to produce fires. A meteoroid which does not completely penetrate 
the spacecraft wall might still result in particle contamination of the space- 
craft cabin atmosphere by producing fragmentation, or spallation of the 
inner surface of the cabin wall. 
Other extravehicular sources, primarily of par title contamination, are 
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extraterrestrial dust and possibly particles of organic matter. Such 
particles could adhere to the space suit or to other equipment during extra- 
vehicular operations on lunar or planetary surfaces. Samples taken from 
extraterrestrial environments are also potentially contaminating, especially 
if they are in the form of small particles or in a liquid state, and are to 
be analysed on board the spacecraft. 
It is thought that almost all particles and droplets which can contami- 
nate the spacecraft cabin atmosphere will originate from endogenous 
sources, or sources existing within the spacecraft cabin itself. Metal 
particles and dust may remain within the spacecraft following its construc- 
tion and subsequent checkout. During preflight and inflight maintenance 
procedures, it might be possible, for example, to release non-chemical 
particles such as metal, glass, and plastic through breakage, chipping, 
or dislodgement; to release chemical particles such as lithium hydroxide 
or superoxides from the environmental control system, or chemical drop- 
lets from biochemical or other analytical systems; and to release micro- 
biologically-contaminated water from the waste disposal system. Also j 
during the normal operation of the spacecraft, particles and droplets might 
be introduced into the spacecraft cabin atmosphere through dislodgement,, 
chipping, and breakage. 
Food, water, and waste sources of particle and droplet contamination 
are apparent. It is noted that solid foods which tend to crumble when 
handled could be a likely source of particle contamination. 
An astronaut could well be the greatest source of particle and droplet 
contamination of the spacecraft cabin atmosphere. Hair and de s quamated 
epithelium, especially as “dandruff”, is shed continuously from the body 
surface. Talking, coughing, and sneezing will eject droplets of saliva 
and respiratory tract mucus into the atmosphere. Lint can be released 
from the astronaut’s clothing, Velcro fasteners, and towels. Droplets of 
urine and wash water, and fecal particles might be accidentally released 
into the atmosphere. Vomiting will be an extremely serious potential con- 
tamination hazard. 
Finally, it should be noted that in-space experiments which utilize 
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chemicals, or fragmentable materials or apparatus might create signifi- 
cant potential particle and droplet hazards, especially if chemicals in bio- 
chemical or other analytical systems are to be replaced or if such systems 
are to be serviced in space. 
Preventive, Control and Protective Measures 
A number of obvious preventive, control and protective measures may 
be taken to eliminate or minimize potential or existing particle and 
droplet hazards in space. Various preventive measures are: the selection 
and design of systems which present minimum po%ential particle and drop- 
let hazards, especially if serviced in space; the exclusion or shielding of 
potentially contaminating systems and subsystems from the rest of the 
spacecraft cabin environment; the use of materials which are non-com- 
bustible, lint-free, and do not splinter, flake or shatter; the preparation 
of foods which do not crumble or powder; the use of contamination “proofed 
and proven ” devices for shaving, hair cutting, teethcleaning, washing, 
urination and defecation; the use of “paper strip” techniques whenever 
possible for biochemical analyses; and the removal of all metal and other 
particles created during the manufacture and servicing of the spacecraft 
before flight. Some control measures are: the compartmentalization of 
the spacecraft interior, thus separating or being able to separate living, 
and various “high risk” areas from each other; the provision of a regulatable, 
efficient air ventilating-filtering system and “vacuum cleaners” which can 
reach anywhere in the spacecraft; the capability of venting a contaminated 
compartment in space; and procedures for “decontaminating” astronauts 
and equipment after extravehicular operations on lunar and planetary sur- 
faces. Various protective measures are: the placing of suitable protective 
equipment such as masks, eye shields, and total body garments throughout 
the spacecraft, readily available for use; the wearing of protective equipment 
in a “high risk” situation; keeping the number of astronauts exposed to a 
“high risk” situation, such as while servicing the environmental control 
system, to a minimum; and the placing of adequate shielding around instru- 
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ments which can be affected by particle and droplet contaminants. 
Predicted Medical Problems 
The medical problems which can result if suspended particles or 
droplets come into contact with an astronaut will be determined by their 
physical, chemical, and microbiological properties. Taking into consider - 
ation the properties which the various possible particle and droplet con- 
taminants of the spacecraft cabin atmosphere might have, the major 
medical problem areas appear to be; eye problems due to non-chemical 
particles:: and chemical particles and droplets; skin burns due to chemical 
particles and droplets; andmedical problems due to the inhalation of non- 
chemical, chemical, and microbiologically-contaminated particles, and 
chemical, and microbiologically-contaminated droplets. A brief discussion 
of various possible eye problems from particles and droplets, and clinical 
problems due to particle and droplet inhalation into the respiratory passages 
follows. Chemical skin burns are discussed in Chapter 13. 
Eye Problems 
The potential hazard to an astronaut’s eyes of an atmospheric particle 
or droplet contaminant will be determined mainly by the physical and chem- 
ical characteristics, and the velocities of the particles or droplets. Non- 
chemical particles, referred to here as “foreign bodies”, can irritate and 
injure eye tissues through a physical, or mechanical effect. Chemical 
particles cannot only act as foreign bodies but also, through a chemical 
effect, irritate and burn eye tissues. Chemical droplets can irritate and 
possibly burn. 
As particles and droplets are accelerated by circulating air, they will 
become more hazardous to the eyes, for their impact frequency will in- 
crease and the “blink” reflex, which prevents approaching particles and 
droplets from impinging on the eyes, will become less effective. It is also 
thought possible that some particles and droplets might acquire a static 
* In subsequent discussions, the terms “non-chemical particle” and “foreign 
body” are used inter changeably. 
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electrical charge and so might be attracted to the eye if in close proximity 
to it. 
A brief discussion of the clinical features and the principles of treat- 
ment in space of possible eye problems caused by foreign bodies and chem- 
icals follows. For more detailed coverage of this area, reference is made 
to the writings of Duke-Elder (12) , Adler (1) Roper-Hall (46) (19) 
Kuhn (34), Ryan (48, 49, 5’), zi mmer man (~0, 61, “), and o~h~:~;tZ, 5’). 
A diagram of the sagittal section of the human eye is provided (Figure 8.1) 
to point out anatomical features of the eye which will be mentioned in the 
following discussion. 
Palpebral Conjunctiva - 
continuous with 
Scleral Conjunctiva-----l’ 
continuous with 
Cornea1 Epithelium---” 
Figure 8. 1 Sagittal Section of Human Eye. 
Foreign Bodies 
Hair s, fibres, desquamated epithelium and small food and metallic 
particles should comprise most of the potential foreign body hazard to the 
eyes in space. Although the risk of meteoroid penetration of a spacecraft 
cabin is extremely low (Chapter 12 ), it should be pointed out that fragments o 
meteoroid and spacecraft wall from penetration will present a particularly 
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great hazard to the eyes because of their great number, high velocities, 
high temperatures , and rough or sharp shapes. 
All eye problems caused by foreign bodies are usually accompanied 
by pain, lacr imation, and blephar ospasm. It should be pointed out that 
in an emergency situation, temporary relief of these symptoms can be 
obtained by instilling a non-allergenic topical anesthetic such as 0. 5 per- 
cent “0 P hthaine” in the affected eye. However, one must assume the risks 
associated with leaving a foreign body either trapped under an eyelid or 
embedded in the cornea. 
The trapping of foreign bodies under the eyelids will probably be the 
cause of most of the eye problems which occur in space. Most foreign 
bodies should only produce irritation. However, some with sharp edges 
or corners could actually injure the cornea or conjunctiva. 
Fortunately, the majority of foreign bodi.es which get under the eyelids, 
especially the lower one, are either coated with mucus and automatically 
worked out by tearing and lid and eye movement, or removed by the well 
known method of overlapping the eyelids. On the other hand, it is possible 
that a trained astronaut might have to evert an eyelid to search for and 
remove a foreign body. Before undertaking this measure, pain and 
blepharospasm should be relieved by instilling a topical anesthetic. A 
foreign body under an eyelid can be removed with a cotton-tipped applicator 
moistened with saline, with cilia forceps or by one of the irrigation methods 
to be discussed under chemical eye problems. Although foreign bodies 
under the eyelids are usually removed by one of the above means, an 
occasional particle, especially if metallic or glass, can become embedded 
in either the palpebral or scleral conjunctiva. In this case, it is necessary 
to use a needle or eye spud for removal. Finally, special note should be 
made always to examine the lacrimal punctae when searching for foreign 
bodies in the eye in space, for it is considered possible that the risk of a 
short hair or fibre entering the eye and then being washed into and becoming 
firmly fixed in a punctum might be much higher in space than on Earth. 
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Such foreign bodies are-easily removed with suitable forceps. 
Any foreign body which becomes embedded in an astronaut’s cornea 
will probably be a small single metal particle. Multiple foreign bodies 
could become embedded at the time of a meteoroid penetration, however. 
The cornea should always be examined if no foreign body is found on 
searching under the eyelids, or if many foreign bodies could have entered 
the eye. Detection of a small embedded foreign body can usually only 
be accomplished with good illumination and magnification. Since the 
cornea is extremely sensitive, it is always necessary to instill a topical 
anesthetic before attempting to remove a foreign body embedded in it. 
A needle or eye spud should be used for removal, and the subsequent 
management of this injury accomplished in the manner outlined below for non- 
penetrating cornea1 injuries. 
A ring of rust or debris may occasionally remain in the cornea after 
removal of a foreign body. This is most likely to occur if easily oxidiz- 
able metals, such as iron or copper are left embedded for a period of 
time. Unless superficial and easily removable in space, rust and debris 
should be allowed to remain in the cornea. 
A foreign body embedded in the sclera is managed in the same way 
as one in the cornea. However, a scleral foreign body is usually more 
difficult to remove because of overlying conjunctiva and hemorrhage, 
neither of which are a problem in cornea1 foreign bodies. 
The majority of non-penetrating injuries inflicted on the eyes by foreign 
bodies involve the cornea. Non-penetrating injuries of the sclera are 
managed similarly to those of the cornea. Conjunctival injuries are best 
left untreated. 
An abrasion or wound of the cornea1 epithelium can result from a for- 
eign body striking but not embedding in the cornea, or by a foreign body 
which is under the lid and is rubbing on the cornea. The wound remaining 
after an embedded cornea1 foreign body is removed is essentially similar 
to an abrasion. Fortunately this injury usually heals within 24 hours un- 
less it becomes infected. 
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A rough or sharp foreign body which strikes the cornea at a high 
velocity or is trapped under a lid and rubs against the cornea could pro- 
duce a laceration which is deeper than the cornea1 epithelium. Healing of 
this wound leads to scar formation and possibly a permanent visual 
defect, depending on the position, size, and density of the scar. 
The diagnosis and determination of the extent of a non-penetrating 
cornea1 injury should be made first by staining the cornea with fluor- 
escein. Use of a sterile paper impregnated with fluorescein (e. g. , 
“Fluor - I- Str ip” applicators) would be more practical in the weightless 
space environment than fluorescein solution. Then a bacteriostatic oint- 
ment, such as 10 percent sulfacetamide ointment, should be placed in 
the eye and a light, dry patch applied over closed lids. In 24 hours, the 
cornea should be stained and re-examined, and if healing is not complete 
but is progressing satisfactorily, the same treatment should be repeated. 
Also on this occasion, 5 percent homatropine might be instilled in the 
eye as a preventive measure for posterior synechiae and for the relief 
of pain due to inflammation of the iris. 
If a non-penetrating injury of the cornea should become infected, a 
batter icidal ointment, such as chloramphenicol or “Neosporin” ointment, * 
should be placed in the eye every three hours. As well, 1 percent 
atropine should be instilled one to three times daily. If possible in space, 
the frequent application of heat to the affected eye is also indicated, 
A foreign body could strike the cornea or sclera of an astronaut’s eye 
with sufficient velocity, as might be attained from a meteoroid penetration 
or explosion, to pierce these structures and enter the globe. The severity 
of penetrating injuries of the eye depends upon such factors as the size, 
temperature and inertness of the foreign body, and the tissues which are 
damaged during penetration. Some foreign bodies, such as plastics, sand, 
and glass,are quite inert. Corrosion-resistant nickel-base berrylium 
and aluminum alloys, and steelalloys containing chromium, vanadium, 
cobalt, nickel, titanium and boron incite little or no reaction with ocular 
tissues, usually becoming encapsulated over a period of time. On the other 
hand, corrosive alloys and various pure metals, such as copper, iron, zinc, 
and aluminum,react to a certain degree with ocular tissues, producing an 
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inflammatory reaction and ultimately visual impairment and perhaps even 
destruction of the involved eye. 
Part of the iris prolapsed through a penetrating eye wound would not 
only be difficult to replace but also invite infection into the eye. Whenever 
the lens capsule iS damaged, a traumatic cataract forms, leading to an 
impairment of vision. Such a cataractous lens can swell and, by block- 
ing the angle of the anterior chamber of the eye, can cause secondary 
glaucoma. 
An inflammatory process involving the uveal tract (iridocyclitis) 
commonly occurs following a penetrating injury of the eye. It is character- 
ized by deep-seated pain, photophobia, miosis and blurred vision. If the 
injury involves the region of the ciliary body, sympathetic ophthalmia, or 
a similar inflammatory process in the other eye may rarely occur, usually 
2 weeks to 2 months after the injury. This extremely serious eye condition 
can progress on to complete loss of vision unless the injured eye is 
ennucleated as soon as symptoms appear in the normal eye. No other 
treatment is definitely effective. Some cases have been controlled with 
rigorous local and systemic corticosteroid therapy (1, 59) . 
Because the skill and special instruments of the ophthalmic surgeon 
are required for the removal of an intraocular foreign body and for other 
emergency surgical procedures on the eye, it is doubtful if such pro- 
cedures, except perhaps for ennucleation will ever be carried out in space (52) . 
Thus the risk of permanent blindness occurring from penetrating 
injuries will be somewhat higher in space than on Earth. It is thought 
that maximum possible supportive therapy may be adequate in most in- 
stances, however. 
If a penetrating injury of an astronaut’s eye is suspected, his visual 
acuity should be determined. Then his lids, sclera and cornea should be 
inspected for a small cut where a foreign body might have penetrated. 
This wound might be detected only by staining with fluorescein. It should 
be remembered that an eye suspected of having a penetrating injury should 
never be palpated and, of course, the astronaut should be warned to avoid 
rubbing his injured eye. Blood might be present in the anterior chamber 
of the eye, and the iris might be torn and the pupil irregular. Flattening 
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of the anterior chamber is an important sign of perforation. If x-ray 
facilities are ever placed on board spacecraft, every suspected case of 
foreign body penetration should be x-rayed. 
Foreign bodies trapped under the eyelids, or embedded in the cornea 
or sclera should be removed. If part of the iris is prolapsed and cannot 
be replaced in the eye, it should best be excised with sterile scissors. 
Since it is thought that most penetrating foreign bodies in space will be 
reasonably sterile when they enter the eye, a local bacteriostatic agent 
might not be necessary (55) . One must keep in mind that such an agent 
in ointment form could itself be a dangerous foreign body if it enters the 
interior of the eye through the wound. However, if single or multiple 
foreign bodies have been removed, or other non-penetrating injuries are 
present, it might be wise to instill an aqueous bacteriastatic agent fre- 
quently in the eye. Prophylactic systemic antibiotic therapy is usually not 
indicated in such cases. 
One percent atropine should be instilled every 8 to 12 hours in an 
eye penetrated by a foreign body, until healing appears complete and all 
signs and symptoms of inflammation have subsided. Both eyes should be 
patched except in critical operational situations when the best vision 
possible is required for a period of time. Except for eye examination, a 
local anesthetic should not be repeatedly instilled in an injured eye for 
the relief of pain. An analgesic or sedative will have to suffice. 
An intraocular infection can result from the entry of bacteria through 
a penetrating wound, either at the time of or after penetration. As well 
as the treatment outlined above, local heat should be applied. Penicillin 
or a sulfonamide may be administered orally or by injection, but these 
drugs are frequently ineffective since they pass across the blood-aqueous 
barrier poorly (1, 55) On the other hand, some success has been reported 
with chloramphenicol i54). 
The drug of choice in the treatment of secondary glaucoma has been 
a carbonic anhydrase inhibitor, such as acetazolamide. Of interest is 
the success reported with intravenous dehydrating agents (10, 18, 23, 58, 
59) . The possible potential usefulness of them.in space has been discussed 
in Chapters 1, 2, 4, and 14. These agents are apparently effective in the 
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treatment of acute glaucoma of both the primary and secondary types, 
and may also aid in the absorption of blood out of the anterior chamber. 
Mannitol has been the preferred dehydrating agent. A carbonic anhydrase inhibitii 
drug can be used in conjunction with a dehydrating agent. In some instances, 
especially where the glaucoma is primarily due to hemorrhage, the fre- 
quent instillation of a miotic drug, such as l/ 2 to 4 percent pilocarpine, 
to maintain continuous pupillary constriction may be indicated. On the 
other hand, it may be advisable to instill instead a cycloplegic drug, 
such as 1 percent atropine, if severe inflammation supervenes. The 
selection of such drugs requires sound clinical judgment based on exten- 
sive ophthalmologic experience. Hence consultation with an Earth-based 
ophthalmologist will be a must if such a situation should develop in space. 
Chemicals 
The severity of any chemical injury of the eyes will depend on various 
factors, such as the type, concentration and physical nature of the chemi- 
cal, and the duration that the eyes are exposed to the chemical. It should 
be remembered that solid reactive chemical particles can produce mechani- 
cal injuries of the eyes as well as severe local burns. 
Alkaline chemicals are a much greater threat to the eyes than any 
(48) other chemical . The greatest degree of damage apparently occurs 
between pH 11 and 12 (48) . Alkalis penetrate the eye tissues rapidly, pro- 
ducing deep burns and all of the possible complications of severe eye burns 
discussed below. On the other hand, serious injuries from acids rarely 
occur above pH 2. 5 and are often limited to the epithelium (48) . Accord- 
ingly, serious complications are less likely to occur following mild expo- 
sures to acids than to alkalis. Eye injuries caused by other classes of 
chemicals have been discussed by Ryan (48, 49, 50) and Gr.t (19) . 
Every effort must be directed at minimizing the use of hazardous 
chemicals in space and at maximizing the safety factors if such chemicals 
are required. The probability of carbon dioxide absorbents, such as lithium 
hydroxide and sodium superoxide, becoming a threat to the eyes might be 
greatly increased if environmental control systems require servicing in 
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space. These absorbents are alkalis which, as mentioned above, are ex- 
tremely damaging to the eyes. As well, they tend to change from pellet 
to powder form as they are utilized. It is noted again that most analytical 
systems will employ hazardous chemicals which could be spilled at the 
time of replacing spent chemicals or servicing a system, or during analyti- 
cal procedures. 
Various degrees of injury, from a temporary mild inflammation to a 
severe burn of the extraocular tissues could be possible if a hazardous 
chemical should come into contact with an astronaut’s eyes in space. A 
mild injury is accompanied by lacrimation, an itching or burning sensation, 
and blepharospasm. A severe burn is accompanied by lacrimation, burn- 
ing pain, blepharospasm, and congestion, edema and possibly immediate 
necrosis of extraocular tissues. 
Perforation of the globe is possible with deep burns. Injured eye 
tissues are very susceptible to infection, which would enhance the degree 
of damage and delay healing. Other serious early complications which 
may follow a seemingly mild chemical burn are iridocyclitis and secondary 
glaucoma. 
A burn involving the subepithelial tissue of the cornea will heal by 
scar tissue formation and ingrowth of vascular tissue, leading to some 
degree of impaired vision. A severe burn of the palpebral conjuntiva 
can be followed by marked contraction of this tissue, resulting in 
inversion of the lid (entropion). A severe conjunctival burn can also lead 
to the formation of adhesions between the eyelids and the globe (symblepha- 
ran). Scarring of the outer surface of the lids can result in lid eversion 
(ectropion). 
If a harmful chemical should come into contact with the eyes of an 
astronaut in space, his eyes should be irrigated as soon as possible with 
copious amounts of water or, if as readily available, isotonic saline or 
other more physiologic solution. Special buffering agents available for 
the irrigation of eye injuries, which could be produced by specific chemicals 
carried on board the spacecraft, might be applicable in the space situation. 
Irrigation is usually continued for at least 20 to 30 minutes for alkalis or other 
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severely damaging chemicals. For more innocuous chemicals, as little 
as 10 minutes irrigation may suffice. 
Irrigation of an eye will be difficult in the weightless environment. 
However, no adequate procedure can be substituted for irrigation. It is 
suggested that with water-absorbing material around the eye, a suction 
vent near the eye, and the water or saline directed in a suitable stream 
at the eye, irrigation of the eye should be accomplished in space without 
creating a droplet hazard. An eye cup with water circulating through it 
might be another method of irrigation to be considered. In order to relieve 
pain and blepharospasm, and so facilitate irrigation under the lids, a local 
anesthetic can be rapidly instilled in the eye just prior to or after having 
started irrigation. The lids should be held open during the irrigation, so 
that the solution reaches all parts of the conjunctiva and cornea. In order 
to be assured that all chemical, particularly if in solid form, has been re- 
moved from the eye, each eyelid should be completely everted and the 
posterior surface of the cul-de-sac irrigated. Solid particles can also be 
removed from the eye with a moist cotton-tipped applicator or suitable 
forceps. 
After irrigation, the cornea and conjunctiva should be stained with 
fluorescein and carefully examined, under magnification if possible, in 
order to determine the severity of injury and, if applicable, detect any 
small chemical particles which still remain in the eye. The importance 
of examining the under- surfaces of the lids and cul-de-sacs cannot be 
overemphasized. 
All chemical burns of the surface of the eye should be treated with an 
ointment or water- soluble preparation which includes both a bactericidal 
agent and a cortisone derivative (3. , “Neodeltacortefl’, “Neodecadron’l). 
Authorities agree that the beneficial effect of a cortisone derivative, es- 
pecially in minimizing the inflammatory reaction,and cornea1 scarring and 
vascularization, far outweighs the potential risk of this agent causing 
aggravation of a possible ocular viral disease. The ointment preparation 
and a mydriatic drug, such as 5 percent homatropine or 1 percent 
atr opine, should be placed in the eye every 8 to 12 hours if a patch is to 
be applied. If the injury is mild or if the eye must be left open, a water- 
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soluble preparation would be preferred, instilled in the eye at least every 
one to 2 hours. A topical mydriatic drug is a necessity for all cornea1 in- 
juries of any significant degree, for it will do much to prevent extension 
of cornea1 inflammation to the iris and ciliary body, and to prevent severe 
ache from iris and ciliary muscle spasm. 
A dry patch should be applied to most mild and all severe chemical 
burns. The patch immobilizes the lids in a closed position, which tends 
to exclude contamination and minimize mechanical trauma. The repeated : 
use of local anesthetics in the eye is contraindicated, for such agents can 
delay healing and may even increase damage. If possible in space, the 
local application of cold may help to prevent or reduce congestion, edema, 
and pain. An analgesic drug should be given as required. 
One of the most common complications of chemical burns of the eye is 
the adherence of the palpebral to the scleral conjunctiva if they are bad1.y 
damaged. The topical ointments mentioned above may prevent this ad- 
herence ta some degree. However, it may be necessary to break down 
adherent points under local anesthesia daily with a suitable instrument 
such as a smooth glass rod. 
The secondary glaucoma which sometimes develops after chemical 
burns, especially from alkaline agents, is usually very difficult to control. 
Foremost in the treatment of this kind of glaucoma is the administration 
of an oral carbonic anhydrase inhibiting drug, such as acetazolamide. 
A topical cycloplegic, such as 1 percent atropine, also can be used, but 
it seldom is effective enough to control severe glaucoma by itself. Use 
of miotics seems unattractive because of the possibility of increasing dis- 
comfort and allowing posterior synechiae to form (19). 
Definitive treatment of complications such as cornea1 scarring and 
vascularization, conjunctival scarring and symblepharon, entropion and 
ectropion of the lids, and secondary glaucoma which has not responded 
to drug therapy, demand the skill and instruments of the ophthalmic sur- 
geon. Hence it is doubtful if such treatment will ever be possible in space. 
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Respiratory Tract Problems 
Predictions 
Busby and Mercer have predicted what the characteristics of particle 
and droplet inhalation into and deposition in the respiratory tract will be 
in the weightless environment (8). Themedical implications to be drawn 
from this study, which is summarized below, serve as a basis for dis- 
cussing various respiratory problems which are considered most likely 
to occur in space. 
The first question which arose was whether or not suspended particles 
or droplets of sizes up to that which can enter the nasal passages or mouth 
can be inhaled if they come into contact with the inspiratory air stream. 
Air flow and particle or droplet size were related in the equation: 
3.42x105 
u=v(l-e- da2 ) 
which gives the velocity, u, which a particle or droplet of aerodynamic 
diameter::, da microns, might have, t seconds after it is introduced into 
air flowing at velocity, v. This relationship is illustrated graphically in 
Figure 8. 2, which shows the times required for particles or droplets of 
various aerodynamic diameters to reach one-half of an air velocity. 
From this relationship it was predicted that particles and droplets of sizes 
having an aerodynamic diameter less than a few hundred microns, if in the 
inspiratory air stream, will approach the velocity of the inspiratory air stream s 
rapidly that for all practical purposes, the concentration and distribution 
of such particles and droplets which enter the nose or mouth during a normal 
:k “Aerodynamic diameter” of a given particle or droplet means the diameter 
of a sphere of unit density having the same settling velocity as the particle 
or droplet at room temperature and pressure. 
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inspiration will not be significantly different from that in the spacecraft 
cabin atmosphere. 
r TIME FOR PARTICLE TO REACH 
Figure 8. 2 Time for Particles or Drop- 
lets of Various Aerodynamic 
Diameters to Reach 50% of 
Air Velocity (v). 
(After Busby and Mercer (8)) 
Since gravity is a factor in determining the particle and droplet depo- 
sition in the respiratory passages, the other question which had to be 
answered was what the characteristics of particle and droplet deposition 
in the respiratory passages might be in the weightless environment. Mer cer 
(40) had modified and extended the method first employed by Findeisen (15) 
to calculate values for the deposition of various aerodynamic diameter 
particles or droplets in the respiratory passages in the Earth (unit gravity) 
environment, and had shown that these values compared quite favorably 
with available experimental data. To consider the analogous situation that 
would exist in the space (weightless) environment, it was only necessary 
to discount in such calculations that contribution made to deposition by 
sedimentation, which is due to gravity. 
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The characteristics of aerodynamic diameter particle or droplet 
deposition in the respiratory passages in the Earth (unit gravity) and space 
(weightless) environments are demonstrated by the “deposition curves++ 
in Figures 8. 3 to 8. 5. All curves were calculated for nasal breathing, a 
tidal volume of 750 cc and a respiratory rate of 15 breaths per minute. 
It is noted that even though these curves are for nasal breathing, avail- 
able experimental evidence suggests that the efficiency of the mouth as a 
filter is similar to that of the nose, providing an individual breathes 
through his mouth in a normal manner (41) . Air at 14. 7 psia is breathed 
in the Earth situation. Since the current literature supports the use of 
reduced atmospheric pressures and thus increased oxygen concentrations 
in spacecraft cabins, calculations were made on the basis of an inhaled 
gas mixture composed of 50 percent nitrogen-oxygen at a total pressure 
of 7. 0 psia (362 mm Hg). Even though the viscosity of the respired gas 
is altered by the relative amounts of nitrogen and oxygen, the effect of 
this change on the “de osition curves” appears to be negligible P 
(41) . 
DEPOSITION AS A FUNCTION OF 
PARTICLE SIZE 
Nasal Breathing 
Tidol Volume 75Occ 
Respiratory Rate 15/min 
14.7psi(20%0~-80%N~) 
2 
Tracheobronchial 
0 I 2 
Aerodynamic Diameter (microns1 
Figure 8. 3 Deposition as a Function of 
Particle or Droplet Size in 
the Earth (Unit Gravity) 
Environment. 
(After Busby and Mercer (85 . 
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As well, it is believed that the substitution of helium or another inert 
gas for nitrogen would alter viscosity by only a few per cent, and hence 
should not alter these “deposition curves” significantly. 
_--- _a-- 
_--- _--- 
/A- 
/- 
_/- 
__-- 
/ SPACE 
DEPOSITION AS A FUNCTION 
I’ OF PARTKXE SIZE 
Nasal Breathing 
Tidol Volume 75Occ 
Respiratory Rate IS/min 
7.Opsi (50% 02 - 50% Ne 1 
Trocheobronchial Deposition 
Pulmonary Deposition 
Aerodynamic Diameter (microns) 
Figure 8. 4 Deposition as a Function of 
Particle or Droplet Size in 
the Space (Weightless) 
Environment. 
(After Busby and Mercer (8)). 
For considerations of the pattern of deposition, the respiratory tract 
was divided into nasal (or nasopharyngeal), tracheobronchial and pulmo- 
nary regions. The subregions of the airways and their dimensions are 
shown in Table 8. 2. The tracheobronchial region includes all the ciliated 
airways (including the larynx), which are assumed to terminate at the distal 
ends of the terminal bronchioles. The pulmonary region includes the distal 
respiratory passages such as the respiratory bronchioles, and alveolar 
ducts and sacs. It is also pointed out that in the discussion which follows, 
the term “upper respiratory passages” refers to the nasal (or oral) 
regions of the respiratory passages, and the term “lower respiratory 
passages” refers to the tracheobronchial and pulmonary regions. 
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SPACE VS EARTH 
TOTAL REPOSITION AS A FUNCTION 
OF PARTICLE SIZE 
Nasal Breathing 
Tidal Volume 750 cc 
Respiratory Rate I5 /min 
Space - 7.Opsi (50X02-50%Nz) 
Earth -14.7psi (20%02-80%N2) 
1 L I I I 1 I I 0 I 2 3 4 5 -6 7 6 -9w 
Aerodynamic Diameter (miCrOnS) 
Figure 8. 5 Total Deposition as a Func- 
tion of Particle or Droplet 
Size in the Earth (Unit Gravity) 
and Space (Weightless) Environ- 
ment. 
(After Busby and Mercer (8)) . 
A number of medical implications can be drawn from these predic- 
tions of the characteristics of particle and droplet inhalation into and 
deposition in the respiratory passages in the weightless environment. It 
is assumed here that all particles and droplets will tend to follow the same 
predicted pattern of inhalationinto and deposition in the respiratory passages 
that would be expected to standard “aerodynamic diameter” particles. 
The tendency for particles and droplets to remain suspended in the 
weightless environment and the predicted characteristics of particle and, 
droplet inhalation into the respiratory passages in the weightless environment 
imply that the amount of particle or droplet contaminant which an exposed 
astronaut might inhale could be markedly increased, possibly by several 
order s of magnitude, over the amount that can be inhaled if the same contami- 
nant is introduced in a similar situation into a unit gravity environment. The 
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TRACHEA (transverse 25% greater than saggital) 13 - 22 mm 
w 
Tracheo- BRONCHI main - 7.5 - 12.5mm 
bronchial w 
Region 
BRgH1oLES 
< 1 mm 
TERMINAL BRONCHIOLES 0.6 mm 
w _-__-___b ________ --__-- ___4 -_-_-------- 
Pulmonary 
Region 
RESPIRATORY BRONCHIOLES 0.4 - 0.6 mm 
w 
ALGf”R OUCTS 
0.2 - 0.4 mm 
ALVEOLAR SACS 0.3 - 0.4 mm 
Table 8. 2 Internal Diameters of the Respiratory 
Passages in the Trachea-bronchial 
and Pulmonary Regions of the Adult 
Lung. 
(After Findeisen (15) , Landahl (36), Sander (51), 
von Hayek (56), and Weibel (57)). 
predicted characteristics of particle and droplet deposition in the respira- 
tory passages in the weightless environment show that in space, as on 
Earth, the nose or mouth should continue to operate as highly efficient 
filters, protecting the lower respiratory passages from all particles and 
droplets above about 10 microns in diameter. Fortunately, this size is 
considerably less than that of particles and droplets of most of the afore- 
mentioned .contaminants which might be introduced into the spacecraft cabin 
atmosphere. In this respect, it should be pointed out that the use of 
powdered chemicals of particle sizes greater than 10 microns in space 
would be an important safety measure. 
It must still be considered possible, however, for an astronaut to be 
exposed to particles (e., aggregates of smoke and fume particles) and 
droplets (3.) liquid ejected as a fine spray) less than about 10 microns 
in diameter. The “deposition curves” predict that fewer inhaled particles 
and droplets between about 0. 5 and about 10 microns in diameter will be 
deposited in the lower respiratory passages, especially in the pulmonary 
region, in the weightless as compared to the unit gravity environment. This 
implies that weightlessness might offer some protection to an astronaut from 
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certain contaminants which, if inhaled in a similar concentration in a 
unit gravity environment, would be irritating to or damage alveoli and 
respiratory bronchioles, or produce systemic toxic effects by being ab- 
sorbed. It is of interest to note that weightlessness exerts its greatest 
protective effect in the pulmonary or non-ciliated region of the respiratory 
passages -- a region where deposited contaminants are not moved out of 
the respiratory passages by ciliary action. This predicted decrease of 
particle and droplet deposition in the pulmonary region in the weightless as 
compared to the unit gravity environment implies that the concentration of 
particles and droplets one micron in diameter inhaled into the respiratory 
pas sages in the weightless environment could be approximately doubled be- 
fore the percent deposition of such contaminants in the pulmonary region 
in this environment would be equivalent to their percent deposition in the 
unit gravity environment. Similarly, the inhaled concentration of particles, 
and droplets could be increased by approximately 6 times for particles 
and droplets 2 microns in diameter, 7 times for those 3, 4, and 5 microns 
in diameter, 6 times for those 6.microns in diameter, 5 times for those 
7 and 8 microns in diameter, and 3 times for those 9 microns in diameter. 
However, even though it is predicted that the pulmonary deposition of 
inhaled particles and droplets between about 0. 5 and about 10 microns in 
diameter will be significantly reduced in the weightless environment, one 
must remember that such contaminating particles or droplets could still 
be suspended in a concentration which would be harmful. 
Since the weightless environment does not alter the high percent 
deposition of particles and droplets below about 0. 5 microns in diameter in 
the lower respiratory passages, the consequences of inhaling such contamin- 
ants will not be different in the weightless as compared to the unit gravity 
environment. Contaminants of this size are most likely to be in the form of 
fumes or smoke. Since particles or droplets below 0. 9 microns in diameter 
will apparently not be deposited in the nasal (or oral) regions of the respira- 
tory passages, their inhalation should not produce clinical problems in the 
upper respiratory passages. On the other hand, because of the very high 
percent deposition of particles and droplets below about 0. 5 microns in 
diameter, tracheobronchial and pulmonary tissues could be severely irritated 
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or damaged. 
From the equation which illustrated the relationship between air flow 
and particle size, Busby and Mercer concluded that the concentration and 
distribution of particles and droplets of diameters up to a few hundred microns 
which will enter the nose or mouth in the inspiratory air stream will not be 
significantly different from that in the spacecraft cabin atmosphere (8). 
Whether or not particles or droplets larger than a few hundred microns in 
diameter (e. g. , several hundred microns to 1 cm) can be inhaled will depend 
less on particle and droplet size, and more and more on such important fac- 
tors as particle or droplet shape and density, their spatial relationship to 
the inspiratory air stream and mouth and nasal openings, their velocities 
and directions of movement relative to an astronaut, the velocity-time pro- 
files of the inspiratory and expiratory air streams, and the duration of the 
pause between inspiration and expiration. Taking all of these factors into 
consider ation, it is predicted that various particles, especially those of 
low density par titles , and droplets of possibly up to 1 cm in diameter, 
could be inhaled in the weightless environment. Accordingly, it is thought 
that as compared to on Earth, an astronaut in space might run a somewhat 
higher risk not only of inhaling large particles and droplets into his nose 
and mouth, but also of aspirating large particles and droplets into his 
lower respiratory tract. For aspiration to occur, it must be assumed that 
normal mechanisms, such as coughing, swallowing and reflex glottic clo- 
sure, which exclude large particles impacting in the oropharynx from the 
larynx might not always be effective, especially if an astronaut should inhale 
several large particles or droplets at one time or if his exposure to and 
inhalation of the contaminant occurs unexpectedly. An inspiratory gasp, 
which produces high air velocities, might occur from an astronaut being 
“startled” or “stimulated” by an inhaled contaminant and could, therefore, 
increase the risk of the contaminant being aspirated. Because a much 
larger particle or droplet can enter and pass through the mouth than the 
nasal passages, aspiration is much more likely to occur if an astronaut is 
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breathing through his mouth. 
Acute Chemical Inflammation of the Upper Respiratory Tract 
The inhalation into the nose of a particulate chemical’, such as lithium 
hydroxide or a superoxide used in environmental systems, or a liquid chemi- 
cal, such as an acid or alkaline reagent used in an analytical system, could 
lead to a severe non-specific inflammation of the sensitive lining of the 
no se and pharynx, or so-called acute chemical rhino-pharyngitis. Con- 
sidered much less likely to occur following inhalation of a chemical, 
severe chemical inflammation of the lining of the mouth is managed in a 
similar fashion to that of the nose. 
The initial response to a chemical deposited in the nose is vasocon- 
striction. This is accompanied by symptoms ranging from an itching-burn- 
ing sensation to severe pain. Within minutes, however, vasodilatation 
occurs. The hyperemic nasal mucosa rapidly becomes edematous and 
secretes a watery fluid. This response can manifest clinically as a feel- 
ing of fullness or tightness in the nose and sinus regions, nasal obstruction, 
a profuse watery discharge, a “sore throat”, lacrimation and continued 
sneezing. The lining of the nose and pharynx can undergo some degree of 
localized or diffuse, immediate or delayed necrosis, particularly if larger 
chemical droplets or particles are inhaled. In this case, the nasal dis- 
charge is in the form of an exudate, which is opaque and viscous. It can 
be blood-streaked and contain pieces of necrotic intranasal tissue. Frank 
nasal and pharyngeal bleeding may occur up to several days after the incident. 
The most common sequela of acute chemical rhino-pharyngitis is secondary 
infection of the damaged nasal and pharyngeal lining. The nasal discharge 
becomes purulent and remains so until the continuity of the ciliated epithe- 
lium is restored. Severe infections are usually accompanied by fever and 
general malaise. The remote possibility of secondary bacterial invaders 
producing disorders of serious consequence, such as sinusitis, otitis 
media, mastoiditis, meningitis, osteomyelitis, and brain abcess, should 
be kept in mind. 
The treatment of acute chemical rhino-pharyngitis has been suggested 
by Fischer (16) (33) and Kilgore . As soon as possible after inhaling a 
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chemical into his nose, an afflicted astronaut should use any method possible 
to irrigate his nose and pharynx. Water or, if available, isotonic saline 
or any other isotonic solution should be flushed in and out of his nose and 
gargled. Irrigation should be continued for several minutes or until the 
initial irritation has subsided. It might be carried out for many minutes 
if he inhales large particles which could be impacted in his nose. 
It is debatable as to whether or not to instill immediately a potent, 
rapid- acting, topical vasoconstrictor, such as l/ 1000 epinephrine, in a 
chemically-inflamed nose. On the one hand, such an agent would, by 
shrinking the nasal lining, allow better nasal irrigation and possibly less 
absorption of a toxic chemical into the body. On the other hand, one must 
keep in mind the damage which would be incurred by a chemical while 
waiting for a vasoconstrictor to take effect. Accordingly, it is thought 
that vasoconstriction should be attempted after some irrigation has been 
carried out. 
As will be pointed out in the discussion of acute chemical inflammation 
of the lower respiratory tract, steroid drugs appear to have an excellent 
anti-inflammatory action on the respiratory tract mucosa. Therefore, 
it is suggested that suitable steroid preparations be administered as indi- 
cated both intravenously (e. g. , hydrocortisone sodium succinate) as soon 
as possible after an astronaut inhales a chemical agent, and instilled in 
his nose (e. g., 1 percent hydrocortisone acetate) after irrigation. An oral 
steroid (e. g. , methylprednisolone) might be given for several days to 
serious cases. 
Control of nasal bleeding secondary to chemical damage can usually 
be accomplished without any special treatment or with the very simplest of 
measures. Since bleeding is most likely to occur from the anterior part 
of the nasal septum, a cotton pledget should be placed in the front of the 
nasal cavity and pressure applied to the nose to compress it against the 
septum. Soaking the pledget with a vasoconstrictor, such as l/ 1000 epine- 
phr ine , or the local application of a hemostatic agent, such as “oxycel”, 
“gelfoam” or topical thrombin might be required to arrest bleeding. Finally, 
nasal packing is a specialized procedure which is rarely required for per- 
sistent nasal bleeding (6). 
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If the lining of the nose has been extensively denuded by a chemical, 
the raw surfaces should be covered w.ith petrolatum gauze to prevent the 
formation of adhesions. This dressing should be changed every 2 to 3 
days until the areas are re-epithelialized. A suitable broad spectrum 
antibiotic should be administered by the oral or intramuscular route if 
infection of damaged nasal or pharyngeal tissues occurs. Finally, it 
should be noted that an analgesic or sedative drug might be required by a 
serious case of acute chemical rhino-pharyngitis. 
Intr anasal Foreign Body 
An astronaut could inhale a non-chemical particle which, because of 
its size and shape, might become impacted in the nasal cavity rather than 
being expelled by sneezing or escaping in secretions. Food, metal and 
plastic particles are examples of such possible foreign bodies. 
A small smooth foreign body in the nasal cavity could give little or 
no discomfort (29). As a result, its presence might remain undetected 
until ulceration of the nasal mucosa occurs fr-om mechanical and possibly 
some chemical irritation. The clinical manifestations of mucosal involve- 
ment may appear from days to weeks after the foreign body enters the 
nose. They are characterized at first by a unilateral serous discharge, 
then an odorous, purulent discharge. Blood streaking of the discharge or 
frank bleeding could occur. 
No foreign body should be allowed to remain in an astronaut’s nasal 
cavity, for it could produce necrosis and secondary infection of nasal 
tissue or be aspirated into his lower respiratory tract (6) . With good 
illumination and a nasal speculum, either the foreign body itself or an ac- 
cumulation of secretion at its site of location will be seen. Better visual- 
ization and possibly facilitated removal of the foreign body might be accom- 
plished by shrinking the nasal mucosa with a topical vasoconstrictor, such 
as l/ 1000 epinephrine (291, The majority of foreign bodies in the nasal 
cavity should be located in the anterior part of the nasal cavity or in the 
inferior meatus along the floor of the nose. If ever possible in space, an 
x-ray of the nasal passages for the location of a foreign body might on 
occasion prove useful. 
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An intranasal foreign body can be removed using an open-ended suction 
tip or cotton- tipped applicator, a blunt bent probe and a suitable forcep, 
such as an alligator forcep. Care must be taken to avoid pushing, or hav- 
ing an astronaut inadvertently suck a foreign body into his pharynx, from 
which the foreign body might be aspirated. Measures which might be taken 
to control secondary bleeding are discussed above. A suitable broad spec- 
trum antibiotic should be administered as indicated for infection. 
Aspirated Foreign Body 
The aspiration of a non-chemical particle into the lower respiratory 
tract in space can lead to a number of serious clinical problems which have 
been discussed so well in the vast literature on this area. Particular ref- 
erence is made to the excellent reviews of Jackson and Jackson (28, 29, 30) 
Hollinger 
(24, 25, 26, 27) and other authors (3, 7, 9, 13, 14, 17, 38, 39, ’ 
42, 43, 45) for greater detail than that to be presented below. 
Generally speaking, both the clinical manifestations produced by an 
aspirated foreign body and the times of appearance of these manifestations 
are highly variable, depending in most cases on the site where the foreign 
body lodges , the degrees of primary obstruction and irritation that it pro- 
duces, and the length of time that it remains in the lower respiratory tract. 
These factors are determined in readily apparent ways by the size, shape, 
and chemical activity of the foreign body. It is also possible that an aspirated 
foreign body in space could be microbiologically contaminated, and thus serve 
as a nidus for infection. 
In the light of the above considerations, it is understandable how a non- 
irritating , non-obstructing foreign body such as a smooth particle of an 
inert metal, glass, or plastic can remain lodged for months to years in the 
lower respiratory tract without giving rise to clinical manifestations (5, 21, 
44) . In the majority of instances, however, the consequences of obstruction 
of the laryngeal, tracheal, or bronchial passages by a foreign body ensue. 
Signs and symptoms may appear immediately if obstruction of a passage is 
complete. They may present after a quiescent period of days to weeks during 
which, through mechanical and chemical irritation, the foreign body causes 
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localized mucosal swelling that perfects the occlusion of the passage. 
Characteristically,the delayed periods are shortest in cases of aspirated 
vegetal foreign bodies, for all vegetal substances irritate the respiratory 
tract mucosa by chemical action, producing a violent laryngotracheo- 
bronchitis and obstructive swelling (14) . On the other hand, clinical mani- 
festations from aspirated metallic foreign bodies often take many weeks to 
many months to appear, even if these foreign bodies are initially rough 
and obstructive or become so by corrosion, or produce some chemical 
irritation through corrosion. 
A foreign body in the larynx of an astronaut will produce paroxysms of 
violent coughing, gagging, choking and wheezing. An obstructing foreign 
body may cause immediate death unless coughed out. Lodgment of a non- 
obstructing foreign body can produce any one or more of the following 
signs and symptoms: hoarseness, croupy cough, stridor, wheezing, 
dyspnea, pain, aphonia, hemoptysis, and a subjective feeling of the presence 
of the foreign body in the larynx. Often a small non-obstructing foreign 
body may become asymptomatic for a period of time. Any foreign body 
remaining in the larynx is potentially dangerous, however, for secondary 
inflammation can produce fatal edema of the larynx, and secondary infection 
can destroy laryngeal tissues and lead to grave consequences by spreading 
out into the tissues of the neck and down into the mediastinum. 
The presence of a foreign body in an astronaut’s larynx is in most 
cases apparent from his history alone. Confusing the diagnosis, however, 
might be laryngeal symptoms persisting from trauma caused by a foreign 
body that has passed on into deeper respiratory and food passages, or by 
one that has been coughed out. Therefore, indirect laryngoscopy and 
rarely, if possible on board the spacecraft, an x-ray are required for con- 
firmation. Since direct laryngoscopy requires special skills and instruments, 
and often general anesthesia, this procedure is not considered possible in 
space in the foreseeable future. It should be remembered that a foreign 
body which is not found in the larynx could be resting temporarily in 
deeper respiratory passages without producing symptoms. 
A non-obstructing foreign body in the larynx is usually coughed out 
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within minute S. The simplest maneuver, such as a slap on the back dur- 
ing an expulsory effort, may sometimes assist to dislodge a foreign body (38) . 
If an astronaut’s larynx is obstructed or suffocation. is threatening, an 
immediate tracheostomy must be performed. It is pointed out that if this 
surgical procedure cannot be performed immediately, life- sustaining ven- 
tilation of the lungs can be achieved temporarily by inserting a large-bore 
needle (e. g. , 16 gauge needle) through the cricothyroid membrane. If efforts 
at expelling a foreign body are unsuccessful, it should be withdrawn as soon 
as possible with suitable forceps and indirect laryngoscopy. This 
procedure is rendered comparatively easy if a suitable topical anesthetic, 
such as 10 percent cocaine or 2 percent xylocaine, is applied to the laryn- 
geal mucous membrane, epiglottis and base of the tongue prior to attempt- 
ing removal. It is possible that disimpaction and possibly removal of a 
foreign body might be carried out by way of a tracheal.wound previously 
made for the relief of airway obstruction. Extreme care must be taken to 
prevent a foreign body in the larynx from being dislodged during removal 
and entering the deeper respiratory passages. Other possible measures 
in the treatment of a foreign body in the larynx in space are supportive. 
A broad spectrum antibiotic may be indicated if infection ensues. If the 
foreign body cannot be removed in space, a more permanent tracheostomy 
might be required until direct laryngoscopic removal can be performed on 
Earth. Measures might be needed for post-hypoxic cerebral edema result- 
ing from the temporary asphyxia (Chapter 1). 
Usually a foreign body in the trachea initially produced paroxysms of 
coughing as well as one or more of the following manifestations: a chronic 
cough, hoarseness, dyspnea, cyanosis, and a slapping feeling on inspiration 
and expiration. A large foreign body may completely obstruct the trachea 
and, in spite of possible immediate attempts to remove the foreign body 
through a tracheostomy wound, may cause death in a few minutes. A for- 
eign body remaining in the trachea is potentially dangerous. Irritative 
inflammation, especially from vegetal foreign bodies, can result in fatal 
obstructive swelling or severe laryngotracheobronchitis. Secondary infection 
may produce a fatal mediastinitis or pneumonitis. 
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If elicited, a history of initial choking, gagging, and wheezing will 
be helpful in the diagnosis of a foreign body in the trachea. The patho- 
gnomonic signs of a foreign body. in the trachea are an “audible slap” 
heard at the mouth and a “palpable thud” felt over the larynx, created as 
the foreign body is trapped at the larynx by the vocal cords during a cough 
or for ted expiration (28, 29, 30). A wheeze is usually heard when the 
foreign body lodges somewhere in the trachea and becomes stationary. 
If ever possible on board the spacecraft, an x-ray might make or confirm 
the diagnosis. 
A non-obstructing foreign body in the trachea is often coughed out with- 
in minute s . This might even be more. the case in the absence of gravity 
which tends to pull a foreign body back down into the trachea. The removal 
of a tracheal foreign body should be attempted immediately through a trach- 
eostomy wound if it is obstructing or threatening suffocation. Bronchoscopic 
removal is a highly skilled procedure which will probably not be performed 
in space in the foreseeable future. Removal of a tracheal foreign body 
might be attempted through a tracheostomy wound if expulsory efforts 
fail and if it is thought that disastrous sequelae could occur prior to return- 
ing to Earth. Otherwise, only supportive forms of therapy, such as a 
broad spectrum antibiotic for infection and an antitussive agent for chronic 
cough, might be given. Measures might also be required for post-hypoxic 
cerebral edema resulting from temporary asphyxia (Chapter 1). 
The initial symptoms produced by a foreign body in a bronchus are 
coughing, asthmatoid wheeze and others mentioned above. At once or after 
a symptomless interval, a productive cough, blood- streaked sputum, 
metallic taste, odor of the foreign body, fever, and malaise may be present 
due to decomposition of the foreign body and the pathologic sequelae it pro- 
duces. As was pointed out above, non- obstructing relatively inert foreign 
bodies can be asymptomatic for weeks, months, or even years. On the 
other hand, obstruction of a bronchus is followed by atelectasis of the por- 
tion of the lung supplied by the bronchus,after which suppurative manifesta- 
tions such as lung abcess, empyema, bronchiectasis, and pneumonia might 
ensue. Such sequelae can also result from prolonged partial obstruction 
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from swelling of the mucous membrane or growth of granulation tissue at 
the site of the foreign body . (42) It is pointed out again that vegetal for- 
eign bodies are markedly irritating by chemical action. They produce a 
violent laryngotracheobronchitis with signs and symptoms of toxemia, 
cough, dyspnea, cyanosis, and irregular fever. Finally, a sharp foreign 
body or one that produces an obstructive emphysema can cause a disrup- 
tion of pulmonary structure, with complications such as a sudden pneumo- 
thorax, mediastinal emphysema extending often into the neck, or acute 
(17, 39). mediastinitis being possible 
The diagnosis of a foreign body in a bronchus of an astronaut will in 
most cases be made from the initial symptoms and the physical findings to 
be outlined below. Occasionally, however, the diagnosis might only be 
based on a high index of suspicion and a careful history, for manifestations 
produced by the foreign body may not appear until long after an episode of 
choking or coughing, at which time the possibility of a foreign body passing 
into a bronchus was not considered. If ever possible in space, an x-ray 
would be valuable not only in making or confirming the initial diagnosis 
but also for diagnosing sequelae and the response of these sequelae to 
therapy. The physical signs will vary with the conditions present in 
different cases and at different times in the same case. Secretions, both 
normal and pathologic, may shift from one location to another. The foreign 
body may change position, admitting more, less, or no air into a lung or 
lung segment. It may shift to a new location in the same lung or even in 
the other lung. The signs of diagnostic importance are chiefly those of 
partial or complete bronchial obstruction. They are classically described 
(29, 30, 42): as follows 
If obstruction is partial, there is usually a persistent 
sonorous rhoncus, more conspicuous during expira- 
tion. In cases with equal air entry and air exit past 
the site of the obstruction, a rhoncus and occasionally 
a small patch of rales over the position of the foreign 
body may be the only signs. In cases with inadequate 
air entry but adequate air exit, partial collapse of the 
lung occurs, associated with dullness, diminished 
breath sounds and rales. In cases with adequate air 
entry but inadequate air exit, obstructive emphysema 
is produced, with hyper-resonance and diminished 
breath sounds being noted over the involved lung. 
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If a major bronchus has been entirely occluded, there 
are the usual signs of an obstructed lobe or lung, 
such as dullness to percussion, diminished fremitus, 
absence of breath sounds and usually some degree of 
mediastinal displacement. 
Past experience has shown that only about 3 percent of foreign bodies 
in bronchi are coughed up spontaneously, the remainder having to be re- 
moved by bronchoscopy (28, 29). Since bronchoscopy is a highly skilled 
procedure which is unlikely to be performed in space in the foreseeable 
future, appropriate supportive therapy will have to suffice until an astronaut 
returns to Earth. With a suitable broad spectrum antibiotic, the septic 
sequelae should be adequately controlled. AS will be discussed under acute 
chemical inflammation of the lower respiratory tract, steroid therapy might 
be of some value in treating cases with fulminating laryngotracheobronchitis 
due to vegetal foreign body. 
Even in cases of profound sepsis, the prognosis for complete recovery 
following removal of a foreign body which has been in a bronchus for a 
prolonged period of time is fortunately excellent. Jackson and Jackson 
point out that 95 percent of cases of foreign body of other than vegetal 
origin completely recover (30) , This figure and the unstated poor prognosis 
of cases of vegetal foreign body would no doubt be bettered by therapy given 
immediately as indicated. 
Acute Chemical Inflammation of the Lower Respiratory Tract 
An acute non- specific inflammation of the lower respiratory passages of 
an astronaut might occur if he inhales an irritant gas or chemically-irritat- 
ing particles or droplets which are small enough to be inhaled beyond the 
nasal or oral regions of his respiratory passages. It might also result from 
the aspiration of chemically-irritating particles or droplets. Possible con- 
taminants fitting into the first category are gases formed by the chemical 
breakdown of metals, plastics, and other materials by spilled acids and alkalis. 
Examples in the second category are: chemical dusts, expecially if powdered 
chemicals are used on board spacecraft; fumes and smokes formed by the 
pyrolysis or combustion of plastics, metals and other materials; and chemi- 
cal mists which might be formed if acids or alkalis are sprayed into the 
spacecraft cabin atmosphere. Of major concern in the third category is 
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vomitus, the aspiration of which is considered particularly prone to occur 
if an astronaut vomits into the helmet of his space suit. It is pointed out 
that the hydrochloric acid content of vomitus is highly irritative. As well, 
if food particles are present in the vomitus, they can produce primary 
obstruction of respiratory passages and possibly further chemical irrita- 
tion. The following discussion deals with the general aspects of chemical 
inflammation of the lower respiratory passages. Although it is considered 
possible that some contaminants might be absorbed from the respiratory 
passages and produce specific toxic effects, such effects can be described 
only after the hazards and their toxicology have been better defined. 
A chemical which enters the lower respiratory tract can induce various 
respiratory protective reflexes such as coughing, apnea, glottic closure, 
adduction of the vocal cords and bronchospasm. These reflexes act to 
exclude the irritant from the deeper respiratory passages, especially the 
delicate alveolar cells. The stimulating action of an irritant is determined 
by its cytotoxic nature, by its solubility in water and, of course, by the 
amount of irritant entering the respiratory passages. Intense stimulation 
may be effective in temporarily excluding an irritant from, and so minimiz- 
ing the toxic effects of the irritant in the lower respiratory passages. Un- 
fortunately, however, these reflexes are not so efficient when a large 
volume of a highly irritating fluid such as vomitus is aspirated (20) . 
After gaining access to the lower respiratory passages, a chemical 
will produce toxic effects in specific regions of or throughout the passages. 
This will depend mainly on the amount of the irritant and its physical proper- 
ties. An irritant gas with a high solubility in water will be extracted by 
the moist surfaces of the upper respiratory tract and high up in the lower 
tract, whereas an irritant gas with a low solubility will penetrate deep into 
the tract producing toxic effects on bronchioles and alveoli. The charac- 
teristics of deposition of inhaled particles or droplets in the lower respira- 
tory passages in the weightless environment have been discussed previously. 
The distance of penetration of an aspirated liquid into the lower respiratory 
tract will depend mainly on the amount of liquid that enters. An aspirated 
particle can lodge in various regions of the lower respiratory passages. 
The more soluble it is, the more immediate and diffuse will be its chemical 
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action, all other cytotoxic factors being e.qual. 
The inflammation produced by a chemical in the lower respiratory 
tract is characterized by vasodilatation, congestion and subsequent transu- 
dation of plasma through hyperpermeable capillary walls in the involved 
tissues. This edema fluid distends interstitial tissues and accumulates in 
the respiratory passages, interfering with the ventilation of the lungs and, 
if the alveoli are involved, impairs diffusion of respiratory gases across 
alveolar membranes and perfusion of alveolar capillary beds. Inflammation 
of the laryngeal and bronchial tissues is usually accompanied by some 
degree of laryngospasm and bronchospasm, which assist in blocking air 
flow. Chemical necrosis of tissues may occur, with debris and hemorrhage 
contributing further to impairment of lung function. Then, as a common 
and often serious sequel, secondary bacterial infection of damaged lung 
tissues can occur. 
In the light of the above considerations, it is obvious how widely 
variable the clinical manifestations produced by a chemical irritant in the 
lower respiratory passages of an astronaut could be. The entry of an 
irritant into the lower respiratory passages can produce signs and symp- 
toms such as apnea, partial or complete blockage of air entry, stridor, 
violent coughing, retching, a severe burning or stinging pain in the throat, 
larynx and trachea, a feeling of substernal pressure, wheezing, dizziness 
and anxiety. If the larynx is severely involved, laryngospasm and rapidly- 
occurring interstitial edema of its tissues can seriously compromise air 
flow, with severe dyspnea, cyanosis and possibly fatal asphyxia coming on 
within minutes after exposure. Signs and symptoms of acute chemical 
laryngotracheobronchitis, such as dyspnea, coarse rales and rhonci, 
cyanosis and the coughing of a copious, possibly blood- stained frothy spu- 
tum,can appear over a period of minutes to hours and cause death. Acute 
chemical pneumonitis usually begins rapidly, either immediately or after 
a relatively asymptomatic period of up to several hours. If the edema is 
severe, there is dyspnea and the coughing of a copious frothy sputum which 
might be blood stained. This edema may lead to cyanosis, right-sided 
heart failure, “shock” and death (47) . Severe necrosis of tissues in the 
lower respiratory passages can result in fatal hemorrhaging. Surviving 
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chemical inflammation and damage of one specific or all regions of his 
lower respiratory passages, an astronaut could develop a secondary bac- 
terial infection over a period of many hours or days. This could manifest 
as laryngotracheobronchitis, bronchopneumonia, empyema or lung abcess, 
and could lead to his demise. 
The diagnosis of chemical inflammation of the lower respiratory tract 
is, in most cases, obvious from the history and physical findings alone. 
It is important to remember that acute pulmonary edema can occur in an 
asymptomatic individual up to several hours after being exposed to a chemi- 
cal irritant. If possible on board the spacecraft, chest x-rays could be of 
some assistance in diagnosing pulmonary edema in its pre-clinical and 
clinical stages, and secondary complications. 
Experimental and apparent clinical success, especially in treating 
chemical inflammation of the lower respiratory tract due to aspirated 
vomitus, has been achieved with steroids 
(4, l-1, 20, 22, 31, 32) The . 
exact mode of action of these drugs is unknown (4, 32) . Further research 
is apparently required to definitely establish their effectiveness in treating 
chemical inflammation in the lower respiratory passages from all causes. 
The standard method of treatment is the administration of a suitable steroid, 
such as hydrocortisone sodium succinate, intravenously as soon as possible 
after an incident. Depending on response to the first dose and the serious- 
ness of the inflammation, repeat doses of such a drug can be given either 
intravenously or intramuscularly over a period of time. After the acute 
phase of the inflammation has passed, a suitable oral steroid preparation, 
such as methylprednisolone, should be taken in decreasing doses for several 
days. 
Other therapeutic measures are taken as dictated by sound clinical 
judgment. A tracheostomy is a life-saving measure which should be per- 
formed as soon as possible in cases with laryngeal edema of rapid onset. 
It is also effective in cases with severe involvement of the lower respiratory 
passages, by allowing less obstructed ventilation of the lungs and providing 
a portal for the removal of copious secretions and possibly blood. Positive 
pressure oxygen will combat not only hypoxia but also pulmonary edema. 
Bronchospasm can be relieved with a suitable bronchodilator drug, such as 
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aminophylline, administered intravenously or intramuscularly. Nebulized 
isoproterenol might also be used for bronchodilation. Rapid intravenous 
digitalization will be required in cases with right heart failure, and 
may be undertaken as a prophylactic measure in potentially serious 
cases. “Shock” should be treated with a suitable vasopressor, such as 
metaraminol, administered intravenously. Analgesia and sedation might 
be indicated. Therapy with a suitable broad spectrum antibiotic might 
be commenced in serious cases even before manifestations of secondary 
infection appear. 
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CHAPTER 9 
URINARY CALCULUS 
Many authors have postulated that bone will undergo partial reabsorp- 
tion in the weightless environment 
(20, 25, 30, 42, 58, 62, 71) They . 
have also pointed out that the resulting excessive excretion of the products 
of bone reabsorption might be conducive to urinary calculus formation. 
Accordingly, it is thought necessary to consider urinary calculus a poten- 
tial medical problem of prolonged space missions until appropriate studies 
in space prove otherwise. This chapter presents information considered 
pertinent to the occurrence of urinary calculus in space. 
Weightlessness and Bone Metabolism 
Bone is a living tissue and, like most other tissues in the body, is 
constantly undergoing the simultaneous processes of formation and destruc- 
tion (84). In bone formation, a matrix of protein and mucopolysaccharide 
is first produced by osteoblastic cells. Then calcium and phosphorus, 
mainly in the form of apatite crystals, is deposited in this matrix. Bone 
reabsorption is due to osteoclastic cellular activity, which is apparently 
responsible for the breaking down of both matrix and bone crystals (62) . 
By means of formation and reabsorption processes, bones are remodeled 
in response to the functional demands which muscular pull, other mechani- 
cal stresses, and presumably gravitational forces place on them. This 
fact was recognized by Julius Wolff in 1868, and has become known as 
Wolff’s law: “Every change in the form and the function of bones, or in their 
function alone, is followed by certain definite changes in their internal 
architecture, and equally definite changes in their external conformation 
1, (103) . . . . . . . . 
If stresses on bones are sufficiently increased by physical activity, for 
example, the physicochemical processes of bone formation in the stressed 
bones will outdistance those of bone reabsorption, and hypertrophic changes 
will occur. Conversely, if the stresses on bones are decreased to a sig- 
nificant degree, atrophic, or osteoporotic changes will result from reabsorp- 
tive processes predominating over formation processes. The osteoporosis 
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which occurs in an extremity which becomes paralyzed, or is immobilized 
for a period of time for therapeutic purposes, is a classical example of 
the effect of decreasing the mechanical stresses on bone. 
In accordance with Wolff’s law, the state of equilibrium of bone meta- 
bolism is influenced by the forces of compression, tension, and shear 
exerted by weight bearing and muscular activity. One would expect, there- 
fore, that removal of the forces normally exerted by weightbearing, as will 
occur in the weightless environment, will alter this state in weightbearing 
bones. Reabsorption processes will exceed formation processes in these 
bones until bone metabolism, as influenced now by only the forces of mus- 
cular activity, returns in time to a state of equilibrium. If the degree of 
osteoporosis produced by the excessive bone reabsorption is severe and 
localized, weightbearing bones could become more prone to fracture (20, 
84) . However, even more important from a space operational standpoint 
is the possibility that the urinary output of calcium and other products of 
bone reabsorption could lead to urinary calculus formation, and the extre- 
mely incapacitating symptoms therefrom, during a space mission (26, 30, 
42, 58, 71, 91, 92) . 
In various attempts to predict what effect weightlessness will have on 
bone metabolism, observations made on immobilized patients and healthy 
experimental subjects have been referred to repeatedly 
(8, 20, 28, 52, 
101, 102, 104) The classical experiment of Deitrick and co-workers (28) . illus - 
trates immobilization carried to one extreme. Four healthy young men 
were immobilized in plaster casts from waist to toes for six to seven weeks. 
They were placed on constant dietary intakes for several weeks prior to and 
during immobilization. Pertinent to considerations in this chapter are 
that immobilization brought about a prompt increase in urinary and fecal 
calcium excretion, which reached a plateau over a period of four to five 
weeks. At this time, the urinary calcium output was between two and three 
times its pr e- immobilization level. The serum calcium tended to rise in 
this study, leading to the suggestion that during immobilization, the increase 
in calcium excretion and hypercalcemia may actually reflect an increase 
in bone reabsorption (100) . Immobilization also led to an increase in urinary 
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and fecal phosphorus excretion. The urinary phosphorus excretion began 
to rise during the first week. It reached a peak which coincided with that 
of increased nitrogen excretion in the second to third week, decreased 
somewhat, and then reached a second peak at the sixth to seventh week, 
when the urinary calcium excretion was at its highest level. Pertinent to 
considerations of urinary calculus formation is the observation that urine 
pH rose slightly so that, as will be discussed below, the solubility of cal- 
cium phosphate in the urine would have been decreased. 
Recently, more practical immobilization experiments have been directed 
at maintaining recumbent, healthy, young subjects at an optimum level of 
physical fitness by having them intermittently perform a variety of appro- 
priate exercises (8, 20, 96) . Hopefully, such exercises, which will undoubt- 
edly be necessary to compensate for decreases in normal physical activity 
during space missions, should eliminate the effect of muscular inactivity 
on bone metabolism. Accordingly, if subjects remain recumbent, the effects 
of weightlessness on weightbearing bones should be fairly well simulated 
in these experiments. 
Throughout a 30-day bed rest study reported by Brannon and co-workers 
(20) , 18 healthy young subjects performed one of three exercise routines, 
and six subjects performed no exercise except for being allowed to sit and 
turn about in bed. All subjects were on constant dietary intakes throughout 
the study. Since bed rest did not produce an increase in the urinary calcium 
output in either the exercise or non-exercise groups, the impression was 
gained that only a small amount of exercise is necessary to preserve muscu- 
lar integrity and prevent bone reabsorption in a physically fit, normal individ- 
ual who is confined to bed. Similar studies by Vogt and co-workers (96) , in 
which specific isometric exercises were found to prevent reabsorption of 
the OS calcis, suggests that appropriate exercises might even effectively pro- 
tect weightbearing bones from reabsorption. 
In contrast to the above findings, Birkhead and co-workers (8) failed to 
prevent bone reabsorption with various exercise regimens in their bed rest 
study. In this study, eight subjects remained recumbent for 24 days. 
All had a constant dietary intake during this period. Exercise was performed 
200 
on a bicycle ergometer for one hour daily by two subjects in a lying posi- 
tion and two subjects in a sitting position. Four subjects sat in a chair 
for eight hours daily. 
From the studies mentioned above, it is apparent that the relative con- 
tributions of muscular activity and the stresses of weightbearing to the 
maintenance of normal bone integrity still remain undetermined. All exer- 
cises which involve the gravity muscles and weightbearing bones simulate 
weightbearing forces to some degree. For this reason, it is unlikely that 
the specific effects of weightlessness on the skeletal system will ever be 
simulated. Whedon (loo) pointed out that we do not even know the exact 
manner in which mechanical stresses exert their effects on bone mass. 
He postulated that these stresses may act through the medium of muscular 
pull on periosteal surfaces and, in weightbearing, more directly through 
bone structures and columns, or by combinations of these two and perhaps 
other factors. On the one hand, muscular pull would seem to be the most 
important factor maintaining normal bone integrity, since slow rocking in 
a Sander’s oscillating bed was effective in preventing the alteration of 
calcium balance of normal immobilized subjects (101) but not of severe 
poliomyelitis and paraplegic cases (104) . On the other hand, Abramson (1) 
showed that osteoporosis in paraplegics was effectively reduced by weight- 
bearing, hence providing evidence for weightbearing as a factor. 
Therefore, it appears that during space missions, efforts should be 
directed not only at maintaining an optimum level of muscular activity, but 
also at attempting to simulate the stresses of weightbearing on bone. Care- 
fully selected exercises should prevent loss of muscle integrity, and the 
bone reabsorption associated with it, in an astronaut who has his physical 
activity reduced during a space mission. Such exercises, which should main- 
tain stability about weightbearing joints and the fitness of postural muscula- 
ture, will also contribute to keeping the risk of injuries from mechanical 
forces in space (Chapter 14) to a minimum. It is thought that an almost if 
not completely adequate simulation of weightbearing stresses on the musculo- 
skeletal system can be accomplished in space by means of selected exercises 
and possibly the application of appropriate mechanical forces to the body. 
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This is an area which certainly requires intensive investigation. 
Urinary Calculus Formation 
Although weightbearing forces on the skeletal system might conceivably 
be adequately simulated in space by various measures, it is believed that 
at the present time, excretion of the products of bone reabsorption, if only 
to a minor degree, should be anticipated during prolonged space missions. 
Since one or more of a number of factors other than bone reabsorption could 
initiate or enhance the formation of a urinary calculus in an astronaut, they 
too must be taken into account when considering the prevention of urinary 
calculus in space. It should be remembered that some of these factors are 
actually potential side-effects of space operations and, either singly or in 
various combinations, might be capable of initiating calculus formation 
even though bone reabsorption might not be occurring. 
Comoonents of a Urinarv Calculus 
The principle component of a calculus formed in a normal urinary tract 
in space will probably be basic calcium phosphate principally in the form 
of either apatite (Cal0 (PO4)6 (OH)2) which is its solid phase about a pH 
of 6. 6,0r brushite (CaHP04. 
6 6 (33, 34, 36, 77) 
2H20) which is its solid phase below a pH of 
. . If a urinary tract is infected with urea-splitting organ- 
lsms, such as Proteus, Staphvlococcus albus and rarely members of the 
colon group of bacteria, ammonia will be formed. Because of alkalinization 
and ammoniation, a calculus which develops in this case will probably be 
composed of apatite and calcium magnesium ammonium phosphate; the latter 
occurs at a pH of 7. 1 when the calcium to phosphate ratio in the urine is 
below the normal mean, and is also known as triple phosphate or struvite 
(35, 36, 40, 77) 
. It is readily apparent that a calculus consisting of layers 
of these different crystalline materials can be produced if conditions under 
which calculi are formed in the urine vary. 
The other component of all urinary calculi is organic matrix. It is 
apparently composed of constant amounts of mucoprotein and mucopoly- 
saccharide, and is evenly distributed throughout a calculus (19). As will 
be pointed out below, the role of matrix in calculus formation has received 
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much debate in the past few years. 
Basic Mechanisms of Urinary Calculus Formation 
The mechanisms underlying the formation of a urinary calculus remain 
essentially undefined. Current thought in this area has been reviewed by 
Boyce and King (17) , Howard (51), Holt (50), Flocks and Bush (40), Fleisch 
(39), and many others (10, 41, 43, 69, 72, 77, 89) . 
Many investigators in this area have held the view that organic matrix 
is required as a framework for calculus formation, while crystal deposi- 
tion z?pears to be a secondary phenomenon. Evidence for this was given 
by the observation that even though concretions of matrix material with 
little inorganic salt content do occur, the converse is not true (12, 17) . 
Fleisch (39) pointed out that if no matrix is formed, no calculus can build 
up, the maximum mineral deposit then being well known “urinary sand”. 
Boyce and co-workers (17, 18, 19) have suggested that the matrix is 
formed from the aggregation and molecular reorientation of uromucoid, a 
mucoprotein-mucopolysaccharide conjugate. Uromucoid is the largest 
single component of the normally excreted urinary bicolloids, and notably 
is one of the bicolloids which is markedly increased in patients with urinary 
calculus disease 
(14, 15, 16) 
. In a normal state, it is believed that there 
is some binding of calcium and phosphorus by uromucoid molecules, but 
little tendency for the molecules to aggregate (17) . Accordingly, some factor 
would have to alter the binding capacity of uromucoid molecules, so per- 
mitting molecular aggregation and orientation to form the structural charac- 
teristics of the calculus matrix (17). The oriented molecules would then 
act as templates or epitactic stimuli for apatite or other crystal formation 
depending on chemical conditions in the urine (17) . 
The origin of uromucoid remains unknown, however. Because of the 
high molecular weight of its constituents, Boyce and King (17) have suggested 
that it is of urinary epithelial origin, either from the renal tubules or the 
transitional epithelium. The hypothesis that the mucoprotein and mucopoly- 
saccharide moieties from the reabsorption of bone matrix are excreted 
in the urine and reform under the proper ambient conditions in the urine 
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into uromucoid or a similar substance remains to be substantiated (50, 87) . 
This mechanism could explain the origin of the matrix in urinary calculi 
attributed to excessive bone reabsorption. Comparison of the urinary 
calcium excretion rates of idiopathic calculus formers with healthy non- 
calculus forming individuals has indicated that under all dietary regimens 
employed, 24-hour calcium excretions of stone formers exceeded that of 
controls 
(13, 17, 60, 64, 88) . Accordingly it has been suggested that 
hypercalciuria per se should be considered a possible stimulus leading 
to the increased production of uromucoid (14, 40) . It is of interest to 
note that some of the calculus-formers whose urinary calcium excretion 
was reduced by diet still formed stones. These stones were described as 
non-opaque, pure matrix-material stones which contained no calcium. 
How hypercalciuria might stimulate the production of uromucoid in 
the urinary tract is a question to be answered. To confuse the issue, it 
has been repeatedly pointed out that prolonged hypercalciuria is not always 
associated with urinary calculus formation (2, 49, 67, 69, 77) Boyce . 
and Garvey (12) found evidence that an organic matrix may form if the 
urinary tract epithelium is irritated by precipitated crystalloids. This 
possible irritative mechanism might also explain the origin of the matrix 
in the calculi which have been attributed primarily to infection of the 
urinary tract. In the case of infection, the bacterial and epithelial debris 
produced by the infection might actually act as the nuclei initiating stone 
formation (40). 
Finally, it has been postulated that uromucoid might be excreted by 
the kidneys as the result of abnormalities, which have apparently been seen 
histologically in the renal connective tissue matrix !3) . The possibility 
that increased calcium transport through the kidneys might produce histologic 
changes has doubtlessly been considered. A possible relationship between 
uromucoid production and physiological “stress” has been suggested (4) . 
Research has, however, led other investigators to believe that organic 
matrix is not a crucial element for urinary calculus formation, but rather 
an incidental inclusion in calculi. In a number of experiments, Vermeulen 
and co-workers (61, 93, 94) have induced the crystalline depositio’n of 
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calculus minerals on a wire loop placed in a great variety of modified 
urine media. Their artificial calculi often assumed many of the struc- 
tural characteristics of authentic calculi. This was found to depend on 
the curious phenomenon of “habit modification”, or the influence which 
other constituents of the urine had on the growth and reworking of the 
calcium phosphate crystalline mass. Surprisingly, the artificial calculi 
also contained a matrix-like component. Their experiments al so demon- 
strated that the matrix arises by incorporation of non-dializable urinary 
constituents into the developing concretion, for when a medium of urine 
ultrafiltrate was used in place of whole urine, no such matrix component 
was present. These observations were interpreted as evidence that urinary 
calculus formation is a crystallization phenomenon and that organic matrix 
is a nonessential component resulting from protein adsorption onto cry- 
stalline surfaces, an occurrence well known to crystallographers. It was 
suggested that matrix may, however, act by modifying crystal habit and 
also serve as a barrier to dissolution of a developing calculus. 
An adequate explanation for the initiation of urinary calculus formation 
has also not been given. It has been suggested that the stimulation of 
uromucoid agglomeration and molecular orientation might depend on the 
presence of a suitable nldus, or nucleus, such as an agglomeration of 
calcium phosphate crystals, desquamated urinary tract epithelium, bacteria, 
or some mixtures of these entities (12, 40, 87) . The hypothesis that 
urinary calculi can originate as microscopic calcific deposits in the renal 
parenchyma is supported by animal experimentation and the finding 
of such deposits, especially in patients with hypercalciuria and proven 
urinary calculus formation (2, 22, 78, 93). Animal experiments have also 
indicated the possible significance of an inadequate dietary intake of vitamin 
A in producing keratinization and excessive desquamation of urinary 
epithelium, which can then serve as a nidus for calculus formation (25, 32, 
40, 46) 
. This might explain the unusually high incidence of urinary calculus 
disease in the citrus areas of Florida and California, for citrus fruits are 
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high in alkaline ash,and low in protein and vitamin A 
(41) . 
Factors Influencing Urinary Calculus Formation 
Since the mechanisms underlying the formation of a urinary calculus 
are not understood, the reasons for the known or postulated effectiveness 
of the various preventive measures to be discussed below can often not 
be adequately explained. The use of such measures has been derived 
from the recognition of the many factors which influence urinary calculus 
formation. Pertinent to considerations of urinary calculus formation in 
space are various factors concerned with the urinary output of the products 
of bone reabsorption, the solubility of calculus crystalloids in the urine, 
the excretion of uromucoid in the urine, the solubility of uromucoid in the 
urine , and the deposition of crystalloids in the calculus matrix. Other 
factors which bear mentioning are urine stasis and foreign bodies. It 
will become apparent that many of these factors can be implicated in 
more than one way in urinary calculus formation. 
The high incidence of urinary calculus formation associated with recum- 
bency is well documented (40, 53, 59, 76) . It must be pointed out, how- 
ever, that urologists generally attribute this to some renal complication 
attendant on recumbency, such as urinary infection, a congenital anomaly 
of the drainage system or perhaps drug-induced injury of the kidney (11) . 
The authors quoted above were unable to differentiate clearly between 
urinary tract infection, and no attempt was made to look into the use of 
potentially nephrotoxic drugs, such as streptomycin, which were admin- 
istered to a number of the patients studied (11) . Presumably, an excessive 
excretion of reabsorbed calcium and phosphate, and possibly bone matrix 
breakdown products, could still initiate and support calculus growth in 
the normal urinary tract of a recumbent individual. Any contribution 
which urine stasis and sedimentation of precipitates makes to the formation 
of a urinary calculus in a recumbent individual would, of course, not occur 
in space. However, although it must for the present be assumed that 
excessive bone reabsorption associated with weightlessness will be conducive 
to urinary calculus formation, the above and other considerations in this 
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chapter indicate that in the absence of other contributing factors, the 
risk of urinary calculus disease from bone reabsorption per se in space 
will be extremely low. 
Disorders which cause excess urinary calcium excretion must be 
taken into consideration here, for they would probably enhance any cal- 
culus-forming tendency predicted for the weightless state. Par titular 
emphasis is placed on screening out potential astronauts who have idiopathic 
hypercalciuria. 
Dietary factors which affect the amount of calcium excreted in the 
urine must be considered. There is no evidence that a high oral calcium 
intake has any significant effect on the urinary calcium of normal human 
(17) beings . On the other hand, it appears that in order to produce a signi- 
ficant lowering of the urinary calcium output, dietary and even therapeutic 
measures would have to be so rigorous that they would be impractical in 
space 
(17, 50, 65) 
. The fact that the intestinal absorption of calcium and 
the amount of it subsequently excreted in the urine is directly influenced 
by the dietary level of vitamin D should be remembered in selecting the 
diet of an astronaut (17) . It might also be necessary to take into account 
the amount of vitamin D production in the astronaut due to his contact with 
ultraviolet light in his space environment. Interestingly, animal experi- 
ments have shown that vitamin A will counteract the hypercalciuric effects 
of hypervitaminosis D, so that an optimum level of vitamin A in the diet 
of an astronaut should also be assured (24) . 
The urine of normal people is often, although not always, supersaturated 
to a minor degree with calculus-forming salts. Various factors, such as 
ion concentration, pH, complexor s, solubilizor s and crystallization inhibi- 
tors, fortunately make degrees of supersaturation in urine much more than 
if these salts were dissolved in water (39). Precipitation probably does 
not occur due to the fact that the ion concentration required to start form- 
ing first crystals is much higher than the concentration necessary for al- 
ready existing crystals to grow further (39). 
The concentrating effect of a low urine output tends to promote cry- 
stallization (36). Inadequate fluid intake, and hence an inadequate urine 
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production, has been implicated as a cause of the seemingly high incidence 
of urinary calculi in individuals exposed to high environmental temperatures 
during the summer months (21, 75) . The high incidence of urinary cal- 
culus observed in flying personnel has also been attributed to dehydration, 
exposure to high environmental temperatures and voluntary restricted 
fluid intake (55). However, this conclusion may be invalid since the 
study and control populations were, respectively, high and low incidence 
(50) groups by virtue of their ages . 
It has been well demonstrated that the pH of the urine is an important 
factor affecting crystallization 
(33, 36, 69, 77, 82) 
. From in vitro studies 
of the various factors which influence the solubility of calcium phosphate, 
Elliot and co-workers (33, 36) concluded that average urine specimens 
which have a pH consistently over 6. 6 will be saturated with calcium un- 
less the urinary calcium output is less than 50 mg per 24 hours. This 
calcium output value is approximately one-quarter to one-third of the 24- 
hour output value of normal individuals . Based on similar studies (13) 
by Meyer , (68) it has been stated that calcium phosphate will remain 
dissolved only as long as the pH of the urine is 5. 6 or lower . This (87) 
“critical” pH corresponds to maximum average 24 hour urinary calcium 
output values of approximately 525 and 825 mg (assuming a 24 hour urinary 
output of 1500 ml) in the two urine specimens studied by Elliot and co-workers 
(36) . Moreover , for normal urine volumes, this solubility- pH relationship 
of calcium phosphate is such that at a pH of 6, the calcium phosphate of 
the urine is at least two times, and at a pH of 7, eight times supersaturated. 
The contributions to calculus formation of a diet-induced alkalinization of 
the urine and of infections of the urinary tract by urea-splitting organisms 
which alkalinize the urine are readily apparent, the latter having been well 
(32, 40, 77) substantiated clinically . 
Since urine is normally often supersaturated with calculus-forming cry- 
stalloids, numerous investigators have searched for excreted substances 
which could be responsible for keeping these calculus-forming salts in 
solution. Butt (21) suggested that protective colloids are present in the 
urine, and that some derangement in these colloids was responsible for 
calculus formation. His hypothesis has not been proven, however (16, 37, 95) . 
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A great deal of interest has been focused on the possible solubilizing 
role of citric acid in the urine. Citric acid chelates, or binds calcium 
ions to form a soluble complex (44) . The high incidence of urinary calculi 
in patients being administered the carbonic anhydrase inhibiting drug, 
acetazolamide, has been attributed to a concomitant decrease in the concen- 
tration of citric acid in the urine (63). However, it is pointed out that 
the concentrations of many other substances in the urine change on 
administration of this drug. The low urinary citric acid levels which 
have been found in patients who are chronic calculus formers have been 
attributed to impaired renal function or t.he utilization of citric acid by 
organisms infecting the urinary tract secondary to the calculus disease (26, 
48, 54, 64, 69, 85) 
. Experiments indicate that urinary citric acid excre- 
tion fails to be increased by a diet-induced increase in urinary calcium 
excretion (64). Thus, even if urinary citric acid is important in prevent- 
ing calculus formation, a possible increase in its excretion to compensate 
for a urinary hyperexcretion of calcium would appear to be inadequate. 
If a therapeutic increase in urinary citric acid excretion is contemplated, 
it is important to note that ingested citric acid (1. 5 to 2. 5 percent of 
ingested citric acid given in doses of 2 to 20 gm) has little if any effect 
on the level of citric acid in the urine (56, 83) . Moreover, even though 
food and ingested alkalis such as sodium bicarbonate increase urinary 
citric acid excretion, they would not be useful since the resulting 
alkalinization of the urine would markedly decrease the solubility of the 
calculus crystalloids in the urine (9, 64, 105) . Finally, it is noted that 
recent evidence suggests that citrate may play a less important part in 
maintaining certain salts in solution than has been thought hitherto (21, 95, 
106) 
. 
A s mentioned previously, factors concerned with the excretion of a 
calculus matrix-forming substance in the urine are inadequately defined. 
It has been suggested that the matrix might form from the excreted mucopoly- 
saccharide and mucoprotein products of bone reabsorption, or mainly 
from uromucoid, the increased production of which might be stimulated 
by hypercalciuria per se, by irritation of the urinary tract by precipitated 
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crystalloids or infection of the urinary tract, by pathological abnormalities 
in the renal connective tissue, or by physiological “stress” (3, 4, 12, 
40, 51, 87) 
. The only therapeutic measure directed specifically at the 
production of matrix material was justified by the finding that increased 
amounts of uromucoid are released in the urine due to a disorder in the 
renal connective tissue (3, 17) . Anti-inflammatory agents, such as 
aspirin, corticosteroids, corticotropin, and phenylbutazone, were given 
to chronic calculus-forming patients. The potential usefulness of such 
a measure has not been established, however. Moreover, there is no 
evidence that such a connective tissue change, which could be treated with 
such drugs, accompanies hypercalciuria in “normal individuals”. 
The factors which affect the solubility of uromucoid in the urine also 
remain undefined. Undoubtedly the urine volume produced will influence 
the solubility of urcmucoid as well as crystalline calculus components. 
Intense interest has been focused recently on factors which appear 
to influence the deposition of crystalloids in the calculus matrix. Based 
on the fact that bone and renal calculi both consist of crystalline and 
matrix phases, it has been speculated that the identification of urine con- 
stituents which affect crystal deposition in bone might afford added insight 
into the genesis and growth of calculi within the urinary tract (89). Des- 
pite the presence of similar calcium and phosphorus concentrations in 
urine specimens, it has been found that the urine from most patients with 
renal calculus disease mineralizes, in vitro, a test substance of hyper- 
trophic bone cartilage from rachitic rats, whereas urine from most normal 
subjects does not (51, 70, 89, 90) . Studies designed to identify constituents 
which might account for this lack of matrix mineralization by urines of 
“normal” individuals have demonstrated that there are a variety of dialysable 
substances in the urine which, if present in adequate concentrations, will 
prevent the mineralization of rachitic cartilage (7, 51, 70, 89) Although . 
it is thought likely that there are as yet unidentified urine substances which 
are of importance in determining mineralizing propensity, the inhibiting 
effects of trace metals such as zinc, manganese, cadmium, cobalt, 
chromium, and vanadium have been proven (” 79 89). The most 
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potent of these inhibitors are zinc and manganese (891, Magnesium has 
been found to enhance the inhibitory effect of the trace metals and also 
alone, in a sufficient concentration, to be inhibitory (70, 891, It is thought 
that these elements inhibit mineralization by blocking matrix or crystal 
templates which are necessary for calcium phosphate crystal formation 
(6, 39, 89). 
Possibly acting in a similar fashion to the trace metals, pyropho sphate 
has been found to inhibit mineralization of rachitic cartilage and to markedly 
increase the solubility of calcium phosphate in solution (39, 8%. It 
has been demonstrated that urinary pyrophosphate is diminished in many 
patients who are chronic calculus formers (39). To test the possible 
therapeutic benefits which might be derived by increasing the concentration 
of this compound in the urine, several investigators have been administering 
oral sodium or potassium orthophosphate, which is excreted in the urine 
as pyrophosphate, to chronic calculus-forming patients (6, 51, 79, 89) . 
This effect is apparently accompanied by a fall in calcium excretion and an 
increase in citrate excretion, both of which might also be expected to 
reduce the tendency for stone formation to occur (79). Although there is 
insufficient confirmatory data at the present, the results of such treatment 
have reportedly been encouraging, for apparently no patient given ortho- 
phosphate sufficient to ensure consistent excretion of a non-mineralizing 
urine has formed new urinary calculi or has increased the size of pre-exist- 
ing calculi. The effect of pyrophosphate on the urinary pH which, as pre- 
viously stated, exerts a profound effect on calcium phosphate solubility has 
not been stated (6). 
It has not been postulated whether pyrophosphate or the trace metals 
mentioned above could play a role in preventing uromucoid agglomeration 
to form the matrix of a urinary calculus. Further research in this area will, 
no doubt, give added insight into the mechanisms in:-olved in urinary calculus 
formation, and possibly substantiate the effective clinical usage of other 
non- toxic inhibitor s . Such research is certainly pertinent to considerations 
of the possible requirements for therapeutic measures directed at the pre- 
vention of urinary calculus in space. Since there is now good experimental 
evidence that chronic calculus-forming patients, and po s sibly even individuals 
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with a calculus-forming tendency have an absence of factors concerned 
with protection from matrix mineralization, a test of astronaut candidate 
urines for mineralizing propensity might be considered, if only for ex- 
perimental purposes. 
Other factors which influence urinary calculus formation and should 
be mentioned here are urinary stasis and the presence of foreign bodies 
in the urinary tract. It is thought that urinary stasis promotes the preci- 
pitation of calculus crystalloids by allowing crystalloid concentrations in 
certain portions of the renal collecting system to rise above critical 
(40) levels . Sedimentation of precipitates in various parts of a normal 
urinary tract should not occur in a weightless environment, however, so 
that weightlessness would counteract this calculus forming effect of urinary 
stasis. The well known fact that static urine is more likely to become in- 
fected is another complicating factor. Although originally thought other- 
wise, operational experience in space is proving that another cause of 
urinary stasis - change in the sensation of urgency - is not a problem 
in the weightless environment (97) . It is probable that earlier reported 
difficulties in voiding in the weightless environment were psychogenic in 
origin, due primarily to the demand placed on subjects, relatively unfamiliar 
with the sensations of weightlessness, to initiate micturition within a short 
period of time in a small aircraft cabin. 
Foreign bodies in the urinary tract, such as a urinary catheter, 
apparently stimulate urinary calculus formation not only by acting as a 
nidus for crystalloid deposition but also by promoting infection of the urinary 
tract (40). 
Clinical Manifestations 
The optimum use of measures directed at adequately controlling the 
various factors which could be responsible for urinary calculus formation 
in space would minimize not only the likelihood of urinary calculus in space, 
but also the rate at which a once initiated urinary calculus grows. As a 
result, the clinical manifestations of a urinary calculus might appear after 
an astronaut has been exposed to the weightless environment for many months 
or even years. 
Some indication of the time required for a urinary calculus to form and 
grow to a size which results in clinical manifestations can be derived from 
studies which have noted the date of immobilization and the date of appear- 
ance of signs and symptoms of urinary calculus in patients immobilized 
for prolonged periods of time due to orthopedic injuries. In one study, 
15 out of 800 such patients developed urinary calculi (53). The shortest 
duration for the appearance of symptoms was 74 days, the longest 1200 
days, and the average 362 days. A similar study reported a shortest 
duration of 76 days, a longest of 622 days, and an average of 276 days (38) . 
In reviewing this data, it is important to note that the conditions under 
which calculi form in patients do not simulate conditions in space for, 
as pointed out above, urologists generally attribute calculus formation 
in recumbent patients to some renal complication attendant on recumbency, 
such as urinary infection, a congenital anomaly of the drainage system 
or perhaps drug-induced injury of the kidney. Furthermore, a calculus 
of a size which is sufficient to produce clinical manifestations may be 
present in the urinary tract for days to months, or even years before 
becoming clinically evident. 
The major clinical manifestations produced by a urinary calculus are 
the pain which the calculus causes as it passes down a ureter, the second- 
ary changes brought about by the irritation of the urinary tract by the calcu- 
lus, and the manifestations associated with accompanying infection (40, 47, 
82) 
Pain is usually associated with the passage of the calculus down the 
ureter. It is classically described as intermittent or colicy (so-called 
ureteral colic), excruciating and agonizing, and is usually prostrating. 
Each attack of colic lasts a few minutes, and after a variable period of 
usually a few minutes, is repeated. Quite often, however, the pain produced 
by a urinary calculus is quite insidious, depending on the size, shape and 
position of the ralculus. Occasionally, it might imitate other abdominal 
conditions, such as appendicitis. A calculus in the renal collecting system 
is frequently clinically silent for a prolonged period of time. On& in the 
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kidney pelvis, however, it usually produces almost immediate symptoms, 
particularly if it is of such a size to act as a proverbial ball in a funnel, 
blocking drainage from the kidney (99) . 
Ureteral colic is due either to distension and hyperactive peristaltic 
waves resulting from an obstructing calculus, or to vasospasm in the 
ureteral wall adjacent to the jagged surface of the calculus (57) . It is 
not really perceived as being along the course of the ureter, but in regions 
supplied by spinal segments Tll, Tl 2, Ll and L2 (ilioinguinal, iliohypogastric 
and genitofemoral nerves) (57) . Depending on the location of the calculus 
in the ureter, this “referred pain” may then arise in the costovertebral 
angle on the involved side and radiate around the loin anteriorly and caudally 
to the respective inguinal or medial thigh regions and testis, or even 
down into the penis. Ureteral colic often begins and is most severe in the 
costovertebral angle and flank and moves downwards as the calculus passes 
the ureter. 
If muscular spasm accompanies ureteral colic, the muscles supplied 
by the spinal segments (Tll to L2) will be involved (46) . These muscles 
include the lower portions of the external abdominal oblique, internal 
abdominal oblique, and transverse abdominal muscles and the cremaster 
(57) muscles . Nausea, vomiting, profuse perspiration and syncope may 
accompany severe ureteral colic (82) . Between attacks of colic, afflicted 
individuals often complain of soreness and tenderness, particularly in the 
renal and lower anterior abdominal areas (82) . 
The most frequently observed secondary changes brought about by the 
irritation of the urinary tract by a calculus are hematuria and dysuria. 
Hematuria is common, resulting from contact of a calculus with the lining 
of the ureter. Red blood cells can be found, intermittently or continuously, 
in the urine of persons with a urinary tract calculus. 
Dysuria, or painful urination can be’caused by reflex reaction in the 
bladder due to ureteral activity from a calculus in the terminal ureter by 
the calculus irritating the bladder wall, or by secondary infection (47) . 
Longstanding ureteral obstruction often leads to infection above the site 
of obstruction. The symptoms and signs are those of pyelonephritis, which 
214 
II 
is characterized by chills and fever and other systemic toxic manifesta- 
tions, loin and costovertebral angle aching and tenderness and renal en- 
largement on the affected side, and pyuria. A low grade infection often 
persists after an acute attack subsides, especially if a partially-obstruct- 
ing calculus is present. Such an infection can be extremely debilitating (47). 
Diagnosis 
An afflicted astronaut’s history and physical examination should yield 
the characteristic clinical findings outlined above. If his urine can be 
examined in space during a period of ureteral colic blood will probably be 
found, if not masked by infection. It is important to note that red blood 
cells may be present in the urine in the absence of or for some time prior 
to the onset of symptoms of calculus. This gives good reason for serial 
urine analyses if a urinary calculus is suspected. 
Almost all symptomatic urinary calculi should be visualized by simple 
x-ray techniques, if possible in space (47) . X-rays of the abdomen, in- 
cluding the urinary tract, prior to missions in space will assist in dis- 
tinguishing a calculus from other abdominal calcium-containing structures, 
such as phleboliths and calcified mesenteric lymph nodes, as well as ruling 
out the existence of a urinary calculus. If ever possible in space, intra- 
venous pyelography could be of great value in confirming the location of 
densities seen on the plain film, and in assessing the degree of urinary ob- 
struction. 
Prevention 
The various factors which could influence the formation of a urinary cal- 
culus in space have been discussed previously. It is at these factors that 
optimum non-therapeutic and possibly various therapeutic measures must 
be directed. It is assumed that appropriate investigative procedures in 
astronaut candidates will rule out any tendency to urinary calculus formation. 
The fact that urinary calculus disease has a familial incidence should be 
kept in mind while taking a candidate’s medical history. A normal urinary 
tract must be ensured by searching for congenital anomalies and infection 
of the urinary tract,and by assuring that there is no difficulty voiding or a 
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calculus already present in the urinary tract. Calcium metabolism must 
be studied intensively, especially with serum calcium and phosphorus 
determinations, and measurements of 24 hour urinary calcium output while 
the dietary calcium intake is controlled. As pointed out above, testing 
of the mineralizing propensity of the urine might be found feasible in all 
or certain cases in the future. 
Hopefully, future studies will determine to what extent the intermittent 
use of selected exercises and other measures in space will simulate normal 
weightbearing stresses on the skeletal system. At the present time, it 
appears that the most appropriate exercises which an astronaut can under- 
take in space are of the isometric or dynamic tension type. It is assumed 
that an astronaut will be in optimal physical condition prior to a mission 
in space and that such exercises will maintain this level of physical condi- 
tion, and hence prevent reabsorption of bone at least from reduced muscular 
’ activity in space. One question which requires answering by research is 
whether an individual with a higher than average urinary calcium output 
would have a greater than normal urine calcium excretion when immobilized 
or placed in a weightless environment (6) . 
To produce a significant lowering of a urinary calcium output by restrict- 
ing an astronaut’s dietary calcium intake, dietary measures would have to 
be so rigorous that they would be impractical. Since the dietary level of 
vitamin D directly influences the intestinal absorption of calcium, the daily 
intake of this vitamin in the diet should not exceed normal recommended 
values. It might also be necessary to restrict the amount of vitamin D 
production in an astronaut by controlling his exposure to ultraviolet light. 
The urinary output should be maintained continuously at a reasonable 
level with an adequate oral fluid intake. A urinary output of at least 2000 
ml per 24 hours has been recommended (87) . This would require a daily 
fluid intake of at least 3000 ml per 24 hours or more, depending on body 
fluid losse-s from other causes, such as perspiration (25, 87) . 
In order to maintain the urinary pH at as low a level as possible in 
space, the dietary intake of urine-alkalinizing foods should be kept to a min- 
imum and urine-acidifying foods to a maximum, while still maintaining 
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adequate nutrition and food palatability. The rigorous treatment of urinary 
tract infections, which are usually caused by urine-alkalinizing organisms, 
is emphasized. 
The role of citric acid in maintaining calculus salts in solution is 
controversial. It is again pointed out that even though certain alkaline 
foods increase urinary citric acid excretion, their tendency to alkalinize 
the urine would have a detrimental effect on the solubility of the calculus 
crystalloids, so contraindicating their use in an astronaut’s diet. 
At the present time, there appears to be no non-therapeutic measures 
which can be directed at inhibiting the excretion of calculus matrix-forming 
substances in the urine, other than the measures directed at preventing 
bone reabsorption in the weightless environment. 
The maintenance of the urinary output at a reasonable level will help 
to maintain uromucoid in solution. It is pointed out that an adequate 
dietary intake of vitamin A must be assured to prevent the formation of 
the calculus nidus presumably made up of cells which are desquamated 
from the lining of the urinary tract secondary to a deficiency of this vitamin (87). 
Further studies identifying constituents in the urine which might inhibit 
the deposition of crystalloids in the calculus matrix might give reason for 
increasing these constituents in the diet. As mentioned previously, an in- 
creased urinary concentration of trace metals, such as zinc and manganese, 
may not only decrease the mineralizing propensity of the urine but also 
inhibit calculus formation. Magnesium’apparently enhances the inhibitory 
effect of the trace metals. These metals are non-toxic when ingested in 
the amounts considered as possibly being adequate for prevention of calculus 
formation (44). 
Urinary voiding should be scheduled if there is any possibility of a 
diminution in the sensation of urgency in space, so minimizing the possibility 
of urinary stasis contributing to calculus formation. It is noted that if a 
urinal sealed to the skin is to be used in space, this apparatus should not 
produce an elevation of intravesical pressure above that required for normal 
micturition on earth in order to accomplish a complete voiding, which should 
leave a residual urine of less than 12 ml (31) . 
The use of an indwelling catheter should be avoided if possible in space. 
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If an indwelling or any other form of catheterization is required, however, 
an appropriate bacteriostatic agent, such as sulfadimethoxine, should be 
administered for a suitable duration to prevent secondary infection. If 
an indwelling catheter is used, the bladder should be irrigated with an 
appropriate solution, such as normal saline, and the catheter replaced 
periodically. 
Since most therapeutic measures produce disagreeable side-effects, 
their use is indicated only if it appears that the non-therapeutic measures 
mentioned above could possibly fail to provide adequate protection of an 
astronaut from urinary calculus in space. One or more therapeutic measures 
might be attempted. 
In the future, it might be possible to administer drugs which have an 
inhibiting effect on the bone reabsorption due to weightlessness. The drugs 
of current interest in this respect are derivatives of gonadal hormones (74, 
100, 102) 
. It is noted that hormonal side-effects might be a problem with 
prolonged usage of such agents. Further research in this area is indi- 
cated, however. 
Orally administered sodium phytate diminishes calcium absorption 
in the intestine by forming an insoluble complex with calcium in the intesti- 
nal lumen (40, 45, 87) . Cellulose phosphate has also been found to exert 
the same effect (29). If the dosages of these compounds are adequate and 
the dietary calcium intake is minimized, it is conceivable that the hyper- 
calciuria resulting from bone reabsorption in space could be effectively 
controlled. However, their use in space might be contraindicated because 
they have a tendency to produce a painless diarrhea (87) . Moreover , these 
compounds, especially phytate, increase the urinary phosphorus excretion, 
with the result that a favorable situation for calculus formation could possibly 
occur under certain conditions (29, 87) . 
Just as a decrease in the urinary excretion of calcium diminishes the 
formation of calcium- containing calculi, so also a decrease in the excre- 
tion of phosphate diminishes the formation of calcium phosphate calculi (87) . 
Shorr devised a low phosphate diet supplemented by aluminum-containing 
drugs in the form of either basic aluminum carbonate gel or aluminum 
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hydroxide gel. The aluminum im’pairs phosphate absorption in the intestine 
by forming the insoluble compound, aluminum phosphate, in the intestinal 
lumen. The Shorr regimen has been highly effective in the prophylactic 
treatment of chronic calculus formers (‘5, 66, 86, 87) 1t might even . 
be effective in maintaining a non-precipitating level of calcium phosphate 
in the urine in space, if excessive bone reabsorption should occur. How- 
ever, the gel is constipating, and the diet tasteless and also constipating (b5, 
87) . Accordingly, the prolonged use of the Shorr regimen in space is 
not recommended. 
Different orally administered substances have been used to increase 
the acidity of the urine, especially ammonium chloride, ammonium nitrate 
and sodium acid phosphate 
(23, 27, 87) . Menthenamine mandelate is 
currently being favored by most urologists and might be considered as 
being appropriate for use in space if acidification of the urine by drugs is 
indicated (73). This drug also acts as a urinary antiseptic, and so could 
also reduce or eliminate the contribution of a urinary tract infection 
to stone formation (5). It is almost without side-effects in contrast to the 
other drugs mentioned above (5). 
Even if increased levels of urinary citric acid might have a solubilizing 
effect on urinary crystalloids, it must be remembered that ingested citric 
acid has little if any predictable effect on the level of citric acid in the urine. 
Moreover, even though ingested alkalis such as sodium bicarbonate in- 
crease urinary citric acid excretion, their tendency to alkalinize the urine 
would have a detrimental effect on the solubility of calculus crystalloids, 
so contraindicating their use. 
The importance of adequately treating any infection in the urinary 
tract in space cannot be overemphasized. The marked influence which 
such an infection can have on stone formation, especially if the infection 
is caused by urea-splitting organisms, is well known. 
The possibility of orally administered trace and other metals effectively 
preventing urinary calculus formation has been mentioned above. These 
metals would undoubtedly be administered in small quantities, and so 
could be added to the food. The toxicology of. such metals should be 
thoroughly assessed before such a measure could be considered, however. 
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The encouraging results with orally administered orthophosphate in 
inhibiting calculus formation in chronic calculus-forming patients may 
prove this agent worthwhile for use in preventing urinary calculus in space. 
In “therapeutic” doses, the drug has apparently no side-effects other 
than occasionally producing diarrhea (6) . 
Treatment 
In the foreseeable future, a urinary calculus which causes signs and 
symptoms in space will have to be managed conservatively either until it 
is passed spontaneously or until manipulative or surgical removal of it 
can be attempted back on Earth. Fortunately, upwards about 80 percent 
of all urinary calculi are passed spontaneously (80, 81, 98) . 
Ureteral colic, irrespective of type of stimulus causing it, can be 
alleviated to some degree by morphine, meperidine, or other central 
nervous system analgesic drugs (57) . If the colic is primarily due to 
vasospasm, its prompt relief might be achieved with the use of vasodilat- 
ing drugs, which act either directly upon blood vessels (e. g. , sodium 
nitrite and papaverine) or by blocking transmission of nerve impulses 
through sympathetic ganglia (e. g. , a tetraethylammonium compound) (57) . 
An adequate urinary output in an astronaut suffering from urinary 
calculus should be maintained by forcing his oral intake of fluids or, if 
necessary, by giving him fluids intravenously. A urine output of at least 
3000 ml per 24 hours should be assured. 
A urinary bacteriostatic agent, such as sulfadimethoxine, should be 
administered to an astronaut from the time that clinical manifestations of 
a urinary calculus appear. An infection might still develop above a partially 
or completely obstructed site in a ureter, in which case the administration 
of a suitable antimicrobial, such as nitrofurantoin or chloramphenicol, is 
indicated. 
A sedative, such as sodium phenobarbital might be required. Active 
movement of the astronaut should be encouraged, however. 
There appear to be no orally or parenterally administered agents which 
are effective in dissolving a urinary calculus (87) 
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CHAPTER 10 
MEDICAL IMPLICATIONS OF CA.RDIOVASCULAR 
ADAPTATIONS TO WEIGHTLESSNESS 
Even during prolonged space missions, optimum physical fitness, 
and hence the capacity of the cardiovascular system to respond adequately 
to a given work load in space, should be maintained by the combined 
effects of routine physical activity and an appropriate exercise regimen. 
It is generally thought, however, that certain cardiovascular adaptations 
to the weightless space environment will still occur. The question arises 
as to whether such adaptations could affect the likelihood of occurrence 
or severity of medical problems arising from certain hazards of space 
operations, especially if a medical problem should occur in the period 
immediately after an astronaut returns to a gravity environment. 
In this chapter the literature is examined in an attempt to determine 
what cardiovascular adaptations to weightlessness do occur, the medical 
implications of these adaptations, and finally the appropriate measures 
which can be taken to prevent adverse effects of these adaptations on 
astronauts. This is not an exhaustive review of the physiology of 
weightlessness. Further information on more specific aspects of this 
area can be obtained from a number of recent reviews which will be cited. 
Cardiovascular Adaptations 
At the present time, cardiovascular adaptations to weightlessness 
can only be inferred from data obtained in a great number of ground-based 
experiments which were intended to simulate the effects of weightlessness 
on the cardiovascular system, and from in-flight and post-flight observa- 
tions made on those astronauts who have been exposed to weightlessness 
for up to a few days in duration. By means of bed rest and water immersion, 
ground-based experiments have attempted to minimize the effect of intra- 
vascular hydrostatic pressures due to the force of gravity. Most of the work 
in this area has been conducted by Birkhead and co-workers (14, 16) 
(46, 49, 50) 
, 
Graveline and co-workers Miller; Stevens and co-workers (75, 2 
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77, 78, 79, 94, 97) 
Vogt, Vallbona and co-workers 
(107, 111, 116, 117’; 
118, 119, 121) and ithers (69, 99) . This area has been reviewed by 
Lamb (59, 60, 61) (71) (1, 43, 50, , Mc Cally and Gr aveline and others 
70, 108, 128) . The extrapolation to operational space conditions of 
cardiovascular findings in individuals exposed to prolonged bed rest or 
complete water immersion must be guarded, however, for these conditions 
do not completely eliminate the effects of gravity on the cardiovascular 
system. Moreover, even though physical and cardiovascular “fitness” 
has been maintained under such conditions with periodic exercises, the 
type and degree of routine physical activity, and in turn the cardiovascular 
dynamics of astronauts in the spacious cabins of spacecraft to be used for 
prolonged missions has not been, and probably can not be, simulated. 
Most observations of cardiovascular responses of astronauts ex- 
posed to weightlessness have been made in the immediate post-flight 
period. Cardiovascular data for all American missions (up to 14 days) 
and Russian missions (up to 5 days) have been reported (8, 12, 39, 83, 87, 
88, 91) . Findings must again be viewed with caution. Restriction, 
limited physical activity during missions, and post-flight fatigue are 
factors which have effects on the cardiovascular system similar to 
those which have been predicted for weightlessness. Post-flight data 
might on occasion have also reflected the effects of dehydration, and 
physiologic events which might be associated with the vague feeling of 
“let-down” often experienced after a prolonged emotionally and physically 
stressful event. 
During up to 42 days of bed rest, 7 days of complete water immersion 
and 14 days of weightlessness, recordings of systolic and diastolic 
pressures, pulse-rate, heart sounds, and electrical activity of the heart 
have remained within normal limits, even in the face of marked physical 
inactivity which led to diminished exercise tolerance (8, 12, 14, 28, 49, 
50, 75, 77, 79, 83, 87, 88, 97, 107, 118) . Therefore it appears likely 
that prolonged weightlessness should not alter cardiac function if cardiac 
work capacity is maintained. This is consistent with the conclusion 
drawn from application of sound biophysical principles to the circulation, 
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in that the hydrostatic factor ( pgh) does not affect the driving forces of 
the circulation directly and inertial factors in the circulation would not 
be affected at all by weightlessness (24, 71) . 
It is generally believed that a cardiovascular adaptation to prolonged 
weightlessness is lowering of blood volume, with decreases of both the 
plasma and red cell fractions of the blood. In conditions of bed rest 
and complete water immersion, healthy subjects have consistently 
demonstrated an acute fall in plasma volume, accompanied by a diuresis 
and a loss of weight 
(28, 49, 50, 61, 69, 75, 77, 79, 85, 94, 97, 119, 
120, 121) . Most of this initial contraction of blood volume has occurred 
during the first 24 to 48 hours of exposure to these conditions (61) . The 
maximum decrease in plasma volume observed has usually been in the 
range of 500 ml, or about 10 percent of the body weight (49, 75, 77, 80, 94, 
97) . A.lthough decrease in blood plasma leads to hemoconcentration, pro- 
longed bed rest studies have demonstrated that over a period of many 
days the hematocrit returns to normal values, presumably due primarily 
to suppression of red cell production 
(61, 75, 77) 
. Bed rest for 4 weeks 
has reportedly produced a decrease of over 700 ml in blood volume (61, 
75, 77) 
. It should be pointed out, however, that in spite of the great 
amount of empirical evidence to the contrary, three well conducted bed 
rest studies of 14, 30 and 42 days in duration have yielded data indicating 
that after a typical initial decrease, blood volumes tended to return 
toward pr e- exposure values (28, 67, 118) . 
Post-flight data on the command pilots and pilots of the 4 and 8 day 
Gemini missions indicated that the blood volume also decreases in the 
(12) weightless environment . A 7 to 15 percent decrease of blood volume 
occurred during these missions. The decrease in plasma volume was 4 to 
13 percent. As compared to bed rest studies, the loss of red cell mass 
was accelerated, possibly due to one or more factors other than blood 
volume changes, including the atmosphere to which the astronauts were 
exposed (’ 2). It was also thought that a weight loss of usually 2 to 5 
percent of body weight, recorded after these and all former space missions, 
might in part be due to this decrease of blood volume, especially since 
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weight loss did not correlate with mission duration, and pre-flight weights 
and plasma volumes were restored rapidly by fluid intake in the post- 
flight period (12, 124) . Immediately after the 14 day Gemini mission, 
however, the blood volumes of both astronauts were the same as those 
recorded pre-flight (12). An increase of plasma volume had compensated 
for a decrease of red cell mass similar to that observed after the 4 and 8 
day Gemini missions. It is clear that the results of the 14 day mission 
do not rule out the possibility that blood volume decreased during the 
early part of this mission. Interestingly, this data is supported by the 
few bed rest studies cited above. 
A number of investigators have advanced reasonable explanations 
for the decrease of blood volume and the diuresis which occur during bed 
rest, complete water immersion and presumably on becoming weightless (5, 
34, 35, 36, 51, 68, 70, 71, 110, 116, 124) . Negation of the gravitational 
component of intravascular hydrostatic pressures due to gravity leads 
to a redistribution of blood (90) 
(104; 
Sjostrand (89) substantiated the earlier 
observations of Thompson , by finding that about 500 ml of the 
approximately 650 ml of blood pooled in the lower extremities of erect 
man shifted on tilt to the thorax. As well, total blood volume actually 
increases slightly for a short period of time when a normal ambulatory 
individual assumes the supine position (9, 17, 58, 64, 104, 105, 127) . 
This is presumably due to the reabsorption of fluid transudate, forced by 
gravity-activated intravascular hydrostatic pressures into the extravascular 
spaces of loosely bound tissues in the lower extremities and elsewhere. 
Gauer and co-workers (5, 6, 33, 34, 36, 37,. 38, 53, 58) have shown that 
due to this redistribution of blood, central venous channels are distended. 
This leads to stimulation of central venous blood volume receptors, located 
mainly in the right atrium. Through reflex pathways, antidiuretic hormone 
production is inhibited. The resulting increase in plasma water excretion 
reestablishes normal central venous volume. Other responses to this 
shift in blood volume also occur, although to a much lesser degree. Due 
to one or more possible mechanisms involving venous and possibly arterial 
volume sensors, and probably osmoreceptors, aldosterone production is 
suppressed, leading to a natruresis (31, 32, 44, 45, 54, 70, 94, 102, 103) . 
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Since this response is sluggish and highly variable, it appears that in 
this case the constancy of osmotic composition is sacrificed in favor 
of the constancy of blood volume 
(33, 54, 70, 80) . Indirect evidence 
of a diuretic factor appearing in the blood plasma remains to be identified (34) . 
Renal hemodynamics do not seem to be altered to a significant degree (20, 
36, 70) . Finally, experiments on normal individuals have shown that 
compensatory events opposite to those described above occur when central 
venous volume is lowered as a consequence of, for example, blood redis- 
tribution due to the force of gravity and measures which force or remove 
blood from the thorax, such as positive pressure breathing and the applica- 
tion of negative pressure to the lower half of the body (42, 44) . 
The question arises as to how much one or more factors other than 
simulated and actual weightlessness could have affected blood volume 
during bed rest and complete water immersion studies, and during the 
few space missions in which this parameter has been studied. For exam- 
ple, results from chair rest and confinement studies have shown that 
even though intravascular hydrostatic pressures due to gravity remained 
unaltered during these studies, subsequent physical inactivity is accom- 
panied by a decrease in red cell mass and plasma volume (15, 62, 63, 65, 
90) . Since plasma volume decreases mostly during the first 48 hours of 
bed rest, and then changes little over a period of several weeks, it has 
been considered possible that physical inactivity might not enhance 
significantly the plasma volume contraction due to weightlessness per se (60) . 
This possibility is supported by results of a few bed rest studies during which 
periodic exercise was performed (78, 112, 115, 117, 121) On the other . 
hand, the decrease of red cell mass and further contraction of blood volume 
in most of the prolonged bed rest studies cited above might have been due 
in part to physical inactivity, for one might expect that blood volume would 
have been maintained by an increase in plasma volume, since homeostatic 
mechanisms restored the hematocrit to a normal level (124) . This area 
does appear to require investigation. 
A decrease in blood volume also accompanies body dehydration, 
which can be due either to inadequate fluid intake or to excessive loss of 
(60) body water . The sensation of thirst can be markedly suppressed in 
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a stressful situation (52). It is also well known that non-thermogenic 
sweating is increased in such a situation (124) . One wonders, therefore, 
if these factors existed to a significant degree during the critical terminal 
phases of space missions, and so accounted in part for the dehydration 
observed after all space flights to date and the decrease of blood volume 
recorded after the 4 and 8 day Gemini flights (12). Sweating from heat 
loads experienced during re-entry and after landing might also have 
led to some dehydration (61) . Both physical and emotional stresses 
can suppress antidiuretic hormone production 
(61, 110) 
. Henc e the se 
too might have been factors producing dehydration, especially toward 
the end of space missions. 
In conclusion, it is readily apparent that dynamic changes in the 
volume of blood, and in its plasma and red cell fractions while in the 
weightless environment, cannot be predicted with certainty at the 
present time. Definite answers in this area might only be obtained by 
further measurements on astronauts during space missions, with 
attempts to eliminate all factors other than weightlessness known to 
alter these parameters. Considerable evidence supports the view that 
blood redistribution in the weightless environment will lead to a decrease 
in blood volume, due initially to a decrease in plasma volume, and then 
to adjustments in both plasma volume and red cell mass as a normal 
hematocrit is gradually reestablished. On the other hand, there is 
evidence indicating that the blood volume could be diminished temporarily, 
possibly for only several days to a few weeks in duration. This rebound 
of blood volume, if it actually occurs, might be attributable to expansion 
of the venous circulation as peripheral venous tone, so important for 
preventing blood pooling in the gravity environment, relaxes as an 
adaptive response to weightlessness. On the other hand, the rebound of 
volume might be due to decreased sensitivity of blood volume receptors 
during chronic exposure to relatively high central venous pressure. 
This mechanism receives much off-on stimulation as a normal ambulatory 
individual moves about in the gravity environment, and like other reflex 
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mechanisms, may respond to chronic “on” stimulation by adaptation 
(86) . 
Other cardiovascular adaptations to weightlessness have been 
implied from observations made during passive upright tilt of bed rest 
and complete water immersion subjects, and post-flight astronauts. 
This is a provocative test of orthostatic tolerance. Since the individual 
is passively supported upright, it assesses the capacity of primarily 
cardiovascular mechanisms to compensate for intravascular hydrostatic 
pressure changes due to the force of gravity 
.(113) 
. A minor reduction 
of orthostatic tolerance is accompanied by an excessive increase in 
heart rate, an excessive narrowing of pulse pressure and a fall in 
systemic arterial blood pressure while passively maintaining the 
(93) erect posture . Failure of cardiovascular compensation to gravity 
leads to the so-called vasodepressor reaction, the manifestations of 
which are presumably due to an overwhelming increase in parasympathetic 
nervous system activity (2, 59; 71, 92) . This reaction is characterized 
clinically by pallor, nausea, dimming of vision, sweating, “air-hunger” 
and eventually loss of consciousness, arising from an acute fall in 
systemic arterial blood pressure, occasioned by bradycardia and a 
decrease in peripheral vascular resistance (7, 30, 59) . 
Definite signs and symptoms of orthostatic intolerance have con- 
sistently appeared after as little as one week of bed rest and 6 to 12 hours 
of complete water immersion (14, 28, 46, 47, 48, 49, 51, 77, 101) 
. 
Orthostatic intolerance was observed after the 9 and 34 hour, one-man 
Mercury missions (la* Abnormal tilt responses were also noted for 
periods of up to 50 hours after the 4, 8 and 14 day, two-man Gemini 
(12) missions . The 14 day Gemini pilot experienced a vasodepressor 
reaction during his first post-flight tilt; his responses to subsequent tilts 
were similar to those of the other Mercury and Gemini astronauts. 
Interestingly, the time for the return of the normal pre-flight response 
to tilt has not correlated with either the duration of space flights to date, 
or decreases in blood volume which occurred. 
As discussed by Lamb (59, 60) McCally and Graveline (71) ,and Vogt (106) , 
and summarized below, many complex physiologic events are thought to 
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maintain cardiovascular integrity in the upright position.. Hence it has 
been difficult to determine with certainty what cardiovascular adaptations 
to simulated and actual weightlessness might have occurred to account 
for the decreased orthostatic tolerance that resulted from exposure to 
these conditions. According to the above named authors, cardiovascular 
reflex mechanisms increase heart rate on becoming upright, and aug- 
ment adrenal epinephrine output to strengthen cardiac muscle contraction. 
Arteriolar tone is also increased in dependent parts of the body to main- 
tain the required distribution of cardiac output to these parts. Venous 
pooling in the lower regions of the body is minimized to assure an 
adequate return of blood to the heart. This appears to be accomplished 
mainly by a reflex increase in venous tone, by the restricting effect of 
skeletal muscle tone on venous distension, by the pumping action of con- 
tracting leg muscles on the veins and by venous valve competence. 
Through mechanisms outlined above, blood volume must also be main- 
tained in the face not only of gravitational pooling of blood, but also of 
transudation of protein-free fluid into the extravascular spaces of the 
lower extremities caused by excess intravascular over extravascular 
pressures, especially in loosely bound tissues 
(104, 116) 
. The tension 
created in tissues as fluid is forced into them would also serve to 
restrict venous distension. 
There is no doubt that the decrease of blood volume and reabsorption 
of fluid transudate from tissues of the lower extremities during exposure 
to weightlessness would diminish orthostatic tolerance, since decrease 
of blood volume in a normal active individual from any cause, such as 
blood loss or dehydration, will result in a strain being placed on normal 
mechanisms required to maintain cardiovascular integrity in the upright 
position (3, 19, 52, 84, 99, 124) . The observations that there has been 
no correlation between the amount of blood volume decrease and the degree 
of orthostatic intolerance resulting from prolonged bed rest, and that 
post-flight Gemini astronauts demonstrated orthostatic intolerance for 
many hours after their blood volumes returned to pre-flight levels, 
suggest that cardiovascular adaptations to weightlessness other than 
decrease in blood volume contributed to this orthostatic intolerance (78, 94, 
100, 126) 
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Since skeletal muscle loses tone, strength, work capacity, and mass 
when its activity is diminished for a period of time, the question arises 
as to whether smooth muscle in a blood vessel wall could undergo 
similar changes when it no longer plays a role in maintaining the wall 
tension required to compensate for the gravitational component of 
intravascular hydrostatic pressure. If so, this adaptive response 
would be expected to occur both in arterial vessels, especially arterioles, 
and in veins in dependent parts of the body, and thus predispose to 
orthostatic intolerance by failing to maintain normal distribution of 
cardiac output and by allowing excessive pooling of venous blood. This 
might well be a fruitful area for study. 
It has been postulated that the mechanisms responsible for increasing 
arteriolar resistance and venous tone in the upright position become less 
(42, 68, 71, 105, 
responsive during prolonged exposure to weightlessness 
109) . Reflex vasoconstriction, as occurs on assuming an upright posture, 
is known to be mediated by the sympathetic nervous system, the 
vascular nerve endings of which release norepinephrine to cause vascular 
(l3, 28, 74, l22, l23) As shown by tilting smooth muscle contraction . 
normal active individuals to various angles, changes in the urinary 
excretion of norepinephrine correlate well with alterations in vasomotor 
activity (98). Hence various investigators have suggested that diminished 
responsiveness of vasoconstrictor mechanisms by weightlessness might 
be reflected by decrease of urinary norepinephrine excretion during 
(43, 47, 105) upright tilt . Such was the case following complete 
immersion of subjects for 6 hours in one study, but not the case in the 
other similar study in this area 
(43, 105) 
. Further investigation is 
therefore required to determine at what neuromuscular level vasoconstrictor 
mechanisms adapt to weightlessness. 
A few other cardiovascular adaptations to weightlessness per se 
have been implicated as contributors to the decreased orthostatic tolerance 
after simulated and actual weightless exposures. Since the sympathetic 
nervous system is also presumed responsible for the cardioacceleration 
and the increase of adrenal epinephrine output associated with assuming 
upright po stur e , it has been suggested that these responses might be 
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diminished by weightlessness (106) . However, no evidence has been ob- 
tained in this area. Since tension exerted on veins by extravascular 
tissue is thought to play an important role in preventing venous pooling 
in the upright position, loss of fluid transudate from tissues of the lower 
extremities in the weightless environment might enhance venous pooling 
as well as loss of blood volume in the erect position, hence contributing, 
especially in the very immediate period after re-exposure to gravity, 
to orthostatic intolerance. 
An enhanced tendency to venous pooling on assuming an upright 
posture does appear to be a major effect of simulated and actual weight- 
lessness. Increases of venous engorgement and leg circumference, 
and dependent cyanosis have been observed during tilt of individuals 
subjected to prolonged periods of bed rest (28, 46, 78) In fact . I 
blood congestion has reportedly been great enough to produce purpuric 
hemorrhages about the feet and ankles, even though blood platelet and 
prothrombin levels were normal (28) . It has also been thought that 
strain gage data obtained on post-flight Gemini astronauts confirmed 
pooling of blood in their lower extremities for the period of time required 
for their tilt responses to return to normal (12) . The adaptive changes, 
and the relative contributions of such changes responsible for venous 
pooling remain to be determined. 
With respect to the possible contribution of physical inactivity, the 
foregoing discussion indicated that failure to maintain skeletal muscle 
strength, tone, and mass would reduce the restrictive effect which 
extravascular tissue tension exerts on venous distension and possibly 
somewhat diminish the pumping effectiveness of muscle contraction, or 
even be severe enough that this effect, in combination with inadequate 
venous tone and diminished tissue turgor, could lead to venous 
valve incompetence. It is also wondered if physical inactivity could 
diminish the capacity of arterioles and veins to maintain adequate tone, 
or the responsiveness of vasoconstrictor and cardiac stimulating mechanisms 
required to maintain cardiovascular integrity on assuming an upright 
position. Miller (78) found that the dependent cyanosis associated with 
prolonged bed rest could be reduced with exercise. Hence it was suggested 
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that inactivity could have an effect on venous pooling, possibly through 
an associated loss of arteriolar or venous, or skeletal muscle tone. 
However, as will be discussed subsequently, attempts to reduce 
orthostatic intolerance from prolonged exposure to simulated and 
actual weightlessness by periodic exercise during exposure have on the 
whole proven unsuccessful. Moreover , one would not expect physical 
inactivity to contribute to orthostatic intolerance observed after 6 to 12 
hours of complete water immersion, especially since the immersed 
subjects were usually unrestricted in movement. Thus it would appear 
that cardiovascular adaptations to weightlessness have overshadowed 
the role played by physical inactivity in producing the orthostatic 
intolerance observed after prolonged bed rest, complete water immersion 
and weightless exposures to date. More conclusive information in this 
area is still required. 
A few other factors have been considered possible contributors to 
the post-flight orthostatic intolerance observed in astronauts. It 
must be kept in mind that their significance is difficult to judge, 
especially since they were not present in simulated weightlessness studies. 
It is a well established fact that post-flight fatigue, which has been ob- 
served to some degree in all post-flight astronauts to date, tends to 
increase the susceptibility to orthostatic intolerance (59). The possible 
occurrence of mild dehydration which, through an associated decrease 
in blood volume, could be a factor in producing orthostatic intolerance 
in the immediate post-flight period has been discussed above. Finally, 
it has been considered possible that orthostatic intolerance might be 
contributed to by physiologic events which might be associated with the 
vague feeling of “let-down” often experienced after a prolonged emotionally 
and physically stressful event, such as a space mission (59). 
In conclusion, studies of tilt responses of individuals who have been 
exposed for prolonged periods of time to simulated and actual weightlessness 
have indicated that the adaptive response of the cardiovascular system is 
not restricted just to blood volume changes. Although a decrease in blood 
volume no doubt contributes causally to orthostatic intolerance observed 
after such exposures, there is both direct and indirect evidence that the 
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ability of the cardiovascular system to maintain its integrity in the up- 
right position decreases during exposure to the weightless environment. 
This is generally thought to result primarily from an enhanced tendency 
to venous pooling, the etiology of which remains to be determined. 
It has been postulated that arteriolar and cardiac responses to the up- 
right position might also be involved. 
Medical Implications 
Other chapters in this report point out the fact that many of the 
medical problems which might arise from hazards of space operations 
can be influenced by, and have profound effects on the functional integrity 
of the cardiovascular system. In the light of the foregoing discussion in 
this chapter, one wonders what effects cardiovascular adaptations to 
weightlessness might have on medical problems. This very important 
area of clinical space medicine has received little attention to date. Hope- 
fully, the following considerations will stimulate further thought and 
investigation in this area. 
As the result of a decrease of blood volume associated with weightless- 
ness, an astronaut who suffers “shock” in space will, in essence, not 
receive the benefit of the “transfusion” of pooled blood which a normal 
ambulatory individual on Earth receives on assuming the supine position. 
As well, it will not be possible in space to enhance brain blood flow of an 
astronaut in “shock” by tilting him to the head-down position. If blood 
volume actually returns to its pre-mission level as exposure to weightless- 
ness continues, one would expect that an astronaut’s susceptibility to 
“shock”, especially from decrease of blood volume, would be somewhat 
r educed. 
Otherwise, there is no reason to believe that the mechanisms which 
compensate for threats to the functional integrity of the cardiovascular 
system, such as blood loss or myocardial damage, should be any less 
efficient in the weightless environment than on Earth. This assumes of 
course that cardiovascular “fitness” is maintained at an optimum level 
in space. The absence of hydrostatic forces due to gravity should, in fact, 
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allow an astronaut to tolerate cardiovascular stresses better while 
moving about in space than while moving about on Earth. Since hydro- 
static forces due to gravity play a great role in producing the vaso- 
depressor reaction, be it on the basis of pain, heat load, postural blood 
shift or pathophysiologic reflex, this reaction might be much less likely 
to occur or to progress on to the syncopal stage in space than on Earth. 
The cardiovascular adaptations to weightlessness are of great con- 
cern to an astronaut who is re-exposed to a gravity environment during 
exploration of a lunar or planetary surface, or is subjected to accelerative 
forces in the head-to-foot direction during take-off and landing operations. 
It is noted that data obtained during passive upright tilt of individuals 
who have been exposed for prolonged periods of time to simulated and 
actual weightlessness do not allow prediction of risks of the vasodepressor 
reaction facing astronauts while standing or moving about in gravity 
environments. This provocative test of cardiovascular function allows 
neither the pumping of venous blood by contraction of muscles of the 
lower extremities, nor the restriction of venous distension by the tone 
of these muscles associated with weightbearing. Accordingly, it is 
thought that if physical, and in turn cardiovascular “fitness” is maintained, 
the risks of an astronaut experiencing a vasodepressor reaction from 
orthostatic intolerance due to the effects of only the cardiovascular 
adaptations to weightlessness will probably be quite low, especially 
during operations in environments with gravitational forces less than 
that on Earth. This view is supported by the fact that astronauts have 
apparently not experienced manifestations of orthostatic tolerance while 
standing and walking about in the post-flight period. It should be noted, 
however, that the decrease of circulating blood volume associated with 
orthostatic intolerance will reduce physical work capacity, whether or 
not orthostatic intolerance is clinically manifest (124). Thus there is 
obviously a great necessity for studies oriented toward determining not 
only the effects which cardiovascular adaptations to weightlessness can 
have on astronauts during operations in various gravity environments, but 
also the need for measures which confer protection from these effects. 
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As would be expected, prolonged exposure to simulated weightlessness 
has been found to markedly reduce tolerance to accelerative forces 
applied in the head-to-foot direction (10, 11, 991, If cardiovascular 
fitness is maintained in space, there is no reason to believe that cardio- 
vascular adaptations to weightlessness will alter an astronaut’s tolerance 
to transversely applied accelerative forces associated with landing and 
take- off operations (75) . 
It is readily apparent from foregoing discussion that cardiovascular 
adaptations to weightlessness will render the cardiovascular system 
less able to maintain its functional integrity in the upright position 
when it is challenged by various stresses (3, 38, 43, 65, 66, 80) One . 
stress is a further reduction of blood volume by such factors as 
hemorrhage, plasma loss and dehydration. Another stress is an ex- 
pansion of circulatory capacity, as occurs on exposure to heat, with 
exercise or during a vasodepressor reaction. Then too, inadequate 
cardiac output could result from an imposed stress of impeded return 
of blood to the heart by, for example, a constricting garment or pressure 
breathing. 
Circulatory adjustments required to maintain orthostatic tolerance 
in the face of cardiovascular adaptations to prolonged weightlessness 
might conceivably increase the risk of an astronaut developing a medical 
problem during operations in a gravity environment. For example, the 
decrease in peripheral blood flow associated with orthostasis might be 
sufficient to render an astronaut more susceptible to cold injury or a 
heat disorder. 
Finally, since any degree of orthostatic intolerance is associated with 
diminished cerebral perfusion and hence borderline cerebral hypoxia, 
it is thought that cardiovascular adaptations to weightlessness might reduce 
significantly an astronaut’s “time of useful consciousness” on exposure to 
a low partial pressure of oxygen after return to a gravity environment 
(Chapter 1), even though lung-to-brain circulation time would be lowered. 
This hypothesis does require experimental verification. 
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Protective Measures 
Foregoing discussion has pointed out the need to assure an astronaut 
that he will not suffer from the adverse effects of cardiovascular adapta- 
tions to weightlessness on being re-exposed to a gravity environment 
during exploration of a lunar or planetary surface, or on being subjected 
to head-to-foot accelerative forces during take-off and landing operations. 
There are two general preventive approaches, the investigative status 
of which has been periodically reviewed 
(60, 71, 75, 85, 117, 126) 
. 
The one approach is to prevent the occurrence of cardiovascular adapta- 
tions to *weightlessness. The other is to protect the astronaut from the 
adverse effects of these adaptations. Those methods which have received 
consideration and study to date in attempts to accomplish these approaches 
are outlined below. Particulars of their application can be obtained from 
cited references. Although some indication of their effectiveness can be 
given, it must be remembered that appropriate selection and optimum 
utilization of a particular method will be assured only by more intensive 
investigation in this area. 
The greatest attention from the standpoint of preventing cardiovascular 
adaptations to weightlessness has been focused on periodic physical exercise 
as a way of maintaining an optimum level of physical “fitness” during 
spa.ce missions. Since exercising increases blood volume in a normal 
ambulatory individual on Earth, it was thought that an appropriate exer- 
cise regimen might minimize the decrease of blood volume associated 
with weightlessness (16, 213 22, 27, 77, 90) As well . 2 
exercising the 
lower extremities in particular might reduce the tendency to venous 
pooling by maintaining muscle tone, strength and mass, and possibly to 
some extent the capacity of vasoconstrictor mechanisms to respond to 
intravascular hydrostatic forces due to gravity (60) . However, a number 
of isotonic and isometric exercise regimens have reportedly had no really 
significant effect on either the blood volume or the degree of orthostatic 
intolerance associated with prolonged bed rest (16, 25, 27, 76, 109, 112, 
117, 121, 125, 126) 
. Bungee cord exercises during the 8 and 14 day, two- 
man Gemini missions were also not protective,even though the cardiovascular 
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response to a calibrated work load might for the most part have been 
maintained by these exercises (12, 91) . If exercise will ever be a 
method which could be used in space specifically for the prevention of 
cardiovascular adaptations to weightlessness is doubtful, but further 
study in this area still appears indicated. 
Various combinations of periodically inflated cuffs placed proximally 
on the extremities have been used in attempts to prevent cardiovascular 
adaptations to weightles sne ss . It was thought that periodic increases 
of intravenous hydrostatic pressures, especially in the extremities, 
might maintain not only venomotor capacity but an optimum level of extra- 
vascular tissue tension during prolonged space missions (26, 29, 71) . 
Another effect postulated was reduction of the degree of central venous 
volume overload, and hence decrease of blood volume associated with 
(26) weightlessness . Indeed, Graveline (46) and then Vogt (111) , found 
that periodic inflation of cuffs placed around all four extremities of 
subjects immersed up to the neck in water for 6 hours maintained 
orthostatic tolerance. When carried out during two weeks of bed rest, 
this technique conferred significant protection from orthostatic 
intolerance as tested by a 10 degree tilt, which presumably simulated 
the effect of the Moon’s gravitational field on the cardiovascular system (76) . 
On the other hand, a variety of cuff configurations applied during a 
number of water immersion and prolonged bed rest studies have been 
unsuccessful in preventing either decrease of plasma volume or orthostatic 
intolerance 
(25, 73, 96, 112, 114, 117) . Periodic inflation of lower 
extremity cuffs on the pilots of the 8 and 14 day two-man Gemini missions 
was also ineffective in lessening post-flight orthostatic intolerance, even 
though there appeared to be some decrease in the degree of post-flight 
pooling of blood in the lower extremities as judged by the strain gage 
technique (29, 91) . Thus it has been concluded that in the light of failure 
to establish definite effectiveness of extremity cuffs in many simulated 
and actual weightless exposures to date, further consideration of the use 
of cuffs in the space flight situation is not warranted (114) . 
Exposure to lower-body negative pressure has been suggested as a 
method of preventing adverse effects of cardiovascular adaptations to 
245 
weightlessness, since its effect on the cardiovascul.ar system is similar 
to that of increasing the gravitational component of hydrostatic pressure (60, 
93) . It was thought that forced pooling of blood in the lower part of the 
body would serve to stimulate expansion of circulating blood volume by 
mechanisms outlined above (60) . Another effect anticipated was transuda- 
tion of fluid, due to increased intravascular pressures, to rehydrate 
and restore tension to tissues of the lower extremities, possibly to 
(60) pre-mission levels . Although lower-body negative pressure has 
been found to produce less of an increase in peripheral venous tone 
than standing, this technique might conceivably restore to some degree 
the capability of veins and, if they are also affected by weightlessness, 
arterioles to respond to intravascular hydrostatic pressures due to 
gravity (4’ 40). A number of studies have shown that lower-body negative 
pressure can either prevent or restore the decreases of plasma volume 
and orthostatic tolerance which result from prolonged bed rest 
(16, 40, 64, 
72, 78, 95, 97) . Of particular importance in terms of space missions 
of long duration is the fact that orthostatic tolerance was restored with 
this method over a period of only 2 days (60, 95, 97) Hence for . 
space missions of any length of time, orthostatic tolerance could be 
reestablished on a short-term basis just prior to entering a gravity 
(60) environment . Although exposure to lower-body negative pressure 
appears to be a very feasible measure for restoring an astronaut’s ortho- 
static tolerance while in space, possible restrictions which this measure 
might place on an astronaut’s activity during a critical phase of a mission 
must be taken into account. There is also an apparent need for studies 
aimed at determining time and pressure modes which would provide 
an optimum effect. 
Again, in an attempt to readapt the cardiovascular system to gravity, 
periodic centrifugation has been assessed for its effectiveness in prevent- 
ing orthostatic intolerance resulting from prolonged bed rest. White 
(125, 
126) has reported that as little as four 7. 5 min rides on a short-arm 
centrifuge largely prevents orthostatic intolerance as judged by syncope. 
However, heart rate and blood pressure responses to tilt, and decrease 
of plasma volume during bed rest, were essentially unaffected by this 
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measure. Interestingly, the s.teep heart-to-foot acceleration gradient 
of 256 percent created by this measure did not preclude movement of 
the head, arms and legs, and motion sickness was not a problem 
for the well trained individual when exposed to high angular rates and 
modest head or limb movements. Further testing of periodic centifuga- 
tion appears indicated (126). It is considered possible that the weight, 
power and volume penalties imposed by a short-radius centrifuge could 
be brought into perspective for spacecraft of the future, if the effectiveness 
of this measure is well established. 
A few other protective measures which have been suggested for use 
in space have been studied, all being essentially ineffective in experiments 
to date. The administration of 9-alpha, fluorohydrocortisone for a short 
period of time towards the end of prolonged bed rest exposures did 
return blood volume to normal and in fact often above normal, but did 
not prevent the orthostatic intolerance resulting from these exposures (57, 
94, 96) . It should also be noted that this drug produced occasional 
nausea, an effect which would be highly undesirable in the space situation (96) . 
Presumably to stimulate peripheral vasomotor reflexes otherwise 
dormant during exposure to weightlessness, variants of positive pressure 
breathing have been applied. However, they have had no significant 
effect on the orthostatic intolerance resulting from head-out water immersion 
and bed rest 
(55, i15) 
. 
The administration of pitressin, with and without concomitant water- 
loading to subjects immersed to the neck in water has prevented the 
diuresis, and associated decrease in plasma volume, but not the ortho- 
static intolerance which results from water -immersion (55, 56, 73) . 
Based on the fact that many of the physiologic responses to hypoxia 
are the reverse of those to weightlessness, individuals have been exposed 
to 10, 000 to 12, 000 ft altitudes during bed rest (60, 61, 95, 97) Although . 
exposure to mild hypoxic conditions did prevent the decrease in red cell 
mass which occurred during bed rest exposures at ground level, it did 
not reduce the orthostatic intolerance produced by bed rest. 
Periodic bouncing exercise on a railed cart between two trampolines 
has been carried out on prolonged bed rest subjects (27) . It was thought 
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that the vascular stimulation of exercise, as well as the repetitive 
“sloshing” of blood, would serve to maintain the capacity of both veins 
and arteries to compensate adequately for intravascular hydrostatic 
forces due to gravity. Although this measure was found ineffective, 
it might warrant further testing. 
What appears to be the most effective measure assessed to date for 
the protection of bed rest and water immersion subjects from orthostatic 
intolerance has been the application of a pressure garment to the lower 
part of the body during tilt. The external pressure primarily acts to 
prevent excessive venous pooling and excessive loss of plasma volume 
through transudation of fluid into the tissues of the lower extremities in 
the upright position (60) . The partial pressure, or so-called “anti-G” 
suit has been used to prevent fainting of individuals suffering from 
(82) postural hypotension . Orthostatic tolerance after 6 hours of head-out 
water immersion was improved, beyond the pre-immersion tolerance 
with an elastic gradient leotard (73) . The partial pressure suit has been 
proven effective in preventing orthostatic intolerance after prolonged 
bed rest (76y 77). It is therefore believed possible that any effective 
pressure garment that can be applied by an astronaut prior to re-exposure 
to a gravity environment will provide a large measure of protection against 
a possible significant decrease in orthostatic intolerance (60) . The 
most suitable garment would appear to be the Jobst stocking or elastic 
leotard. They can be adequately ventilated and permit normal body 
movement, and can be easily donned. In such a garment, one could perform 
normal activities. 
Finally, protection from adverse effects from cardiovascular adapta- 
tions to weightlessness might be a factor coming into considerations of 
whether to provide astronauts artificial gravity in space. It is readily 
apparent from above discussion that the weight this factor should have in 
reaching this decision remains to be established. If artificial gravity 
is employed, the level required for preventing orthostatic intolerance in 
various gravity environments to be encountered during space missions will 
have to be determined. 
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CHAPTER 11 
ACUTE RADIATION EFFECTS 
Assessments of the presently known and anticipated radiation hazards 
in space are indicating that serious acute radiation effects should not be 
suffered by astronauts if adequate precautions are taken. One must 
remember, however, that current information on ionizing radiations, 
particularly from solar flares in space, is based on relatively sparse 
data. Therefore, it is still considered necessary to assume that there 
could be a requirement for the treatment of acute radiation effects in 
space. This chapter briefly outlines the acute medical problems which 
result from unexpected exposure of astronauts to various radiations during 
space missions. Emphasis is placed on the characteristics and management 
of ionizing radiation effects which are presently thought most likely to 
occur following exposure to solar flare radiation. 
Various radiation terms to be used in this chapter are defined in 
Figure 11. 1. The relative biological effectiveness (RBE) of a particular 
type of radiation is a multiplier which equates the biologic response of 
this radiation to that of X or gamma radiation having a linear energy 
transfer (LET) equivalent to 3 Kv/p of water and being delivered at the 
rate of 10 rads/min. When an RBE value is used for a specific biologic 
endpoint, it is commonly referred to as a quality factor (QF). 
RAD I 
100 ergs/gm 
any medium X 
REM 
Applied to man, and 
corrects for change 
in dose-response 
relations due to 
, specific ionization 
of different radiations 
Radiation Relative 
-Absorbed 
-Dose 
- Biological 
-Effectiveness - - 
QuaEiy 
-Factor - 
Roentgen 
Equivalent 
-Man - 
Figure 11. 1 Radiation Terms 
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Space Radiation Hazards 
The various radiations to be expected in the space environment 
have been discussed extensively in the literature. Therefore they are 
dealt with briefly below, with major references from which further detail 
can be obtained being cited. 
Trapped (Van Allen) Radiation 
Because flight plans usually call for orbits beneath or transient passage 
through the zones of geomagnetically trapped radiation surrounding the 
Earth, this source is considered a relatively minor hazard to astronauts. 
The location and characteristics of the zones are being so precisely defined 
that depending on the spacecraft shielding and trajectories selected, 
radiation exposure can be maintained at safe levels during both orbiting 
and non-orbiting missions. It is conceivable, however, that during an 
emergency extravehicular operation on the fringe of a zone, or intra- 
vehicular operations within the zones , there might be a danger of skin 
injury from high energy particles (117) . Radiation zones around planets 
being explored are yet to be identified and their characteristics thoroughly 
studied. 
Artificial Radiation Belts 
Artificial radiation zones of high energy electrons can be created by 
nuclear explosions in space. They could present a serious biologic 
hazard, especially to orbiting astronauts. The dose of radiation an 
astronaut could receive will depend on pre-flight planning and the amount 
of contingency exposure in flight. Dose rates measured four months after 
the Starfish nuclear explosion in space were dangerously high, at 30 rads/hr 
behind 4. 5 gm/cm2 bras s shielding 
(18)* 
Due to flux decay, the dose 
rates were below 0.2 rad/day behind 5 gm/cm 
2 
aluminum two months 
later. Such a dosage would not produce acute radiation effects. 
Galactic Cosmic Radiation 
Galactic cosmic radiation is believed to originate outside of our solar 
system, but within our galaxy (28) . This radiation consists of extremely 
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high energy atomic nuclei, of which approximately 86 percent are 
protons, 13 percent are alpha particles and the remainder are elements 
of higher atomic number (120) . Since cosmic. particles produce discreet 
dense ionization tracks in tissues, the possibility that they might 
seriously injure such vital organs as the lens of the eye, the retina, 
the hypothalamus, or the brain has been considered. Schaefer (97) has 
recently estimated that exposure to galactic cosmic radiation in free 
space would have a significant life-shortening effect, possibly as much 
as 20 percent. Inadequate simulation in gr.ound-based experimentation 
and biologic exposures in space have precluded definitive evaluation 
of this hazard (25, 26, 94) . Otherwise , unless streams of cosmic 
radiation exist in space, these particles are so few in number that they 
do not now appear to be an acute hazard to astronauts (65, 94) The . 
average whole-body dose rate of this radiation in free space is generally 
thought to be about 5 rads/yr during the period of maximum solar 
activity and about 15 rads/yr during minimum solar activity (1, 41, 42, 
47, 73, 80, 97) . It is noted that the latter dose is just about 100 times 
larger than the background dose at sea level on the Earth (97) . 
Radiation Sources On Spacecraft 
Nuclear energy used for propulsion or as a source of power during 
space flight should not be a radiation.hazard if adequate precautions are 
taken to ensure protection of astronauts both during normal operations 
and in an emergency. By the same token, it is assumed that astronauts 
will be adequately shielded from the strong magnetic fields which might 
be used in magnetohydrodynamic propulsion or for repelling high energy 
solar flare protons from the spacecraft hull, and from microwaves 
emanating from activated radar systems. 
Solar Electromagnetic Radiation 
Solar electromagnetic radiation should not be hazardous to an astro- 
naut who is adequately shielded by the wall of his spacecraft or by his 
space suit. The radiant energy output of the sun in the ultraviolet, 
visible, and infrared spectrum is remarkably constant in spite of the 
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occurrence of sunspots and associated activity (94) . Even though 
adequate measures will presumedly be taken to maintain environmental 
temperatures in space at comfortable safe levels, it is still considered 
possible that breakdown of a temperature control system could cause 
an astronaut to suffer from a heat disorder (Chapter 6). 
The visual spectrum can be dangerous in that the warning glow 
seen on Earth as the line of sight approaches the sun is not seen in space. 
Filtration of sunlight must be adequate to prevent temporary retinal 
effects such as glare or flash-blindness or permanent retinal burns, 
both of which could result from inadvertent glances by unprotected 
eyes at the sun. These disturbances are discussed in detail under 
meteoroid “flash” in Chapter 12. 
The types of plastics used for visors or windows offer adequate 
protection from ultraviolet light. In selecting materials for the space 
suit visor, it must be kept in mind that repeated protracted exposures 
to ultraviolet light during extravehicular operations necessitate an 
optimum degree of protection (45) . If not, this radiation, especially at 
wave lengths shorter than 0. 32~, could damage the surface cells of 
the eye, leading to the condition variously known as “snow blindness”, and 
sunlamp or welder’s keratoconjunctivitis. Associated signs and 
symptoms, which characteristically appear after a latent period of up 
to several hours, are severe eye pain, photophobia, conjunctival conges- 
tion and swelling, marked lacrimation, disturbances of vision, a granular 
appearance within the cornea1 epithelium, and with relatively severe 
exposures, cloudiness of the cornea1 stroma. Although the pain can be 
controlled with a topical anesthetic and cold compresses to the eyelids 
(Chapter S), this condition usually heals in one to several days. An 
astronaut could be seriously incapacitated by this condition, especially 
if he is extravehicular at the time of its onset or requires full visual 
function to perform a critical task. 
Solar x-rays, even from the solar flares to be discussed below, 
appear to be of too low energy and flux rate to penetrate a spacecraft 
or space suit and administer a significant harmful dose of radiation to an 
astronaut. 
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Solar Particulate Radiation 
Solar “Wind” - A large number of particles, mainly protons and 
electrons, are c.ontinuously given off by the sun 
(27,. 47, 48) . 
Even during periods when the sun is more active, the kinetic energy of 
this plasma, or so-called solar “wind”, does not reach levels which are 
high enough to cause concern as a radiation hazard to occupants inside 
of the spacecraft. On the other hand, this radiation must be carefully 
studied to determine whether or not it could be a potential hazard, 
especially to the skin, during extravehicular activity. 
Solar Flar es - Radiation emitted into space by the so-called solar 
flares or solar cosmic ray events presents the most uncertain and 
probably by far the greatest potential biologic radiation hazard in space. 
Therefore this hazard is discussed here in some detail, with emphasis 
being placed on anticipated flare characteristics which determine the risk 
of a serious exposure, the type and severity of acute radiation effects, 
and thus the possible requirements for the treatment in space of medical 
problems from radiation. 
A solar flare is usually a short-lived increase in radiation intensity 
originating in the vicinity of a sunspot, persisting up to several days 
at any point in the solar system (94) . The higher energy components 
of the radiation flux from a flare is comprised mainly of protons with 
energies ranging from 10 Mev to a few Bev. Since these particles are 
the most biologically hazardous component, most shielding and biologic 
considerations have dealt only with them. Alpha particles can be nearly 
equal to or, on occasion, even greater in number than protons over a 
period of time during an event (47) . The contribution of alpha particles 
to the total biologic hazard is less well defined than is the case for 
proton radiation, although much is known of their biologic effects (52, 96) . 
Very little information is available on the distribution within flares and 
the biologic effects of heavier particles 
(87, 116) 
. The electromagnetic 
1-2 ultraviolet, x-ray, gamma) components of a flare are not considered 
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a significant hazard to an astronaut behind typical space suit shielding (47, 
53, 94) . 
The number of solar cosmic ray events follows the 11 year sunspot 
cycle in that these events tend to occur with greater frequency during 
the high incidence range of the cycle (80) . AS shown in Table 11.1, 
the past cycle, which has allowed the first accurate studies of flare 
and sunspot occurrences, began in 1954, reached a maximum early 
in 1958, and reached a minimum in 1965. From this cycle it appears 
that even though the greatest number of events take place at sunspot 
maximum, most of the major events might occur from one to 2 years 
after this maximum (47, 53, 73) . Since over a period of many decades, 
the frequencies of sunspots and flares appear to correlate, long term 
(years) predictions of sunspot size, nature and frequencies might also 
be rough forecasts of future radiation hazards. On the other hand, 
there are at present apparently no substantial criteria for making short 
term (hours) predictions of solar flares (40, 94) . 
The arrival time and flux of solar flare protons at a point in space 
are related to the original velocities of the protons and the influence 
of magnetic fields in space. There is a delay from minutes to hours in 
the arrival of these particles, and their flux can be so dispersed that they 
can continue to arrive over a period of hours to days. Webber and 
Fr eier (122) have pointed out that for all flares, the protons with higher 
energies are detected sooner, and have a shorter rise time (time to reach 
maximum intensity) and a shorter decay time than protons with lower 
energies. Moreover, the flux decay of protons above a particular energy 
is exponential at most times for a wide range of proton energies (122). 
With these characteristics of a solar flare applied to measured flux-time 
profiles of protons above certain energies, it may be possible to reason- 
ably predict the magnitude of a flare from measurements made by instru- 
ments which not only integrate dose but also differentiate energies during 
the early part of an arriving flare. This knowledge could then indicate 
whether or not special shielding measures or, if such is available to 
astronauts, a radio-protective drug is required to prevent radiation injury. 
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Event Date 
2-23-56 
8- 3-56 
l-20-57 
a-29-57 
10-20-57 
3-23-58 
7- 7-58 
a-16-58 
a-22-58 
8-26-58 
9- 22- 58 
5-10-59 
7-10-59 
7-14-59 
7-16-59 
4- 1-60 
4- 28- 60 
5- 4-60 
5-13-60 
9- 3-60 
9-26-60 
11-12-60 
11-15-60 
11-20-60 
7-11-61 
7-12-61 
7-18-61 
7- 20- 61 
9-28-61 
10-23-62 
Exposure (Rads) 
Shielding gm/ cm2 
1.0 2.0 5.0 
309.0 185.0 103.0 
9. 1 5. 3 2.4 
112.0 45. a 7.1 
78.7 26. 2 3.5 
19.3 10.0 4.7 
1.5 0.6 0. 1 
156.0 55.0 9. 6 
24.0 
46.0 \ 151.2 
9. 3 
81.25 
,15.3 
23.4 
1 
1.7 
48.0 2.0 6. 9 
3. 2 
4.4 1.3 0.2 
484.0 217. 0 66. a 
440.0 1 220.0 86.0 
675.0 1507.0 312.0 728.0 91.0 253.8 
392. 0. 196.0 1 76. 8 f 
2.0 1.0 0. 5 
2. 2 1 1.1 0. 4 
2.3 6.4 1.2 
1 
3.2 0.6 
1 
1.3 
1.9 0.9 0. 3 
13.5 7.0 3. 2 
1.2 0.5 0. 1 
117.0 
64.9 185.7 
3. 8 I 
1.5 0.7 0.2 
26. 3 1.2 
132.0 161.8 8.8 63. 0 72. 5 25. 2 27.0 
2.0 1.0 0.4 
ZI 4 1.1 0.5 
0.1 0.0 0.0 
Table 11.1 Integral Unit Sphere FreeZSpace Proton Exposures 
Under 1, 2, and 5 gm/cm Aluminum Shielding for 
Major Cosmic Ray Events Occurring During Solar 
Cycle 19. 
(After Langham, Brooks and Grahn (653 . 
Because the proton flux from a solar flare event is widely distributed 
in energy and direction, and varies among different events and at different 
times during an event, no average biologic hazard can be described for 
solar flares. As shown in Table 11. 1, the biologic hazard can be markedly 
modified due to a number of solar flares occurring over a period of 
several days. Finally, it should be kept in mind that until the next pre- 
dicted period of maximum solar activity in 1969, few direct measurements 
of flares will have actually been made in free space. 
Since shielding on most dosimeters has not allowed an adequate assess- 
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ment of the low energy radiation spectrum in space, the possible hazard 
of low energy protons and alpha particles to astronauts during extra- 
vehicular activity in free space remains to be defined. Solar flares 
which occur frequently and emit low energy protons are being identified (48) . 
These and the solar “wind” might be a skin hazard and require investigation 
for evaluation of shielding provided by space suit materials. 
The air dose rate of radiation imposed on an astronaut in a space- 
craft being bombarded by solar flare protons will be determined primarily 
by the energy-flux characteristics of the protons stream, the type (atomic 
weight), thickness and geometry of the spacecraft shielding and by the 
astronaut’s spatial position in the spacecraft. Figure 11. 2 illustrates 
the effect of shielding thickness on air dose rate from incident protons. 
It is noted that neutrons contribute negligibly to the total dosage at 
shielding thicknesses of less than 10 gm/cm 
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aluminum (72y 123). Short 
electromagnetic waves produced by the interaction of protons with such 
a metal of low atomic weight can also be considered insignificant (65, 72, 
94, 123) 
Integral cabin air doses as a function of spherical shielding thick- 
ness have been estimated for a number of flares of the last solar cycle 
(Table 11. 1). Since a better understanding of the contribution of high 
energy particles to the total flare dose was brought into these calcu- 
lations, the data are considered the most accurate available up to the 
present time. Table 11. 1 lists only solar flare events for which there 
was sufficient flux data to justify free-space dose estimates. The 
effect of shielding in attenuating solar flare radiation dosage is again 
well demonstrated. Assuming that such data are reasonably correct, 
it will become evident in subsequent discussions that only the cumulative 
doses from two solar flare series (1959 and 1960) would have been suffi- 
cient to have had a significant effect on an astronaut in a spacecraft 
providing him spherical shielding of from 2 to 5 gm/cm’ aluminum. 
Results of model calculations of proton depth-dose patterns using 
data of various flares are shown in Figures 11.3 and 11.4. Both serve to 
illustrate the marked decrease in tissue dose with increasing depth from 
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Figure 11. 2 Calculated variations of primary and secondary point- 
target air dose rates as a function of the thickness 
of a spherical aluminum shield for the May 10, 1959 
solar flare spectrum, measured 33 hours after onset. 
(After Langham et al, (65) redrawn from Wilson and Miller (1231, . 
the skin surface. Figure 11. 3 represents calculated depth-dose patterns 
for three different solar flare rigidities considered representative of 
past flares. It is noted that even for the most energetic incident flare 
spectrum the tissue dose drops from about 30 percent of the skin surface 
dose at 5 cm depth. Figure 11.4 shows the depths of critical organs 
and tissues in relation to depth-dose distribution, in a spherical phantom, 
calculated for the May 10, 1959 solar flare event. 
If past solar flare flux-energy-time, shielding, and tissue depth-dose 
data presented above are valid for predicting future radiation hazards 
in free space from flares, one can say with reasonable confidence that 
the occurrence of serious injury to deep tissues, such as the hematopoietic 
system and gastrointestinal tract, from a flare or series of flares with 
the order of magnitude and separation of those recorded in the last solar 
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Tissue Thickness in cm (behind 2gm/cm2Al) 
Figure 11.3 Tissue dose variation with increasing depth from 
skin for various incident flare spectra (P repre- 
sents the rigidity, or spectrum of particlOe mo- 
menta at the time of maximum flare intensity). 
(After Jones et al (61)) . 
cycle, will be highly unlikely. The skin may, however, be damaged 
under these conditions. 
The acute skin dose of 200 KVP x-rays required to produce erythema 
is about 650 to 700 rads (65). As shown in Figure 11. 5, protraction of 
exposure allows some repair of skin damage to take place during exposure, . 
so that the dose required to produce erythema is increased. By the same 
token, Figure 11.6 demonstrates that previous skin exposure reduces 
the allowable next dose because of residual unrepaired damage. If it is 
assumed that solar flare protons and 200 KVP x-rays have the same QF 
for skin injury, and solar flare data in Table 11. 1 are reasonably 
accurate, then Figures 11. 5 and 11. 6 indicate that past flares and series 
269 
120 
100 
ii 
0” 40 
z 
i= 
a 
d 
a 20 
-SKIN I 
OCULARLENS I 
t TESTES 
t 1 I I (+~oNE MARROW 
I 
A T 
G.I. TRACT 
5 IO I5 
DEPTH IN TISSUE (CM) 
Figure 11.4 Depth range and mean depths of critical organs and 
tissues in relation to proton depth-dose distributio2 
inside a spherical phantom placed behind 2 gm/cm 
shielding, calculated for the May 12, 1959 solar event. 
(After Langham et al, (65) drawn from Grahn (49) and Schaefer (95)) . 
of flares would probably not have been sufficient magnitudes to produce 
erythema of skin protected by spherical shielding equivalent to 2 to 5 gm/cm 2 
aluminum shielding. Such shielding is thought to be representative of present 
day manned spacecraft hulls (1) . On the other hand, at 1 gm/cm2 aluminum, 
protraction and fractionation would probably not have been sufficient to pre- 
vent the occurrence of erythema (65) . 
In conclusion, an optomistic picture of the potential solar flare hazard 
to astronauts on prolonged space missions has been presented. It should 
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EXPOSURE TIME (DAYS) 
Figure 11. 5 Total skin dose of 200 KVP x-rays, or a radiation 
with a QF of unity, required to produce a slight 
erythema as a function of time over which expo- 
sure is spread. 
(After Langham et al (65)). 
be remembered, however, that the above predictions were based on 
limited data from only one solar flare cycle. Accordingly, the treatment 
in space of various acute radiation effects, particularly skin injury, 
should be considered in emergency planning. 
Acute Ionizing Radiation Effects 
Studies of humans suffering from acute ionizing radiation effects 
following radiotherapeutic, nuclear reactor and nuclear bomb exposures 
have indicated that a stereotyped clinical picture of such effects, based on 
dosage alone, cannot be described (16, 24, 54, 65, 66, 79, 88, 101, 121) . 
This applies even more so to radiation exposures in space. The different 
component particles and the energy-flux-time spectra of space radiations, 
with resulting variations in RBE and tissue depth-dose distributions of 
these radiations, are critical. These are only the major determinants of 
doses received by individual organs and tissues which, when damaged, are 
directly or indirectly responsible for producing the medical problems from 
radiation exposure. 
The wide differences in species sensitivity to radiation is well known, 
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EXPOSURE TIME (DAYS) 
Figure 11.6 Maximum daily dose of 200 KVP x-rays, or a radia- 
tion with a QF of unity that can be given and not ex- 
ceed the slight erythema threshold as a function of 
the period over which the exposure is protracted. 
(After Langham et al (65)). 
so that extrapolation of even subhuman primate radiation exposure data 
to man must be made with caution (13, 23, 32) . The effects of protons 
on animals have been studied and compared to the effects of other radiations (4, 
15, 30, 31, 32, 33, 34, 61, 67, 103, 104, 105, 114) 
. In contrast to gamma 
or x-irradiation, studies of several species have indicated that for a 
total body dose, protons are more prone to damage the gastrointestinal 
tract than the bone marrow (30, 31, 32, 33, 34, 61, 67, 103, 114) Early . 
findings that hemorrhagic phenomena occur earlier and are more severe 
in large animals irradiated with protons than those irradiated with x-rays 
have not always been substantiated (31, 33, 83, 114) . 
The clinical manifestations of early, or acute effects of a radiation 
exposure, tend to appear when the total dose of radiation absorbed by a 
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critical volume of tissue within a certain period of time exceeds some 
critical level, or threshold. For a single uncomplicated solar flare, 
this threshold will probably not be exceeded if signs and symptoms of 
radiation effects do not, appear within 60 days after exposure to the 
flare (65). 
Clinical Picture Following a Highly Penetrating Exposure in the LD50 __. 
Range 
For the purpose of determining what therapeutic measures might be 
required for the treatment of acute radiation effects in space, a rather 
idealized clinical picture resulting from a total body dose of highly pene- 
trating radiation given at a mid-lethal dose (LD ), such as 450 to 500 
rads of 250 KVP x-rays, is described here 
(3, 8, 21, 24, 51, 65, 76) . 
What usually occurs at this dose level is the so-called hematopoietic form 
of the acute radiation syndrome. The clinical course of this form of 
reaction passes through four phases - the initial or prodromal phase, 
the latent phase, the bone marrow depression phase, and the recovery 
(3) phase . At lower dose levels, the bone marrow depression phase is 
less likely to become clinically apparent; symptoms characteristic of 
only the prodromal phase occur in about 5 to 10 percent of individuals 
receiving 50 to 100 rads , and in about 25 to 50 percent of those receiving 
100 to 200 rads (61) . At levels above the LD50, evidence of gastro- 
intestinal damage will appear. This so-called gastrointestinal form of the 
acute radiation syndrome, characterized by a severe prodromal phase, 
a short latent phase and a phase of usually fatal gastrointestinal distur- 
bances, overshadows clinical manifestations from bone marrow depression 
at a total body dose in the range of 750 to 800 rads. As mentioned above, 
for a given total body dose, the human gastrointestinal tract might be . 
more susceptible to proton injury than to injury from x-rays or gamma 
irradiation. The predominance of gastrointestinal injury might therefore 
occur at a somewhat lower dose after proton irradiation from a highly 
penetrating solar flare. At still higher total body radiation doses, the 
so-called cerebral form of the acute radiation syndrome appears, being 
characterized by an explosive initial phase followed by irrational behavior, 
273 
neuromuscular incoordination, convulsions and death within a few hours. 
Finally, it should be remembered that since depth-dose patterns are 
considerably different from those of the LD50 x-ray model, the 
clinical manifestations resulting from doses between 450 and 500 rads 
from solar flares may also be quite different than those discussed 
below. 
Initial, or Prodromal Phase - Anorexia, nausea, retching, vomiting, 
listlessness, apathy, increased fatigability and occasionally diarrhea 
usually begin within 2 hours after an acute radiation exposure in the LD50 
range (20, 43, 65J 79, 86, 88, ‘19) Weakness, fatigue . , lethargy , 
and irritability, which have been attributed to the direct cerebral effects 
of radiation, may also become evident (98) . Clinical experience indi- 
cates that the higher the integral dose, the shorter the latency of what- 
ever prodromal symptoms occur. Signs and symptoms in the pro- 
dromal phase usually reach a peak within 4 to 6 hours after exposure, 
then improve rapidly, seldom lasting beyond 48 hours in duration. 
The severity of clinical manifestations occurring in the prodromal 
phase correlates poorly with the integral dose of radiation received, 
being markedly influenced by individual susceptibility, which cannot be 
pre-determined, and by psychologic factors such as motivation (16, 65, 98) . 
Some authors are of the opinion that the severity of nausea and vomiting 
might be proportional to the amount of food in the stomach at the time 
of injury, and may be prolonged by attempting to feed the irradiated 
individual (3 ). Symptoms might also be aggravated by fluid and electrolyte 
losses in vomiting. 
It is readily apparent that the prodromal phase could be a threat to 
continued astronaut performance, especially if severe signs and symptoms 
occur during a crucial spacecraft maneuver. Vomiting into the weight- 
less environment will also create a potentially disasterous droplet hazard 
(Chapter 8). 
Latent Phase - The prodromal phase is usually followed by an asympto 
matic period, or latent phase of up to several days in duration. Weakness 
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and fatigue can continue into this phase due to fluid and electrolyte 
losses from vomiting in the prodromal phase. Epilation usually occurs 
within two weeks, and involves mainly head and body hair, the eyelashes 
(3). and eyebrows being less sensitive to radiation The duration of the 
latent phase is governed by the severity of the radiation exposure, and 
hence the damage incurred by the exposure. 
Bone Marrow Depression Phase - Marked depression of circulating 
white blood cells, with associated failure of the body’s immune mechanisms, 
leads to enhanced susceptibility to infection. Inflammation, with chills, 
fever and general malaise, is usually suffered first in the oropharyngeal 
region. Gingival and pharyngeal tissues, and tonsils can become severely 
swollen and ulcerated. Step-like fever suggests septicemia. A bacteremia 
can lead to abcess formation in any tissue of the body. Bacterial 
pneumonia and gastroenteritis can also be the cause of fatality. 
Due to marked depression of circulating platelets, disturbance of 
blood clotting also becomes clinically evident. The gingival tissues 
bruise and bleed easily. Petechiae and ecchymoses may involve broad 
areas of skin. Gastrointestinal and urinary tract bleeding may also 
occur. Gross hemorrhage from body orfices and into hollow organs is, 
however, usually not massive and continuous, but is self limiting (3) . 
In the average individual, clinical manifestations from an LD 
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dose of total body radiation usually reaches a peak about the fourth to 
fifth week after exposure. Death may occur primarily from infection or 
bleeding, or both. 
Recovery Phase - The recovery phase is usually quite prolonged, last- 
ing from 2 to several months in duration. Repeated infections, involving 
especially the respiratory system and skin, may occur. Bacterial resis- 
tance to available antibiotics can become a serious problem during this 
period. 
Skin Manif e stations 
If the skin receives a radiation dose which is less than that required to 
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produce wet desquamation or ulceration, it will show a variable amount 
of flushing, (3) or erythema . This primary effect appears within hours, 
increases to a maximum intensity within 24 hours and disappears com- 
pletely by the third day after exposure. There might ,be an accompanying 
sensation of warmth or itching resembling a mild sunburn. About 10 
to 15 days after exposure, the skin again becomes erythematous, this 
time more intensely than the more fleeting early erythema. The \ 
involved skin in this so-called main erythema phase, which usually 
lasts about 2 weeks in duration, gives symptoms of a severe sunburn. 
Depending on the body sites and surface areas involved, it is readily 
apparent that an astronaut could be markedly impaired during this phase, 
especially if affected sites must be in contact with tight-fitting or poten- 
tially chafing parts of a space suit. 
With larger doses of radiation, the skin may develop a bluish- red 
color with superficial scaling (dry desquamation) or a more severe 
reaction with blisters (moist desquamation). These extremely irritating, 
painful conditions usually develop by the ninth day after exposure. 
Severe toxicity and the serious sequelae of plasma protein, fluid 
and electrolyte losses can become part of the clinical picture if a 
large area of the body surface is involved with blistering. After still 
larger doses of radiation, blisters may ulcerate to form so-called 
roentgen ulcers over a period of several weeks (3) . These extremely 
painful, slow healing ulcers are characterized by marked pain, a 
punched out appearance, undermining growth and a tendency to recur (3) . 
Any areas of skin breakdown are markedly prone to become infected. 
It is noted that the clinical course of primates dying from proton radiation 
injury to skin is in many ways similar to that following third degree 
thermal burns (Chapter 13) (27, 29). A severe, persistent edema, 
which often progresses to fibrosis or necrosis, can develop under severely 
irradiated skin from many weeks to many months after exposure (50) . 
This delayed phenomenon has been well demonstrated in primates whose 
skin was irradiated with high doses of 32 Mev protons, and is thought to 
be due to increased capillary permeability in conjunction with a moderate 
hypoalbuminemia (27, 29). Severe subcutaneous fibrosis with contracture 
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and decreased mobility often leads to slow starvation death in these 
primates. 
The effect of radiation on the skin varies, depending on the RBE 
of the radiation, on the degree of protraction or fractionation of the 
dose, on the site exposed, and probably on the surface area exposed. 
Reference is again made to data depicting the effect of dose protraction 
and fractionation on the production of skin erythema, presented in 
Figures 11.5 and 11.6. In general, the threshold dose at a depth of 1 mm 
for a slight erythema is about 650 to 700 rads of rapidly administered 
200 KVP x-rays (59, 65). After an acute exposure with 200 KVP x-rays, 
a sharp erythema is seen about 1050 rads and a blistering reaction about 
2000 rads. 
Diagnosis 
For the most part, the diagnosis of acute radiation effects, especially 
skin inj ur y, should be easily made in space. Measurement of the energy- 
flux-time characteristics of a radiation exposure and subsequent estima- 
tion, especially of tissue dose received by an astronaut over a period of 
time should, based on prior human and animal studies, allow reasonably 
accurate prediction of clinical outcome. Hopefully the time sequence 
and characteristics of acute radiation effects will not have to be relied 
upon as the first warning of radiation exposure. Whenever possible 
on board future spacecraft, hematologic studies, such as total and 
differential white cell count, and hemoglobin and hematocrit determination, 
to assess the degree of hematopoietic depression or secondary blood loss, 
could be a valuable aid for therapeutic decisions and prognosis. As well, 
fluid and electrolyte studies might be indicated for assessing the degree 
of fluid and electrolyte imbalance resulting from a radiation exposure, 
and for accurately determining the required replacement therapy. 
Prevention 
The importance of minimizing the amount of radiation which an astro- 
naut receives by the use of adequate shielding and, whenever possible, 
by controlling the duration of his exposure, has been emphasized. For 
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necessary exposures, daily fractionation in equal exposure increments 
would be simpler and preferred, so that the limits within which an ex- 
posed astronaut can operate without decrement in health or performance 
can be predicted WI. Radiation dose limits currently recommended 
by the National Aeronautics and Space Administration are listed in 
Table 11. 2. The models of man on which these standards were based 
are presented elsewhere (44). It has been stated that these maximum 
permissible doses are probably on the conservative side when one 
takes into consideration the effect such doses would have on astronaut 
performance and consequently on the safety of a mission (9) . For example, 
fatal mistakes might be made if a radiation prodromal reaction peak 
should occur in one or more crew members when some critical maneuver 
such as rendezvous and docking, or a mid-course trajectory correction 
would be required. On the other hand, this peak might occur over a 
period when only a minimum amount of crew activity would be required. 
The mission plan could then be altered so that this period could be pro- 
Critical organ Maximum RBE Average Maximum Maximum 
permissible (rem/ rad) yearly permissible permissible 
integrated dose (rad) single acute single acute 
dose (rem) emergency emergency 
exposure, exposure, 
protons. only alpha particles 
bad) and protons 
(rem) 
Skin of whole 
body 
Blood-forming 
tissues 
1600 
270 
1.4 
(appr 04 
1.0 
250 500,: 700,: 
55 200 200 
Feet, ankles, 
and hands 
Eyes 
4000 1.4 550 
7oo:::::: q80:‘::: 
* :: :: 
270 2’ 27 100 200 
,:.Based on skin erythema level. 
Based on skin erythema level; however, these appendages are believed to be less 
:r ::: :> radiosensitive. 
Slightly higher RBE assumed since eyes are believed more radiosensitive. 
Table 11. 2 Radiation exposure dose limits currently recommended by 
the National Aeronautics and Space Administration. 
(After Gill (35), National Academy of Sciences Space Science Board (59) , 
and Billingham (8’). 
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longed enough to allow recovery. Finally, it should be pointed out that 
one important change was made in the original radiation exposure limits 
table established by the National Academy of Sciences Space Science 
Board (84). Pointing out that alpha particles may be present in greater 
numbers in large solar flares than originally.predicted, Billingham (9) 
suggested that it was more logical to specify biologic limits in terms of 
rem since the alpha particles encountered during space missions would 
probably have an RBE greater than 1. Although penetration of the space 
suit by solar “wind” alpha particles will be so small that these particles 
will have essentially no biologic effectiveness, alpha particles from high 
energy solar flares could, on the other hand, present a significant hazard 
to occupants of spacecraft, especially if shielding is minimal (22, 96) . 
If there is a significant risk of an astronaut being exposed to levels 
of radiation dosage above those in Table 11. 2 or its future modifications, 
it will be necessary to have him take special protective measures. This 
is based on the fact that increasing the shielding incorporated in a space- 
craft hull or providing a highly shielded compartment in a spacecraft 
might not be possible in the light of the great weight penalties these measures 
impose. Optimum cabin shielding should be provided by distributing 
on-board systems and stores to keep the doses to critical organs to 
a minimum. Since estimated doses received from solar flares tend to 
vary considerably in different parts of space cabins, an astronaut may 
be able to take up a “safer” position in the cabin during a solar flare. 
The early high-energy component of a flare is essentially unidirectional 
(73) in space . Orienting the spacecraft in the direction of the arriving 
flux could therefore be an effective protective measure. Appropriate 
distribution of moveable on-board equipment and stores might add to 
the directional shielding effect. In an emergency situation it might be’ 
found necessary to provide an astronaut with local shielding which could 
be placed over critical areas of his body, such as eyes, thorax or 
abdomen. Lastly, the space suit should be designed to provide adequate 
shielding during extravehicular operations, or the durations of such 
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operations carefully controlled to protect an astronaut, especially from 
skin injury. 
Several recent reviews have indicated that there is no radio-protec- 
tive drug with a therapeutic index suitable for human use at the Present 
time (6, 7, 58, 65, 89, 93, 99, loo, 1 12, 1 15) . Although hundreds of 
chemical compounds have been shown to have some radio-protective 
effect in mammals, marked species variability, especially with respect 
to toxicity, has prevented extrapolation of results with such compounds 
to man (35, 37, 38, 58, 65, 69, 85, 93, 100, 112, 115, 119) . Further - 
more, no data are available on the single or combined use of such drugs 
on humans. 
A rather “shotgun” approach to drug studies has evolved from a 
failure to define the exact mechanism of radiation injury. Current thought 
supports simultaneous action of radiation on critical biologic molecules 
through direct hit phenomena and harmful secondary reactions of chemically 
reactive ions and radicals with critical sites on molecules. Free 
radicals are created mainly by the action of radiation on the abundant 
intra- and extracellular water. Apparently by scavenging free radicals, 
compounds consisting of a free sulfhydryl group separated by not more 
than 3 carbon atoms (e. g. , cysteine, glutathione, cysteamine, AET or 
aminoethylisothiourea, MEA or mercaptoethylguanidine) have, especially 
in the light of their relatively low toxicity, been the more effective 
radiotherapeutic agents in animal studies (35, 37, 58, 65, 69, 77, 93, 
100, 112) . Other antioxidants (3. , ascorbic acid, BHT or butylated 
hydroxytoluene) have been particularly effective in the rat (38) . 
Possibly on the same basis, various natural food substances (*, alfalfa, 
broccoli, vitamin mixtures) have been mildly effective in the guinea pig (85) . 
The radioprotective effect of drugs such as 5-hydroxytryptamine, histamine, 
and epinephrine has been attributed to the lowering of tissue oxygen, an 
increased amount of which appears to enhance the production of these 
harmful radicals 
(65, 112) 
. Several investigators have recently found 
that for some unknown reason, dimethylsulfoxide (DMSO), which has 
remarkably low systemic toxicity in both animals and humans, exerts 
a radioprotective effect in animals (5, 39, ‘3, 81, 9’) Since this agent . 
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has a high penetrating power through intact skin and promotes the 
cutaneous penetration of certain drugs, the question is raised as to 
whether or not it alone or in combination with another radioprotective 
agent might give not only systemic, but also selective dermatologic 
protection from radiation when applied topically 
(63, 108, 109) . 
The toxicity and rapid detoxification or metabolic breakdown of al- 
most all radioprotective drugs and the extreme rapidity of ion and free 
radical formation in the tissues have dictated that virtually all of these 
drugs be administered just prior to exposure (35, 58, ‘5, “2) Analysis . 
of the energy-flux relationships in early stages of a flare may allow pre- 
diction of organ-specific doses during the remainder of the flare and 
the subsequent potential value of radioprotective drugs. 
A.n adequate tissue level of the prophylactic agent must be main- 
tained during the anticipated exposure. At the present time, the 
low therapeutic index of radioprotective drugs renders their use in 
space impractical. Toxicity might be adequately reduced, however, 
by using combinations of these drugs, each in a lower dosage. It 
cannot be overstressed that the potential hazard presented by a radiation 
exposure must always be weighed against the potential toxicity of the 
radioprotective drug in the light of maintaining optimum astronaut 
efficiency and assuring mission success. 
Finally, since skin injury appears to be the most likely radiation 
effect beyond prodromal reactions to occur in space, one might suggest 
the development of a radioprotective agent which would selectively fix 
in the skin. Such drugs would require freedom from local and systemic 
toxicity to make their use in space practicable. It is also hoped that 
skin fixation may reduce the systemic component which is currently the 
limiting factor in the use of radioprotective agents. 
Treatment 
From past experience with acute effects of radiation on humans, it 
would, in general, seem best to treat in space clinical manifestations 
from radiation exposure as they arise, providing symptomatic therapy 
as dictated by sound clinical judgment (1.7, 21, 57, 65, 74, 76, 106) . 
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This is due to the fact that many acute radiation effects are non-specific, 
so that therapeutic measures are directed mainly at signs and symptoms, 
such as nausea and vomiting, and infection. 
Many drugs, given both orally and systemically, have been used 
to treat especially nausea and vomiting in the prodromal phase of 
the acute radiation sickness syndrome 
(19, 55, 60, 64, 70, 102, 110, 
111, 118) . Assessment of their effectiveness is difficult, however, 
due to the lack of well controlled clinical studies, ignorance of the 
precise etiologic mechanisms involved in the prodromal phase, and 
the fact that psychogenic overlay in tense, nervous individuals, 
especially those already suffering from unrelated illness, undoubtedly 
influences response to such drugs 
(16, 64, 111) 
. Vitamins of the B 
complex, particularly pyridoxine, were the first agents with reported 
effectiveness, and are still widely used (lo2, 111, 118) Although . 
antihistamines, such as cyclizine hydrochloride and diphenhydramine, 
have proven useful for motion sickness, they have not successfully 
controlled clinical manifestations in the prodromal phase 
(110, 111) 
. 
In the past few years, phenothiazine derivatives, such as chlorpromazine, 
prochlorperazine thiopropazate, fluopromazine, pecazine, trifluoperazine 
and triethylperazine have been tried extensively and found to be more 
effective than all other drugs (19, 55, 60, 70, 110, 111) Of these . 
tranquilizing agents, triethylperazine has shown the greatest promise 
for the control of nausea and vomiting in the prodromal phase (19, 55, 
60) . This drug, which appears to sedate both the chemoreceptor trigger 
zone and the vomiting center, is relatively free of side effects (19, 55, 60, 
64) . Further substantiation of the drug’s effectiveness is still required. 
Finally, in the light of the lack of overwhelming success of any drug in 
controlling clinical manifestations in the prodromal phase, this area 
demands intensive investigation. 
If a drug is available in space for the prodromal phase it might be 
given prophylactically to an astronaut who has received a high dose of 
radiation. In this respect, one must keep in mind the dangerous situation 
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which will result if an astronaut vomits into the weightless environment 
(Chapter 8). 
Diarrhea following radiation exposure might be controlled with 
an antidiarrheal drug, such as methscopolamine bromide or diphen- 
oxylate hydrochloride. The administration of an intravenous electrolyte 
solution, such as Ringer’s lactate solution, might be indicated for the 
restoration or maintenance of fluid and electrolyte balance. Any 
infection must be treated with an appropriate broad spectrum antibiotic. 
No specific treatment of radiation injury of the skin has evolved 
from past experience in this area. Artz (3) recommends application 
of a bland ointment, protection of lesions from further trauma and air 
with large bulky dressings, and relief of associated discomfort with 
an analgesic. Topical anesthetics are apparently ineffective in control- 
ling pain. Radiation lesions would then be managed in space in a 
manner similar to that described for thermal burns in Chapter 13. 
Recently, attempts have been made to modify the skin reaction 
to radiation with topical and oral cortisone preparations (11, 56, 62, 
71, 82, 113) . Results, however, have been equivocal. There may be 
some suppression of the early erythema and some delay in the onset 
and initial severity of the main erythema phase, but the degree of skin 
damage eventually incurred by radiation has not been significantly altered 
by these preparations. Pertinent to an astronaut’s performance following 
a severe skin dose of radiation is the fact that it has not been noted 
whether or not cortisone agents can reduce discomfort associated with 
the early and main erythema phases. 
As previously mentioned, a significant risk of damage to an astronaut’s 
bone marrow by solar flares in space cannot be definitely established 
from data to date. Accordingly, a requirement for transfusions of blood 
elements (e.g. , red blood cell, white blood cell or platelet concentrates) 
or bone marrow transplants in space, cannot be predicted. If the need 
for such measures is indicated by future assessments of space radiation 
hazards, the cryogenic storage of blood cell concentrates and homologous 
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or autogenous bone marrow should be considered (2, 8, 12, 75, 76, 78, 
107) 
. It is hoped that rapid advances in this technology could make 
such an approach feasible for space operations. 
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CHAPTER 12 
INJURIES FROM METEOROID PENETRATION 
Knowledge to date has indicated that the probability of penetration of 
a spacecraft cabin wall or space suit by a meteoroid during missions 
along relatively meteoroid-free routes in space is quite low 
(12, 45, 52) 
. 
Uncertainties still remain, however, for a great deal more data is required 
on the frequency, density and frangibility of meteoroids, and on the particle 
characteristics for penetration of various spacecraft wall and space suit 
materials . Accordingly, it is apparent that in the face of current opti- 
mism, attention must still be given to the possibility of having to treat 
in space any one or more of a number of injuries which could result from 
the primary (flash, heat, blast, projectiles) or secondary (e. g. , decom- 
pression, fire, electrical disruption) effects of meteoroid penetration. 
This chapter briefly discusses the meteoroid hazard, and the characteris- 
tics, diagnosis and treatment of injuries thought possible from meteoroid 
penetration of the spacecraft cabin wall and space suit. 
Meteoroid Hazard 
Current information on the meteoroid environment in space can be 
obtained from the studies of Cosby and Lyle (12) and others (7, 15, 22, 28, 
45, 50, 52, 53) 
. The word “meteoroid” is a general term applied to 
particles of matter traveling in space. Ninety percent of meteoroids 
are presumably of cometary origin; the remainder are of asteroidal origin 
(50) . Seventy percent apparently travel in random directions through 
space; the remainder travel in streams (45). The majority of meteoroids 
are thought to be highly porous and frangible with densities as low as 0. 5 
gm/ cm3 (cometary meteoroids) (28, 37) . A few denser meteoroids have 
predicted densities of up to 9 gm/cm3 (asteroidal meteoroids) (22) . The 
geocentric velocity of meteoroids apparently varies from -11 to 72 Km/set 
(28) . 
Since the Earth passes through streams of meteoroids traveling in 
heliocentric orbits, the meteoroid flux in the near-Earth environment 
varies at regular intervals during the calendar year. This flux is highest 
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in the summer months (May through October) and lowest during the late 
winter months (January through April) (7). The various known meteoroid 
streams and their orbits have been discussed by Burbank and Cour-Palais 
(7) . Such information could prove quite valuable in mission planning, 
especially if potentially penetrating particles are present in these streams. 
The best data to date on the probability of meteoroid penetration of 
various thicknesses of aluminum are summarized graphically in Figure 12.1. 
The best estimate curve shows that for a spherical shell 3 meters in dia- 
meter, penetration of an 0. 03 cm thick aluminum wall would occur on the 
average of about every 2.3 years. There is, however, a level of uncer- 
tainty of about one order of magnitude surrounding this and other esti- 
mates of the penetration hazard (45) . Additional data, especially on 
meteoroid density and frangibility, are needed to establish more accurate 
estimates. 
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Figure 12. 1 Time to meteoroid perforation of a 
spherical thin metal shell 3 meters 
in diameter (28 square meters in 
surface area). 
(After Whipple (52)) . 
Injuries From Meteoroid Penetration 
of a Spacecraft Cabin Wall 
Events and associated injuries from meteoroid penetration of a space- 
craft wall have been described by Roth (45). Pertinent to his considera- 
tions were various ground-based studies simulating penetration conditions 
(23, 33) . 
Meteoroid penetration of the spacecraft cabin wall might be partial 
or complete. A partial penetration might cause injuries if particles spall, 
or chip off the inner surface of the wall. If complete penetration occurs, 
vaporized molten and hot, fragmented, meteoroid and wall materials will 
be ejected into the cabin. The vaporized materials will immediately 
under go “explosive oxidation”, and hence constitute a flash, burn and 
blast hazard. Molten and hot fragmented materials could travel at high 
velocities , mechanically injuring an exposed astronaut and damaging 
equipment . Finally, fragmented meteoroid and wall could penetrate 
container s, disrupt tubes and pipes, and even cut electrical wires, 
thereby markedly increasing the fire hazard. 
The probability of meteoroid penetration of a spacecraft cabin wall 
can be reduced by placing penetration barriers around the whole space- 
craft or over critical areas of its hull. The most effective barrier appears 
to be a so-called “bumper shield” which fragments or disperses the 
meteoroid. A core material can be placed under the shield to accept the 
momentum of the fragmented and molten meteoroid and shield before 
these materials reach and damage the spacecraft cabin wall. Further 
design measures in meteoroid protection are discussed below. 
Possible injuries due to the primary phenomena (flash, heat, blast, 
projectiles) ass0ciate.d with meteoroid penetration of a spacecraft cabin 
wall are discussed below. It must be kept in mind, however, that the 
severity of injury and consequent functional impairment of an exposed 
astronaut will also depend on the magnitude of secondary effects of pene- 
tration. Explosive decompression injuries (Chapter 3), acute hypoxia 
(Chapter 1) and ebullism (Chapter 2) might occur. The magnitude of the 
decompression hazard will depend on the size of the hole a meteoroid 
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makes in the cabin wall, the cabin volume, the initial cabin atmospheric 
pressure and emergency recompression and patching capabilities. There 
might also be risks of thermal, electrical and chemical burns from fires, 
disruption of electronic circuitry, and release of chemicals from life 
support and analytical systems (Chapter 13). Any one or more of a great 
variety of clinical problems might also result from the release of hazard- 
ous particles and droplets into the spacecraft cabin atmosphere (Chapter 8). 
Light (Flash) Injury 
The “oxidative explosion” of the vaporized meteoroid and spacecraft 
cabin wall materials will produce a flash which will probably last on the 
order of 1 millisecond (23) . The intensity of this flash will depend on the 
magnitude of the penetration, the composition of the wall, and the composi- 
tion and pressure of the cabin atmosphere. Titanium alloys produce more 
severe flashes in 100 percent oxygen environments than do aluminum 
(33) alloys . The peak flash intensity is markedly increased in pure oxygen 
as compared to air, especially at an atmospheric pressure of 5 psia (23) . 
The flash associated with meteoroid penetration of a spacecraft cabin 
wall might produce either transient (flashblindness) or permanent (chorio- 
retinal burn) visual impairment of an exposed astronaut. Factors in- 
fluencing the degree of this impairment include the proximity of the eye 
to the site of penetration, the direction of gaze, the reflective properties 
of surfaces, and level of illuminance in the cabin and the size of pupil 
at the moment of the flash. A recent review has summarized current 
knowledge in this area (59). 
Chorioretinal burns produce permanent blindness. The chorioretinal 
burn threshold for the dilated human eye has been estimated to be about 
2 (34) 240,000 lumens/ft . In a simulated meteoroid penetration study, 
hypervelocity particles passing through aluminum targets into a 100 per- 
cent oxygen atmosphere at sea level pressure and at 5 psia produced 
light flashes as high as 273, 000 lumens/ft 2 (23) . This value was reduced 
by 85 percent when the flash occurred in air at sea level pressure and 
in a 50 percent oxygen-nitrogen atmosphere at a pressure of 7.0 psia. 
Hence the concentration of oxygen in the spacecraft cabin atmosphere 
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could markedly influence the risk of blindness from meteoroid penetration 
of a spacecraft cabin wall. From these considerations, it appears that 
this risk will be low unless an astronaut is in a high oxygen environment 
and is in close proximity to the site of penetration. On the other hand, 
a varying degree of flashblindness is considered highly probable. Further 
study in this area is warranted, however. 
Flashbiindness is a transient reduction of visual acuity due to bleach- 
ing of visual pigment by a flash of light. The blind area usually occupies 
the central field of vision, so that useful vision is temporarily lost. The 
data of Severin and co-workers (21, 48) indicate that the recovery time 
of flashblindness probably varies between 6 and 48 seconds in the 100,000 
to 240,000 lumens/ft2 flash exposure range. The marked effect’an in- 
crease in visual field illumination has in reducing visual recovery time 
has been demonstrated 
(26, 34, 48) 
. 
Various specific measures can be suggested for the protection of 
an astronaut’s eyes from meteoroid flash, especially if a potentially 
hazardous meteoroid flux is predicted or encountered during a space 
mission. So-called “fixed filter” goggles use a selected filter of fixed 
density to absorb or reflect radiant energy before it enters the eye. 
Since these goggles would have to be worn continuously during high risk 
situations, there would have to be a compromise between the degree of 
filter opacity required for protection and the transmission necessary 
for adequate vision. 
The monocular eye patch is simple and reliable, but has some obvious 
drawbacks (29). Stereoscopic vision is lost and the visual field is restricted. 
If the exposed eye is injured, the covered eye would become the sole 
visual resource of the astronaut (59). 
The effectiveness of “peep-hole” or eye slit shields is based on the 
fact that by reducing the angle of vision, the chance of a flash of light 
being directly focused on the retina is reduced (59). The obvious limita- 
tion to this technique is restriction of the visual field. A variation of the 
eye-slit technique is the use of a visor, screen, of bilateral blinders to 
restrict the field of vision. Again, these measures would be effective 
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only if a flash occurred outside of the momentary field of view. 
The most desirable all-around protective system would be clear eye 
shields impregnated with a phototropic substance which is darkened by 
intense light (59). To be effective in a meteoroid penetration situation, 
the photochemical reaction time would probably have to be considerably 
less than 1 millisecond (33). Various types of photoreactive devices are 
described in the literature (1, 20, 59). 
A drug-induced miosis could serve to prevent chorioretinal burns 
and reduce the duration of flashblindness. Experiments have indicated 
that a pilot can perform instrument readings under minimum instru- 
ment illumination while his pupils are constricted, that eye discomfort 
from ciliary spasm was not a significant side-effect of this measure, 
and that based on the laws of optics, the limitation of light entering the 
eye should afford chorioretinal burn protection and minimize the dura- 
tion of flashblindness (35) . However the potential usefullness of a miotic 
drug in a high risk space situation will require a complete assessment, 
especially with respect to visual-motor task performance under induced 
miosis in the simulated spacecraft environment. 
There is no definitive therapy for either chorioretinal burn or 
flashblindne s s (34, 48) . 
Burns 
Since the flash of “explosive oxidation” extended only a few inches 
into model spacecraft cabins in simulated meteoroid penetration studies, 
it is considered likely that the “explosive oxidation” produced by a smaller 
penetrating meteoroid particle in space will be highly localized in the 
spacecraft cabin (23). Even so, there will be a risk of an exposed astronaut 
suffering a local burn if he is in close proximity to or in direct contact 
with the “explosive oxidation”. Respiratory tract damage from the 
inhalation of hot gases and noxious fumes is also considered possible. 
Molten and hot meteoroid and wall materials ejected into the cabin could 
produce multiple small burns on body areas in direct line with the move- 
ment of these materials. Involvement of the eyes, especially cornea1 
burns, could be extremely incapacitating. It should also be remembered 
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that these missiles could compound the risk of burns by starting fires in 
the spacecraft cabin. 
Burns in general are discussed in Chapter 13. The treatment of 
cornea1 injuries is covered in Chapter 8. 
Blast Injuries 
The “explosive oxidation” of vaporized meteoroid and spacecraft 
cabin wall materials will not only produce a flash and a local increase 
in temperature, but also a local increase in pressure which will be 
rapidly propagated throughout the cabin. The blast hazard based on 
a comparison of findings in simulated meteoroid penetration studies with 
estimated pressure-duration relationships required for 50 percent 
lethality of adult humans has been assessed (45) . However, even though 
it was concluded that spacecraft penetrations of magnitudes similar to 
these studies would not cause lethal blast injuries to an astronaut sitting 
in the center of a 100 cubic foot cabin, many specific factors which are 
yet to be assessed could greatly modify this hazard. Some of these 
factors are pointed out below. One should also keep in mind that explo- 
sions in the cabin from other causes would produce injuries similar to 
those from a meteoroid blast. 
The physics, biophysics,and pathophysiologic and clinical conse- 
quences of blast have been well documented in the literature. Ex- 
cellent reviews written by Clemedson (11) , White and co-workers (5, 13, 
39, 56, 57, 58), Chiffelle (10) and others (14, 18, 30, 41, 45, 49) make 
it unnecessary to discuss this area in detail here. It is important to 
note, however, that even though a great deal of information has been 
obtained from the exposures of man and animals to bombs and other 
sources of blast, much is to be learned of the possible biologic conse- 
quences of blast in the closed cabin situation, particularly under condi- 
tions of lowered ambient atmospheric pressure and altered atmospheric 
pressure and gas composition. 
The overpressure or “shock” wave of an explosion spreads out radially 
from its source. Peak overpressure (pressure above ambient atmospheric 
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pressure) and time-integral of overpressure (impulse) decrease expo- 
nentially, so that its injurious power is rapidly lost. The rising phase 
of a pressure wave hitting a target is steep unless propagation is slowed, 
as for example, by the interposition of barriers between the source and 
target. Extremely pertinent to considerations of explosions occurring 
in a confined volume such as a spacecraft cabin is the fact that pressure 
reflections occur when a blast wave impinges on a solid object. The 
magnitude of focused and reinforced reflection can be two to nine times 
greater than the incident pressure (58) . Hence, depending on such fac- 
tors as the site of meteoroid penetration, the geometry of the cabin, 
the pressure reflective and absorptive properties of the cabin walls, and 
his position in the spacecraft cabin, an astronaut could be exposed to a 
steep, step-wise,injurious pressure loading from an otherwise non-in- 
jurious incident pressure pulse. The underpressure (pressure less than 
ambient atmospheric pressure) which usually follows the passage of a 
blast-produced overpressure will probably be reduced in a spacecraft 
cabin explosion by reflected pressure waves. The role which rapid or 
- “explosive” decompression could play in altering the meteoroid blast 
hazard has apparently not been determined. Translational wind loading 
from a meteoroid blast should not be of a significant magnitude to cause 
injuries by imparting movement to an astronaut or by creating missiles 
of disrupted cabin structures. On the other hand, such traumatic events 
could result from associated rapid or “explosive” decompression (Chap- 
ter 3). 
The amount of bodily injury an individual exposed to a blast over- 
pressure will suffer is determined mainly by the rate of rise, magnitude 
and duration of the overpressure (5, 39, 55, 57) . The blast hazard in a 
closed environment such as a spacecraft cabin will probably be modified 
to a great degree by the step-wise characteristics of the overpressure 
rise, the atmospheric pressure, and the position and orientation of the 
individual to the incident pressure wave and reflecting surfaces (55) . 
Simulated meteoroid penetrations indicate that blast injuries following 
a meteoroid penetration in space will be due to extremely fast-rising 
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overpressures of short duration (23). However, no simulations of pene- 
tration of large cabins have been performed. 
Tissue damage from the absorption and passage of a blast wave 
through the body appears most commonly where density gradients of 
interfaces between tissue components are greatest (10) ; however, it is 
considered possible that some tearing of tissues can result from shear 
stresses produced by acceleration of adjacent tissues of different den- 
sities (“I. Hence most blast pathology is seen within or in close proxi- 
mity tc air and gas-containing organs, such as the tympanic membranes, 
lungs, gastrointestinal tract and paranasal sinuses. 
Which of many proposed mechanisms is the primary one in produc- 
ing the tissue-air interface type of injury cannot be stated, however (9) . 
Passage of a pressure wave across such a sharp density interface 
appears to have a bursting or shredding effect on tissues, but whether 
spallation actually occurs is not clear (11). It might even be possible 
that the heat associated with bubble compression might be damaging (9) . 
Disruption of blood vessels might be caused by the forced displacement 
of blood due to inadequate equalization of pressures in internal body 
spaces with blast overpressures (58) . Air might even be forced into 
the circulation when the pressure pulse reaches air spaces into which 
vessels have ruptured. 
Pure air blast injury is characterized by lesions in various internal 
organs without any signs of external injury (11) . Tt;;o;yyaaniIcn rflaecc;b;;;e s 
are the structures most vulnerable to shock waves . , 
threshold for disruption is thought to be about 5 psia for fast-rising over- 
pressures. Tympanic membrane disruption with or without dislocation 
of the ossicles is common, especially when the rise of ovkrpress’ure is 
steep (30). Structural damage of the organ of Corti can also result from 
violent inward displacement of the membrane-ossicular system. 
The more serious pathophysiologic effects of blast are predomi- 
nantly attributable to damage to pulmonary tissues. The major determi- 
nant of survival in the immediate post-exposure period is the amount of 
air which enters the vascular system through disrupted pulmonary and 
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bronchial veins, and capillaries at the time of blast and subsequently 
with each respiratory cycle (58) . Although it is not definitely known 
over how long a period this phenomenon can occur, the early steep por- 
tions of time-mortality curves of animals exposed to blast overpressures 
indicate that most air entry takes place within 30 minutes from the time 
of blast (45’ 46). Reflex vasoconstriction and blood clotting tend to stop 
air from entering the pulmonary circulation. Aggravating this emboliza- 
tion are coughing, partially obstructed airways, left cardiac decompensa- 
tion and the ill-advised use of positive pressure breathing in treatment. 
There is no clear correlation between the degree of pulmonary hemorr- 
hage and the occurrence of air embolism (10) . The air which enters the 
pulmonary venous system embolizes to the left heart, and thence to the 
systemic arterial system. By producing local ischemia in such vital 
tissues as the brain, spinal cord, and heart, these bubbles can cause 
a great variety of mild to serious, temporary or permanent clinical 
manifestations. 
Air can also pass through disrupted alveolar walls into peribronchial 
tissues. It can dissect through these tissues into the hilum of the lung 
and even up into the subcutaneous tissues of the neck and face. In the 
mediastinum, air can exert pressure on large central vessels, restrict- 
ing blood flow through them (24) . This serious consequence of mediastinal 
emphysema is considered unlikely except in extremely severe cases, 
(9) however . 
A blast wave can also produce a frank laceration of a lung leading 
to hemorrhage and the passage of air into the pleural cavity (11) . A 
torn pleural flap can have a flutter valve effect, allowing air to enter 
but not leave the pleural cavity. The resulting so-called “tension” pneumo- 
thorax can lead to severe cardio-respiratory embarassment and a poten- 
tially fatal situation within minutes. 
If an individual survives the initial effects of a severe blast, he 
might be faced with severe respiratory embarrassment due to pulmonary 
hemorrhage and edema. A bacterial pneumonia is also more likely to 
occur in a severely damaged lung (9) . An irreversible consequence of 
blast injury of the lung is chronic respiratory embarrassment from severe 
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alveolar disruption and subsequent patchy fibrosis of pulmonary tissue 
(11, 55) . 
Gastrointestinal hemorrhage and perforation can be produced by 
shock waves striking the body (11, 58) . Ensuing contamination of the 
peritoneal cavity can lead to fatal peritonitis. Yet another tissue-air 
effect of blast overpressures is bleeding from the paranasal sinuses. 
Contusion of the heart, often associated with disruption of papillary 
muscles and chordae tendinae, has been observed in individuals exposed 
to severe blast overpressures (58) . Liver and splenic hematomas and 
lacerations can also result from blast, presumably due to tissue shearing 
effects. 
It is readily apparent that many causes of “shock” and death are 
possible following blast exposure. Other than the organ injuries com- 
pletely incompatible with life, such as cardiac rupture, massive air 
embolization to the brain and heart appears to cause the majority of 
blast fatalities in the early post-exposure period. Asphyxia from pulmo- 
nary hemorrhage and edema, and cardiac decompensation due to myo- 
cardial ischemia can occur from minutes to days following blast. 
Pneumonia and peritonitis could lead to “shock” and death over a period 
of many hours to several days. 
The clinical manifestations of blast trauma are extremely variable. 
An individual can be killed outright without external signs of injury, al- 
though blood-tinged froth or frank blood often appears in the nose and 
mouth. Survivors frequently suffer from air hunger, with rapid shallow 
respirations , 
of time (10)~ 
and are usually quiet, apathetic or even lethargic for a period 
A marked reflex bradycardia, probably from the stimulation of 
stretch receptors in the carotic sinus and lungs by the pressure pulse, 
can cause an immediate profound hypotension which might be severe enough 
to produce faintness or loss of consciousness (10, 11) . In moderate 
blast injuries, systemic arterial pressure may recover slowly over a 
period of several days (11) . 
A period of apnea, lasting several seconds to more than a minute in 
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duration usually follows exposure to a shock wave. If the lungs are 
severely injured by blast, breathing may be slow, shallow and weary, 
often with extreme expiratory dyspnea (11) . Panting respiration in 
other cases is usually associated with complaints of tightness across 
the chest and varying degrees of chest or abdominal pain. Coughing will 
occur, but not usually early (10) . Hemoptysis may appear, often well 
within an hour, and tends to be repeated (10) . Epistaxis may occur from 
nasal sinus hemorrhage. Frothy blood coming from the mouth and nose 
is usually a bad prognostic sign (11) . Physical exertion tends to aggra- 
vate pulmonary bleeding, hence giving strong support for early and com- 
plete immobilization of an individual injured by blast (10) . Severe lung 
damage, or cardiac damage, and secondary pulmonary edema can lead 
to cyanosis and “shock” from impaired ventilatory function. 
Any number of clinical manifestations due to focal or diffuse dam- 
age of the central nervous system by air emboli can occur. These in- 
clude unconsciousness, convulsions, general and local paralyses and 
disturbances in equilibrium. Myocardial ischemia produced by bubble 
emboli or secondary to contusion can produce angina1 pain, fatal cardiac 
arrhythmias and myocardial insufficiency leading to pulmonary edema, 
extreme dyspnea, cyanosis, “shock” and death. Less massive air 
embolization may simply cause temporary chest or abdominal pain (58) . 
A large pneumothorax, particularly of the “tension” variety, can 
produce cardiorespiratory embarrassment characterized by severe 
chest pain, dyspnea, hemoptysis, cyanosis and “shock”. Mediastinal 
emphysema can lead to cardiac insufficiency with much the same clinical 
picture. 
Persistent diffuse abdominal pain with accompanying signs of peri- 
tonitis such as fever, vomiting, intestinal ileus, guarding, rebound ten- 
derness and rigidity are usually indicative of a perforated hollow viscus. 
Confusing this clinical picture is the possibility that except for fever, 
these signs and symptoms might be present for several hours in a mild 
form without gastrointestinal perforation having occurred (58) . 
Damage to the tympanic membrane,and middle and inner ear struc- 
tures by blast is indicated by ear ache, tinnitus, some degree of hearing 
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loss, and occasionally vertigo. Unruptured tympanic membranes may 
demonstrate hemorrhagic blebs and be the cause of serosanguineous 
oozing from the external ear (10) . When only membrane rupture occurs, 
there is usually a temporary low tone loss on the order of 10 to 30 decibels 
and a high tone loss of 40 to 80 decibels until healing occurs 
(30) . Ossi- 
cular disruption produces a permanent conductive deafness for all fre- 
quencies. Full or partial recovery from acoustic trauma to the middle 
ear may be slow, often several months in duration (30) . 
Possible late sequelae of blast include cardiac decompensation 
from extensive myocardial damage, recurrence of pulmonary hemorr- 
hage, pneumonia, empyema and even lung abcess. They can become 
manifest and lead to “shock” and death up to several days after a blast 
exposure. 
Recovery from blast injuries can be fast or slow, complete or incom- 
plete. At best, especially if there have been neurologic manifestations, 
several days may be required for recovery, which may be surprisingly 
sudden and complete. Cardiac damage in blast tends to be permanent. 
A careful medical assessment of an injured astronaut will be required 
as soon as possible after meteoroid penetration of a spacecraft cabin 
wall to determine not only the presence and severity of blast and other 
injuries mentioned in this chapter, but also to assess the immediate 
treatment needs of the astronaut. As a rule, the initial history and thorough 
physical will indicate the over-all injury severity. Close continuous ob- 
servation will be necessary if there are any signs or symptoms of pulmo- 
nary, cardiovascular, nervous system or gastrointestinal involvement. 
Monitoring of the iystemic arterial pressure and heart rate will bring 
to light any changes in cardiovascular status. If available on board a 
spacecraft, electroencephalography and electrocardiography might be 
used for establishing the presence of neurologic and cardiac involve- 
ment, respectively. X-rays could also be of some value in determining 
the degree of lung damage and the occurrence of visceral perforation. 
Various measures which attenuate a blast overpressure or offer some 
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degree of body protection from the consequences of a blast wave can pre- 
vent or reduce the possibility of serious injury to an astronaut exposed 
to a meteoroid blast. The design of the spacecraft cabin structure so 
as to provide maximum attenuation of blast overpressures might be a 
highly effective measure. Although rigid thoracoabdominal shielding 
has been effective in reducing blast injury in animals, this measure 
might be too impractical for use in space (32, 62) . It should be pointed 
out, however, that lightweight thoracoabdominal shielding is also 
suggested for the protection of an astronaut from mechanical injuries 
while moving about in the spacecraft cabin (Chapter 14). Moreover, 
from discussion in Chapter 3, such shielding could also offer an astro- 
naut a considerable reduction of risk of internally inflicted injuries 
from “explosive ‘I decompression. 
From the number and severity of different blast injuries and their 
sequelae, it is readily apparent that no outline of the definitive treatment 
of an astronaut who has been subjected to blast can be presented. Treat- 
ment must be based on sound clinical judgment, supported by a thorough 
understanding of possible blast effects. 
Complete rest is considered to be absolutely essential for most 
blast injury cases 
(10, 27, 51, 58) 
. The work load on damaged lungs 
and heart must be minimized in order to reduce the risk of incurring 
further air embolization, pulmonary hemorrhage and edema, and cardiac 
decompensation. Sedation must be used with caution to prevent masking 
of various progressive signs which would indicate serious injury. 
Positioning an astronaut in the head-down left lateral position in 
order to promote pulmonary drainage and minimize the migration of 
air emboli into his coronary and nervous system blood vessels, will 
obviously be of no therapeutic benefit in the weightless environment, 
but should be carried out under subgravity conditions. The early use 
of positive pressure breathing is contraindicated, for this measure may 
reopen alveolar-venous fistulae and introduce new showers of air emboli 
into the pulmonary veins (27) . Whole body pressurization to several atmos- 
pheres is a proven highly effective measure in the treatment of all air 
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embolic phenomena. For critical blast injuries, this measure would be 
required almost immediately after a blast, when most of the air emboli- 
(54, 58) zation appears to occur . The installation of a recompression 
facility on board the spacecraft for the treatment of air embolic pheno- 
mena is considered under the treatment of decompression sickness in 
Chapter 4. Since a space suit pressure of possibly up to 5 to 7 psia 
over the cabin atmospheric pressure might be attainable, a potential 
mechanism is available for increasing the total body pressure as well 
as for maximizing the partial pressure of oxygen administered to an 
astronaut when a recompression facility is not on board the spacecraft. 
The administration of 100 percent oxygen might be indicated for the 
treatment of local (e. g. , cerebral ischemia, myocardial ischemia) and 
systemic (e. g. , pulmonary insufficiency, “shock”) hypoxia. Since pul- 
monary hypoxia and reflexes caused by lung damage markedly constrict 
the pulmonary ve s s els , administering pure oxygen, which is a proven 
pulmonary vasodilator, might conceivably aggravate the tendency for lung 
hemorrhage and edema, and air embolization 
(2, 11, 19, 42, 54) 
. 
Whether increased oxygen tensions can actually overcome the protective 
vasoconstriction in a lung with blast injury is still open to question, how- 
ever. Favoring the use of oxygen in the immediate post-blast period is 
the fact that any bubbles of pure oxygen in the cardiovascular system 
will be much more rapidly absorbed than bubbles containing an inert 
(46) gas such as nitrogen . Hence the immediate administration of 100 
percent oxygen - which probably will be part of the emergency decom- 
pression protocol following meteoroid penetration - should lower the 
risk of serious complications from air embolization. Because of the 
high mortality and serious sequelae of air embolization, oxygen should 
be used immediately after blast, in the hope that adequate reflex vaso- 
constriction and clotting will seal disrupted pulmonary vessels. Defini- 
tive studies on the effect of oxygen on vasoconstriction in a traumatized 
lung appear in order. 
The question arises as to whether pure oxygen should be given beyond 
30 minutes, which is considered the upper limit of the embolization period (54) . 
Cyanosis or other signs of hypoxia would be a definite indication for continuing 
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or resuming oxygen administration. Because of the pulmonary vasodilatory 
effect of oxygen, the period of protective vasoconstriction might be pre- 
maturely shortened by this therapy. This failure of vasoconstriction 
has been shown in animal experiments to aggravate bleeding from vessels, 
disrupted by blast, especially if clotting is inadequate (8) . Again 
further experimentation is indicated. 
The atelectatic tendency of pure oxygen must be kept in mind, 
especially in instances of treating severe lung injury cases with this 
gas (44). As well, it should be noted that the prolonged administration 
of oxygen at a partial pressure above 400 mm Hg, as could be accom- 
plished in a space suit within a pressurized spacecraft cabin could not 
only lead to primary pulmonary effects of oxygen toxicity such as toxic 
bronchitis and pneumonia with hyperemia and edema, but also markedly 
exaggerate the pathologic effects of blast on the lung (36, 45) . 
Intravenous digitalization might be indicated for manifest cardiac 
decompensation (58). A vasopressor, such as metaraminol, should be 
used primarily for the treatment of non-hemorrhagic “shock” (16). 
Whether or not myocardial damage is suspected or evident, such a drug 
should probably be administered at the time of digitalization. Intra- 
venous fluids should be used with extreme caution, especially during 
the first few hours after a blast exposure. A fluid overload could 
overstrain a damaged heart and aggravate pulmonary hemorrhage and 
edema. Therefore blood replacement agents, such as blood, plasma 
and dextran, used for the treatment of hypovolemic “shock” in space 
should be administered only if absolutely essential for the treatment 
of evident hemorrhagic “shock” from blast injuries. 
The routine use of a vasopressor, even without evidence of non- 
hemorrhagic “shock”, just to stop pulmonary bleeding is questioned. 
It is known that the bleeding following blast occurs from both the thin- 
walled subendothelial bronchial and pulmonary veins and capillaries (54) . 
Arteriolar and venous constriction should reduce this bleeding. Since 
vasopressors, such as levarterenol and metaraminol, constrict bronchial 
vessels to the same degree as peripheral vessels, and pulmonary 
vessels to a lesser degree, such a drug might be useful for decreasing 
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bronchial and possibly pulmonary hemorrhage 
(2, 3). However this 
indication for a vasopressor might be outweighed by the possibility that 
the damaged pulmonary vessels, which have been constricted by hypoxia 
and by local reflex action, might be opened by the increased pulmonary 
blood pressure and flow caused by the drug 
(2, 54) . The beneficial effects 
of the vasopressor drugs primarily for the treatment of pulmonary 
complications of blast remain to be determined. 
An analgesic, sedative or narcotic drug must be given with caution 
in the immediate post-blast period in order to prevent the possible 
masking of signs and symptoms which indicate serious injury. An 
antitus sive , such as dehydrocodeinone bitartrate, might be indicated 
during the first few days after exposure to prevent hemorrhage due to 
excess coughing. A suitable broad-spectrum antibiotic will be required 
for peritonitis or pneumonia. It has been suggested that a suitable 
antibiotic-cortisone combination be administered as a prophylaxis for 
infection and to minimize pulmonary fibrous tissue formation for at 
least two weeks if severe lung damage has occurred (9). 
Therapeutic pneumothorax as a “last-ditch” measure to control 
pulmonary hemorrhage, thoracentesis to remove air, fluid and blood 
from the pleural space, pericardiocentesis to remove pericardial 
fluid and blood, nasogastric intubation or gastrointestinal decompression 
for perforated viscus or temporary ileus, and laparotomy for perforated 
viscus are a few of the highly specialized procedures which may be nec- 
essary following a severe blast exposure (25, 31j 58, 60) These pro- . 
cedures would definitely require a specially trained astronaut and in 
many cases, a physician-astronaut. In the instance of a perforated vis- 
cus, facilities for performing abdominal surgery would also be necessary. 
Until such sophisticated treatment is possible in space, only more con- 
servative supportive therapy will be available and a high morbidity and 
mortality from serious blast injuries in space must be accepted. 
Penetrating Injuries 
Molten and fragmented meteoroid and wall materials ejected into 
the spacecraft cabin at high velocities could inflict a variety of single or 
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multiple penetrating injuries. Some associated burning of tissues is 
also likely. The majority of these missiles will probably be stopped 
by superficial tissues, with only small superficial lacerations being 
incurred. However, laceration of major vessels, nerves and other 
vital deep structures should still be considered possible. The treat- 
ment of penetrating injuries in space is discussed in Chapter 14. 
One must also keep in mind the potentially great hazard of parti- 
cles impinging on the eyes at the time of penetration and if these 
particles remain suspended in the weightless environment, for some 
time thereafter . Eye problems due to such foreign bodies are discussed 
in Chapter 8. 
Meteoroid Penetration of the Space Suit 
Little is known about the injuries which might result from meteoroid 
penetration of the space suit (4) . Fortunately it appears that through the 
use of a meteoroid bumper and absorbing materials in the outer layers 
of the suit, an astronaut will be reasonably well protected from such an 
event during extravehicular operations in space (6, 38) . What is presently 
thought to be an extremely low probability of penetration is apparent. 
If an approximate suit area of 25 square feet (2. 5 square meters) and 
approximate thickness equivalent of 0. 040 inch (0. 12 cm) aluminum 
are applied to the “time to meteoroid perforation” data of Whipple 
(Figure 12. l), it is apparent that there is an extremely low probability 
of penetration, even though there is a level of uncertainty of about one 
order of magnitude surrounding this estimate 
(4). It is noted that the degree 
of protection offered by the “shatterproof” space suit helmet and visor 
materials is many times greater than that offered by other parts of the 
suit (4). 
&Aolten and vaporized meteoroid and suit materials, and fragmented 
meteoroid might come into close contact with or impinge on the skin of 
an astronaut if a space suit is penetrated. An “explosive oxidation” of 
vaporized materials will probably also occur at the site of penetration. 
Experiments which are attempting to simulate meteoroid penetration of 
the space suit in space are demonstrating that the suit materials do not 
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tear from or spa11 at the site of penetration and that these materials are 
not ignited by the penetration even at maximum suit pressurization with 
100 percent oxygen (6y 38). From these studies, it appears that the 
most likely injury an astronaut will sustain during a penetration of the 
space suit by a minimum penetrating meteoroid will be a circular- 
shaped burn at the site of penetration. This burn area might vary from 
several millimeters to a few centimeters in diameter, depending on 
the magnitude of the penetration. Undoubtedly the degree of tissue 
damage by burn will be greatest in the central part of this area. The 
management of burns in space is discussed in Chapter 13. 
Single or multiple meteoroid fragments of larger penetrations might 
also penetrate the skin and subcutaneous tissues to a variable depth. 
Due to their high temperatures, these fragments might also produce 
some thermal damage of the tissues. The majority of these missiles 
will probably be stopped by superficial tissues with only small, super- 
ficial lacerations resulting. However, laceration of major vessels, 
nerves and other vital deep structures should still be considered possible. 
The management of such penetrating injuries is discussed in Chapter 14. 
Finally, if the size of the hole produced by a penetration is so large that 
the pressure in the space suit cannot be maintained long enough for an 
astronaut to carry out emergency measures such as returning to the 
spacecraft, he might be subjected to the decompression effects (Chap- 
ters 1, 2, and 3). 
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CHAPTER 13 
BURNS 
In this chapter, the characteristics and principles of management 
in space of thermal, electrical, and chemical burns will be briefly 
discussed. It must be kept in mind that a relatively minor burn of 
a functionally important body area such as a finger or eye could 
seriously reduce the operational capabilities of an astronaut for a 
prolonged period of time. Moreover, intensive supportive therapy 
and definitive surgery normally employed in the treatment of major 
burns will probably not be possible in space in the foreseeable future. 
The importance of ensuring maximum burn protection as well as the 
best therapy possible for burns during space operations cannot be 
over emphasized. 
It should also be mentioned that if programmed decompression- 
recompression of a spacecraft cabin is ever to be employed for ex- 
tinguishing a fire or removal of toxic products of combustion or 
chemical contaminants from a cabin atmosphere, a protected astronaut 
could suffer acute hypoxia (Chapter 1 ), and possibly ebullism (Chapter 
2) for a short period of time. Although a much less effective immediate 
emergency measure, purging of the atmosphere with an inert gas such 
as nitrogen could also lead to acute hypoxia. 
Thermal Burns 
Design of spacecraft cabins to provide optimum fireproofing and 
protection from meteoroid penetration, and the installation of adequate 
fire detection and extinguishing systems should reduce the risk of 
thermal burns in space to a minimum. The influence of various 
possible space atmospheres on this risk has been intensively assessed 
by Roth (45’ 46) . 
It is readily apparent that the type and degree of a thermal burn 
suffered by an astronaut in space will be determined by one or more 
of many factors. The relation of time and intensity of applied thermal 
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energy to burn severity has been discussed in detail by many authors 
(6y 14’ 19’ 34’ 36’ 4o’ 41) and will therefore, not be considered here. , 
From a causative standpoint, if a meteoroid should penetrate a space- 
craft cabin wall (Chapter 12), a localized, possibly deep burn any- 
where on the body could be produced by contact with the flash or by 
being struck with molten and hot fragments of both meteoroid and wall. 
Such a burn could also follow meteoroid penetration of a space suit. 
A serious linear thermal burn, most likely of the hands, could result 
from contact with a wire rendered hot by short circuit. A fire in a 
spacecraft cabin could burn large areas of an astronaut’s body. Assum- 
ing that fire resistant clothing is worn, only exposed skin areas, such as 
his face, neck, arms and hands might be burned. Although space suit 
materials will have a high melting point, heat transfer from fire in con- 
tact with the suit might be sufficient to cause extensive thermal skin injury. 
Respiratory tract damage from the inhalation of hot air and gases of com- 
bustion is considered a major potential consequence of unprotected ex- 
posure to a fire in a “closed” space environment. 
Characteristics 
Burns of the skin can be divided into three categories - first, second, 
and third degree burns. First and second degree burns are referred 
to collectively as partial-thickness burns. Third degree burns are also 
termed full-thickness burns. 
A first degree burn is similar to the familiar “sunburn”. It involves 
only the superficial or outer layer of the epidermis. Er ythema, pain, 
and occasionally slight edema of the involved skin subside within one 
or two days. During this time, the area is dry, warm, and tender. 
Destruction of the superficial epidermis to a sufficient depth can lead 
to scaling, often with an associated severe itching sensation, during the 
healing phase. Infection of this damaged skin does not characteristically 
occur. 
A second degree burn is slightly deeper than a first degree burn. It 
involves all the layers of the epidermis. Small islands of germinal 
cells which remain in the deeper corium eventually reform an intact 
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epidermis. Blisters, severe pain, and marked subcutaneous edema 
are characteristic. Removal of blistered tissue leaves a pink, moist, 
extremely tender surface. Healing occurs uneventfully in 14 to 21 
days unless infection supervenes (4). A deeper second degree burn 
can be readily converted into a full thickness burn by infection. 
In a third degree burn, the entire dermis and corium down to the 
subcutaneous fat are destroyed. Deeper tissues such as large blood 
vessels, nerves, muscle and tendon may also be involved. The des- 
troyed skin is insensitive, white or charred in appearance, and dry. 
Subcutaneous edema is usually more marked than in the second degree 
burn. In the neck, this edema can produce airway obstruction. In an 
extremity, it can seriously jeapordize blood flow to the whole or distal 
part of the extremity. The dead tissue, or eschar usually begins to 
separate from the living tissue within two to three weeks, and eventually 
leaves an open wound. If this wound is too large to be covered by normal 
skin and if it is not covered with a skin graft, a thick layer of granulation 
tissue can form. Over a period of many months, this tissue becomes 
a scar and can produce severe contractures of the burn area. It 
should be remembered that burned dead tissue provides an excellent 
medium for bacterial growth, so that third degree burns tend to become 
infected. 
Inhalation of hot air, and irritant smoke and gases produced by a 
fire can lead to some degree of injury to respiratory tract tissues (15, 
20, 31, 42, 43, 44, 47) 
. Even though involvement below the larynx 
is usually prevented by reflex glottic closure, lower respiratory 
tract damage is considered to be more likely to occur in a spacecraft 
because of the rapid spread, high concentrations, and persistence of 
the products of combustion in a confined environment (31) . An edema of 
rapid onset in the larynx and epiglottis might seriously obstruct air 
flow t4). Involvement of the lungs is usually extensive and bilateral (42) . 
With extensive alveolar damage, survival is highly improbable (39). 
The damaged tracheobronchial mucosa and alveoli can immediately 
become edematous and can produce sufficient transudate to cause death 
from suffocation (31). A severe irritative bronchospasm may also 
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be a factor in producing asphyxia (15). Infection of a damaged respiratory 
tract usually becomes evident within three days (42) . An exudative 
tracheobronchiolitis usually leads to massive or patchy atelectasis, 
bronchopneumonia, and all too frequently, death (42, 47) . Respiratory 
tract damage should be suspected if there is a facial burn, singeing 
of the nasal hair, redness of the pharyngeal mucosa, hoarseness or 
rales in the chest (39, 43) . Serious damage is indicated by severe 
substernal pain, coughing of abundant fluid, and cyanosis. 
Burn deaths result from a number of causes other than respiratory 
tract damage. In extensive second and third degree burns, a rapid 
excessive loss of protein-rich intravascular fluid into the involved 
skin to form blisters and into the involved subcutaneous tissues to form 
edema, may result in profound “shock” unless this fluid is adequately 
replaced. As discussed in Chapter 10, it is not known to what degree 
the tendency for “shock” to occur from loss of fluid from the circu- 
lation will be aggravated by the decrease of fluid volume which appears 
to result from exposure to weightlessness. For an unknown reason, 
paralytic ileus often occurs after an extensive burn and can, especially 
if oral fluids are administered, lead to vomiting (4) . Fatal aspiration, 
a not uncommon event in a moribund burn patient, would be even more 
likely to occur in the weightless space environment (Chapter 8). The 
vomitus could also be a serious particle and droplet hazard to other 
astronauts. Beyond the first few days after a burn, death can occur 
from an overwhelming septicemia, in most cases by hemolytic 
Staphylococcus aureus or Pseudomonas aeruginosa (2) . These highly 
pathogenic organisms usually enter the blood stream from a suppurating 
burn wound. Also during this period, death occasionally occurs due to 
hemorrhage from an acute upper gastrointestinal, or so-called Curling’s 
(4) ulcer . 
Weight loss, accompanied by marked negative nitrogen balance, 
characteristically occurs in an extensively burned individual. It is 
proportional to the extent of the burn, and is restored at a rate which 
depends upon the adequacy of the nutritional regimen, the time of 
removal of necrotic tissue and closure of the burn wound, and whether 
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or not wound infection is present. It has recently been noted that a 
significant amount of this weight loss can be attributed to an excessive 
metabolic demand placed on the body secondary to heat loss from 
fluid vaporization from the burn surface (38) . Various measures 
to restore the water barrier to burn areas have apparently success- 
fully reduced this strain on the body 
(28, 37, 38) 
. 
Mild to severe anemia can appear in the period immediately 
following, or several days after a burn. Deep burns can immediately 
destroy or increase the fragility of exposed red blood cells. Anemias 
which appear later are attributed mainly to a combination of suppressed 
red cell production due to inadequate nutrition, toxins from necrotic 
tissue and bacteria, and red cell loss from the wound site. 
Diagnosis 
Initially, it can be difficult to distinguish a second from a third 
degree burn. The diagnostic characteristics of the three degrees of 
burns have been pointed out above. 
A reasonably accurate estimate of the total burned surface area 
is important, especially to determine whether fluid therapy is needed, 
and if so, the amount of fluids which should be administered. A rapid 
popular method is the “Rule of Nines” shown diagramatically in Figure 
13 1 (4, 5) . . It is not as accurate, however, as the Lund and Browder 
chart, pictured in Figure 13. 2 (4) . Best use can be made of such a 
method after the burn wound has been cleansed and all loose, devitalized 
tissue removed. For estimating fluid requirements, the total burn area 
estimated by either of these methods is the sum of the second and third 
degree areas only. 
If ever possible in space, various laboratory procedures can be 
of benefit in the assessment and therapy of a seriously burned astronaut. 
These procedures and the rationale of their use are discussed below. 
Treatment 
Minor burns - Partial-thickness burns covering less than 10 per- 
cent of the body surface area, or full-thickness burns of less than 
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Total Per Cent Burned 2” t 3” = 
Figure 13.1 The “Ruleof Nines”(Adult) 
Total Per Cent Burned 2” + 3” = 
Figure 13.2 Lund and Browder Chart (Adult) 
(After American College of Surgeons 13)). 
2 percent are considered minor burns (4). Milder first degree burns 
may involve a much larger area. Fluid replacement for minor burns 
is usually not required. 
First degree burns require no special care. The surface should 
be protected from irritating garments. A topical anaesthetic, such 
as 1 percent cinchocaine ointment, may provide some relief of pain 
and tenderness. 
It is recommended that all second and third degree burns, except 
possibly of certain areas of the face, be treated in space by the so-called 
“closed” method. This measure will provide less risk of wound infec- 
tion and further ‘trauma of burned tissue, provide greater comfort, and 
pr.event the release of infected wound material into the spacecraft cabin 
environment. First, any loose dead tissue, except blisters on the palm 
of a hand or sole of a foot, should be debrided and if required, the in- 
volved surface gently washed with isotonic saline solution. Then the 
burned surface should be covered with an evenly placed layer of either 
fine-mesh gauze, petrolatum gauze, carbowax gauze, or a commercial 
nylon preparation. Finally, a layered, occlusive burn dressing should 
be applied. 
Although locally applied anti-bacterial agents have in general not 
been successful in preventing and controlling burn sepsis in the past, 
success has recently been reported with 0. 5 percent silver nitrate 
solution and with 10 percent mafenide acetate cream 
(5, 24, 28, 33, 37) . 
For reasons which are readily apparent in the writings cited and be- 
cause it could present a serious droplet hazard in space, silver nitrate 
solution does not appear suitable for use in space. On the other hand, 
if mafenide acetate cream is found suitable for use in space, it might 
be impregnated in the initial layer of a burn dressing. This water-rich 
cream has controlled burn wound sepsis, involving even Pseudomonas 
aeruginosa. It has also minimized weight loss from vaporizational 
heat loss, from toxic products of bacteria and tissue breakdown, and 
from inadequate dietary intake associated with repeated general anesthesia 
for extensive wound debridement. Further clinical use of mafenide 
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acetate is required befor’e it can be recommended for burn treatment in space. 
A burn should be redressed at least every 5 to ‘7 days. Infected 
wounds often require more frequent dressing changes. Adherent 
dressings should be moistened with saline, particularly if over second 
degree burns, in order to prevent damage to delicate newly formed 
epithelium. Although some necrotic and liquified burn tissue will 
be removed along with the dressing, any remaining in the wound 
should be debrided surgically, especially if the wound becomes in- 
fected. Enzymatic debridement of necrotic burn tissue has not proven 
to be of practical value (4, 8, 26) . It is important to note that extreme 
care must be taken to prevent the release of infected material into 
the spacecraft cabin atmosphere. This might be accomplished by 
means of various suction techniques. A suitable mask should be 
worn by anyone potentially exposed, including the injured astronaut. 
An analgesic drug should be‘ administered with care during the im- , 
mediate post-burn period. It can be used thereafter as required, 
especially at times of dressing change and surgical debridement. 
On the whole, systemic antibiotic therapy has been relatively 
ineffective in controlling burn wound infections. This generally fails 
to provide bactericidal levels of drug in infected avascular burn tissue, 
and promotes the emergence of antibiotic-resistant organisms and 
sensitizes patients to anti-bacterial drugs (26, 33) . Tetanus anti- 
toxin or toxoid will probably not be required in space if astronauts 
have been immunized against tetanus prior to space missions. 
Major burns - All partial-thickness burns affecting more than 
25 percent of the body surface area, or full-thickness burns of more 
than 15 percent may be considered as major burns (5) . These burns 
fall into the “potentially lethal” category. They usually require in- 
tensive therapy. This therapy centers mainly on providing adequate 
fluid replacement for the protein-rich fluid lost in burn blisters and 
edema, minimizing vaporizational fluid losses from the burn surface, 
protecting the burn from and treating secondary infection, undertaking 
as much debridement of burn tissue as possible whenever feasible, 
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closing full-thickness wounds as soon as possible, and maintaining 
the nutritional status of the patient. It can be expected that if inten- 
sive therapy, in particular definitive surgery such as extensive wound 
debridement and skin grafting cannot be undertaken in space, the US- 
ually severe morbidity and high mortality associated with major burns 
will be markedly increased. This will, of course, be the case for 
many years to come. Hence a regimen similar to a “shelter plan” 
may only be possible. A completely austere approach would include 
medication for pain, proper positioning of affected parts, oral fluids, 
wound coverage which might be of the simplest sort (e. g. plastic bags 
for hands), and the use of an oral airway in instances of facial edema 
and respiratory tract damage (7) . Even if intravenous fluids are 
carried on board a spacecraft, their use might not be feasible for 
severe extensive burn lesions. 
Burn depth and extent should be assessed as soon as possible 
according to the criteria discussed above. Second and third degree 
burn areas are added for determining fluid requirements. Intra- 
venous fluids are usually administered as soon as possible to individuals 
who have more than 25 percent burns (5). They may also be given 
for burns of lesser extent but of greater depth, or for burns with 
marked edema. As noted in Chapter lo, it is considered possible that 
due to a decrease of circulating blood volume in the weightless space 
environment, the tendency for “shock” to occur from intravascular 
fluid loss in burns might be greater in space than on Earth. Accord- 
ingly, appropriate changes might have to be made in any Earth- 
based formula to be used for estimating fluid replacement for major 
burns in space. 
One of the most popular formulae used to estimate the amount 
of fluid required by a burned individual is the so-called “Brooke 
Formula”. It states that each of the following fluids should be given 
intravenously in the first 24 hours after a major burn is sustained (4) . 
COLLOID (0. 5% dextran, plasma or blood) 
0. 5 ml/Kg/% of body surface burned. 
ELECTROLYTE SOLUTION (Ringer Is lactate or isotonic saline) 
1. 5 ml/Kg/O/o of body surface burned. 
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WATER REQUIREMENTS (5% glucose in water) 
2000 ml. 
One-half of the fluids required in the first 24 hours 
should be administered over the first 8 hours, and 
one- half over the remaining 16 hours. In the second 
24 hours, about one- half of the first 24 hour require- 
ment is recommended. Burns of more than 50 percent 
of the body surface are calculated as for 50 percent 
burns, or an excess quantity of fluid can be ad- 
ministered. It is noted that these fluids should be 
administered with great care if the respiratory 
tract has been damaged, in order to prevent the 
initiation or aggravation of pulmonary edema. 
Dextran has been considered as effective as plasma in fluid replace- 
ment for burns (4, 9, 26) . Opinion to the contrary may have been due 
to the fact that larger molecular weight dextran preparations used in 
the past may cause some interference in clotting time and may promote 
agglutination of red blood cells (26) . The use of blood, even if carried 
on board spacecraft, in early burn therapy is quite controversial. It 
is currently thought that blood should be reserved for individuals who 
have a proven decrease in circulating red cell volume (33) . Ringer’s 
lactate solution is preferable to isotonic saline because a burned indi- 
vidual tends to develop metabolic acidosis in the early post-burn period 
(4) In fact, Moyer and coworkers (38) . have advocated the use of only 
Ringer’s lactate solution, with its pH adjusted to 8. 2, for the treat- 
ment of burn “shock”. Their reported success with this agent indicated 
to them that burn “shock” is not primarily oligemic in origin, but 
is mainly due to an extravascular sodium deficiency resulting from 
the thermally injured, vascularly isolated tissues taking up large 
quantities of salt and water. They suggested that Ringer’s lactate 
solution be given fast enough during the 24 to 36 post-burn hours to 
keep the burned individual safely alive, making urine and remaining 
oriented - but not so fast or in such quantity to raise central venous 
pressure significantly and sustainedly above normal. As to whether 
Ringer’s lactate solution will become the sole recommended infusate 
for burn “shock” will depend upon the results of further clinical use of 
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this age,nt. 
The great quantities of intravenous fluids are administered to 
burned individuals through one or more large bore (18 gauge or larger) 
needles or polyethylene cannulas inserted into a large vein through 
the skin or by cut-down. At the time of an initial venipuncture, blood 
can be taken for hematocrit. A narcotic agent, such as morphine, 
may be administered intravenously, but only if absolutely required for 
apprehension and pain (4, 5) . 
The best single indication of the adequacy of fluid therapy is 
probably an hourly urine output between 20 and 50 ml. This should be 
determined continuously by means of an indwelling urinary catheter, 
especially if large areas of the body surface are burned. The catheter 
can usually be removed within 2 to 3 days. While it is in place and 
at least for a week after its removal, a suitable urinary antibacterial 
agent, such as sulfadimethoxine, should be administered. 
Venous pressure is an excellent parameter that can be used to 
avoid over-transfusion. It is generally agreed that to obtain a valid 
measure of venous pressure, it is necessary to introduce a catheter 
into the vena cava or right atrium. There appears to be no reason, 
however, why measurements of venous pressure made in a large 
peripheral vein should not be valid in the weightless environment. 
In a situation where the exact state of total body hydration is in 
doubt, the serum sodium concentration, if ever possible to determine 
in space, would be an especially useful guide to fluid therapy. A 
decrease in serum sodium indicates an excess of body water, and an 
increase, an excessive water loss. The latter, which is often seen in 
burn patients who have an enormous insensible water loss, indicates 
(11) the need for water without salt, rather than more dextran or plasma . , ’ 
The value of the hematocrit in assessing the adequacy of fluid 
therapy in burns is presently being debated, since the pathophysiology 
of the changing red cell mass in a burn 
tration is a result of more than the loss 
fore the efficacy of the hematocrit must 
before recommending its use in space. 
is complex and hemoconcen- 
of plasma (1” 38). There- 
be. thoroughly assessed 
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Several other points should be kept in mind when determining 
the adequacy of fluid therapy in burns. A fluid deficiency can be indi- 
cated by severe thirst, tachycardia and systemic arterial hypotension. 
On the other hand, it is important to point out that blood pressure and 
pulse can be maintained at normal levels at the expense of a drastic 
vasoconstrictive reduction of the peripheral vascular bed. Interest- 
ingly, death from burn “shock” is often slow, whereas death from 
hemorrhagic “shock” is often sudden (38) . It should be noted that 
restlessness, irritability, and disorientation are manifestations of a 
fluid deficit, the treatment of which is fluid, not a narcotic. Abnormal 
venous distension and the appearance of rales in apparently undamaged 
lungs point to a fluid excess. 
If the urinary output remains low in spite of an apparently adequate 
restoration of blood volume and tonicity, some degree of renal failure 
might have resulted from a period of “shock”. Further intravenous 
fluids should then be given with extreme caution, especially if the 
lower respiratory tract might be damaged. As pointed out in Chapter 14, 
the usefulness of an intravenously administered osmotic diuretic, such 
as mannitol, for preventing renal failure from “shock” has been well 
established. Whether this agent can also be employed to prevent or 
reduce burn edema should be investigated, for it is considered possible 
that edema can contribute markedly to the amount of tissue devitalization 
resulting from a burn (47) . 
Since a paralytic ileus, often with accompanying vomiting, frequently 
occurs in severe burn cases, an astronaut suffering from a major burn 
should not have any oral intake until it is assured that he is passing gas 
per rectum, his abdomen is not distended,and good bowel sounds are 
heard on auscultation (25) . Particular care must be taken when oral 
fluids are eventually administered, since vomiting in the weightless 
environment will create a serious droplet hazard (Chapter 8). In 
fact, if there is a possibility of vomiting in the post-burn period, naso- 
gastric intubation should be performed. 
Although a burn patient might be able to tolerate his metabolic 
food requirement and large amounts of fluid taken orally, large quantities 
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of intravenous fluid might still be required after 48 hours .because of 
a marked diuresis due to the reabsorption of edema fluid. Since the 
body tends to retain sodium at this time, the replacement fluid should 
be 5 percent glucose in water. Serum sodium determinations would 
be valuable for assessing the state of sodium balance. Potassium (40 
to 80 mEq/day) should be given intravenously if this form of therapy 
is continued beyond 3 days and there has been an inadequate oral food 
intake. 
A tracheostomy might be indicated if serious respiratory tract 
damage occurs or if there has been a deep burn of the face and neck. 
The risk of infection spreading from a septic burn wound and involving 
the tracheostomy and lower respiratory tract should be kept in mind 
when assessing the need for this measure, however. Although one 
would prefer to wait as long as possible before performing a tracheostomy 
in the space situation, it must be remembered that laryngeal edema can 
occur quite rapidly and this procedure will be difficult after edema forms 
in a burned neck. 
The prophylactic use of antibiotics in the treatment of major burns 
is presently being debated (47). Systemic antibiotics of whatever com- 
bination are of value only in the first six to seven days, during which 
they can prevent septicemia (47). These drugs should be added to the 
intravenous fluids in order to maintain continuous high levels in blood 
and tissues, especially during the first two to three days after a burn. 
Thereafter the intramuscular route of antibiotic administration is con- 
sidered adequate. Burn wound or respiratory infection attended by 
a high fever will usually indicate the need for an increase in dosage, 
the addition of a different antibiotic or a change to an entirely different 
antibiotic regimen. Antibiotics might be selected on the basis of culture 
and sensitivity studies of bacteria taken from the wound, if such studies 
are ever possible in space. Otherwise, a rather “shotgun” therapeutic 
approach will have to be used. The possible usefulness of locally 
applied mafenide acetate cream for the prevention and control of burn 
wound infection in space has been discussed above. The early removal 
of dead tissue in preventing the ravages of the septic or auto1yti.c phase 
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of burns cannot be overemphasized. 
The local treatment in space of major burns will be the same as 
that discussed above for minor second and third degree burns. It 
must be remembered that eventual closure of third degree burns 
by skin grafting will have to be undertaken after completion of the 
mission, so that up to this time the treatment of these burns will be 
aimed at providing the best supportive therapy and wound care possible 
in space. However, in the very prolonged mission where extensive 
skin grafting is not possible, strips of skin taken under local anesthesia 
by means of an air- driven dermatome might be very advantageous (5) . 
Respiratory tract damage - A definitive treatment regimen for respira- 
tory tract damage by hot air, and smoke and gases of combustion has 
not been established (7). It is possible that intensive therapy with 
steroids , as in the treatment of chemical inflammation of the lower 
respiratory tract (Chapter 8), might be of considerable value, not 
only to combat acute inflammatory edema and bronchospasm but also 
to reduce tissue necrosis which can eventually lead to infection, 
bronchiectasis and bronchial stenosis (15) . It is suggested that a 
suitable steroid, such as dexamethazone, be inhaled in its nebulized 
form and be administered systemically. Bronchospasm might also 
be combatted with nebulized isoproterenol or intravenous amino- 
phylline (15). 
Otherwise, the treatment of this type of respiratory tract damage 
is supportive. A tracheostomy appears to be of little value except to 
relieve early acute localizing obstruction (31) . It might also be 
required for suction of copious quantities of exudate from a seriously 
involved lower r e spir atory tract. Oxygen administered under positive 
pressure might successfully combat pulmonary edema and hypoxia (7) . 
Intensive broad spectrum antibiotic therapy is indicated in all cases 
with respiratory tract damage. 
Burns of the hand - The astronaut’s hands are thought to be one 
of the most likely parts of his body to suffer thermal injury in space. 
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For this reason, and since serious functional impairment can follow 
even a relatively minor burn of a hand, the treatment of these burns 
deserves special mention here. 
Burn blisters on the palm of the hand have a thick covering which 
should not be broken or removed at the time of their initial dressing. 
The occIusive dressing should be applied lightly in such a way as to 
immobilize the hand and fingers in a position of function. Care must 
be taken to place the dressing between the fingers. A splint may be 
or may not be used. Again, debridement should be as thorough as 
possible at the time of each dressing change. The requirement for 
early vigorous physiotherapy of a burned hand cannot be overempha- 
sized (32). 
Recently, a fabricated mitten type of dressing, saturated with 
silicone fluid and covered with a plastic bag, has been utilized in 
the treatment of burned hands (2%. This dressing is changed daily. 
Finger motion is maintained and removal of eschar and exudate is 
apparently considerably enhanced. This technique has also reduced 
the need for skin grafting and has decreased both the extensive care 
usually required and the morbidity associated with this injury. It 
is thought that this approach to the treatment of hand burns and 
possibly cold injuries (Chapter 7) might be especially suited to the 
space situation, particularly for the reason that some degree of 
hand function can be maintained. 
Electrical Burns 
Even though spacecraft electrical systems should be adequately 
shielded, astronauts might be exposed to an electrical burn hazard 
if a system is disrupted by a docking or landing accident, or by 
meteoroid penetration, or if they must make repairs on a system in 
space. Electrical burns characteristically penetrate deeply into 
tissues, so that even a small electrical burn of the hand, which is 
considered by far to be the most likely site of this injury, could produce 
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marked functional impairment of an astronaut. 
Characteristics 
For an electrical injury to occur, some part of the body must be 
interposed between two conductors having different electrical poten- 
tials. The current which flows between the conductors tends to follow 
the most direct path possible. Its type (alternating or direct), inten- 
sity, path and duration of flow are the major determinants of the patho- 
physiologic disturbances it produces. These determinants have been 
discussed extensively in the literature 
(12, 13, 17, 21, 22, 23, 35) 
. 
Most important to note is the fact that an alternating current is more 
harmful than a direct current, especially in the 60 cycle range which 
is particularly disturbing to cardiac and respiratory function (35). 
The most frequently observed pathophysiologic disturbances from 
current flow through the body have been cutaneous burning, deep burn- 
ing with progressive necrosis, fracture of bones or dislocation of 
joints by violent uncoordinated muscular contractions, and immediate 
death from circulatory or respiratory arrest (10) . 
The degree and site of an electrical burn is determined by the 
resistance which a tissue offers to current flow (35) . Because dry skin 
has a high electrical resistance, electrothermal injuries are usually 
limited to it and immediately subjacent tissues. On the other hand, 
moist skin has a much lower resistance than dry skin, so that deep 
burning, especially of muscle, can result from electrical contact. 
If the contact between the skin and an external conductor is large, 
the generation of heat per unit area of surface may be inadequate to 
produce a burn, yet the current flow may be more than enough to 
paralyze respiration or produce ventricular fibrillation (35) . Con- 
versely, the heat generated at the site of a small contact, may be 
sufficient to produce a severe burn, even though the cur rent flow 
through the body is inadequate to cause a significant degree of physio- 
logic disturbance. 
Electrical burns are in most cases deeper than ordinary flame 
burns (4). Some degree of coagulation necrosis occurs in the skin and 
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deeper tissues. A major feature is the extensive vascular thrombosis 
which usually occurs in surrounding tissues over a period of hours 
to several days after an electrical burn is inflicted. Consequently, 
the extent of injury usually does not become apparent for up to several 
days, and is always much more severe than originally anticipated (4, 16) . 
Deep structures which are often involved include muscle, blood vessels, 
nerves, tendons, and even bone. In the hand, all of these structures 
are in close proximity to one another and to the surface, so that electri- 
cal burns of the hand tend to be extremely serious. Because of both 
the tendency to grasp a wire and the spastic grip produced by electric 
current flow up the arm, burns on the palm of the hand occur much 
more frequently than on its dorsum. 
Extensive muscular damage can lead to a variety of serious secon- 
dary consequences. Loss of potassium from damaged muscle can 
produce a hyperpotassemia sufficient to give rise to severe failure 
of cardiac function (17). Hyponatremia can result from a large scale 
afflux of sodium ions into severely affected muscle. Release of 
myoglobin and hemoglobin from hemolysed red cells can lead to 
anuria and fatal uremia. Damaged muscle is particularly prone to 
become infected (4). 
An electrical burn is usually white or charred, and insensitive. 
Local edema can be quite marked and, when combined with the tissue 
necrosis, can give the wound the appearance typical of moist gangrene (4) . 
One of the most serious complications of electrical burns is 
hemorrhage, resulting from necrosis often of the walls of major 
vessels (4, 16) . Profuse arterial or venous bleeding might occur. 
Treatment 
In general, an electrical burn is managed in a similar fashion to 
a thermal burn. More intensive fluid therapy is usually required in 
electrical injuries than in thermal burns (5) . The administration of 
potassium should, of course, be restricted. 
One must be sure that there is no muscle damage beneath a full- 
thickness burn eschar (5). When dead muscle is present, it must be 
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excised. However, an extensive wound debridement may be difficult 
if not impossible to undertake in space in the foreseeable future. 
Since acute renal failure occurs not uncommonly following large 
electrical burns, an osmotic diuretic , such as mannitol, might be 
given if the urinary output is low, in spite of adequate fluid adminis- 
tration 14). Alkalinization of the urine with intravenous and oral 
bi carbonate might reduce the damaging effects of myoglobin and 
hemoglobin on the kidneys (17) . 
If there is no dead muscle, it is recommended that an electrical 
burn not be debrided until ten to fourteen days, when the living 
and dead tissues are well demarcated (5) . Since hemorrhage is a com- 
mon complication of electrical burns, great care must be taken with 
debridement close to major blood vessels. It is difficult to stop 
bleeding by local pressure or even hemostatic agents, such as gelfoam 
or topical thr ombin. Arterial bleeding might have to be arrested by 
ligature. 
Finally, if circulation or respiration are arrested by an electrical 
shock, resuscitative measures discussed in Chapter 1 may be under- 
taken. It is thought that permanent respiratory arrest is unlikely 
unless an electrical current is sufficiently great to cause gross 
burning (23). Hence artificial respiration might have to be carried 
out for a prolonged period of time before adequate breathing returns. 
Chemical Burns 
The burn hazard presented by a corrosive chemical spilled by 
accident into the spacecraft cabin atmosphere will be greatly magnified 
in space, for not only will droplets and particles tend to remain sus- 
pended in the weightless environment, but also their atmospheric 
dilution will be limited by the confined environment of the spacecraft 
cabin. Such a hazard must be seriously considered when analytical 
systems requiring replacement chemicals are carried on board space- 
craft. Notably, a caustic burn hazard will exist while servicing life 
support systems which contain lithium hydroxide or a superoxide as the 
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carbon dioxide absorbent. 
Characteristics 
Corrosive chemicals include mineral acids and alkalis, strong 
organic acids and alkalis, and inorganic oxidizing agents. Many also 
possess systemic toxicity, even if absorbed only through the skin. 
All these agents are protoplasmic poisons through their ability to pro- 
duce protein hydrolysis, either by a hydrogen or hydroxyl ion effect. 
Acute chemical injury of the skin is in many ways similar to that 
produced by heat (4). In fact, injurious effects of chemicals are some- 
times due in part to the development of heat. A highly variable picture 
of injury may be present. Of interest is the fact that alkalis tend to 
penetrate and so burn deeply into tissues, whereas acids burn more 
superficially. Severe burns are characterized by a central zone of 
necrosis, surrounded by less damaged, more hyperemic, partial- 
thickness burn areas. Chemical injuries of the eyes and respiratory 
tract are discussed in Chapter 8. 
Treatment 
Immediate irrigation of the involved area of the body with copious 
.amounts of water still remains the best emergency measure for chemical 
skin burns. Not only does water carry away the chemical, but also the 
heat of dissolution. This might be accomplished in space with a special 
body cleansing apparatus. Another suitable measure might be the immediate 
application of materials soaked with water or a suitable neutralizing or 
buffering agent to the area of contact. Any irrigation procedure should 
be carried out for at least 10 minutes or even longer, especially for 
alkali burns. Other than such an emergency procedure, the treatment 
of chemical burns will be similar to that described previously for thermal 
burns. 
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CHAPTER 14 
INJURIES FROM MECHANICAL FORCES 
Astronauts will face a potential risk of injuries from mechanical 
forces during operations in space. Many causes of this form of trauma 
can be envisaged. While some injuries may prove to be peculiar to the 
space environment itself, any type and severity of mechanical injury is 
possible. 
This chapter briefly discusses possible causes, prevention, and 
principles of diagnosis and treatment of mechanical injuries during mis- 
sions in space. Notably, it above all others raises the question as to 
what level of medical care might be given in space. It would seem rea- 
sonable that one or more astronauts should be trained in the essential 
requirements of handling medical problems which might occur in space. 
However, as is apparent throughout this report, the clinical judgment 
and skills of a physician-astronaut would be highly desirable for the opti- 
mum handling of such problems. The topic will be discussed in greater 
depth in Chapter 16. 
The possibility that the healing of various wounds might be 
altered to some degree by the weightless environment or by spacecraft 
atmospheres should be kept in mind. This is an area to which no signifi- 
cant research contributions appear to have been made. 
Causes 
While moving freely about in the weightless environment of his 
spacecraft cabin, an astronaut might misjudge the velocity and direction 
of motion which he imparts to his body (7, 10) . As a result, he might sus- 
tain an injury by striking an immovable structure, especially a protruding 
sharp edge or corner. It is also possible that if unrestrained, he might 
be injured by being thrown about in the cabin or by being struck by displaced 
objects during maneuvering, docking, and landing operations. There might 
be some risk of mechanical injury associated with servicing and repair 
procedures within the spacecraft. Most injuries in the above situations 
will probably be of a minor nature, such as abrasions, lacerations, and 
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contusions. On the other hand, high momentum accidents might lead to 
more serious consequences, such as concussion and fractures. 
As was pointed out in Chapter 12, a great variety of minor and major 
mechanical injuries could result if a meteoroid should penetrate the wall 
of the spacecraft cabin. Molten and fragmented meteoroid and wall 
materials ejected into the cabin at high velocities could inflict single or, 
multiple penetrating injuries and lacerations, probably with some associated 
burning of tissues. Particles could enter the eyes and produce a variety 
of problems discussed in Chapter 8. Such injuries might also be produced 
in partial penetration conditions by metal fragments which spa11 from the 
inner surface of the cabin wall. It is conceivable that a translational wind 
load from a meteoroid blast could be of a sufficient magnitude to create 
missiles of disrupted cabin structures or force an astronaut against 
immovable structures in the cabin. If this event should occur, any 
number of mechanical injuries similar to those discussed below for “ex- 
plosive” decompression might result. 
As discussed in Chapter 3, mechanical inj ur ie s might be inflicted 
externally during an “explosive ‘I decompression of the spacecraft cabin, 
especially if an astronaut is unrestrained and is either close to the de- 
compression orifice or in a narrow passageway between parts of the cabin. 
As well, items of equipment or other materials in the cabin might detach 
or fragment at the moment of decompression and become missiles. This 
hazard will. probably be greatest if the cause of the decompression is a 
meteoroid penetration. Closed wounds such as contusions and fractures 
might result if an astronaut is thrown against immovable structures by 
the blast of escaping air. Violent blows to his body might disrupt hollow 
viscera and produce contusions or lacerations of solid organs, particu- 
larly in the abdominal region. Chest trauma might result in single or 
multiple rib fractures, hemothorax, pneumothorax, and pulmonary or 
cardiac contusion. Possible craniocerebral injuries include skull fracture, 
concussion, cerebral contusion or laceration, subdural or extradural 
hematomas, chronic subdural hematoma and damage to the labyrinthine 
system. Open wounds such as abrasions, lacer ations and penetrating in- 
juries might result not only if an astronaut is flung against sharp protruding 
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structures in the spacecraft cabin, but also if he is struck by various 
missiles. These wounds may involve superficial tissues or vascular, 
nervous, skeletal or visceral structures, leading to death of an astronaut. 
An astronaut might also be injured during an extravehicular operation 
in space or on a lunar or planetary surface. The velocity and direction 
of motion which he or his extravehicular maneuvering unit impart to 
his body might be misjudged, causing him to strike the spacecraft, 
especially protrusions from its surface, with sufficient velocity to pro- 
duce injury in spite of the cushioning effect of his inflated space suit. 
Possible injuries expected in this case are contusions and fractures, es- 
pecially of the ribs. Closed abdominal and thoracic injuries might also 
occur. There is also the danger of an astronaut being trapped between 
docking space vehicles or moving sections of a space station being assem- 
bled in space. As a consequence, the involved part of his body might sus- 
tain a closed crush injury of any severity, even without suit disruption. 
Injury might be sustained during operations on extraterrestrial sur- 
faces. Awkward mobility in the space suit, associated with possible 
balance and locomotion difficulties while walking in unfamiliar gravity 
environments and on unfamiliar terrain, will predispose to falls which, 
despite the cushioning and splinting effects of the space. suit, could result 
in contusions, strains, fractures, and dislocations. For the same reasons, 
there will also be a risk of penetrating wounds, lacerations and decom- 
pression effects (Chapters 1, 2, and 3), especially if sharp or pointed 
tools are to be used for climbing, digging or chipping, or if an astronaut 
has to walk or climb over jagged terrain. 
Finally, it should be noted that meteoroid penetration of the space 
suit might occur during extravehicular and extraterrestrial operations. 
As discussed in Chapter 12, single or multiple meteoroid fragments might 
penetrate the skin and subcutaneous tissues to any depth, producing mechani- 
cal and possible thermal tissue damage. Deep penetration by these missiles 
might result in serious and potentially fatal organ damage. 
Prevention 
A number of measures should be taken in order to minimize the risk 
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of an astronaut being injured by mechanical forces during operations in 
space and on lunar and planetary surfaces. The need to keep design 
engineers and astronauts continually aware of this area cannot be over- 
emphasized. It is also important to point out that the astronaut who main- 
tains himself at peak physical condition while in space will keep the risk 
of certain injuries, such as strains and sprains to a minimum. 
Hazardous projections into the spacecraft cabin must be eliminated. 
Necessary projections must be shielded or padded, or have their edges 
and corners rounded. All detachable items of equipment and other 
material must be firmly fixed to or enclosed in fixed structures when 
not in use. Materials with low mass and fragmentation potential must be 
used whenever possible. Consideration must be given to providing opti- 
mum vehicular protection from meteoroid penetration and personal pro- 
tection from penetrating fragments in various parts of the spacecraft 
cabinduring high risk phases of a mission. Compartmentalization of the 
spacecraft cabin could be a measure affording protection from mechani- 
cal injuries in instances of meteoroid penetration and “explosive” decom- 
pression. A.11 hatches on all spacecraft should be designed and standard- 
ized to facilitate rescue of injured crew members. Astronauts must be 
trained in rescue operations. 
An astronaut should limit uncontrolled “free-floating” movements 
about the spacecraft cabin as much as possible. During such movements, 
the wearing of comfortable light-weight protective equipment such as a 
helmet, possibly with an attached faceguard, and a rib protector might 
be indicated. An astronaut should be restrained in the cabin during all 
spacecraft maneuvering, docking, and landing operations. When the risk 
of meteoroid penetration and “explosive decompression” is increased, 
an astronaut should don a space suit and be restrained. Hazards asso- 
ciated with possible servicing and repair procedures on board the space- 
craft should be recognized. Procedures should then be outlined and mea- 
sures taken to ensure that they will be carried out safely. 
Several measures should be taken to minimize the risk of mechanical 
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injuries during extravehicular operations in space. Astronauts should be 
provided with an adequate propulsion system and be thoroughly proficient 
at maneuvering in space before attempting major tasks. Close atten- 
tion must be given to minimizing hazards presented by projections from 
the surface of the spacecraft, particularly in the hatch area. An astro- 
naut must exercise extreme caution to avoid getting crushed between 
docking space vehicles or moving sections of a space station being 
assembled. 
During extravehicular operations on lunar and planetary surfaces, 
an astronaut must exercise extreme caution in walking and climbing 
over unfamiliar and rough jagged terrain. He might use a mechanical 
support to assist his balance and locomotion, hence preventing falls. 
Anchor or safety ropes might be used in certain circumstances. Extreme 
care must be taken in handling sharp and pointed tools. 
Finally, it is assumed that an astronaut will be provided with as 
durable a space suit as possible. A suitable external protective garment 
might be indicated in various situations. 
Diagnosis 
The diagnosis of a mechanical injury in space will be made primarily 
by history and physical examination. The history must be centered on 
eliciting symptomatology in detail and the mechanism of injury. The 
physical examination must be thorough, determining both the extent and 
severity of tissue damage and assessing the astronaut’s total response 
to the injury. Periodic monitoring of his vital signs is indicated if 
serious bleeding has occurred or is suspected, or if he is in respiratory 
distress. If possible on board the spacecraft, basic laboratory and x-ray 
studies will be useful in confirming and diagnosing injuries. 
Treatment 
Basic surgical principles will still apply to the treatment of mechani- 
cal injury in space. In the foreseeable future, definitive surgical pro- 
cedures in space will undoubtedly be limited mainly to wound closure, 
and closed reduction of fractures and dislocations. Thus, in certain cases, 
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anatomical reconstruction of damaged tissues will have to be done after 
return to Earth. Due to weight penalties imposed by transporting stored, 
fresh whole blood into space, only reconstituted plasma or a suitable 
plasma-expanding agent such as dextran might be available for replace- 
ment of blood loss. It is apparent, therefore, that all minor mechanical 
injuries should be adequately treated in space. On the other hand, limita- 
tions placed on the surgical, and possibly the supportive treatment of 
major mechanical injuries will be such that the duration and degree of 
functional impairment and the mortality from these injuries will on the 
whole be much greater in space than on Earth. 
Although the pr aces ses of repair are fundamentally the same in all 
body tissues, tissue differences in ability to survive and regain function 
following various types of damage will make each wound an individual 
problem in treatment. It is of utmost importance, therefore, to have a 
sound knowledge of the healing potential of various types of wounds and 
of the factors that enhance or impede healing. Above all, one must be 
cognizant of the serious consequences which can result if a wound should 
become secondarily infected. 
Local and regional anesthesia for the repair of wounds in space is 
considered ideal in the light of the greater weight penalties and problems 
with atmospheric contamination which would be associated with the ad- 
ministration of a general anesthetic in space. Such might also be used 
instead of analgesic and sedative drugs if the astronaut must be maintained 
at an optimum functional capacity. 
The immediate care of an injured astronaut must be directed at con- 
trolling bleeding, ensuring an adequate airway, and preventing “shock”, 
further tissue damage, and further contamination of an open wound. 
External bleeding can, in most cases, be arrested by a sterile compressive 
dressing. As a rule, a well-padded tourniquet should be applied only when 
a major vessel in an extremity is severed, and should not be removed 
until definitive treatment of the wound has been instituted. A.dequate 
ventilation of an unconscious astronaut might be attained by inserting a 
suitable mouthpiece. The respiratory distress associated with a chest injury 
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such as single or multiple rib fractures may be aided by stabilizing.the 
involved area of the chest wall with strapping or infiltrating the appro- 
priate intercostal nerves with a local anesthetic agent, such as 2 per- 
cent lidocaine. If these measures fail or are likely to fail, tracheostomy 
might be indicated. Sucking wounds of the chest must be securely closed 
with an airtight dressing. The atelectatic tendency in a 100 percent oxygen 
atmosphere makes rapid treatment of a sucking wound mandatory. 
The general condition of an injured astronaut should be allowed to 
stabilize before definitive treatment of his injury is commenced. Blood 
loss should be replaced with colloid or whole blood, if available. If a large 
crew is on board a spacecraft, use of donor blood from other crew members 
whole blood is known to be compatible might be possible. 
As pointed out in Chapter 10, cardiovascular adaptations to weight- 
lessness will take place during prolonged space missions. A temporary, 
and possibly persisting decrease of blood volume will occur. Thus an 
astronaut who suffers from blood loss in space will in essence not receive 
the benefit ,of the “transfusion” of pooled blood if he was rendered recum- 
bent due to blood loss prior to leaving Earth. It is thought that cardio- 
vascular mechanisms which compensate for blood loss should not be altered 
by weightlessness. Since cardiovascular adaptations to weightlessness reduce 
orthostatic tolerance, “shock” might result from a relatively minor blood 
loss if measures (Chapter 10) are not taken to adequately protect an astro- 
naut from orthostatic intolerance on return to a gravity environment. 
Closed Wounds 
Even though the skin remains intact following non-penetrating trauma, 
any underlying tissue in the body can be damaged. Closed injuries are 
characterized by the tearing and crushing of soft tissues, fractures and 
dislocations. From previous discussion, it appears that the majority of 
closed injuries in space will be contusions, sprains, strains, fractures, 
and dislocations, of which most will not be life-threatening. On the other 
hand, violent non-penetrating blows might produce potentially fatal organ 
disruption and internal hemorrhage. 
Contusions are usually produced by direct blunt force and crushing 
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trauma. Usually only subcutaneous tissues are injured. Small blood 
vessels are torn and bleed into interstitial spaces. Exudation of serum 
into the damaged tissues enhances swelling. When muscle is contused, 
a large vessel might be torn, resulting in profuse hemorrhage and possibly 
“shock” . Extravasated blood may collect between layers of tissues to 
form a hematoma. Bleeding may also occur into a joint or tendon sheath 
to irritate and produce inflammation of these structures. An expanding 
hematoma may produce enough ischemia of skin and pressure on surround- 
ing tissue to cause necrosis and secondary infection. Minor superficial 
contusions are swollen, tender and usually produce no loss of function. 
On the other hand, bleeding into a muscle, joint or tendon sheath can 
produce a severe restriction of movement and pain. A contused nerve 
in which the axons are not disrupted (neurapraxia) will be associated 
with temporary pain, paresthesia and paralysis in the nerve distribution, 
whereas disruption of axons (axonotmesis), usually occuring in associa- 
tion with a closed fracture, results in complete motor and sensory 
paralyses which recover completely over a period of weeks to months. 
The majority of the contusions discussed above are treated by non- 
surgical measures which are directed first at controlling bleeding, and 
later at hastening the resolution of the residual hematoma and edema, and 
restoring the injured part to optimum function. The immediate application 
of a suitably padded compression bandage over the site of contusion may 
have some effect in limiting the initial extravasation. If possible, cold 
compresses might also be effective, especially in areas which are super- 
ficial and not easily bandaged. Activity should be curtailed insofar as is 
practical until an astronaut is over the period of acute local tenderness. 
Rarely is it necessary or advisable to evacuate a large superficial 
hematoma either to hasten return of function or prevent skin necrosis. 
Evacuation may be accomplished in the first few hours by needle aspira- 
tion, or if this is not possible, owing to clotting, by expressing it through 
a small incision made under local anesthesia. Following the se pr oc edur e s , 
a pressure dressing must be applied to prevent recurrence of the hema- 
toma. One might also consider aspirating blood from a joint, especially 
the knee, for the relief of pain. It is important to point out that a definite 
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risk of introducing infectious organisms into damaged tissues must be 
assumed when carrying out the above procedures. 
To assist the absorption of hematoma and edema fluid, the affected 
part should be placed at rest and, if possible in space, heat applied 
periodically. Graduated activity of the part should be commenced’when 
deemed feasible. Recent interest has been focused on the use of orally 
administered and locally injected protease (plasminogen)-activating 
enzymes, such as combined streptokinase- streptodornase, to assist 
absorption of hematoma and edema fluid (2, 6, 12, 13) . Whether agents 
presently in use significantly ameliorate symptoms and shorten recovery 
time remains open to question, however. 
Tearing of ligaments is defined here as a sprain, and tearing an 
avulsion of muscle or tendon as a strain. These injuries are caused by 
either direct or indirect violence, and vary from incomplete to complete 
disruption of the continuity of these tissues. The resulting pain, swell- 
ing and loss of function are dependent upon degree of tissue damage. 
The initial treatment of sprains and strains is similar to that for 
contusions. An analgesic or sedative might be required for pain. If 
an astronaut must be kept at an optimum functional level, local or regional 
anesthesia might be used instead of these drugs. Placing these injuries 
at rest is essential until healing is well progressed. In most cases, 
bandaging or strapping should provide adequate support. Splinting, as 
used for the treatment of fractures, might be required for more serious 
injuries, especially those which would be treated on Earth by operative 
repair . Graded activity, with care to avoid placing undue strain on heal- 
ing tissues, should be commenced as dictated by clinical judgment. 
Fractures and dislocations are also caused by direct or indirect 
force. A fracture can be “closed” or “open”, depending on whether or 
not ,there is a communication between the site of fracture and the outside 
air through the skin or mucous membrane. It may be incomplete (e. g. , 
fissure, depressed, puncture, and greenstick fractures) or complete 
(e.g. 9 simple, cornminuted, impacted, compression and avulsion fractures) 
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Fracture fragments may or may not be displaced. In addition to a frac- 
ture lesion or dislocation, there may be associated injuries to contiguous 
nerves, joints, tendons, and viscera. The possible existence of multiple 
fractures at different levels in the same bone or in other bones, or a 
combined fracture-dislocation must always be kept in mind. The degree 
of incapacitation of an astronaut will depend on the site and nature of 
the fracture or dislocation and the amount of associated soft tissue 
damage. 
Careful handling of an obvious or suspected fracture or dislocation 
is mandatory to prevent fracture displacement, further soft tissue in- 
jury and the possible creation of an open fracture. For quick efficient 
temporary immobilization of an extremity fracture, a suitable pneumatic 
splint might be used (7) . 
A displaced fracture should be reduced into as best alignment as 
possible in space by traction and manipulation. Ideally, reduction 
might be most easily and painlessly accomplished during the period 
of local numbness and paralysis which usually lasts for many minutes 
after injury. However it might be delayed if an astronaut requires resus- 
citation, treatment of more serious injuries or debridement of damaged 
tissues associated with an open fracture. If analgesia is required, an 
injection of local anesthetic into the fracture site might control pain 
until reduction is accomplished. More preferable, however, is the use 
of regional anesthesia, which provides both analgesia and muscular 
relaxation and eliminates the risk of introducing infection into the fracture 
site. 
The treatment of open wounds with underlying fractures should be 
similar to that to be discussed for all open wounds. Because of the 
serious consequences of infection of a fracture site, a suitable broad 
spectrum antibiotic should be administered prophylactically for a period 
of time to all open fracture cases. 
Complete immobilization of most fractures is essential for their 
healing. The type of immobilization employed will depend on the site 
and nature of the fracture and the availability of materials which can be 
used for such a purpose in space. If specific lightweight mate.rials for 
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splinting or encasing fractures are not carried into space, a suitable 
splint might be fashioned from expendable or repair materials on board 
the spacecraft. Some fractures can be suitably treated by methods other 
than splinting or encasement. For example, adhesive strapping can 
be used to immobilize fractures of the clavicle, upper humerus, mandi- 
ble or ribs. Other fractures may require no specific treatment except 
rest and perhaps temporary bandaging to minimize associated bleed- 
ing, give protection and relieve pain. It is noted that rib fractures 
frequently require only the relief of pain by infiltration of the appro- 
priate intercostal nerves with a local anesthetic. Finally, it is pointed 
out that treatment facilities in space in the foreseeable future will be 
such that open reduction and internal fixation of fractures will not be 
possible. 
Any dislocation should be reduced as soon as possible in order to 
minimize injury of contiguous structures, especially nerves and blood 
vessels. Regional anesthesia might be of great benefit by providing 
temporary relaxation of muscles as well as analgesia around the dislo- 
cation. Complete immobilization of the joint for several weeks might 
be required to allow healing of torn joint structures. Otherwise, move- 
ment might be restricted for a short period of time, followed by a 
graded activity as indicated. 
Violent trauma can produce a great variety of closed injuries of 
a more serious nature than those discussed above. Of particular con- 
cern are the consequences of severe blows and crushing forces, es- 
pecially in the head and thoracoabdominal regions. These forces can 
disrupt underlying viscera and supporting structures leading to serious 
internal bleeding. It is important to point out that many serious closed 
injuries can occur not only in the absence of early or obvious external 
signs of violence, but also far removed from the site of external impact. 
A blow to the head can produce concussion or unconsciousness due 
to functional or anatomic derangement of the brain stem. It is noted 
that concussion, brain contusion or laceration, and skull fracture may 
occur singly or in any combination (5) . Consciousness may return within 
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seconds following concussion or may take minutes to days following 
more serious brain injury. Cases which recover slowly pass through 
a transitional state of semi-consciousness characterized by disorientation 
and confusion which are attributed mainly to cerebral edema. Common 
complaints during this period are severe headache, lightheadedness 
or vertigo, and nausea and vomiting. Permanent residual psychologic 
and motor defects may result from anatomic damage to the brain. 
A delayed deterioration of consciousness or a deepening coma may 
occur following head trauma, due to an enlarging intracranial mass 
such as an extradural, subdural, or intracerebral hematoma, to a sub- 
dural collection of cerebrospinal fluid, or to cerebral edema. Deteriora- 
tion due to expansion of a chronic subdural hematoma may follow a lucid 
interval of several days to a few weeks, even after a seemingly minor 
blow to the head. Fractures through the temporal region may affect 
vestibular function possibly resulting in severe vertigo, nausea, and 
vomiting. Open skull fractures, especially those associated with 
dural laceration, may discharge cerebrospinal fluid and allow the 
entry of infectious organisms to produce meningitis, osteomyelitis, 
cerebritis, or brain abcess. 
A severe blow or crushing injury of the chest may produce a hemo- 
thorax. A fractured rib can penetrate the lung to produce a pneumo- 
thorax with or without associated bleeding. The pneumothorax may be 
of the “tension” variety in which the passage of air back out of the pleural 
cavity is blocked by the flap of torn lung pleura which acts as a ball 
valve, so leading to serious pulmonary and cardiovascular insufficiency. 
Air escaping from the disrupted lung may dissect along bronchovascular 
roots of the lung into the mediastinum to produce mediastinal emphysema. 
It may even track into the neck, face, scalp and thoracic wall to pro- 
duce subcutaneous emphysema. This condition becomes serious when 
air within the mediastinum produces an acute restriction of venous 
return to the heart or when secondary mediastinal infection occurs. 
Severe blows over the cardiac region of the chest may contuse the heart, 
resulting in a clinical condition not unlike that of coronary artery 
occlusion with myocardial infarction. 
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A blunt force to the abdominal region can contuse or lacerate. 
solid viscera, or rupture hollow viscera. All types of abdominal injury, 
regardless of the organ injured, may produce two primary effects - 
“shock” and tlperitonitis” - either singly or together. A fixed organ is 
more likely to be injured than one which is more mobile. Organs 
frequently injured on Earth, in approximate order of frequency, are 
liver, spleen, small bowel, large bowel, kidneys, stomach, urinary 
bladder, and diaphragm (left side) (8) . Certain parts of the small 
intestine are much more prone to injury, such as the third part of the 
duodenum, the proximal jejunum and the distal ileum. Delayed intra- 
abdominal hemorrhage may occur from a damaged spleen, liver duo- 
denum, pancreas, or kidney. It is noted that closed abdominal in- 
juries usually present a particularly difficult problem in early diagno- 
sis, for the initial trauma may be remarkably trivial and a severe blow 
to the abdomen may be followed by rapid recovery and an interval of 
several hour s, and rarely days without implicating signs and symptoms 
before the actual injury becomes clinically manifest. 
As was previously pointed out, definitive surgical procedures in 
space in the foreseeable future will be limited mainly to wound closure 
and closed reduction of fractures. Thus the treatment of serious 
closed injuries will be supportive. Intravenous fluids and electrolytes 
to maintain water and electrolyte balance, fluids such as plasma, a 
plasma expanding agent, or whole blood for blood loss, analgesic drugs 
for the control of pain, and a suitable broad spectrum antibiotic for 
the prevention and control of infection are considered the most essential 
forms of therapy to have available in space. Numerous other supportive 
measures are conceivable. A cerebral dehydrating agent such as 
mannitol might be used for relieving post-traumatic cerebral edema 
or preventing post-traumatic renal tubular necrosis. An ataractic 
drug, such as sodium phenobarbital, might be administered to control 
agitation associated with brain injury. A tracheostomy might be performed 
to improve lung ventilation. The removal of air or blood from the pleural 
cavity might be accomplished by periodic needle aspiration or, in a 
case with severe bleeding or Ittension” pneumothorax, by continuous 
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suction. Acute restriction of venous return to the heart due to mediastinal 
emphysema might be relieved by an incision made under local anesthesia 
at the base of the neck. Cardiovascular drugs such as a rapid-acting 
cardiac glycoside (e. g. , digoxin) or a vasopressor agent (e. g. , metara- 
minol) might be administered to cases which develop myocardial in- 
sufficiency due to cardiac contusion. Nasogastric intubation might be 
necessary to relieve upper gastrointestinal distension or vomiting, 
decompression of the upper gastrointestinal system, or for feeding. 
An indwelling urinary bladder catheter might be required for bladder 
drainage in an unconscious astronaut or to decompress a damaged urinary 
tract. Finally, even though the view is held that definitive surgery will 
not be performed in space in the foreseeable future, it is considered 
possible that physician-astronaut might, under certain circumstances, 
make a heroic operative attempt to save a fellow astronaut’s life using 
the limited instruments available. Some operations which come to 
mind are trephining, spenectomy, amputation, and repair of a disrupted 
hollow or solid abdominal viscus. 
Open Wounds 
Open wounds denote a break into or an actual loss of the protective 
skin barrier , with the underlying tissues being damaged to varying 
degrees and extent. As compared to closed injuries, open wounds are 
subject to contamination by bacteria introduced into the wound by the 
wounding agent or by foreign material. 
The various types of open wounds include abrasions, lacerations, 
penetrating injuries, avulsions and crushing injuries. The degree of 
damage to deeper tissues is often suspected from the nature of the trauma 
and the type of wound produced. Injured nerves, muscles and tendons 
in wounds involving the extremities can usually be diagnosed by testing 
the function of parts distal to the site of injury. On the other hand, the 
ultimate extent of injury in penetrating injuries of the neck, thorax, and 
abdomen may not be obvious. No wound in any location should be probed 
in an attempt to establish the extent or depth of injury, for this maneuver 
cannot be expected to yield reliable information and can cause further 
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harm by accentuating hemorrhage and introducing further contamination. 
An abrasion is the most superficial type of open wound, with only 
the skin being destroyed to a variable depth. Slight bleeding and serum 
exudation occur from the injured surface and form a thin‘eschar under 
which the denuded epithelium regenerates. If infection supervenes, 
healing is delayed. 
A laceration is a linear wound in which the skin and underlying 
tissue damage are localized to the path of the wounding agent, which 
-can be either a sharp or blunt object. It may vary from a neatly incised 
defect to one with irregular torn and contused edges with much associated 
tissue loss. 
A penetrating wound is created by a missile or sharp object which 
might pass to any depth into or right through tissues. The greater the 
velocity of the penetrating agent,the less the likelihood of skin or cloth- 
ing being carried into the wound by the agent. Due to its mass and 
velocity, a penetrating agent may dissipate enough kinetic energy in its 
passage to produce extensive tissue damage around the wound tract. 
Of note is the fact that in perforating injuries from high velocity missiles, 
wounds of exit are usually larger than those of entrance. Thus it is 
conceivable that in the space situation, a penetrating, high velocity, dense 
meteoroid or spacecraft wall fragment might conceivably damage blood 
vessels, nerves and other tissues at varying distances from the course 
of the “missile”, with the external appearance of this serious wound being 
quite misleading. That even more widespread tissue damage might be caused 
by bone and “missile” fragments is also possible. Reference is made to 
further discussion of injuries due to meteoroid penetration in Chapter 12. 
Avulsions are characterized by the tearing of tissues from their 
attachments. Skin and subcutaneous tissues can be either partially or 
completely avulsed from underlying tissues. Any degree of extent of 
damage to deeper structures can occur. A torn flap may or may not 
remain viable, depending on the adequacy of its blood supply. 
Open crushing wounds can be present with any combination of the various 
types of open wounds discussed above. Open or closed damage to deeper 
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tissues, including bones and viscera, may be extensive. 
The treatment of all open wounds in space will be governed by the 
same surgical principles as on Earth. The primary objective will be to 
convert, as soon as possible, an open contaminated wound into a sur- 
gically clean, closed wound. There is a generally accepted optimal 
time or so-called “golden period” of eight hours during which, from 
the standpoint of minimizing bacterial invasion of tissues, wound care 
should be under taken. However there may be many other factors, such 
as wound blood supply, and devitalization and contamination of tissues 
which have to be taken into consideration other than such an arbitrary time 
limit. If wound care must be delayed until an astronaut’s general condition 
is stabilized or a more serious injury is treated, the wound should be 
covered with a sterile compressive dressing to minimize further contamina- 
tion and bleeding. It is noted again that as a rule, a well-padded tourniquet 
should be applied only when a major vessel in an extremity is severed, 
and should not be removed until definitive treatment of the wound has been 
instituted. Whether local or regional anesthesia will be used during wound 
repair in space will depend upon the nature of the wound. 
Wound cleansing, using aseptic precautions (sterile surgical gloves, 
surgical mask, etc. , ) is the first step in definitive open wound treatment. 
After carefully cleansing the surrounding skin with an antiseptic agent 
(-2 hexachlorophene soap) and possibly shaving off hair, it may be 
necessary to irrigate the wound with a suitable sterile solution (e., 
isotonic saline) and remove loose foreign material. Droplet contamination 
of the spacecraft cabin atmosphere might be avoided by keeping a sterile 
absorptive material and strong suction device in close proximity to the 
wound, or by completely enclosing the wounded area in a container. which 
might be used for washing purposes in space. Draping the wound from 
unprepared skin surfaces might be accomplished with a sterile adhesive 
material, or by the circumferential application or tying down of a sterile 
nonadhesive material. 
The next step in definitive wound treatment in space will be to make 
the wound as surgically clean as possible. This goal is accomplished by 
debriding or removing devitalized tissues, foreign substances and tissues 
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which are hopelessly damaged, so leaving a wound which contains only 
viable tissues with an adequate blood supply. It may be necessary to 
enlarge a wound in a suitable line to display the full extent of damage. 
Each type of tissue encountered must be removed only after a careful 
intelligent evaluation of its viability, for there must be no needless 
sacrifice of tissue. Blood clots must be removed and careful hemo- 
stasis achieved. 
The repair of wounds in space will be limited mainly to wound clo- 
sure. On the other hand, it is considered. possible that an experienced 
physician-astronaut might undertake in space, when indicated, nerve, 
blood vessel, and tendon repairs with appropriate suture materials. 
Every open wound in space should be closed if at all possible, pro- 
viding that undue tension does not have to be placed on the tissues. 
Minimal skin tension might be relieved with subcutaneous sutures or by 
making relaxing incisions. Suturing with a fine, non-reactive material 
still remains the best all-around technique for skin closure. Exper i- 
mental and clinical success has recently been reported in closing skin 
with a sterile surgical adhesive tape (3, 4, 11) . Although s.uch a tape 
is highly recommended for use in space, it is probable that tape methods 
of skin closure will never completely replace suture methods, especially 
in moist, oily or highly mobile surface areas, or for closing jagged 
or sharply angulated wounds. It appears that where a broad defect 
exists, taping can oppose skin edges which would otherwise be closed 
only after undermining of the skin or making relaxing incisions. 
After wound closure, a generous dressing must be applied and, 
if necessary, the part immobilized to promote healing and prevent in- 
fection. Broad spec tr urn .antibiotic s might be administered pr ophylacti- 
tally where there is a high risk of a contaminated wound becoming infected. 
Finally it should be mentioned that due to extensive tissue loss, 
post-traumatic swelling or severe contamination, primary closure of 
a wound may not either be possible or advisable. The wound must then 
be packed with fine mesh gauze or other suitable material, a generous 
dressing applied and the affected part splinted. So-called delayed pri- 
mary closure of a wound, if clean, should then be attempted in about five 
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to seven days. If a wound becomes infected or if the defect is too large 
to close, one will have to allow it to close by granulation, or by so- 
called “secondary intent”. Repeated dressing changes and continued 
support of the part will be required until healing is complete. Antibiotic 
therapy should be administered to infected wound cases. 
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CHAPTER 15 
CARBON DIOXIDE (C02) TOXICITY 
Astronauts risk exposure to a toxic level of CO2 during space missions. 
An accumulation of this waste product of body metabolism could occur in 
the atmosphere of a spacecraft cabin or space suit due either to a partial 
to complete failure or a temporary overloading of a C02-absorbing system. 
Fortunately an astronaut’s inspired CO2 can be prevented from reach- 
ing a toxic level in a number of ways. Environmental control systems 
can be designed to handle all possible peak CO2 loads. The reliability 
of these systems can be increased with emergency subsystems which 
either absorb CO2 or purge atmospheres of this gas. As well, breath- 
ing gas can be supplied directly to an astronaut if he is exposed to a 
toxic ambient CO2 level. 
Although adequate measures will presumably be taken to prevent the 
occurrence of CO2 toxicity in space, it is still considered possible 
that such measures could become inadequate, especially during prolonged 
missions and particularly strenuous extravehicular operations. For 
example, if failure of a CO2 -absorbing system occurs, atmospheric purg- 
ing or breathing oxygen from an open loop system might have to be limited, 
and so some elevation of atmospheric CO 2 tolerated, in order to conserve 
oxygen. Accordingly, it is necessary to consider themedical consequences 
of such a situation and determine what therapeutic measures might be 
taken in space to combat CO2 toxicity and so maintain an astronaut’s 
performance capacity at an optimum level. 
This chapter presents various aspects of CO2 toxicity considered 
pertinent to the space situation. It will become apparent that differences 
between the short and long term effects on man, and between the possible 
circumstances of exposure to CO2 in space dictate the necessity to discuss 
this area under the separate headings of “Acute CO2 Toxicity” and “Chronic 
CO2 Toxicity”. 
Also by way of introduction, it should be pointed out that virtually all 
364 
studies in the past have stated inspired CO2 levels as “percent” rather 
than as “partial pressure”. The partial pressure of CO2 actually deter- 
mines pathophysiologic effects of this gas. It also remains constant as 
the percent composition of this gas changes for different space atmos- 
pheres and will probably be sensed by all space atmospheric monitoring 
systems 
(35, 134) . Hence the use of this unit is definitely preferable, 
especially when recommending maximum allowable levels of CO2 for 
space atmospheres. 
An accurate conversion of percent CO2 data stated in the literature 
to partial pressure values will not be attempted in this chapter, for few 
investigators have made note of ambient atmospheric pressure, temperature, 
and relative humidity. However, most of the information involving the 
inhalation of CO2 has given the inhaled dry air percentages of C02. It 
is thought that atmospheres of past experiments can be reasonably well 
approximated by assuming a sea level pressure of 14.7 psia (760 mm Hg). 
Hence a partial pressure of CO2 of about 7. 5 mm Hg would represent one 
percent C02. 
A physiological basis of comparison is the partial pressure of 
tracheal C02. This value is stated in terms of body temperature, at 
ambient atmospheric pressure in air saturated with water vapor (BTPS). 
The relationship of the partial pressure of tracheal CO2 and barometric 
pressure (or altitude) for various sea level equivalent percentages of CO2 
is shown in Figure 15. 1. 
In this chapter, CO2 levels will still be stated conventionally as per - 
cent, but whenever exposure of an astronaut to CO2 in space atmospheres 
comes into consideration, partial pressures of CO 2 equivalent to concen- 
trations in the sea level atmosphere defined above will also be stated. 
Acute CO2 Toxicity 
Broadly speaking, acute CO2 toxicity denotes the effects suffered 
by an astronaut who is exposed to toxic atmospheric CO2 levels which are 
reached within and persist at varying and maintained levels for minutes to 
as much as 24 hours in duration. An acute toxic condition in this case 
differs considerably from one resulting from a more prolonged, or chronic 
365 
Tracheal PM., (mm Ha) 
Tracheal P,-+ (mm Hg) 
L I I I I I I I II I I I I I I L II I I1 
0 I 2 3 4 5 6 7 8 9 IO II 12 13 I4 15 I6 17 18 I9 20 21 
COz-% Sea Level Equivalent 
Figure 15. 1 Relationship of partial pressure of tracheal 
CO2 and barometric pressure (altitude) for 
various sea level equivalent percentages of 
co2. 
(After Luft (124)). 
exposure to C02. It could arise from a temporary CO2 build-up in cabin or 
suit atmospheres due to inadequate functioning of life support systems. 
The accumulation of CO2 will obviously be much faster in a space 
suit than in a spacecraft cabin atmosphere. Rough calculations based on 
current suit data indicate that an astronaut who is walking on a lunar or 
planetary surface can increase his inspired CO2 to a highly toxic level, 
as will be defined below, within one to two minutes after a complete cessa- 
tion of CO2 absorption by his extravehicular life support system (134, 175) . 
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It is noted, however, that CO2 storage by the body would have a sig- 
nificant retarding effect on rates of atmospheric CO2 accumulation only 
in such a small rebreathing volume as that in a space suit 
(60, 61, 68, 169) . 
. 
In fact, recent evidence indicates that the immediate storage of CO2 in- 
volves a body compartment with a volume corresponding to that of the 
extracellular space (68’ 147). Carbon dioxide storage by the body should 
therefore be taken into account when attempting to predict such rates 
accurately. As far as CO2 accumulation in spacecraft cabins is concerned, 
it is estimated that three astronauts who are carrying out normal intra- 
vehicular operational tasks would not, even in the confined volume of the 
Apollo Command Module, experience symptoms of CO2 toxicity until about 
6 to 7 hours after CO2 removal from their atmosphere ceases. From 
such considerations, then, one can foresee the possibility of toxic levels 
of CO being reached over a period of minutes in space suit atmospheres 2 
and over a period of hours in spacecraft cabin atmospheres. Because 
of such a marked time difference, the question arises as to whether or 
not the rate of CO increase can significantly alter an astronaut’s res- 2 
ponse to acute exposures to this gas in space. Fortunately such infor- 
mation can be obtained from reports of past exposures of man to constant 
and gradually increasing levels of inspired C02. For all practical pur- 
poses, it can be assumed that exposures to constant levels of CO2 are 
equivalent to those that could occur over a brief period of time in a space 
suit. 
Pathophysiology 
Since the pathophysiology of man’s response to acutely elevated partial 
pressures of CO2 in his inspired air is well documented in the literature, 
it will receive only brief attention here. Particular emphasis will be 
placed on those aspects which are considered practical from a space 
operational standpoint and pertinent to ensuing discussions of the clinical 
manifestations, diagnosis, prevention, and treatment of acute CO2 toxicity 
in space. Greater detail in this area is provided by the references to be 
cited. 
Carbon dioxide is a powerful stimulus to breathing. This is an effect 
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which, within limits , is the major factor protecting man from acutely 
elevated, otherwise toxic concentrations of this gas in his ambient atmos- 
phere. The increase in pulmonary ventilation produced by CO2 varies 
markedly at different times in a normal individual and throughout the nor-’ 
ma1 -population 
(55, 93, 100, 188, 223) 
. The population response character- 
istic appears to account to some degree for variations in tolerance to C02, 
for it has been demonstrated that individuals with a relatively large tidal 
volume and slow respiratory rate show less of a respiratory and sym- 
pathetic nervous system response, and less symptoms while breathing low 
concentrations of CO2 than individuals with a relatively small tidal volume 
and fast respiratory rate 
(178, 188) 
. Accordingly, knowledge of responses 
to CO2 might have some practical value from a monitoring standpoint. 
An average effect of various inspired air-CO2 mixtures upon the 
steady state alveolar minute ventilation and partial pressure of CO2 of 
normal resting man at sea level is shown in Figure 15. 2. This response 
curve, which can be calculated from equations developed by Gray (84, 85) > 
car relates well with other data in the literature (29, 67, 82, 98, 100, 171, 
188, 223) 
. It demonstrates the increasingly inadequate ventilation, notably 
paralleled by an accelerating rise of alveolar C02, as the ambient CO2 
increases. This dulling of man’s ventilatory response to progressively 
increasing levels of CO 
2 
has been attributed to a combination of the narcotic 
effect of CO on respiratory center neurons, the stimulation of pressure 
2 
receptors in the thorax by hyperventilation and the fatiguing of respiratory 
muscles (41, 55) . 
Much research has failed to adequately define the mechanisms by 
which an increase in inspired CO2 produces an increase in pulmonary 
ventilation (91, ‘12, ’ 14) . A few aspects of this area are pertinent to this 
discussion. For greater detail, the excellent reviews by Hamilton and 
Brown (91), Heymans and Neil (96) Kellogg (102) Tenney and Lamb (212) 
and others (40, 51, 52, 85, 88, 99,’ 113, 120, 155, 211) can be consulted . 
It has been observed in humans, and substantiated by animal experi- 
mentation, that breathing 100 percent oxygen at pressures near sea 
level for short periods of time significantly depresses respiratory 
reactivity to C02, presumably through the effects of oxygen on 
peripheral chemoreceptor sensitivity for CO, (19, 91, 113, 114, 121) . 
90 100 110 120. 130 I40 150 
Tracheal O2 (mmklg) 
Figure 15. 2 Effect of inspiring various C02-air mixtures 
upon the steady state alveolar gas 5omposition 
of normal man at rest. The ratio VA/ V. 
represents liters (BTPS) per minute of 2 
alveolar ventilation for every 100 ml(STPD) 
of oxygen consumed per minute. R represents 
the respiratory exchange ratio (volume of CO2 
output for volume of O2 intake) and would be 
equal to the respiratory quotient (RQ) under 
steady state conditions at sea level. 
(After Fenn (64, 65)) . 
This effect was not found, however, when a few individuals were exposed 
to 100 percent oxygen at an atmospheric pressure of 200 mm Hg for 4 days, 
or when sleeping subjects near sea level breathed 40 to 100 percent oxygen 
for periods of 40 minutes to a few hours in duration (34, 47) . The reason 
for these divergent results cannot be given. As far as the potential exposure 
of an astronaut to increased levels of CO 
2 is concerned, studies of man’s 
response to CO2 in various possible space atmospheres which contain 
oxygen above that breathed on Earth appear indicated. As well, it is 
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deemed advisable to assess this response in atmospheres containing 
inert gases which are being considered for use in space. 
The ventilatory responsiveness to CO2 is initially increased on ex- 
posure to altitude, or exposure to lowered partial pressures of oxygen (200, 
214) 
. It then returns to normal over the period of several days required 
to acclimatize to the altered atmosphere 
(200, 214) 
. The finding that a 
reduction of cerebrospinal fluid bicarbonate occurs during acclimatization 
points to the importance of the fluids in which the respiratory neurons 
are bathed in governing central chemoreceptor activity 
(112, 200) 
. 
The observation that the ventilatory response to inspired CO2 lags 
changes in alveolar C02, which consistently overshoots or undershoots 
its steady state value, has been attributed to the time taken for CO2 in 
tissues surrounding central chemoreceptors to equilibrate with altered 
blood CO2 
(73, 88, 158, 171) . This lag effect might result in a hypocapnia 
sufficient to produce the clinical manifestations which can accompany CO2 
withdrawal (’ 88). 
The question arises as to whether or not an increasing level of CO2 
in an astronaut’s ambient atmosphere could actually confer some pro- 
tection on him from decreasing otherwise hypoxic levels of oxygen. It 
has been suggested in theory and established empirically that by stimulat- 
ing ventilation with a proper amount of CO 2 in the inspired air, the 
alveolar oxygen tension can be somewhat increased, and so performance 
and well- being at moderate altitudes maintained (123, 161, 194, 210) . 
However, since the major factors underlying this phenomenon are the 
displacement mainly of nitrogen in alveolar air by C02, with an associated 
elevation of the alveolar oxygen tension due to increased ventilation, it 
is readily apparent that CO2 can not confer any protection from hypoxia 
in a pure oxygen space atmosphere (123) . Moreover, it is doubtful if 
this effect could exist to a significant degree in proposed space atmos- 
pheres, which have a much lower inert gas concentration than air (124) . 
Although it has not been shown by some investigators, there appears 
to be a significant decrease of man’s respiratory responsiveness to 
CO2 with increasing depth of natural sleep (10, 16, 34, 126, 170, 173) . 
As well, there is an associated respiratory depression resulting in an 
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elevation of alveolar and hence arterial CO2 (10, 16, 17, 34, 66, 73, 173) . 
One group of investigators recorded a peak alveolar CO2 increase averag- 
ing 9 mm Hg in 14 subjects who were in deep sleep not assisted with a 
hypnotic drug w* Since the majority of normal individuals studied 
remained asleep until their ambient CO2 reached 4 percent or their 
alveolar CO2 reached 50 mm Hg, one wonders, therefore, if an astro- 
naut exposed to an increasing level of inspired CO2 while asleep might 
on awakening suffer from the clinical manifestations which can accom- 
pany CO2 withdrawal (16, 34, 173) . 
An elevated level of inspired CO2 can lead to a decrease in body 
temperature, even in a comfortable or warm high humidity environment (2% 
32, 90) (28) . For example, Brown recorded a 1 to 3” F decrease in body 
temperature, with associated chilly sensations, during, and for many 
minutes after their subjects ceased breathing about 5 percent C02, 
which accumulated in their 72” to 77” F environment over a period of 
several hours. This lowering of the body heat store may be due to a 
combination of a number of CO2 effects on the body. Increased heat loss 
will result from.C02 -induced cutaneous vasodilatation and hyperventila- 
tion (33, 75, 186) . In the past few years, attention has been focused’ on 
the marked increase in sweating which accompanies acute exposures to 
toxic levels of CO2 (31, 109, 178) . This phenomenon, which cannot be 
attributed per se to an increase in ventilatory work, may be due to one -- 
or more of several factors, such as a lowering of the thermostatic setting 
of the hypothalamus, an increased sensitivity of cuta.neous thermor eceptors, 
an increase in sympathetic nervous system activity, or an augmentation 
of sweat gland effector activity (32) . It has also been shown that toxic 
levels of CO2 markedly suppressed the shivering which followed exposure 
to a cold environment (33). In the light of the above considerations one 
wonders, therefore, if acutely elevated CO concentrations could increase 
2 , 
an astronaut‘s susceptibility to cold, leading to a lowering of body tempera- 
ture and associated symptoms sufficient to reduce his functional capacity 
or even to render him significantly more susceptible to hypothermia 
(Chapter 7). 
A practical question that arises is whether the oxygen cost of increased 
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ventilation in response to elevated levels of inspired C02, especially if 
this gas is maintained at tolerable levels for a prolonged period of time, 
could possibly impose a significant drain on space suit or spacecraft 
cabin oxygen stores. In one study, the oxygen consumption of 12 normal 
subjects exposed to elevated concentrations of CO2 in air increased 
linearly by 2. 3 ml per minute per mm Hg rise in alveolar C02, or by 
1.4 ml per liter of air breathed . (24) The latter value corresponds quite 
(37, 38, 44) Applying well to other data on the oxygen cost of breathing . 
the former value to the CO2 reSponse curve in Figure 15.2 and assum- 
ing an R of 0. 8, the inhalation of 2. 8, 5.6, and 8.4 percent CO2 would 
on the average increase the oxygen uptake by about 6, 21, and 47 ml 
per minute, respectively. Such data indicates, therefore, that until 
the inspired CO2 reaches highly toxic levels, as will be defined below, 
increased ventilation should place a relatively insignificant demand on 
oxygen stores in space systems. By the same token, it is noted that 
at highly toxic CO2 levels, there. will also be a significant increase in 
CO2 output, and hence an accelerated rise of atmospheric C02. - 
Data on the effects on man of breathing various concentrations of 
CO2 while performing at various work loads have been confusing. In 
one study it was shown that 3 percent CO2 augmented the ventilatory 
response on commencing work, yet in another, 5 percent CO2 did not 
alter this response (97, 109) . Sustained work has been found to depress 
the threshold of the respiratory center to C02, presumably due to lactic 
acid accumulation and elevated body temperature (5). Combined work 
and CO have reportedly had additive and multiplicative effects on ventila- 
tion (4,2111) Craig (45) . generalized from his own as well as other data 
that although the increment of minute ventilation produced by a change 
from rest to exercise is increased by C02, the ratio of exercise minute 
volume to resting minute volume is decreased by this gas. It was 
assumed that this effect was due mainly to a depression of the respiratory 
center by increasing partial pressures of alveolar C02. 
From a space operational standpoint, however, it is important to 
point out that an astronaut’s work capacity could be significantly limited, 
possibly at CO2 levels, which would not have an observable effect on him 
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at rest. In 1908, Hill and Flack (98) reported that the work output of 
a mine worker diminished when the level of CO2 accumulating in his 
breathing apparatus passed 2 percent. It is a well known fact among 
submariners that dyspnea and fatigue can severely limit the performance 
of heavy manual tasks when the ambient atmospheric CO2 concentration 
rapidly reaches 3.0 to 3.5 percent. Although such information is of 
great operational value with respect to manned space missions, the 
effects of various partial pressures of acutely elevated inspired CO2 on 
man’s maximum work capacity have apparently not been reported in the 
open literature. ’ Instead, interest has been focused on more physiologic 
aspects of exercise-CO2 interactions, especially on associated changes 
in lung ventilation. 
The cause of this inordinate dyspnea and fatigue, which characteristi- 
cally occur at much lower levels of ventilation than that produced by 
severe work or by breathing a high CO2 level alone, is unknown (224) . 
It has recently been shown in animal experiments that the ability of the 
body to increase metabolism above basal levels is significantly inhibited 
by hypercapnic acidosis (145, 165) . Since the availability of free acids, 
which are the main fuel utilized by the body during exertion, is limited 
by acidosis, the combined-acidotic effects of ‘work and CO2 breathing on 
this metabolic pathway might account for the lowered CO2 tolerance for 
a given work level, and vice versa (141) . -- 
Since dyspnea is the major symptom which limits work performance 
in a C02-containing atmosphere, the ventilatory responses to low levels 
of inspired CO2 at rest and during exercise might indicate what mini- 
mum level of acutely inspired CO2 might possibly affect an astronaut’s 
maximum work capacity. Haldane and Priestley (89) reported that 
during work in a closed chamber, accumulating CO2 in the chamber 
appears to “affect r e spiration” at an atmospheric concentration of 2 per- 
cent, as compared to 3 percent at rest, due to increased metabolic pro- 
duction of C02. Kr ogh and Lindhard (109) observed that the initial increas 
in ventilation on commencing severe exercise is markedly elevated in a 
3 percent CO2 atmosphere as compared to when the same degree of work 
is performed in air. Brown (28) noted that active exertion had a slight 
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effect on the respiration of his subjects when their ambient atmospheric 
CO2 accumulated to the 2 percent level. Data has also been compiled 
showing that sustained exercise can markedly lower the ventilatory 
threshold for CO2 (5). Thus it is conceivable that a relatively low 
level of atmospheric C02, possibly as low as 2 percent, might degrade 
an astronaut’s maximum work capacity significantly. Again, it is 
apparent that space- oriented research aimed at better defining man’s 
work capacity at various levels of inspired C02, especially at maximum 
recommended levels of CO2 for space atmospheres, is definitely indicated. 
An increase in sympatho-adrenal activity is another major physiologic 
response which appears to protect man from otherwise toxic concentra- 
tions of CO2 to which he is acutely exposed. It is a well established 
fact that up to highly narcotic levels of C02, an increase output of 
catecholamines counteracts the depression of cardiac and smooth muscle 
produced by the CO2 -induced acidosis and thereby prevents eventual 
secondary hypotension and “shock” (29, 131, 136, 144, 155, 167, 194, 198, 
212) . It should be remembered, however, that hypercapnic acidosis 
produces two antagonistic effects in the mammalian preparation (127, 129, 
141, 145, 165) 
. On the one hand, the sympatho-adrenal system is stimu- 
lated by the decrease of arterial pH. On the other hand, the functional 
effects of the catecholamines are inhibited, again presumably due to 
the lowering of pH. The net result of this antagonism on the cardio- 
vascular system might be altered considerably by such factors as drugs, 
hemorrhage, plasma and fluid 10s s, or concomitant metabolic acidosis 
or alkalosis. 
Many investigators have shown that systolic and diastolic blood pres- 
sures and heart rate increase when normal individuals breathe CC2-rich 
mixtures (29, 55, 82, 119, 138, 188, 194, 198) In spite of earlier . 
reports to the contrary, cardiac output also increases (3, 55, 128, 167, 
194, 198) . These cardiovascular events have been attributed to two actions 
of co2. First, the increase in ventilation in response to CO2 could aug- 
ment venous return, and so cardiac output through the thoracic pump 
mechanism (3, 75, 198) . This mechanism may well operate alone up to 
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inspired CO2 concentrations of about 6 percent, and appears to exert 
its greatest effect when the subject is in a horizontal p’osition, which 
(3, 82) minimizes venous pooling in the extremities . Second and most 
important, Sechzer and coworkers (198) have demonstrated in normal 
subjects that at alveolar CO2 levels above 50 mm Hg (corresponding to 
an inspired CO of about 6 percent in Figure 15. 2), the concentration 2 
of catecholamines and 17-OH corticosteroids in the blood begins to 
increase. They believe that epinephrine liberated from the adrenal 
medulla and norepinephrine secreted in the myocardium, together with 
the effects of increased respiratory effort account for the cardiovascular 
events produced by CO2 above this level. The importance of the sym- 
pathetic response in protecting man from high concentrations of CO2 
is demonstrated by the fact that sympathectomized subjects respond 
to CO2 with hypotension rather than hypertension 
(43, 207) . The sym- 
pathetic response to CO2 may also have been primarily responsible 
for preventing orthostatic intolerance both in subjects who breathed 
4 to 7 percent CO2 for varying periods of time after exercise and in 
(54, 1.30) quadriplegics who breathed 5 percent CO2 during tilting . 
Although 17-OH corticosteroids do appear to help maintain normal myo- 
cardial contractility and may also be important in regulating smooth 
muscle activity, their role in orthostasis has not been defined (205, 212) . 
It cannot be stated with certainty if CO2 accumulation in an astronaut’s 
ambient atmosphere would enhance his susceptibility to or protect him 
from orthostatic intolerance on return to a gravity environment, 
especially if he has sustained some degree of cardiovascular decondition- 
ing during his exposure to weightlessness (Chapter 10. It is a well 
established fact that both CO2 and exercise are vasodilatory. Accordingly, 
it is thought possible that this susceptibility might be significantly in- 
creased, especially when an astronaut ceases muscular activity, since 
the latter assists in maintaining an adequate venous return and provides 
some protection against orthostatic intolerance. 
Finally, it should be noted that studies of the effects of intravenous 
buffering agents on the sympatho-adrenal response to CO2 appear to have 
elicited the probable major mechanism by which CO produces toxic 
2 
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manifestations. The C02-induced changes in blood pH in animals have 
been buffered with intravenous sodium carbonate ‘or an amine buffer, 
tris (hydroxymethyl)-aminomethane. In a study using sodium carbonate, 
the blood catecholamines increased, whereas in studies using the amine 
buffer, the blood catecholamine s remained unaltered 
(101, 117, 118, 
143, 144) . Based on earlier work in this area, the difference in these 
observations was attributed to the fact that blood sodium bicarbonate, 
which increased during the sodium carbonate infusion, diffused less 
rapidly than CO2 into the intracellular space, whereas the amine buffer 
rapidly distributed itself throughout both the intra- and extracellular 
snaces. and thus maintained more constant intracellular bicarbonate- 
carbonic acid relationships 
(101, 117, 142, 143, 156, 174, 220). These 
findings suggest, therefore, that the sympatho-adrenal response to 
CO2 results from intracellular pH changes. Since administration of the 
amine produces a marked suppression of respiratory activity, it is 
probable that intracellular acidosis is the major mechanism of CO2 
toxicity (14, 22, 27, 122, 142, 154) . This action of tris (hydroxymethyl)- 
aminomethane will again come into consideration when its potential 
value in treating CO2 toxicity in space is assessed. 
Natural body buffering activity does not respond rapidly enough to 
counteract the acidotic effects of an acute exposure to CO2 
(20, 46, 53, 
57, 69, 81, 152, 168, 196, 197, 212, 219) 
. This fact was borne out well 
in the experiments of Schwartz and coworkers, who noted that if humans 
breathed high concentrations of CO2 for one to 2 hours, there was only 
a slight increment in blood bicarbonate in the face of a doubling of the 
arterial CO2 from 40 to 80 mm Hg and a profound drop in arterial pH (20, 
196) . As will be pointed out in the discussion of chronic CO2 toxicity, 
many hours, days, and even weeks may be required for extrarenal 
and renal buffer mechanisms to achieve presumably adequate total body 
buffering of the acidosis produced by a given level of inspired C02. 
Accordingly, it is reasonable to suggest that buffering agents be admin- 
istered to compensate for this deficiency. 
Very little is known about the relative contributions of an increased 
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partial pressure of CO2 per se and the concomitant C02-induced decrease -- 
in the pH of body tissues to the primarily neurological signs and symptoms 
of acute CO2 toxicity (136, 155, 201, 21% 221, 225) There appears to . 
be little doubt that CO2 exerts a narcotic effect, possibly through the 
combination of CO2 and amino acids which then participate in reversible 
biochemical equilibrium reactions, or through a mechanism involved in 
the production of general anesthesia 
(60, 202) 
. On the other hand, it 
may well be that the manifestations of CO2 toxicity are mainly due to 
alterations of the hydrogen ion concentration in the cellular environment. 
This is supported by the fact that the tolerance to high partial pressures 
of blood CO of patients suffering from chronic respiratory acidosis 2 
correlates well with the ability of the body to maintain blood pH at or 
near normal by buffering mechanisms (136, 157, 201, 221) Westlake . 
and coworkers (221) presented a plausible explanation for this hydrogen 
ion effect, noting that even small changes in intracellular pH produced 
bY co2 will depress tissue oxygen consumption, which is a vital factor 
for the maintenance of consciousness. This again brings up the question 
of whether practical measures could be taken in an emergency situation 
in space to enhance the intracellular buffering capacity and so increase 
an astronaut’s tolerance to inspired C02. 
The diuresis produced by even low toxic levels of CO2 is a physio- 
logic reaction which might conceivably have adverse effects on an astro- 
naut. Barbour and coworkers (6) found that exposure of normal recum- 
bent subjects to 5 and 7 percent CO2 produced a threefold increase in 
urine output over and above the normal diuretic response to recumbency. 
These investigators also showed that exposure to 5 percent CO2 for 
over 3 hours without replacing the fluid loss could lead to marked hemo- 
cone entration. They and others have noted that the diuretic response is 
slight in the sitting position, may be abolished by the erect posture or 
by applying high tourniquets on the thighs while supine, and that it may 
be restored by standing in a tank of water or by mild exercise (218) . 
Accordingly, it has been suggested but not proven that this response 
results from stimulation of intravascular stretch receptors in the left 
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atrium and pulmonary vessels by an increase in central blood volume, 
by some mechanical action on the atria1 wall from exaggerated 
respiratory movements,or by an increase on the atria1 transmural 
pressure gradient 
(58, 141, 218) . If one or more of these mechanisms 
does operate to some degree, afferent connections from these receptors 
would inhibit the production of antidiuretic hormone by the neurohypophysis 
(95) . Since voluntary hyperventilation, with alveolar CO2 being maintained 
constant by inhaling a 2 percent mixture, has been shown to produce much 
less of a diuresis than CO per se, 
dq- - 
it is also likely that CO2 acts directly 
on the neurohypophysis Support for this action being hydrogen 
ion dependent is given by the findings that a C02- induced diuresis did 
not occur either when the blood pH was maintained near normal by ad- 
ministering a buffer on exposure to C02, or during the first few days at 
altitude when an uncompensated respiratory alkalosis would presumably 
have prevented the attainment of a critical intracellular pH on breathing 
co (163, 217, 218) 
2 . 
Finally, there still remains the possibility that 
CO2 might inhibit the effectiveness of antidiuretic hormone on the renal 
tubule (209). 
Since CO2 exerts such a marked diuretic effect on man in the recum- 
bent position, it is probable that this effect would be of similar, if not 
greater magnitude in the weightless environment. Study of the diuretic 
response to various concentrations of C02, especially with the exposed 
individual performing at various work loads, is indicated before potential 
hazards of such a diuresis can be implied. One would think that if a 
significant diuresis can occur at relatively asymptomatic levels of C02, 
exposure of an astronaut in a space suit to such levels might limit the 
duration of his extravehicular activity by virtue of a need to void urine. 
It should also be kept in mind that excess loss of body fluid will decrease 
tolerance to heat and cold and increase the orthostatic intolerance of an 
astronaut entering a gravity environment. 
The effect of combined CO2 and heat stresses on man has apparently 
not been determined. Since they are both vasodilatory and, as previously 
mentioned, CO2 markedly increases sweating, it is likely that CO2 could 
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enhance an astronaut’s susceptibility to heat disorders (Chapter 6). This 
could be particularly significant if an astronaut commences activity in 
a gravity environment after exposure to a period of weightlessness which 
might render him more susceptible to orthostatic intolerance. 
As was pointed out in Chapter 4, CO2 markedly increases an 
individual’s susceptibility to decompression sickness. The risk of develop- 
ment of manifestations of decompression sickness would, of course, be 
enhanced still further if a CO 2 exposure occurs while an astronaut is 
performing work under conditions of decompression (Chapter 4). 
A review of the literature has failed to find reference to gross or 
microscopic pathologic changes which can result from an acute exposure 
to co2. The often marked increase in intracranial pressure, frequently 
accompanied by papilledema, in patients suffering from respiratory 
acidosis has been attributed to marked C02-induced cerebral vaso- 
dilatation, with or without cerebral edema secondary to the altered 
hemostatic s 
(136, 167) 
. It could well be that many symptoms of acute 
CO2 toxicity, especially those that continue for some time beyond the 
period of exposure, result from either cerebral edema or a vasomotor 
phenomenon caused by exposure to, then withdrawal from CO2 environ- 
ments (186) . Except for these effects, which do not seem to produce 
permanent pathologic changes, it appears that any other temporary or 
permanent toxic consequences of CO2 exposure would be found at the 
biochemical level. 
Clinical Manifestations 
The clinical manifestations of acute CO, toxicity are also well docu- 
mented in the literature. Altho’ugh several zxcellent reviews (56, 136, 
155, 157, 201, 221) have discussed the consequences of acute CO2 reten- 
tion in patients suffering from lung disease, such information is quite 
impractical from the standpoint of predicting an astronaut’s response 
to acutely elevated partial pressures of CO2 in his inspired air. Caution 
must be taken in extrapolating to space operational situations the results 
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of numerous experiments in which man has been exposed from minutes 
to several hours to constant or gradually increasing levels of C02. 
As will be pointed out in the following brief summary of these experi- 
ments, practically all CO2 exposures have been carried out on resting 
subjects. Since exercise appears to markedly effect man’s tolerance 
to co2, one would not expect the results of resting exposures to be 
applicable to a situation in which an astronaut is exposed to elevated 
levels of inspired CO2 while having to perform work, such as during 
extravehicular operations in space. It will also become apparent 
that past experiments have actually yielded very little information 
on the time of onset and the degree of functional impairment which 
occurred during and in the immediate period after various acute ex- 
posures to C02. Although past experiments have yielded enough in- 
formation for reasonable recommendations of maximum allowable 
levels of CO2 for acute exposures to this gas in space, confirmatory 
data should be obtained in studies which simulate possible modes of 
exposure during operations in space, especially extravehicular activity 
while performing various work loads. Finally, it should be kept in 
mind as experimental data is taken into account,that air resistance 
imparted by breathing circuits could have aggravated toxic responses 
to co2, and SO could have produced the variable results in various 
studies where subjects breathed the same concentrations of CO2 (8, 24, 
38, 72, 160) . 
Much has been written on man’s clinical response to various con- 
stant CO2 levels to which he is acutely exposed. As pointed out above, 
such exposures simulate for all practical purposes the rapid increase 
of CO 2 in space suits. 
Schaefer and coworkers 
(183, 188) 
recorded the symptoms experienced 
by 39 normal resting subjects who were alternately exposed for 15 min- 
utes to air and, in order, 1. 5, 3. 3, 5.4, and 7. 5 percent C02. No 
symptoms were reported at the 1. 5 percent level; those at other con- 
centrations are listed in Table 15. 1. It was noted that these symptoms 
usually appeared during the last 5 minutes of the exposures. The marked 
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effect which 7. 5 percent CO2 had on the nervous system is readily 
apparent. Symptoms at this level would no doubt have led to severe 
impairment of performance of a psychomotor task. Also of interest 
was the observation that individual differences in response to CO2 
in this study were related to the pre-exposure respiratory patterns 
of the subjects. It was noted that those individuals who had the com- 
bined respiratory characteristics of a relatively high tidal volume, 
slow respiratory rate and high partial pressure of alveolar CO2 before 
exposure to a given level of C02, showed less of a ventilatory response 
and experienced much milder symptoms than those who had the com- 
bination of a relatively low tidal volume, fast respiratory rate and low 
alveolar partial pressure of C02. 
3. 3% co2 
Dyspnea 
Headache 
Stomach ache 
Dizziness 
Sweating 
Salivation 
Numbness of extremities 
Cold sensations 
Warmth sensations 
Increased motor activity 
Restlessness 
Loss of control over limbs 
(overactivity) 
Loss of balance (spatial 
disorientation) 
Color distortion 
Visual distortion 
Irritability 
Mental disorientation 
2 
0 
0 
0 
1 
0 
0 
1 
1 
0 
0 
0 
0 
0 
0 
0 
0 
5.4% co2 7. 5% co2 
4 24 
0 15 
0 1 
0 6 
1 5 
0 1 
0 5 
1 3 
1 4 
0 10 
0 10 
0 4 
0 7 
0 
0 it 
0 4 
0 2 
Table 15. 1 Symptoms occurring in 39 resting subjects 
who inhaled CO for 15 minutes. 
2 
(After Schaefer et al (’ 88)). 
From numerous other studies, a more detailed CO2 response spec- 
trum can be described. During the first day of their exposure to 3 per- 
cent C02, several individuals remained mentally keen in spite of exhibit- 
ing general excitement and increased activity (36, 183) . Four per cent 
CO2 was found to be the upper limit tolerated by sleeping individuals and 
has been shown to increase the auditory threshold significantly and to 
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lengthen the latent period of the negative afterimage (16, 78, 79). 
Proficiency at card naming and sorting was unaltered during the 
exposure of 31 subjects to 5 percent CO2 for 16 minutes, although all 
of these subjects were moderately dyspneic, most reported fatigue, 
fogginess and an effort to concentrate, two experienced visual distur- 
bances,and one failed to complete the last minute because of dizziness, 
marked dyspnea and impending fainting (223) . It is noted that most of 
these individuals, of whom many were experienced pilots, were of the 
opinion that 5 percent CO2 for a 16 minute period was close to a mar i- 
nal concentration for the safe operation of an automobile or airplane 
(225) . 
Other studies carried out at the 5 percent level have found a significant 
increase in the pain threshold and decrease in the fusion frequency of 
flicker 
(189, 204, 20% 
. 
Two observers who entered a 5.7 percent CO2 atmosphere in which 
several individuals were tolerating a gradual increase of CO2 immediately 
became so dyspneic that they were unable to make observations (28) . 
Seven subjects tolerated 6 percent CO2 for about 22 minutes, but ex- 
perienced marked dyspnea, flushing and sweating of the face, and feel- 
ings of stupification and impending collapse, especially toward the end 
of the exposure (23, Visual intensity discrimination has also been 
shown to be affected in studies at the 6 percent level (74) . Prolongation 
of the time required for addition and cancellation tests, and the existence 
of dissociation, perseveration and an increase in the unusualness of res- 
ponse has been demonstrated in subjects breathing 6 to 7 percent CO2 (76, 77) . 
In contrast to the symptoms reported in the above exposures to 6 per- 
cent C02, the “mental status seemed unaffected” in 7 subjects who breathed 
7 percent CO2 for 40 to 90 minutes, although all suffered from dyspnea 
and some complained of mild headache and burning of the eyes (20) . 
Exposure to 7. 5 percent CO2 for 3. 5 to 6 minutes has been tolerated, 
but symptoms had a shorter lag time than in 7 percent CO2 (29). The 
7.5 percent CO2 level has also been found to decrease the inhibitory 
effect of light stimulation on brain waves - a finding which demonstrated 
the depressive or narcotic action of CO2 on the central nervous system (1891, 
An experiment in which 42 subjects who breathed 7.6 percent CO2 for 
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2. 5 to 10 minutes yielded results similar to the other experiments 
near this CO2 level, although one subject did lose consciousness (29, 188) . 
Individuals who have been exposed to 10 percent CO2 have immediately 
experienced one or more of a number of clinical manifestations, such 
as extreme dyspnea, visual and auditory hallucinations, chilliness, 
nausea, and vomiting, a strangling sensation, burning of the eyes, 
cloudiness of vision and profuse sweating. They have usually become 
stuporous within 10 minutes and lose consciousness within 15 minutes (29, 
41, 55, 64, 199, 222) . Although CO2 concentrations of over 20 percent 
have been used for the treatment of mental disorders and experimentally 
for anesthesia, it is considered probable that if an individual who does 
not have the benefit of therapeutic support is exposed to CO2 levels 
above 10 percent, he will rapidly suffer the sequence ,of respiratory 
depression, convulsions, “shock”,and death 
(116, 132, 135, 222) 
. 
The classic work of Haldane and Smith in 1892 (90) elicited many 
of the clinical manifestations to be expected from exposure to gradually 
increasing inspired C02. These investigators had normal resting sub- 
jects rebreathe air while enclosed in a 70 cubic foot chamber. As noted 
previously, the rate of CO2 accumulation in this volume would apply 
to that generally expected in spacecraft cabin atmospheres. In one 
experiment, chamber CO2 increased linearly over an 8 hour period to 
6.4 percent, while oxygen decreased to 13 percent. About 4 percent 
co23 the subject became aware of increased breathing and began to com- 
plain of headache and nausea. For the last two hours of exposure, when 
CO2 had passed about 5. 2 percent, breathing was “painfully labored and 
required so much exertion as to cause great exhaustion”. This marked 
dyspnea eventually caused termination of the experiment. Another sub- 
ject showed a similar response, having to end his 7 hours in the chamber 
after linear CO2 and oxygen changes to 5. 8 and about 14 percent, res- 
pectively. By allowing changes in either CO2 or oxygen in the chamber, 
Haldane and Smith (90) showed that the decrease in inspired oxygen in the 
above experiments could not have been a factor in producing these various 
manifestations of rebreathing air until the oxygen concentration fell below 
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13 percent. Finally, they demonstrated that resting subjects who re- 
breathed air from a 225 liter bag could tolerate a maximum CO2 con- 
centration of about 10 percent, attained in about 1. 5 hours. They 
suffered from mental confusion and extreme perspiration in addition 
to the manifestations described above, as this level was reached. 
Studies by Brown in 1930 (28, 29) have also yielded valuable infor- 
mation on man’s response to gradually increasing inspired C02. Normal 
resting subjects in groups of four rebreathed 654 cubic feet of chamber 
air (164 cubic feet per man). In the first experiment described, the 
chamber CO2 increased linearly to 4.7 percent, while oxygen decreased 
to 15.5 percent, over a period of 10 hours. At about 2 percent C02, 
“active exertion had an effect on respiration”. All subjects tolerated 
this exposure, none complaining of actual dyspnea; one suffered from a 
mild headache for the last 3 hours. General fatigue and listlessness 
experienced during the exposure did not seem to alter subject alert- 
ness. In the second experiment, CO2 was gradually introduced into 
the chamber, with linear changes in this gas and oxygen to 4.8 and 
17. 8 percent, respectively, taking about 5. 3 hours. Notably, all 
subjects reported chilly sensations during the final hours, in spite of 
an average chamber temperature of 75” F and relative humidity of 74 
percent. Oral temperatures recorded in three subjects fell 1. 0, 2. 2, 
and 3” F. Again, dyspnea was noted, mild headache occurred in one 
subject, and general fatigue and listlessness were outstanding. In the 
third experiment, CO2 was again introduced into the chamber, and 
changed along with oxygen in an essentially linear manner until these 
gases reached 5.2 and 15.6 percent, respectively, by the end of 8 hours. 
Breathing became decidedly labored for all subjects, with two reporting 
dyspnea in the last half hour, when the CO2 level was above about 4.8 
percent. Fatigue was more marked than in the above experiments and 
again all subjects had chilly sensations, associated with a fall in body 
temper atur e. Three experiments similar to the last reached 5. 6, 5. 7, 
and 5.8 percent CO2 and 16.1, 15.4, and 14. 2 percent oxygen in 8 hours. 
All subjects made note of experiencing a pronounced increase in the 
depth of breathing soon after the 4 percent CO2 level was reached, the 
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stage of panting virtually setting in at this time. During the last hour in 
all three of these experiments, when CO2 was above 5.1 percent, all 
subjects except one who was found to be relatively resistant to C02, 
complained of dyspnea in addition to exhaustion from severe panting. 
Most reported headache, which was frequently associated with nausea, 
for the last two hours, when the CO2 was above 4.6 percent. Again, 
mild hypothermia with associated chilly sensations occurred in spite 
of the subjects being in a presumably comfortable environment. A num- 
ber of experiments with similar increases of CO2 as those above, but 
with oxygen maintained near normal levels, ruled out a significant con- 
tr ibution of deer eased oxygen, at least down to the 15. 5 percent level, 
in producing these various toxic manifestations. From his own and 
other past studies, Brown estimated that oxygen depletion would begin 
to have an effect about the 14 percent level. In the experiments where 
co2 and oxygen reached respective levels of 5.8 and 14.2 percent, 
and 5. 3 and 20. 5 percent, Brown found evidence that excellent psycho- 
logical reserve was maintained, with subjects failing to show an altered 
response to a variety of tests of attention, memory, association, deduc- 
tion, and motor coordination. 
Other studies have substantiated the findings of Haldane and Smith, 
and Brown (1, 42, 89, 92, 98, 194) . In experiments in which inspired 
CO2 increased to the 5 to 7 percent range in one to 4 hours, it was 
also noted that the incidence of clinical manifestations of CO2 toxicity 
increased rapidly above 5 percent CO2 (92) . Particular attention is 
drawn to the occurrence of nausea and vomiting above this level, for 
vomiting in the weightless environment will be an extremely hazardous 
event (Chapter 8) (192) . Mental confusion and dizziness occurred about 
(92) 7 percent CO2 . In other r ebr eathing experiments, the maximum 
tolerable limit was again about 10 percent C02, this‘ level being reached 
in about 4 hours (98) . 
As mentioned above, symptoms can be experienced after the cessation 
of certain exposures to CO2 and, as the examples given below will show, 
can result in even greater functional impairment than symptoms experienced 
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during such exposures. This phenomenon may have been a major factor 
preventing the successful escape of personnel from the sunken sub- 
(1) marine Thetis . 
A number of C02-withdrawal symptoms have been reported follow- 
ing exposures to various maintained levels of C02. This reaction and 
its marked variability was well demonstrated by a study in which 5 sub- 
(1) jects breathed 6. 7 percent CO2 for one hour . On ceasing their 
exposure, one subject immediately vomited repeatedly and complained 
of nausea and headache, two experienced temporary severe incapacitating 
headaches,and two complained of only slight headache. In other studies, 
subjects exposed to 3 percent CO2 for many hours apparently complained 
(36, 179). of only a mild headache on returning to air Headache was 
also complained of after exposures to 5. 2 and 6.4 percent CO2 for 
2 hours . (50) A frequent symptom after cessation of exposures to 7.6 
percent CO2 for an average of 7.4 minutes and 10.4 percent CO2 for 
an average of 3. 8 minutes was temporary dizziness (55). 
Clinical manifestations have also occurred after withdrawal from 
exposure to gradually increasing ambient CO2 levels. A classical 
example of a particularly severe CO2 -withdrawal reaction was cited by 
Alexander and coworkers (1). Their subject tolerated an increase in 
CO2 to 6.6 percent over a 14.5 hour period, yet, when subsequently 
exposed to oxygen, immediately vomited a pint of clear fluid in spite 
of not having ingested anything for over 16 hours. He also began to 
suffer immediately from a violent diffuse headache, which appears to 
have incapacitated him for about an hour. In the Haldane and Smith 
study (90) the headache and nausea experienced by the two subjects, as 
CO2 increased to 6.4 and 5.8 percent over 7 and 8 hours, was reported 
to have temporarily worsened when they left the chamber. In Brown’s 
experiments (28, 29) , withdrawal from concentrations of CO2 reaching 
from 4.8 to 5.8 percent over 5. 3 to 10 hours was accompanied either 
by the onset or aggravation of headache or nausea which lasted for 1 to 
3 hours. Hayter and Duffner (92) found that for an as yet unexplained 
reason, the headaches resulting from exposure to C02, which increased 
to 5 to 7 percent over one to 3 hours, were much worse, occurred with 
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greater frequency, and lasted much longer in subjects who breathed air 
as compared to those who breathed oxygen after exposure. 
The cause of the above clinical manifestations of CO2 withdrawal 
is unknown. The brief hypotension which coincided with the temporary 
dizziness immediately after ceasing the brief exposures to 7. 6 and 10.4 
percent CO2 might possibly be due to the vasodilatory action of CO2 
persisting beyond its sympathetic action in the immediate post-exposure 
period (55, 167) . Other effects of altered sympatho- adr enal activity, 
which could accompany CO2 withdrawal, might conceivably cause symp- 
toms (141). Whether the temporary undershoot of alveolar C02, ob- 
served when 15 minute exposures to 5.4 and 7.5 percent CO 2 were 
terminated, might produce a hypocapnia of a sufficient magnitude to 
produce a symptom such as dizziness remains to be determined (188) . 
Finally, it is conceivable that a cerebral vasomotor phenomenon 
caused by exposure to, then withdrawal from a CO2 environment might 
be a major etiologic factor (186) . 
A review of the pertinent literature indicates it is unlikely that 
CO2 exposures in space will ever be severe enough to cause such 
serious consequences of CO2 withdrawal as prolonged profound hypo- 
tension and grave cardiac arrhythmias which are prone to occur 
following marked CO retention in anesthetized patients (25, 26, 31, 
39, 83, 137, 155, 16& 167) . 
Finally, it is pointed out that certain symptoms which are not 
really specific effects of CO2 withdrawal might occur in the post- 
exposure period. Marked, general fatigue, and soreness in the region 
of the diaphragm have been reported after most of the prolonged acute 
exposures to over 4 percent CO 2 described above. Such symptoms 
could no doubt limit an astronaut’s physical work capacity for several 
hours after such an exposure. Conceivably, intense shivering might 
be experienced after certain exposures to CO2 which, as mentioned 
above, can cause an excessive loss of body heat during exposure. 
The results of most of the experiments in acute CO2 toxicity have 
been summarized graphically in Figure 15.3 for CO2 exposures of up to 
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80 minutes. This graph again points out that resting man appears to 
tolerate acute exposures to about 3 per cent CO2 quite well. It 
should also be noted that the degree of distracting discomfort between 
3 and 4 percent CO2 is minimal, and beyond 4 percent symptoms 
rapidly appear and become functionally limiting. 
TIME - minutes 
Figure 15. 3 General symptoms experienced by most 
resting subjects when exposed for the times 
indicated to mixtures of carbon dioxide in 
air at a total pressure of one atmosphere. 
(Drawn from data of King (103) , Nevison (15’) and 
Schaefer (180) for Bioastronautics Data Book 
(149) 
1. 
This graph also points out the fact that relatively high concentrations 
of CO 2 can be tolerated by resting man for only brief periods of time. 
Accordingly, it would not be wise to recommend short-time maximum 
allowable limits for emergency situations in space, especially for extra- 
vehicular operations when performing quite high work loads. 
It is apparent both from foregoing discussions and this graph that man 
can better tolerate an acute exposure to CO2 which accumulates in his 
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atmosphere slowly rather than rapidly. However, the gain in tolerance 
to CO2 by allowing this gas to accumulate slowly tends to be nullified 
by the subsequent consequences of CO2 withdrawal. It is again em- 
phasized that an extremely serious situation could develop in an astro- 
naut, who has tolerated a gradual increase in his inspired CO2, should 
vomit into his weightless environment or suffer from a functionally 
incapacitating headache as the result of CO2 withdrawal. 
Diagnosis 
Acute CO2 toxicity should usually be easily recognized in space, 
for an astronaut should know of a partial or complete failure of his 
CO2-absorbing system for minutes to hours prior to experiencing symp- 
toms. A possible exception to this could be temporary overloading of 
a CO 2 -absorber, especially that of the space suit. Accordingly, it is 
considered most important to have devices which monitor closely vital 
environmental control system functions and the partial pressure of CO2 
at appropriate sites in the extravehicular life support system or space 
suit helmet,and in the spacecraft cabin. Such a monitoring system 
should also provide an adequate signal to an exposed astronaut and 
other members of the crew if a system begins to malfunction or CO2 
accumulation occurs. The many clinical manifestations which point 
diagnostically to acute CO2 toxicity are apparent from previous dis- 
c us s ion. 
Prevention 
As subsequent discussion will point out, there is at present no 
practical measure for the specific treatment of acute CO2 toxicity in 
space. Therefore various modes of keeping an astronaut’s partial pres- 
sure of inspired CO 2 below reasonably safe levels might have to be com- 
pletely relied upon during operations in space. Environmental control 
systems must be designed to handle immediately all possible peak CO2 
loads. The reliability of these systems can be increased with emergency 
subsystems which either absorb CO2 or purge atmospheres of the gas. 
An astronaut might be supplied his breathing gas directly by mask or 
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mouthpiece if exposed to a toxic ambient CO2 level. Finally, activation 
of one or more extravehicular life support systems might suffice tem- 
porarily for CO2 removal from a spacecraft cabin atmosphere. 
In the light of previously mentioned factors which must be taken 
into account when recommending maximum allowable, “acute” levels 
of CO for space atmospheres, 
2 
data on past exposures of man to CO2 
indicate that: 
-the CO 
exceed 3 
level in the spacecraft cabin should never 
percent, or a partial pressure of 22.5 mm 
Hg. t for more than several hours in duration. In 
stating this level, it is assumed that the astronaut 
will be awake and performing only light work during 
his exposure. Although symptoms such as a notice- 
able increase in breathing and, following longer ex- 
posures, a mild headache can be expected during 
exposure and for some time after exposure to this 
level, they should not significantly affect an astro- 
naut’s functional capacity. 
-the CO level in the space suit helmet should never 
exceed 2 percent, or a partial pressure of 15 mm 
Hg. In stating this level, it is assumed that the 
astronaut will always be moving about or working 
in his pressurized suit, and so performing up to a 
very high work load during his exposure. Dyspnea 
can be expected at this level of C02,particularly at 
moderate or high work loads. However, if the 
astronaut controls his work load and allows time 
for excess CO2 to be purged and possibly absorbed 
from his space suit atmosphere, he should be able 
to keep this symptom from becoming severe enough 
to prevent his executing a required task before he 
returns to the spacecraft. 
- space suit environmental control systems should 
be designed to maintain space suit helmet CO 
below one percent or 7. 5 mm Hg. This woul St 
always 
allow 
for some CO2 accumulation and yet have the level of 
inspired CO kept well below that which could adversely 
affect the 3 as ronaut, especially when he has to perform 
at high work loads. 
Treatment 
The question has already arisen as to whether there is a practical 
measure which might be used in space to increase an astronaut’s tolerance 
to acutely elevated inspired C02. Looking back over the literature, it is 
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found that during World War II, Pointer (164) attempted to find a way 
of increasing the CO2 tolerance of submarine personnel by having these 
individuals ingest rather large amounts of sodium and potassium salts 
while exposed to a 2 to 3.5 percent CO2 atmosphere. The se alkaline 
salts did shorten the time for blood pH to return to normal, and treated 
individuals suffered somewhat less from symptoms of acute CO2 toxicity, 
such as headache and restlessness, as compared to those untreated. 
However, the value of this medication was not permanent, as the degree 
of affected performance, as will be described under “Chronic CO 2 
Toxicity”, was similar in both groups when their C02-induced acidosis 
was apparently totally buffered, or compensated for by body buffer 
mechanisms. As to whether such a measure could be used for the 
treatment of acute CO2 toxicity in space is debatable, for it is thought 
that the rate and degree of enhanced body buffering which could be 
attained with these salts would fail to compensate adequately for either 
the rapid rises or the high levels of CO2 which could be reached during 
space operations. Also militating against the use of these salts in 
space is the tendency for large doses to produce irritation of the gastro- 
intestinal tract. 
More recently, other measures have been utilized in attempts 
to combat body pH changes, and so improve the state of patients suffer- 
ing from acute CO2 retention, or uncompensated respiratory acidosis 
due to lung disease. Results with infusions of sodium lactate and 
sodium bicarbonate have not been encouraging, for only weak alkaline 
solutions can be tolerated intravenously, thus necessitating the admin- 
istration of large volumes of fluid over a prolonged period of time to 
give any sustained effect (’ 28y 186’ 202) Moreover, these solutions . 
are not really suitable for the treatment of hypercapnia since they 
generate CO2 and, therefore, increase the amount of CO 
(141) 
2 which has 
to be excreted by the lungs . 
In 1959, Nahas (1391, noting that organic CO2 buffers were highly 
capable of maintaining virtually constant partial pressure of CO2 in 
the gas phase of in vitro systems, -- suggested that such buffers, in parti- 
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cular tris (hydroxymethyl)-aminomethane*, or so-called tris buffer, 
might be found useful in treating respiratory acidosis (108, 159). 
Tris buffer rapidly distributes itself throughout both the intra- and 
extracellular spaces (140) . It exerts a large part of its titrating effect 
in the extracellular compartment by increasing the buffer capacity of 
this compartment, which acts as a CO2 “sink” (141) . By decreasing 
the partial pressure of CO2 in the extracellular fluid, tris buffer 
also decreases the partial pressure of CO2 in the intracellular com- 
partment, with a resulting increase in pH therein (140) . It is also 
true that this agent penetrates the intracellular compartment to some 
degree, but its intracellular titrating effect should not be quantitatively 
as important as its extracellular titrating effect (141) . 
Numerous investigators have assessed the therapeutic effective- 
ness of tris buffer in various studies in animals and humans (12, 14, 
21, 22, 23, 27, 59, 101, 117, 122, 128, 139, 142, 144, 146, 154, 202) 
. 
However, reports indicate that results of treating patients in uncompen- 
sated respiratory acidosis with tris buffer have not been startling and, 
therefore, do not support the use of this drug in an emergency situation 
in space (21, 122, 128, 154, 202) . Tris buffer has been difficult to use 
and has produced a pumber of serious side-effects. Taken orally, it is 
unpalatable and usually produces severe diarrhea (22) . Notably, weak 
acid salts of tris buffer, which retain up to 70 percent of their titrating 
activity, were administered orally in one study to animals for periods 
of up to 3 months (148) . Gastrointestinal disturbances were apparently 
not observed in these animals. The base content of the blood remained 
significantly elevated during the period of administration. This raises 
the question as to whether or not there is indeed a conjugated form of 
tris buffer that can be tolerated when taken orally by man. If so, it 
is thought that short periods of CO2 inhalation might be better tolerated 
by individuals in whom the buffering capacity of the body fluids has 
been elevated by this agent (141) . Intensive experimentation is warranted 
-‘Tris (hydroxymethyl)-aminomethane works according to the general equation 
R-NH2 t H20 t CO24 -HC03-t RNH3+ 
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to assess practicability of this measure. 
Tris buffer has been routinely administered intravenously to patients. 
Even then, severe vascular irritation and thrombosis, and sloughing 
of tissue due to extravasation of this agent at the site of infusion have 
(21, 22) occurred all too frequently . Studies in which the acidosis 
of individuals acutely exposed to elevated levels of inspired CO2 was 
corrected with tris buffer have shown that because of its rapid short- 
term action, this agent must be administered continuously, preferably 
with the blood pH being monitored. While changes. in blood pH due to 
CO2 are being adequately controlled with tris buffer, sudden and drastic 
changes in the body’s electrolyte balance and a marked hypoglycemia, 
(27, 154) 
even if glucose is given in the infused solution, can occur . 
Electrolyte loss is probably the cause of the prolonged retching, weak- 
(27) ness and somnolence observed after such infusions . Finally, it 
is important to point out that tr is buffer appears to produce a profound 
respiratory depression, apparently due to intracellular hydrogen ion 
buffering in the respiratory centers. Administration of this agent to 
animals and normal individuals who are not exposed to elevated levels 
of inspired C02, to normal individuals who are exposed to elevated 
levels of inspired C02, and to patients suffering from acute CO2 reten- 
tion or uncompensated respiratory acidosis due to lung disease has 
produced concomitant decreases in the arterial oxygen tension (14, 22, 
23, 27, 12’2, 142, 154, 202) 
. This side- effect might also contraindicate 
the use of tris buffer in space, especially in a borderline hypoxic situation. 
From the above discussion, it is apparent that there is at present 
no specific practical measure which might be used to combat the toxic 
effects of CO on an astronaut. 2 Since the acidosis accompanying acute 
CO2 toxicity corrects itself within a few minutes, after even a pro- 
longed acute CO2 exposure, it is important to remember that the admin- 
istration of a buffering agent to an astronaut who has suffered a severe 
exposure would not be effective (216) . More important, however, would 
be to assure him adequate ventilation and to treat the consequence of 
possible associated hypoxia (Chapter 1). Whether various drugs in 
common use might be effective in treating symptoms of CO2 toxicity, 
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such as headache, nausea, and vomiting remains to be determined, 
for a therapeutic attack on symptoms in either the exposure or post- 
exposure period has apparently not been attempted during past ex- 
posures of man to acutely elevated inspired levels of C02. 
Chronic CO2 Toxicity 
The above heading encompasses a possible exposure of an astronaut 
to a toxic partial pressure of C02, this exposure lasting for days to 
weeks and even many months in duration. Two possible causes for 
such an exposure,which can lead to a spectrum of clinical manifesta- 
tions quite different to that of acute CO2 toxicity, are conceivable. 
Firstly, a spacecraft life support system could malfunction for a pro- 
longed period of time, possibly until the completion of a mis sion. 
Secondly, it is considered possible that the upper limit of atmospheric 
CO2 specified for a normally operating spacecraft life support system 
might be too high, the decision for this limit being implied from ground- 
based studies which have been too short in duration to have elicited 
clinical manifestations. As well, it has been stated that a somewhat 
elevated partial pressure of CO2 in space atmospheres would not only 
increase the efficiency of physical, chemical and biotic CO 2 scrubbers 
but, as a consequence, enable reductions of such highly significant 
penalties imposed by a life support system as weight, volume, and 
power (7, 47, 94) . 
As will become readily apparent in the following discussion, the 
maximum allowable levels of CO2 for chronic exposures in space and 
the possible medical problems resulting from chronic exposures above 
these levels will have to be determined from a very few studies in 
which man has been exposed to relatively low CO2 levels for prolonged 
periods of time. In fact, the longest of all such exposures lasted for 
only 6 weeks. Therefore, it will be most important to have a critical 
look at even minor physiological changes which have occurred during 
these exposures, being careful not to assume that the absence of 
clinical manifestations of CO2 toxicity in them would necessarily also 
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hold for longer exposures during prolonged space missions. 
Pathophysiology 
“Operation Hideout”, a study in which 23 normal subjects were 
exposed to 1. 5 percent CO2 in air for a period of 42 days, has yielded 
the greatest amount of data to date on the physiological and possible 
pathological effects on man from a prolonged exposure to a relatively 
low level of C02. Averaged results of this study, which have been 
discussed in numerous publications bv Schaefer and coworkers (18,. 105, 
180, 181, 182, 184, 185, 191, 192, 193) , indicated that no alterations 
in basic physiologic parameters, such as blood pressure, pulse rate, 
weight and temperature, occurred. On the other hand, data on 
respiration, acid-base balance, calcium and inorganic phosphorus 
metabolism, adrenal cortical activity, and cardiovascular capacity 
revealed significant changes, some of which might have important 
clinical implications. Before presenting the data considered pertinent 
to assessing potential harmful effect of 1. 5 percent CO2 on man, it is 
noted that even though most of the changes occurring in this study con- 
tinued throughout the 9 day post-exposure study period, all had essen- 
tially returned to pre- exposur e levels after 4 weeks of breathing air. 
Alterations of blood and urine pH, and urine CO2 clearly indicated 
the existence of a phase of slight uncompensated respiratory acidosis 
for the first 23 days, followed by a phase of compensated respiratory 
acidosis for the remainder of the exposure. In spite of the increase 
in respiratory minute volume in response to 1. 5 percent CO2 during 
these phases, the partial pressure of alveolar CO2 still rose about 
3 mm Hg throughout the exposure and the 9 day post-exposure study 
period. This ventilatory effect was the net result of a progressive 
increase in tidal volume and decrease in respiratory rate during exposure, 
with a further drop in respiratory rate and slight rise in alveolar CO2 
occurring when air was again breathed. A diminished respiratory res- 
ponsiveness to 5 percent CO2 was demonstrated when the acidosis 
was compensated, presumably due to the increase of the buffering 
capacity of the body secondary to the breathing of C02. Whether such 
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an alteration in buffering capacity would significantly alter an astro- 
naut’s clinical response to an acute CO2 exposure cannot be determined 
from this data. 
Possibly relevant to assessing whether or not 1. 5 percent CO2 
can be significantly toxic for man was the finding that all respiratory 
dead spaces,and both arterial alveolar CO2 and oxygen gradients were 
elevated during the exposure, especially in the uncompensated phase 
of respiratory acidosis and during the 9 day post-exposure study period. 
Although it was pointed out that such dead space and gradient changes 
might be explained on the basis of the increased tidal volume, possible 
airway dilatation and possible altered pulmonary perfusion from breath- 
ing C02, the thought that actual physicochemical and even pathologic 
changes in the subjects ’ lungs might have contributed was also entertained 
(191). Microscopic studies of the lungs of animals chronically exposed 
to low ambient CO2 levels have found evidence suggesting that such an 
exposure alters production of pulmonary surfactant, and leads to atelectasis, 
hyaline membrane formation and perivascular edema 
(12, 133, 153, 187) 
. 
Because these harmful effects of CO2 on animals’ lungs were apparently 
seen only during the uncompensated phase of respiratory acidosis, they 
were attributed to the acidosis rather than to a direct action of C02. 
Whether such effects could occur to a significant degree in man, possibly 
increasing the susceptibility of his lungs to secondary infection, to 
damage by elevated partial pressures of oxygen, or to atelectasis in 
pure oxygen atmospheres remains to be determined. 
Blood and urine pH, and total pulmonary and urinary CO2 excretion 
were reduced below control values during the 23 day period of uncompensated 
respiratory acidosis. During the phase of compensated respiratory 
acidosis, the blood pH returned to control values, whereas the urinary 
and pulmonary CO2 excretion and the urine pH were elevated above 
contr 01 value s . Aft-er transition to air, CO2 stored by the body during 
the exposure appeared to be almost entirely eliminated in 9 days. In 
the post-exposure period, the increased pulmonary CO2 excretion peaked 
on the first and eighth days and the increased urinary CO2 excretion, 
paralleled by the elevated urine pH, peaked on the second day. Accordingly, 
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it was suggested that this release of CO occurred at different rates 
from three different body CO2 stores 
(185, 192). 
Studies of calcium and inorganic phosphorus metabolism brought 
to light the mechanisms apparently responsible for the pH and CO2 
changes noted above. The venous plasma ionized calcium paralleled 
the changes in blood pH, showing a decrease during the first 23 days 
of exposure, a return to normal levels during the latter part of the 
exposure, and a rise above control values during the 9 day post- 
exposure study period. This suggested that the long time period for 
CO2 retention, or the phase of uncompensated respiratory acidosis, 
was related to the slow equilibration of the bone CO2 store with the 
elevated blood C02. Furthermore, a blood calcium tide, commensurate 
with the highest peak in pulmonary CO2 excretion and ‘an increased 
urinary calcium excretion, occurred 8 days after ceasing the exposure 
to co2. This seemed to indicate that at this time, the bones released 
much of their previously stored C02. The plasma inorganic phosphorus 
was elevated throughout the exposure period, and apparently up to 4 weeks 
post-exposure. The urinary inorganic phosphorus excretion increased 
markedly during the phase of uncompensated respiratory acidosis and, 
except for a transient sudden fall 8 days post-exposure, remained 
so for the rest of the exposure and post-exposure study periods. 
In the detailed discussion of urinary calculus formation in Chapter 
9, it was pointed out that increased urine pH and calcium levels, 
especially if occurring together, are factors conducive to urinary 
calculus formation. Since the urine pH was elevated above control 
values during the phase of compensated respiratory acidosis, and both 
the urine pH and calcium were elevated above control values in the 9 day 
post-exposure study period, it is conceivable that a chronic exposure to 
CO2 could be associated with a risk of a calculus forming and growing 
in the urinary tract. If so, repeated chronic exposures would increase 
the likelihood of a calculus reaching such a size as to cause symptoms. 
Evidence which seems to support this hypothesis is found in animal 
experiments in which chronic exposures to relatively low levels of CO2 
resulted in the deposition of calcium in, and associated damage of kidney 
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tissues 
(133, 186, 190, 206). On the other hand, the literature has not 
recorded any increased incidence of urinary tract problems in submarine 
cr.ews who have been repeatedly subjected over several days or weeks to 
ambient CO2 levels which often reached up to 3. 5 percent. In fact, 
the only pathology apparently associated with altered calcium metabolism 
in these crews has been the presence of areas of hypercalcification in 
(164) the fingernails . Even though an epidemiological study may prove 
that there is no significant risk of urinary calculus in individuals 
chronically exposed to CO2 on Earth, it is still considered possible 
that this risk might become significant in space if urine changes due 
to CO2 were combined with those resulting from perhaps even a minor 
degree of bone demineralization due to reduced physical activity and 
weightlessness. 
What might well be a significant effect of CO2 on man is the 
increase in adrenal cortical activity which was found during the 42 days 
of exposure to 1.5 percent CO2 and the 9 day post-exposure study 
period (’ 04). This response, mirrored by an increase in the ketosteroid 
output in the urine and a decrease in the absolute number of circulating 
eo s inophils , was greater during the phase of compensated respiratory 
acidosis and post-exposure study period than early in the phase of 
uncompensated respiratory acidosis. It was also noted that the number 
of complaints showed a trend opposite to changes in adrenal cortical 
activity (’ 07). Accordingly, Schaefer (180) has suggested that independent 
of blood pH changes, an increase of the partial pressure of CO 
2 
in the 
blood might produce a significant “physiologic stress” response. 
This suggestion appears to be supported, not only by identical findings 
as those stated above, but also by histologic evidence of adrenal cortical 
strain in a study in which rats and guinea pigs were exposed to 1. 5 per- 
cent CO2 for 42 days (106) . However, it would appear that the possibility 
“physiologic stress ” due to confinement and handling of the exposed 
animals was not ruled out by having unexposed control animal groups 
in these studies (70) . It is also noted that in human studies, confinement 
per se produces an adrenal cortical response similar to that observed in -m 
“0 P eration Hideout” 
(71) . The importance of having control groups in 
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future animal and human chronic CO2 studies cannot be overemphasized. 
If CO2 is found to produce changes in adrenal function, one wonders 
whether a chronic exposure to a relatively low level of CO2 could 
significantly alter the body’s capacity to handle such superimposed 
stresses as infection, hemorrhage, plasma loss, acute radiation 
effects and severe tissue trauma. This certainly appears to be an 
area requiring investigation. 
Finally, it should be mentioned that the cardiovascular capacity, 
as measured by various tests of cardiovascular function when the sub- 
jects were subjected to various work loads, decreased significantly 
throughout the exposure to 1.5 percent CO2 and during the 9 day 
post-exposure study period. Although the subjects were undoubtedly 
carrying out less physical activity during the period of confinement, 
this reduction of circulatory reserve has been attributed mainly to 
co (185) 
2 - 
Again, the importance of control studies bears re-emphasiz- 
ing . If this level of CO2 does affect cardiovascular function, the question 
arises as to what effect it might have on the performance of various work 
loads. 
Man’s response to 3 percent CO2 has been observed in chronic 
exposures of a much shorter duration than that of “Operation Hideout”. 
Schaefer 
(176, 177) exposed subjects to 3 percent CO2 in air for periods 
of up to 144 hours. He found that the phase of uncompensated respira- 
tory acidosis lasted only 2 to 3 days, indicating that renal mechanisms 
rather than bone CO 
2 stores were primarily responsible for the return 
of blood pH to normal values (185) . Various recorded physiologic 
changes and alterations in subjective complaints and performance to 
be discussed, indicated that the phases of uncompensated and compensated 
respiratory acidosis were associated with respective increases of sym- 
pathetic and parasympathetic nervous system tone. Increased sympathetic 
tone was characterized by significant increases above control values 
of resting pulse rate, neuromuscular excitability, responsiveness of 
the circulatory system to exercise and heat production after a cold load. 
The most undesirable clinical manifestations from breathing 3 percent 
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CO2 appeared during the phase of increased parasympathetic tone, 
which was characterized by significant decreases of these physiologic 
parameters to below control values. Schaefer (179) noted that this phase 
continued for about 5 days into the post-exposure study period and 
could be maintained if subjects .extended their exposure to 3 percent 
co29 but breathed this gas for only 8 hours daily. Finally, he sub- 
stantiated the findings in this study with observations made during 
chronic exposures of submarine crews to CO2 levels in the range of 
3 percent, pointing out that the concomitant lowering of the level of 
oxygen in the submarine atmospheres would not have been sufficient 
enough to have played a significant role in causing the effects noted 
above. 
Another study with 3 percent CO2 has more closely simulated 
possible chronic exposures to CO2 in low pressure, oxygen enriched, 
space atmospheres (47). Eight normal individuals successively 
breathed, for periods of 4 days, atmospheres of air at 700 mm Hg; 
air at 700 mm Hg, containing CO2 at 21 mm Hg; air at about 747 mm Hg; 
oxygen at 200 mm Hg; and oxygen at 200 mm Hg, containing CO2 at 21 
mm Hg. There was no difference in either the ventilatory response to 
CO2 or the increase of the partial pressure of alveolar CO2 produced 
by breathing CO2 at these different ambient atmospheric pressures. 
The respiratory acidosis, as noted by changes in blood pH was essen- 
tially compensated in 3 days in each CO2 exposure period. This blood 
pH change has also been observed in a recent study in which normal 
individuals breathed air at 700 mm Hg, containing CO2 at 21 mm Hg 
for 5 days (80) . Finally, it is noted that these and other recorded 
physiologic parameters studied demonstrated that the partial pressure 
of inspired oxygen being the same, the response of man to CO 
2 in a low 
pressure atmosphere is essentially the same as for an equivalent 
partial pressure of CO2 at an atmospheric pressure near sea level. 
In yet another study at the 3 percent CO2 level, respiratory 
center sensitivity of 2 normal individuals who breathed this level for 
78 hours decreased significantly (36) . This was indicated by an increase 
in the breath-hold break-point, a decrease in the ventilatory response to 
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a CO2 load, and a temporary, further increase in alveolar CO2 on 
breathing air at the end of the exposure. Similar findings have been 
reported elsewhere in this chapter and in the literature (176, 179) . 
As pointed out above, the question as to whether a chronic, compensated 
exposure to CO2 could significantly alter an astronaut’s physiological, 
and hence clinical tolerance to an acute CO2 exposure remains to be 
answered. 
The marked predisposition of patients suffering from emphysema 
and other hypoventilatory states to develop peptic ulceration has been 
well documented (87, 11% 1% 16% 1% 203) One wonders, there- . 
fore, whether an astronaut who is chronically exposed to an elevated 
level of inspired CO2 might also be predisposed to develop such a 
serious manifestation. 
There is considerable empirical evidence suggesting that the 
mechanism responsible for the increased gastric acid secretion seen 
in emphysematous patients involves CO2 retention, but this mechanism 
remains undefined (151) Browne and Vineberg (30) . noted that acid 
secretion from a total gastric pouch in dogs varied directly with 
blood bicarbonate level and was independent of alterations in blood pH. 
This finding was subsequently duplicated in man by Apperly and Crabtree (2) , 
who altered blood bicarbonate and chloride in normal fasting subjects. 
Browne and Vineberg also showed that gastric hypersecretion produced 
by vagal stimulation was inhibited by hyperventilation and restored by 
raising the CO2 level of the inspired air. Davenport (48, 49) discovered 
that the administration of CO2 in air to various animal species is asso- 
ciated with an increase of carbonic anhydrase activity in parietal cells, 
and hence an increase in gastric acid secretion. Newman and coworkers (151) 
have demonstrated in animal experiments that an intact vagus is required 
for CO2 to have this effect. By altering the inspired oxygen and CO2 
tensions in man, Tenney and Naitove (213) have reported findings 
suggesting that the level of gastric acid secretion is directly related to 
the alveolar CO2 tension and that for any given CO2 tension, secretion 
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is inversely related to the oxygen tension. 
Although the above experiments lend strong support for CO2 
retention with associated hypoxia being the major etiologic factor 
involved in peptic ulceration in patients with emphysema and other 
hypoventilatory states, it must be noted that there is evidence that 
the “stress” of disease can markedly increase adrenal cortical activity 
in these patients 
(86, 151) . The possibility that CO2 per se stimulates -- 
the adrenal cortex has been mentioned previously in this chapter. The 
fact that adrenal cortical hormones can increase both gastric acid and 
pepsin secretion, and so promote the formation of peptic ulceration, 
is well known (86) . Accordingly, it is likely that both CO 2 retention 
with hypoxia and increased adrenal cortical activity are to some degree 
responsible for producing ulceration in these patients. 
It is readily apparent, therefore, that one cannot state whether 
the chronic exposure of an astronaut to an elevated level of inspired 
CO2 will significantly increase the probability of his suffering from a 
peptic ulcer in space. Although an epidemiologic study has never been 
undertaken, peptic ulceration does not appear to have been a problem 
of World War II submarine crews who were exposed for weeks at a time 
to ambient CO2 levels of up to 3. 5 percent (186) . As far as the space 
situation is concerned, one would certainly have to take into account 
the ulcerogenic effects not only of CO2 retention but also of the “stresses” 
of space flight. This appears to be an area requiring further study. 
In conclusion, this discussion of the pathophysiology of chronic CO2 
toxicity has indicated that even though the body adapts physiologically 
to an elevated level of inspired C02, undesirable physiologic and 
possible pathologic changes in the body, either from direct effect of 
CO2 or secondary to adaptive processes, could occur if an astronaut 
should be chronically exposed to a relatively low level of increased CO2 
tension. Unfortunately, most of the undesirable changes mentioned 
here had to be predicted from information obtained in very few studies 
in which man and animals have been chronically exposed to CO2 levels 
of only 1.5 to 3 percent. It is readily apparent that data on more prolonged 
402 
exposures to other low levels of C02, while simulating as closely as 
possible the conditions under which the astronaut could be exposed to 
CO2 in space, are greatly needed. 
Finally, as far as simulating the chronic exposure of man to CO2 
by animal experimentation is concerned, it is considered important to 
note here that there can be marked species differences in CO2 tolerance. 
This has been particularly well demonstrated by a primate experiment 
in which monkeys (Macaca mulatta), exposed to 3 percent CO2 in air’ 
for 93 days, exhibited no demonstrable changes in any of the numerous 
physiologic parameters studied (208) . 
Clinical Manifestations 
No signs or symptoms which could be attributed directly to CO2 
appeared during or after the 42 day exposure of 21 normal individuals 
to 1. 5 percent CO2 (“Operation Hideout”) 
(62, 180) 
. This CO2 level 
did not alter the performance of a number of tests of psychomotor 
function. 
In contrast, chronic exposures to 3 percent CO2 have usually 
produced a characteristic clinical picture. Various investigators 
have reported that for the first day breathing 3 percent C02, experi- 
mental subjects and submarine crews have manifested signs and symptoms 
of mild ner.vous system hyperactivity, such as increased motor activity, 
a feeling of excitement, euphoria, mental keenness and sleeplessness (9, 
36, 166, 176, 183) 
. During the second day, they often complained of 
headache. Of a greater significance, however, is a state of nervous 
system depression which set in at this time. This was characterized 
by a feeling of mental depression and cloudiness, the belief that memory 
and attentiveness were decreased, somnolence, mood alterations, and 
deer eased appetite. Although this state improved somewhat after the 
third day of exposure, subjects never returned to normal during 
exposure. The somnolence has reportedly disappeared after 2 weeks 
exposure during submarine operations, but beyond this time, unexplained 
irrational ideas and bizarre behavior have usually appeared (183) The . 
transition to air has often induced a temporary headache; it has taken 
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4 to 6 days until subjects felt completely well again. Results of psy- 
chomotor tests have improved during the first day of exposure to 3 
percent C02, but thereafter and for several days into the post- 
exposure period, have indicated a significant impairment in perfor- 
mance 
(177, 180) 
. Finally, it is considered important to mention that 
most individuals were aware of increased breathing at the 3 percent 
CO2 level, particularly when performing light physical work or when 
fatigued. This symptom reportedly disappears after 2 to 3 days of 
(47) exposure . It has not been stated as to whether or not man’s 
capacity to do physical work which, as mentioned previously, would 
probably be initially limited at this CO2 level, also improves at this 
time. From a space operational standpoint, it would also be impor- 
tant to know what effect this level of CO2 has on fatigability and on 
recovery after strenous activity. 
Again it is important to note that the studies cited above have never 
definitely ruled out the contribution of confinement to the production of 
signs and symptoms attributed to CO2 toxicity. A recent, comprehen- 
sive review of confinement by Fraser (71) cites many confinement studies 
which were characterized by clinical manifestations identical to and occur- 
ring often in the same time sequence after individuals were confined as 
those reported from chronic exposure to COZ. 
Diagnosis 
The diagnostic features mentioned previously under “Acute CO2 
Toxicity” also apply here. In addition, monitoring the effectiveness of 
urine pH control measures for the prevention of urinary calculus with 
an appropriate pH indicator might be desirable during and for some time 
after a chronic exposure to CO2 (Chapter 9). 
Prevention 
Again, as in managing acute CO2 toxicity, the only measure which 
can be used to keep an astronaut from suffering from a chronic exposure 
to an elevated partial pressure of CO2 is to maintain the CO2 in his 
inspired air below a recommended maximum allowable level. This can 
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be accomplished by methods described under “Acute CO2 Toxicity”. 
Even though almost all studies in the area of chronic CO2 toxicity 
have been carried out at .the 1. 5 and 3.0 percent CO2 levels, man’s 
pathophysiologic and clinical responses to these levels appear to fit 
a pattern which, although still requiring a great deal of substantiating 
data, is considered quite appropriate for use in determining the maxi- 
mum allowable “chronic II CO levels for space atmospheres. Schaefer (180) 2 
has described this pattern as consisting of 3 response zones, divided, by 
limits of tolerance to C02. In the first zone, thought to be about 3 per- 
cent CO 2 and above, 
a chronic exposure to CO2 soon results in a variety 
of undesirable clinical manifestations, including performance deterioration 
and alterations in physiologic functions which can lead to pathologic 
changes. In the second zone, which presumably encompasses from about 
0.8 percent to less than 3 percent C02, chronic exposure to CO2 only 
results in slow adaptive processes in electrolyte exchange and acid 
base balance, and mild adrenal stress, which might predispose to 
pathophysiologic states, depending on the CO2 level and duration of 
exposure. In the third zone, assumedly under 0. 5 to 0.8 percent C02, 
chronic exposure to CO2 apparently has no effect on man. Therefore, 
taking into account this concept in the light of previous discussion of 
the probable and possible effects of chronic exposures to relatively 
low levels of CO2 on man, one can justifiably recommend that: 
-the CO2 level in the spacecraft cabin should 
never exceed one percent, or a partial pressure 
of 7. 5 mm Hg., for exposures lasting more than 
a day in duration. In stating this level, it is 
assumed that the astronaut will still respond to 
co2. However, it is thought that adaptive pro- 
cesses and adrenal stress will be insignificant at 
this level. Measures may have to be taken to 
minimize the risk of urinary calculus at this level 
(Chapter 9). 
- spacecraft environmental control systems should 
be designed to maintain the CO2 level below 0. 5 
percent, or a partial pressure of 3.8 mm Hg. 
Treatment 
The treatment of the clinical manifestations resulting from a chronic 
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exposure to an elevated inspired CO 2 level has not been djscussed in 
the literature. As was discussed under “Acute CO2 Toxicity”, there 
are at the present time no practical specific therapeutic measures 
for treatment of the C02-induced acidosis in space. A suitable oral 
analgesic, such as propoxyphene, might alleviate the headache which 
can manifest initially on exposure to C02. Successful use might be 
made of an orally administered tranquilizing agent, such as reserpine 
or chlorpromazine, which might control the alterations in sympatho- 
adrenal activity that apparently cause the.sleeplessness and excitement 
in the early stages of CO2 toxicity. It is also possible that an oral 
central nervous system stimulant, such as dextroamphetamine or 
methylphenidate, might combat the state of depression which can 
apparently occur after compensation to C02. An amphetamine might 
also be proven successful for decreasing the fatigability associated with 
CO2 exposure. 
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CHAPTER 16 
GENERAL ASPECTS OF MEDICAL MANAGEMENT 
This chapter focuses on the general aspects of the manageme.nt in 
space of medical problems arising from hazards of space operations. 
Firstly, attention is directed towards the diagnostic techniques and 
therapeutic measures indicated in this report. These measures are tabu- 
lated and various factors considered pertinent to their selection and possible 
development for use in space are noted. Secondly, thought is given to the 
level of medical competence required for carrying out optimum management 
of medical problems in space. 
Diagnostic Techniques and Therapeutic Measures 
The diagnostic techniques which have been suggested in this report 
are listed in Table 16. 1. Although many more could have been mentioned, 
it is apparent that the diagnosis of most of the medical problems discussed 
can be made on the basis of a detailed history and a thorough physical 
examination. The techniques derive from traditionally accepted methods of 
examination applied to diagnosis of medical problems in space. It is 
interesting to point out that the sophisticated diagnostic techniques requiring 
advanced hardware development, such as blood hemoglobin and hematocrit 
determinations, and electrolyte microscopic and x-ray studies, are those 
that would appear to be more and more indicated as crew size, and mission 
distance, duration, and complexity increase6 
Throughout this report, serum electrolyte studies, other than the 
measurement of serum sodium, were not specifically defined. While it is 
not appropriate to enlarge on the specific requirements for electrolyte 
determinations at this time, it is apparent that knowing the serum chloride 
and potassium concentrations can also be valuable for assessing the need 
for intravenous fluid and electrolyte replacement. 
Many of the diagnostic instruments used on Earth may require only 
minor modifications for use in space. A few will, however, require 
development and extensive testing in Earth and orbiting space laboratories 
before they will become part of medical facilities on spacecraft. Such 
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Blood Hemoglobin Determination 
Blood Pressure Determinations 
Systemic arterial 
Peripheral venous 
Body Temperature Determinations 
Oral 
Rectal 
Electrocardiography 
Electroencephalography 
Electrolyte Studies 
Serum sodium concentration 
Urine sodium concentration 
Fluorescein Staining of Eye 
Hematocrit Determination 
Indirect Laryngoscopy 
Microscopic Studies 
Blood-total while cell count, differential 
white blood cell count 
Urine 
Ophthalmoscopy 
otoscopy 
pH Urine 
Rhinoscopy 
X-ray Studies 
Table 16. 1 Diagnostic Techniques. 
diagnostic hardware must be designed with their weight, power, and volume 
penalties being kept in mind, for these factors may play a great role in 
determining whether a particular diagnostic measure will or will not 
be carried into space. The development of microtechniques for body fluid 
studies, and multiple measurement diagnostic systems is therefore con- 
sidered mandatory. It is again important to point out that associated 
particle and droplet hazards must be considered before any chemical 
analytical system can be placed on a spacecraft, especially if such a 
system might require servicing in space. 
The diagnosis of medical problems rn space will probably always 
receive ground-based support. The member of the space crew who is res- 
ponsible for the management of such problems should have the means available 
for immediate consultation, if possible by both audio and visual communication, 
with medical monitors and other specialized members of the medical community. 
He should also be able to telemeter diagnostic information, such as electro- 
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cardiographic, electroencephalographic, and x-ray data to Earth for pur- 
poses of still more expert analysis and interpretation. 
The definitive and supportive therapeutic measures indicated %n this 
r report are presented rn Table 16. 2. This is, of course, an idealized list. 
It is conceivable that all of these measures might be possible to carry 
out on spacecraft in the future. However, the actual need for each 
measure must be determtned rn the light of its probability of use in space, 
its weight, power and volume constraints, and the necessity of having 
the skills a physician-astronaut to accomplish the measure. 
The manner of carrying out therapeutic measures in space will, in 
general, be no different from that on Earth. Some will, however, require 
adaptation for use in the weightless environment. The potential use of 
topical solutions in space should be kept to a minimum, with techniques 
for their administration being developed with their associated droplet 
hazards in mind. Topical ointments can be applied directly. Syringes 
and systems for administering intravenous fluids must be designed to 
prevent gas bubbles from entering them. Intravenous fluids cannot be 
admmistered in space by the gravity drip technique. Hence it will be 
necessary to develop a system in which pressure is applied to the fluid 
in such a manner that fluid flow can be both controlled and measured. 
Various methods of irrigation in the weightless environment were suggested 
in Chapter 8. The importance of eliminating droplet hazards associated 
with such methods is again emphasized. For sterile surgical procedures, 
wounds might be draped off with a circumferentially-applied or adherent 
sterile material. Undesirable movement of surgical instruments might be 
reduced with magnetic or Velcro contacts. Sutures might be held down by 
passrng them through small loops in the draping or by attaching them to 
sterile clamps on the draping. 
Devices and instruments used for carrying out therapeutic measures 
in space must be carefully selected not only for their versatility and 
flexibility, but for their minimum weight and volume penalties. With 
appropriate attachments, the tubing for the administration of intrave.nous 
fluids might also be used for nasogastric intubation and urinary bladder 
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Airway Maintenance 
Oral 
Endotracheal 
Tracheostomy 
Cricothyroid membrane puncture 
Aspiration Procedures 
Aspiration of hematoma 
Thoracentesie 
Pericardiocenteeis 
Paracentesie of tympanic membrane 
Blood Transfer Between Astronauts 
Cold Application 
Drug Administration 
Oral 
Topical 
Local and regional 
Systemic (intramuscular and intravenous) 
Eye Patching 
Foreign Body Removal from Eye, Nose and Larynx 
Heat Application 
Hyperbaric Recompression 
Hypothermia Induction 
Immobilization of Body Part 
Temporary 
Indefinite duration 
Intravenous Fluid Administration 
Irrigation of Skin, Eye, and Upper Respiratory Tract 
Laparotomy 
Myringotomy 
Naeogaatric Intubation for Aspiration and Feeding 
Oxygen Administration 
Ambient pressure 
Intermittent positive pressure 
Pinch Grafting 
Politzerization 
Suction 
Upper gastrointestinal tract 
Respiratory tract 
Tr ephining 
Urinary Bladder Catheterization 
Repeated 
Indwelling 
Wound Management 
Antiseptic preparation 
Debridement 
Blood ves se1 ligature 
Wound closure 
Dressing 
Table 16. 2 Definitive and Supportive Therapeutic Measures. 
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catheterization. Intrave,nous solutions should be constituted in space 
by adding necessary electrolytes and nutritives to sterile water stored 
in containers from which these solutions can be administered. This 
would greatly reduce the volume of fluid stored for intravenous use 
on spacecraft. The water would be available for irrigation procedures 
and non-therapeutic purposes. Finally, as was pointed out throughout 
the report, systems and materials on spacecraft primarily for other 
purposes might also be utilized for the treatment of medical problems. 
An air lock might be used for hyperbaric recompression, and a liquid 
cooled garment for inducing hypothermia. A splint might be fashioned 
from a spacecraft repair material. 
The types and modes of administration of drugs which appeared to 
be most definitely indicated for treating the medical problems discussed 
in this report are recorded in Table 16. 3. It is noted that most of the 
examples given are the preference of the author and therefore cannot be 
recommended for use in space until endorsed by the aeromedical 
community. An intensive “space- oriented” pharmacologic review is 
indicated. 
It is readily apparent that the types of drugs listed generally satisfy 
the drug requireme,nts for all medical problems in space, not only those 
described in this report, but also those due to naturally-occurring diseases. 
To this list will probably be added drugs for managing psychiatric problems 
and for controlling motion sickness, and others which might be proven 
potentially useful for treating medical problems in space through ground- 
based research and clinical usage. 
Certain factors should be kept in mind when selecting drugs for use 
in space. They should be chosen on the bases of both single and multiple 
usefulness. This is well demonstrated by the fact that the sedative, 
phenobarbital, also has anticonvulsant activity, and the shivering 
suppressant, chlorpromazine, is also a potent tranquilizer. Undesirable 
side effects which could diminish an astronaut’s functional capabilities 
will als,o determine selection. Drug preparations should be developed for 
administration by as many modes as might be indicated. Astronaut response 
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Types of Drugs 
Analgesic 
Anesthetic, 
eye 
larynx and throat 
skin 
nerve block 
Antibacterial 
antiseptic, skin and 
wound 
bacteriostatic, eye 
bacteriostatic. skin 
bacteriostatic, urinary 
antibiotic, eye 
antibiotic- steroid, eye 
broad spectrum anti- 
biotic 
Anticonvulsant 
Antidiarrheal 
Antiemetic 
anti-radiation sickness 
Antitussive 
Bland Ointment 
Bronchodilator 
Modes of 
Administration 
oral and systemic 
$9 
topical 
topical 
topical 
local and regional 
topical 
topical 
topical 
oral 
topical 
topical 
oral and systemic 
oral and systemic 
oral 
oral and systemic 
oral 
topical 
nebulized 
systemic 
Exampkes given in 
Report Chapters 
meperidine, morphine, 
propoxyphene 
most 
“Ophthaine” 8 
cocaine, xylocaine 8 
cinchocaine 13 
lidocaine 7, 14 
hexachloraphene 
sulfacetamide 
mafenide 
sulfadimethoxine 
chloramphenicol, 
“Neo spor in” 
“Neodeltacortef” 
“Neodec’adron” 
7, 13, 14 
: 
9: 
13 
13 
8 
8 
penicillin, chloromyetin 
tetracycline 
phenobarbital, chlorpor. 
mazine 
most 
1 
methscopolamine, 
diphenoxylate 11 
triethylperazine 
dihydrocodeinone 
petrolatum jelly 
isoproterenol 
aminophylline 
continued on the next p 
11 
3, 8. 12 
11 
8, 13 
8, 13 
Se) ::: 
Examples were usually not given for analgesic, broad spectrum antibiotic and sedative drugs. 
::: ::: 
Both intramuscular and intravenous routes of administration. 
Table 16. 3 Types and Modes of Administration of Drugs. 
to drugs should be tested before space missions,- not only to identify 
idiosyncrasies necessitating selection of alternate drugs, but also to determine 
optimum dosage levels. Certain anti-bacterial drugs might be indicated 
after determining, in the pre-mission period, the drug sensitivities of skin, 
respiratory tract and intestinal pathogens which might cause primary or 
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Type of Drugs 
Carbonic Anhydr as e 
Inhibitor 
Cardiac Glycoside 
Central Nervous System 
Stimulant 
Corticosteroid 
(Steroid) 
Dehydrating Agent 
(Osmotic Diuretic) 
Hemostatic 
Miotic 
Mydr iatic 
Sedative 
Shivering Suppr e s sant 
Sympathetic Blocking 
Agent 
Tranquilizing Agent 
Vasoconstrictor 
decongestant 
vasopressor 
Vasodilator 
Modes of 
Administration 
Exampies given in 
Report Chapters 
oral 
oral and systemic 
oral 
topical and nebulized 
oral 
systemic 
intravenous 
topical 
topical 
topical 
oral and systemic 
systemic 
oral and systemic 
oral 
topic al 
oral 
systemic 
oral and systemic 
acetazolamide 8 
digoxin most 
dextroamphetamine, 
methylphenidate 15 
hydrocortieone, 
dexamethazone 8, 13 
methylprednisolone 8 
hydrocortisone 3.8 12,13 
mannitol 1.2.4.6 
8.13. 14 
“Oxycel”, gelfoam, 8, 13 
topical thrombin 
pilocarpine 8 
homatropine, atropine 8 
phenobarbital most 
chlorpromazine 1.4.6 
tetraethylammonium 
compound 7. 9 
chlorpromazine, reserpine 1, 15 
epinephrine 5 
pseudoephedrine 5 
metar amino1 most 
papaverine, 9, 12 
sodium nitrite 
isoproterenol 
Table 16. 3 (contrnued) Types and Modes of Administration of Drugs. 
secondary infections in space. 
The intravenous fluids mentioned in this report are listed in Table 16.4. 
Although administration of all these fluids in space appears to be technically 
feasible fn the foreseeable future, the potential requirement for blood 
formed element concentrates will depend on future assessments of space 
radiation hazards. As well, the requirement for mannitol will depend on its 
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I 
- .- 
Isotonic Saline 
Glucose in Water 
Ringer’s Lactate Solution 
Bicarbonate Solution 
Calcium Gluconate Solution 
Supplemental Potassium Solution 
Plasma-expanding Agent (-, dextran. blood plasma) 
Fresh Whole Blood 
Carried into space 
Transferred between compatible astronauts 
Blood Formed Element Concentrates (e. 
9’ 
red ,blood 
cells, white blood cells, p atelets, bone marrow) 
Mannitol Solution 
Table 16.4 Intravenous Fluids. 
established usefulness in treating the various medical problems discussed 
in this report. As was pointed out elsewhere, the current state-of-the-art 
in the prolonged storage and easy reconstitution of blood indicates that 
whole blood and blood cell transfusions will be possible in space in the 
foreseeable future. The astronauts who have blood compatibilities with 
their fellows should be determined so that blood from on-board sources 
may be used, and appropriate equipment included. 
Medical Competence 
The question arises as to what level of medical competence is indicated 
for carrying out optimum management of medical problems in space. It 
is readily apparent that an astronaut who is trained to diagnose and treat 
common anticipated medical problems would at best be a poor substitute 
for a physician-astronaut who has acquired a high degree of clinical judgment 
and technical skill over many years of academic training and continuing 
work in the field of Clinical Medicine. 
Whether or not a physician-astronaut is on spacecraft in the future, 
it is considered mandatory to train one or more crew members, who will 
be least exposed to the hazards of space operation, in the basics of medical 
management in space. This training might be essentially similar to that 
of a hospital corpsman. It must be realiz’ed, however, that risks of 
inadequate management and complications of treatme.nt will be greater in 
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the hands of these astronauts than in the hands of physician-astronauts. 
Several factors will-determine whether a physician-astronaut will 
or will not be required on a mission. Some factors are the mission 
distance, duration and complexity, the crew size, the magnitudes of 
hazards associated with the mission, the medical facilities that can be 
taken into space, and the requirement for intensive direct physiologic 
monitoring during the mission. It is thought that a physician-astronaut 
will be carried on all long missions and on missions, the duration of which 
is a significant increment over prior missions. 
This report indicates that a physician-astronaut will acquire necessary 
clinical judgment and technical skill through advanced training and experience 
in both surgery and aerospace medicine. It is of absolute necessity that 
he also be a keen monitor of physiologic functioning. 
Finally, the physician-astronaut must also be trained to perform 
duties which will make him a continuously useful member of the space crew. 
Some possible duties include managing life support systems, evaluating 
work-rest and dietary schedules, carrying out specific biologic and 
medical research, and making observations in all aspects of the life 
sciences. 
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“The aeronautical and space activities of the United States shall be 
conducted so as io contribute . . . to the expansion of human knowl- 
edge of phenomena in the atmosphere and space. The Administration 
shall provide for the widest practicable and appropriate dissemination 
of information concerning its activities and the results thereof.” 
-NATIONAL AERONAUTKS AND SPACE ACT OF 1958 
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‘TECHNICAL REPORTS: Scientific and technical information considered 
important, complete, and a lasting contribution to existing knowledge. 
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language considered to merit NASA distribution in English. 
SPECIAL PUBLICATIONS: Information derived from or of value to NASA 
activities. Publications include conference proceedings, monographs, data 
compilations, handbooks, sourcebooks, and special bibliographies. 
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